data_2aw0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2aw0 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.5 p . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 121.036 0.446 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -128.47 173.15 10.48 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.799 1.639 . . . . 0.0 108.446 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -137.86 141.07 40.73 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.901 0.88 . . . . 0.0 108.998 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -130.71 135.8 48.16 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 124.376 1.07 . . . . 0.0 109.68 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.8 t -101.05 107.14 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 172.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.2 mt -99.85 121.52 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -75.79 125.7 29.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 57.8 mt -123.36 98.75 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -174.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -99.73 152.57 19.94 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.49 16.83 48.01 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.54 1.067 . . . . 0.0 112.323 -173.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 97.7 mtp -79.86 110.06 14.87 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.3 t -84.58 -37.93 20.56 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.286 0.635 . . . . 0.0 111.776 -173.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.2 p -158.48 179.72 8.87 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.119 0.568 . . . . 0.0 109.884 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -69.09 -13.33 62.37 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -173.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.7 p -59.83 -36.71 77.38 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.074 0.852 . . . . 0.0 110.12 170.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -59.56 -51.73 68.59 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.38 0.672 . . . . 0.0 109.608 174.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.2 t -52.17 -55.4 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.672 0.789 . . . . 0.0 110.234 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -57.61 -52.48 65.24 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.523 1.129 . . . . 0.0 111.647 -177.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.8 p -61.14 -48.95 79.24 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.694 0.398 . . . . 0.0 111.132 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 88.2 mt -59.19 -54.92 27.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.896 0.878 . . . . 0.0 110.233 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -62.21 -37.71 86.4 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.633 0.651 . . . . 0.0 111.194 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.41 -53.99 40.59 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.829 0.728 . . . . 0.0 111.294 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.22 -54.12 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.642 0.777 . . . . 0.0 110.431 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.4 mt -63.2 -39.86 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 122.891 0.476 . . . . 0.0 111.797 -172.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.6 p -55.96 -24.71 39.98 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -89.49 -9.28 50.61 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.076 0.951 . . . . 0.0 112.184 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -70.35 141.52 88.53 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 118.897 0.771 . . . . 0.0 109.693 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.4 132.55 29.65 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.859 2.373 . . . . 0.0 109.842 -177.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.21 -26.82 22.82 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 118.7 -1.055 . . . . 0.0 112.83 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.0 t -68.27 138.66 22.09 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 118.428 1.114 . . . . 0.0 110.149 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -119.95 -102.6 0.41 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.55 1.14 . . . . 0.0 108.89 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.8 p -80.2 150.77 30.01 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 118.362 0.528 . . . . 0.0 109.853 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.3 tt -150.12 139.48 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 123.329 0.652 . . . . 0.0 110.256 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -139.01 97.39 3.3 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.173 1.389 . . . . 0.0 108.602 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.8 t -99.17 142.27 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 124.476 1.11 . . . . 0.0 108.631 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.0 t -139.84 131.98 28.06 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.803 0.841 . . . . 0.0 110.711 -174.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.8 tp -70.42 -51.57 28.55 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.105 1.362 . . . . 0.0 109.112 169.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.39 -47.16 76.27 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.112 1.365 . . . . 0.0 111.889 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -89.3 -7.78 54.67 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.046 0.538 . . . . 0.0 111.236 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.0 m 54.11 56.55 6.89 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.391 1.477 . . . . 0.0 110.932 174.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -161.31 172.83 15.93 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.632 0.373 . . . . 0.0 111.883 -172.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -137.09 112.8 0.96 Allowed Glycine 0 C--N 1.339 0.727 0 C-N-CA 126.276 1.893 . . . . 0.0 109.29 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.5 m -99.43 103.74 15.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.6 t -116.29 123.95 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 124.285 1.034 . . . . 0.0 109.428 -170.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -89.95 132.36 35.37 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 169.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -150.33 163.24 38.82 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.046 0.539 . . . . 0.0 112.097 -171.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -97.39 115.43 65.74 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.728 1.211 . . . . 0.0 109.932 173.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -47.47 -38.41 27.49 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 125.28 3.987 . . . . 0.0 115.894 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 mp -69.92 -29.87 67.14 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.075 0.398 . . . . 0.0 111.368 -174.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.9 mt -99.72 -31.77 11.38 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.095 0.958 . . . . 0.0 111.932 -173.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.7 t -151.59 171.78 17.08 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.377 0.671 . . . . 0.0 109.822 175.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.3 p -141.79 164.2 35.91 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.229 1.012 . . . . 0.0 110.329 -174.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -53.34 -39.48 81.2 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.274 2.649 . . . . 0.0 112.081 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -67.86 -38.96 83.78 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.781 0.833 . . . . 0.0 111.698 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 m -61.83 -50.27 72.97 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.35 0.523 . . . . 0.0 109.863 175.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 61.7 mt -60.61 -53.0 62.73 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.509 1.123 . . . . 0.0 110.578 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -52.29 -46.58 65.97 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.151 1.38 . . . . 0.0 110.197 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.55 -53.41 38.87 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.788 1.185 . . . . 0.0 111.425 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.63 -44.51 90.03 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 117.672 0.736 . . . . 0.0 111.727 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.8 mt -60.77 -44.53 97.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 122.791 0.436 . . . . 0.0 110.015 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -61.35 -40.03 92.76 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.725 0.81 . . . . 0.0 110.824 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -63.82 -41.14 97.93 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.453 1.101 . . . . 0.0 110.999 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.9 mtp -59.49 -45.76 90.76 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.025 0.375 . . . . 0.0 110.267 173.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.48 63.04 0.14 Allowed Glycine 0 C--N 1.341 0.815 0 C-N-CA 123.552 0.596 . . . . 0.0 111.774 169.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -140.42 158.13 44.47 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 124.057 0.943 . . . . 0.0 109.379 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -76.9 93.44 3.76 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.37 121.13 40.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.76 1.224 . . . . 0.0 109.367 -175.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.6 t -148.45 148.26 30.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.891 0.876 . . . . 0.0 108.85 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.1 mt . . . . . 0 CA--C 1.531 0.235 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -178.394 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.5 p . . . . . 0 CA--C 1.528 0.128 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -141.12 173.24 11.67 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.353 1.461 . . . . 0.0 108.898 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -123.98 141.54 51.96 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.651 1.18 . . . . 0.0 108.559 172.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -130.77 130.77 44.15 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.116 0.966 . . . . 0.0 109.489 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 77.6 t -99.9 104.97 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.2 mt -99.98 126.01 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -75.05 129.71 38.07 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 174.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.9 mt -128.18 90.22 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -99.66 161.11 13.81 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.08 21.14 61.52 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 119.246 -0.752 . . . . 0.0 112.533 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 69.9 mtm -79.85 130.01 34.96 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 118.333 1.067 . . . . 0.0 108.389 170.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.4 m -84.43 -46.25 11.87 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.195 0.598 . . . . 0.0 110.573 -173.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 p -165.38 175.78 8.84 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.328 0.651 . . . . 0.0 110.268 -170.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -52.09 -35.71 48.63 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.907 1.283 . . . . 0.0 113.301 -173.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.1 p -50.28 -41.04 50.01 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.903 0.774 . . . . 0.0 111.64 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.2 m -64.28 -49.11 73.12 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.382 0.673 . . . . 0.0 110.58 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.8 t -51.93 -53.86 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.975 0.91 . . . . 0.0 110.346 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -62.49 -43.22 99.36 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.792 0.837 . . . . 0.0 111.547 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.4 t -59.56 -53.4 58.5 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.012 0.525 . . . . 0.0 110.663 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.8 mt -56.39 -52.44 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.342 1.057 . . . . 0.0 109.576 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -52.82 -55.1 25.5 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.449 1.1 . . . . 0.0 110.531 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.09 -53.66 42.9 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.385 0.993 . . . . 0.0 111.9 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.61 -50.55 78.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.423 0.689 . . . . 0.0 110.975 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 76.7 mt -68.67 -41.07 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.648 -175.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.3 p -55.68 -25.15 38.14 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -89.25 -8.51 53.33 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.134 0.974 . . . . 0.0 112.169 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -70.5 140.75 87.42 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 119.116 0.871 . . . . 0.0 110.532 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.1 128.91 20.54 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.674 2.249 . . . . 0.0 109.181 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.82 -39.27 2.97 Favored Glycine 0 C--N 1.336 0.554 0 CA-C-O 119.073 -0.848 . . . . 0.0 111.557 -175.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.0 t -70.37 137.83 23.18 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 CA-C-N 117.881 0.84 . . . . 0.0 109.419 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -114.24 -98.3 0.44 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.313 1.045 . . . . 0.0 108.186 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 86.7 p -90.27 155.43 18.99 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.953 0.501 . . . . 0.0 110.128 176.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.59 143.05 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.186 0.995 . . . . 0.0 109.859 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.36 105.91 8.2 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.686 1.195 . . . . 0.0 108.653 173.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.6 t -98.06 136.42 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 172.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -139.05 126.94 22.2 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.651 0.78 . . . . 0.0 110.451 -176.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.3 tp -69.68 -45.73 67.66 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.455 1.102 . . . . 0.0 109.857 171.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.73 -47.15 67.56 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.458 1.103 . . . . 0.0 111.497 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -89.38 -12.37 40.56 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.293 0.637 . . . . 0.0 111.797 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.3 m 53.44 58.08 5.55 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 125.317 1.447 . . . . 0.0 110.441 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.9 p-10 -156.39 173.36 17.0 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.991 0.516 . . . . 0.0 111.953 -174.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.45 110.97 0.83 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 126.719 2.104 . . . . 0.0 108.015 174.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.8 m -99.24 101.45 12.77 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.8 t -110.96 125.37 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 124.664 1.186 . . . . 0.0 109.424 -169.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -91.26 127.82 36.85 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 169.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -146.77 167.17 24.51 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.442 0.697 . . . . 0.0 111.86 -169.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -105.64 111.14 64.78 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.155 1.382 . . . . 0.0 109.368 174.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -45.31 -37.27 13.81 Favored 'Trans proline' 0 C--N 1.348 0.552 1 C-N-CA 125.44 4.093 . . . . 0.0 116.248 177.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -70.21 -30.61 67.75 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.173 0.442 . . . . 0.0 111.33 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.3 mt -99.96 -32.38 11.0 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.212 1.005 . . . . 0.0 112.042 -172.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.7 t -149.9 170.59 18.46 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.785 0.834 . . . . 0.0 109.428 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.6 p -137.85 162.25 55.41 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 123.967 0.907 . . . . 0.0 110.643 -176.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -53.05 -39.12 80.73 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.321 2.681 . . . . 0.0 112.043 172.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -68.32 -40.04 81.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.779 0.832 . . . . 0.0 111.482 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.3 m -60.37 -50.35 73.94 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.926 0.49 . . . . 0.0 109.941 175.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.1 mt -59.51 -50.12 75.13 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.234 1.014 . . . . 0.0 110.511 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -52.5 -48.71 65.81 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.843 1.257 . . . . 0.0 110.627 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.75 -46.47 89.62 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.319 0.962 . . . . 0.0 111.785 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.74 -44.41 96.28 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.117 0.567 . . . . 0.0 111.467 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.44 -45.26 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.082 0.553 . . . . 0.0 110.075 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -59.42 -42.13 91.14 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.731 0.813 . . . . 0.0 110.696 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -62.44 -44.52 96.23 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.742 0.817 . . . . 0.0 111.217 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.9 mtm -59.91 -36.47 77.04 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.657 0.383 . . . . 0.0 110.898 174.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.0 59.91 0.34 Allowed Glycine 0 C--N 1.341 0.811 0 C-N-CA 123.758 0.694 . . . . 0.0 111.996 169.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -140.38 158.64 43.71 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.898 0.879 . . . . 0.0 109.379 173.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -75.77 94.32 3.27 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.5 112.08 24.34 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.967 1.307 . . . . 0.0 110.084 -172.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.9 p -142.56 133.05 25.07 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.575 0.75 . . . . 0.0 109.757 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.5 mt . . . . . 0 CA--C 1.532 0.288 0 C-N-CA 123.455 0.702 . . . . 0.0 110.85 -179.767 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.9 p . . . . . 0 CA--C 1.53 0.184 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -142.05 171.66 13.75 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.589 1.155 . . . . 0.0 109.238 173.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -139.99 141.69 36.34 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.327 1.051 . . . . 0.0 108.752 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -131.23 138.27 49.27 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.469 1.107 . . . . 0.0 109.81 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.3 t -106.11 100.54 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 174.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.0 mt -99.76 115.21 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -67.01 124.98 24.56 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.4 mt -113.72 100.8 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 106.662 -1.606 . . . . 0.0 106.662 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -99.67 146.37 26.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.698 0.799 . . . . 0.0 109.465 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.84 27.69 31.07 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.226 0.917 . . . . 0.0 112.839 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 73.2 mtm -80.45 135.42 36.14 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.23 1.015 . . . . 0.0 108.93 170.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.7 m -84.22 -48.0 10.23 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.004 0.922 . . . . 0.0 110.201 -174.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 p -161.06 -178.4 6.74 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.48 0.712 . . . . 0.0 109.618 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -61.23 -23.26 65.51 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.614 1.166 . . . . 0.0 113.321 -176.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.3 m -57.61 -37.99 74.19 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.598 0.635 . . . . 0.0 111.266 174.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.4 m -63.85 -51.81 62.96 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -51.85 -49.49 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.521 1.128 . . . . 0.0 110.552 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -57.95 -47.72 82.09 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.431 1.092 . . . . 0.0 110.998 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.7 t -62.22 -52.55 63.33 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.475 0.71 . . . . 0.0 111.188 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.9 mt -54.7 -56.24 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.962 1.305 . . . . 0.0 109.719 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -59.18 -46.77 87.55 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.445 0.698 . . . . 0.0 110.562 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.82 -48.6 50.53 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.932 1.254 . . . . 0.0 112.162 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.18 -62.56 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 117.507 0.653 . . . . 0.0 110.218 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.2 mt -58.82 -39.12 76.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.978 0.911 . . . . 0.0 112.108 -169.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 77.9 p -49.99 -33.84 19.17 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.846 0.859 . . . . 0.0 113.183 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -89.66 -14.89 33.86 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.605 0.762 . . . . 0.0 112.295 -175.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -71.14 143.66 88.81 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 118.689 0.677 . . . . 0.0 110.662 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -63.06 137.39 61.62 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.241 2.627 . . . . 0.0 110.663 -174.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.51 -35.66 4.57 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 119.128 -0.818 . . . . 0.0 111.793 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.0 t -68.45 128.57 32.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 CA-C-N 118.017 0.909 . . . . 0.0 109.847 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -99.68 -103.47 0.23 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.917 1.287 . . . . 0.0 107.854 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.9 p -87.2 154.12 20.97 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.6 0.76 . . . . 0.0 109.519 173.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.7 tt -150.41 135.24 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 123.172 0.589 . . . . 0.0 109.974 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 -134.68 100.82 4.74 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.916 1.287 . . . . 0.0 108.683 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.8 t -98.76 139.12 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.235 1.014 . . . . 0.0 108.637 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.4 t -135.6 132.18 36.78 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 124.445 1.098 . . . . 0.0 110.646 -173.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.7 tp -72.48 -49.45 33.09 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.318 1.047 . . . . 0.0 109.357 173.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.94 -44.82 78.77 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.08 1.352 . . . . 0.0 111.762 -177.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -89.23 -9.68 49.82 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.234 0.613 . . . . 0.0 111.201 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.1 m 54.44 52.42 12.44 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.61 1.564 . . . . 0.0 111.05 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -157.24 170.41 22.53 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.972 0.415 . . . . 0.0 111.838 -173.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.08 113.67 1.69 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 126.561 2.029 . . . . 0.0 108.658 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.3 m -98.77 93.19 5.94 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.8 t -105.63 120.57 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 124.398 1.079 . . . . 0.0 109.009 -171.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -89.78 133.81 34.51 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 169.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -150.25 166.79 28.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.838 0.455 . . . . 0.0 112.145 -169.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -102.78 113.2 66.04 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 125.255 1.422 . . . . 0.0 108.573 172.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -44.35 -36.1 9.05 Favored 'Trans proline' 0 C--N 1.347 0.467 1 C-N-CA 125.49 4.127 . . . . 0.0 115.077 173.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.6 mt -65.36 -36.6 84.49 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.237 0.615 . . . . 0.0 111.768 -177.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.1 mp -99.65 -34.26 10.28 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.956 0.902 . . . . 0.0 111.59 -171.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.3 t -147.82 177.32 9.42 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.457 0.703 . . . . 0.0 109.952 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.9 p -148.39 163.98 23.94 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 124.085 0.954 . . . . 0.0 110.264 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.4 -40.79 77.07 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.398 2.732 . . . . 0.0 112.078 174.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -67.91 -39.41 83.57 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.6 0.76 . . . . 0.0 111.369 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.7 m -61.5 -49.95 74.68 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.898 0.479 . . . . 0.0 110.068 175.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.0 mt -60.2 -48.79 80.22 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.172 0.989 . . . . 0.0 110.633 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -53.27 -50.09 65.56 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.69 1.196 . . . . 0.0 110.23 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.9 -43.21 92.66 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.523 1.059 . . . . 0.0 112.273 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.92 -42.07 98.67 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.344 0.572 . . . . 0.0 111.12 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.4 mt -66.75 -40.4 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.105 0.562 . . . . 0.0 110.389 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -59.01 -43.36 91.53 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.775 0.43 . . . . 0.0 110.78 172.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.39 -44.48 97.07 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.205 0.602 . . . . 0.0 111.03 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.2 mtm -62.29 -33.78 75.3 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.852 0.461 . . . . 0.0 111.26 174.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.3 56.59 0.42 Allowed Glycine 0 C--N 1.341 0.842 0 C-N-CA 123.814 0.721 . . . . 0.0 112.53 169.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -140.41 150.95 44.51 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.665 0.786 . . . . 0.0 109.424 172.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -75.45 98.63 3.96 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.62 128.24 45.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.68 1.192 . . . . 0.0 109.732 -175.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.3 t -150.08 169.34 21.48 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.145 0.978 . . . . 0.0 108.552 175.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 CA--C 1.534 0.332 0 C-N-CA 122.727 0.411 . . . . 0.0 110.183 -178.463 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.6 p . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -126.33 149.9 48.87 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 169.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -119.74 149.04 42.67 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.741 0.816 . . . . 0.0 110.144 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.4 t -145.63 146.93 31.52 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.097 0.959 . . . . 0.0 109.102 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.9 t -113.11 125.61 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 172.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.5 mt -120.33 131.64 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -80.75 122.82 27.62 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 173.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.65 95.79 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -99.29 146.71 25.94 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.442 0.697 . . . . 0.0 109.438 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.1 42.26 7.17 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.12 0.867 . . . . 0.0 112.235 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.1 mtt -79.49 143.47 34.88 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 169.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 64.1 p -84.51 -42.37 15.59 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.597 0.759 . . . . 0.0 110.462 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.4 p -163.63 -179.71 6.6 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.126 0.97 . . . . 0.0 109.24 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -63.04 -24.86 68.11 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.163 0.985 . . . . 0.0 113.164 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m -53.13 -35.03 59.24 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.747 0.703 . . . . 0.0 111.574 174.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.5 m -58.34 -49.0 78.75 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.014 0.526 . . . . 0.0 110.834 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.2 t -50.81 -51.46 20.18 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 C-N-CA 123.773 0.829 . . . . 0.0 109.779 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -57.73 -53.7 55.26 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.928 0.891 . . . . 0.0 110.398 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.5 m -54.98 -46.93 75.15 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.244 0.618 . . . . 0.0 111.801 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 57.1 mt -60.65 -59.22 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 124.078 0.951 . . . . 0.0 109.8 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -60.72 -35.71 77.02 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 118.233 0.469 . . . . 0.0 111.302 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.62 -60.31 9.21 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 124.363 0.982 . . . . 0.0 110.676 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.55 -58.02 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 123.002 0.521 . . . . 0.0 110.139 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.9 mt -60.04 -41.33 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.29 0.636 . . . . 0.0 111.892 -169.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.4 p -54.38 -30.83 53.23 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.727 0.694 . . . . 0.0 112.833 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -89.42 -11.32 43.48 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.529 0.731 . . . . 0.0 112.559 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -68.86 141.31 92.22 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 119.253 0.933 . . . . 0.0 109.752 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.08 131.28 26.48 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.991 2.461 . . . . 0.0 110.083 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.8 -33.24 6.72 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-O 118.711 -1.049 . . . . 0.0 112.181 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.3 t -67.3 139.06 21.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-N 118.256 1.028 . . . . 0.0 110.478 -176.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -121.12 -105.65 0.38 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.317 1.447 . . . . 0.0 108.144 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.0 p -80.03 144.85 32.85 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.652 0.66 . . . . 0.0 110.018 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.29 144.09 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.543 0.737 . . . . 0.0 110.824 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -140.28 131.96 27.28 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.123 1.369 . . . . 0.0 107.728 169.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.9 t -123.97 145.8 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.998 1.319 . . . . 0.0 108.229 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.7 t -139.16 132.82 30.55 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 124.138 0.975 . . . . 0.0 110.776 -173.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.9 tp -74.35 -49.98 20.58 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.72 1.208 . . . . 0.0 109.301 171.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.65 -46.15 67.03 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.732 1.213 . . . . 0.0 111.536 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -89.58 -12.13 40.69 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.427 0.691 . . . . 0.0 111.611 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.6 m 53.13 52.06 14.46 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 125.181 1.393 . . . . 0.0 110.581 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -154.47 172.57 17.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.961 0.504 . . . . 0.0 111.687 -175.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -142.76 116.25 1.01 Allowed Glycine 0 C--N 1.338 0.648 0 C-N-CA 125.644 1.592 . . . . 0.0 109.392 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.5 m -99.55 115.56 29.65 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.4 t -128.23 129.07 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 124.007 0.923 . . . . 0.0 109.755 -170.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -97.87 133.65 42.08 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 168.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -150.47 167.06 28.27 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.332 0.653 . . . . 0.0 111.482 -171.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -101.53 113.88 65.76 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.636 1.174 . . . . 0.0 109.431 173.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -43.37 -39.74 9.3 Favored 'Trans proline' 0 C--N 1.348 0.526 1 C-N-CA 125.603 4.202 . . . . 0.0 115.51 176.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.1 mt -63.98 -34.31 77.7 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.377 0.671 . . . . 0.0 111.81 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.3 mt -102.8 -29.27 11.57 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.912 0.885 . . . . 0.0 112.269 -172.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.8 t -152.55 165.92 33.66 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.415 0.686 . . . . 0.0 109.491 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.0 p -138.75 167.51 19.17 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.592 1.157 . . . . 0.0 110.041 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.35 -38.35 89.0 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.436 2.757 . . . . 0.0 112.181 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -67.08 -38.85 86.47 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.912 0.885 . . . . 0.0 111.508 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.4 m -62.58 -48.75 78.09 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.862 0.465 . . . . 0.0 109.933 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.4 mt -59.0 -53.23 60.8 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.373 1.069 . . . . 0.0 110.302 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 66.0 ttp85 -53.18 -46.02 68.79 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.987 1.315 . . . . 0.0 110.843 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.77 -49.09 77.28 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.489 1.042 . . . . 0.0 111.809 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.07 -46.78 89.28 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 117.385 0.593 . . . . 0.0 111.243 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.0 mt -57.34 -44.16 83.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.653 0.781 . . . . 0.0 110.019 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -61.47 -42.79 99.32 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.812 0.445 . . . . 0.0 110.605 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.14 -39.3 92.13 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.157 0.983 . . . . 0.0 111.926 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 28.8 mtt -55.79 -48.13 75.9 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 118.348 0.522 . . . . 0.0 110.128 173.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.45 58.99 0.13 Allowed Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 174.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -140.08 152.49 46.21 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.384 1.074 . . . . 0.0 108.707 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -72.76 99.98 2.75 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.8 122.29 42.55 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.693 1.197 . . . . 0.0 109.671 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.6 t -150.08 144.19 25.59 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 47.0 mt . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.698 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 43.1 p . . . . . 0 CA--C 1.532 0.251 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -125.63 169.22 12.71 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.913 1.285 . . . . 0.0 109.106 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -131.76 148.21 52.55 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.553 1.141 . . . . 0.0 109.608 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -146.22 148.69 32.76 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.681 1.192 . . . . 0.0 108.972 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.3 t -120.85 128.08 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.6 mt -122.28 126.84 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -67.8 133.05 48.55 Favored 'General case' 0 CA--C 1.526 0.051 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 172.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.5 mt -131.27 88.78 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -99.8 164.19 12.14 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.81 16.7 69.62 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 119.244 -0.753 . . . . 0.0 112.445 -174.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.1 mtm -79.81 124.9 29.04 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.384 1.092 . . . . 0.0 108.389 170.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.1 p -84.53 -40.9 17.06 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.763 0.825 . . . . 0.0 110.934 -175.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.4 p -158.85 -178.39 7.21 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.893 0.377 . . . . 0.0 110.717 -174.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -57.49 -28.35 63.35 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.623 1.569 . . . . 0.0 113.65 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 m -54.82 -41.28 70.46 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.233 0.613 . . . . 0.0 111.142 175.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.4 m -62.51 -51.47 67.31 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 122.864 0.465 . . . . 0.0 110.016 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.4 t -50.51 -56.35 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.96 0.904 . . . . 0.0 110.14 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -59.77 -50.66 72.94 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.463 1.105 . . . . 0.0 111.488 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.2 p -60.99 -50.39 73.6 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.906 0.482 . . . . 0.0 111.47 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.6 mt -57.75 -52.65 55.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.136 0 C-N-CA 123.353 0.661 . . . . 0.0 109.474 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -54.04 -49.62 68.53 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.289 0.636 . . . . 0.0 110.677 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.15 -54.9 33.87 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.3 0.953 . . . . 0.0 112.309 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.22 -55.47 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.392 0.677 . . . . 0.0 110.613 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.2 mm -64.34 -39.03 84.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 123.55 0.74 . . . . 0.0 111.47 -173.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.7 p -55.02 -30.59 59.87 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.972 0.806 . . . . 0.0 112.69 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -89.41 -3.27 58.49 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.99 0.916 . . . . 0.0 112.267 -175.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -73.12 125.5 90.93 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 119.03 0.832 . . . . 0.0 109.006 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -48.53 118.1 3.1 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.746 2.964 . . . . 0.0 112.128 176.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.37 -36.63 3.54 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 124.042 0.829 . . . . 0.0 111.849 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.7 t -72.66 130.55 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-N 117.87 0.835 . . . . 0.0 109.433 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -90.03 -105.09 0.09 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.0 p -90.62 159.02 16.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.055 1.342 . . . . 0.0 109.852 171.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.8 tt -150.42 134.04 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 123.921 0.888 . . . . 0.0 109.245 173.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -118.28 106.69 13.04 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.866 1.266 . . . . 0.0 108.975 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.2 t -95.35 145.25 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.097 0.959 . . . . 0.0 108.419 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -144.59 128.01 16.92 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.624 0.77 . . . . 0.0 110.461 -177.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.4 tp -70.92 -46.33 62.68 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.558 1.143 . . . . 0.0 110.011 172.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.37 -45.36 65.75 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.397 1.079 . . . . 0.0 111.565 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -89.59 -17.01 29.31 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.557 0.743 . . . . 0.0 111.5 178.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m 54.94 57.73 5.38 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.254 1.422 . . . . 0.0 110.117 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -156.21 173.19 17.2 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.274 0.63 . . . . 0.0 111.627 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.08 116.22 1.7 Allowed Glycine 0 C--N 1.338 0.65 0 C-N-CA 126.438 1.971 . . . . 0.0 108.271 174.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.7 m -99.38 102.52 14.14 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.8 t -108.56 131.55 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 124.428 1.091 . . . . 0.0 110.073 -169.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -101.25 130.6 47.41 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 168.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -150.81 174.79 12.67 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -169.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -115.73 110.36 44.49 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.747 1.619 . . . . 0.0 109.384 174.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -41.58 -38.94 4.42 Favored 'Trans proline' 0 C--N 1.349 0.571 1 C-N-CA 125.999 4.466 . . . . 0.0 115.19 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.1 mt -62.44 -30.71 71.44 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.442 0.697 . . . . 0.0 112.174 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.6 mt -109.52 -36.51 5.95 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.437 1.095 . . . . 0.0 112.018 -171.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.2 t -144.58 171.49 14.3 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.914 0.886 . . . . 0.0 109.303 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.6 p -150.3 161.28 31.23 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 123.215 0.606 . . . . 0.0 110.506 -175.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -49.09 -48.74 17.3 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.947 3.098 . . . . 0.0 113.99 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -66.12 -31.94 73.09 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.257 0.623 . . . . 0.0 112.443 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.0 m -68.11 -48.16 66.23 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 44.4 mt -60.5 -48.46 81.66 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.369 1.068 . . . . 0.0 110.174 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -51.5 -48.99 62.72 Favored 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 124.611 1.165 . . . . 0.0 110.224 172.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.79 -47.1 80.88 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.339 0.971 . . . . 0.0 112.15 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.7 84.16 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.411 0.684 . . . . 0.0 111.212 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.7 mt -61.16 -43.41 96.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.3 0.64 . . . . 0.0 110.048 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -60.82 -41.18 95.21 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.594 0.758 . . . . 0.0 110.719 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.86 -40.97 97.22 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.679 0.791 . . . . 0.0 111.185 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.3 mtp -59.52 -40.45 87.16 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.077 0.399 . . . . 0.0 110.635 173.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.12 62.0 0.22 Allowed Glycine 0 C--N 1.342 0.879 0 C-N-CA 123.712 0.672 . . . . 0.0 111.917 169.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -140.5 160.79 39.22 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.814 0.846 . . . . 0.0 110.02 175.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -77.1 89.62 3.61 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.44 115.15 28.61 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.48 1.112 . . . . 0.0 109.734 -173.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 81.2 p -141.17 148.62 40.3 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 124.17 0.988 . . . . 0.0 108.955 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 52.1 mt . . . . . 0 CA--C 1.531 0.232 0 CA-C-N 118.086 0.403 . . . . 0.0 110.748 -178.956 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.0 p . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -146.88 163.53 35.81 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.967 1.307 . . . . 0.0 108.983 169.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -125.32 143.56 50.91 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.344 1.458 . . . . 0.0 108.517 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.2 t -150.12 165.68 32.09 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 122.931 0.493 . . . . 0.0 111.072 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.1 t -130.59 134.81 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 170.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.2 mm -113.63 127.34 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 172.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -85.5 122.4 29.58 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 172.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.1 mt -121.98 97.07 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 125.336 1.454 . . . . 0.0 107.691 -169.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -99.79 154.47 18.3 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.959 0.409 . . . . 0.0 110.017 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.55 11.25 51.71 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.734 1.159 . . . . 0.0 112.152 -171.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 98.2 mtp -79.89 116.33 19.98 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.155 0.978 . . . . 0.0 108.597 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.0 p -84.71 -47.85 10.04 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.701 0.801 . . . . 0.0 111.529 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.8 p -153.98 -179.67 8.08 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.09 0.556 . . . . 0.0 110.512 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -58.28 -25.35 61.69 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.343 1.457 . . . . 0.0 113.523 -177.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 t -55.34 -40.63 71.45 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.102 0.561 . . . . 0.0 110.626 174.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.0 m -63.49 -46.97 83.71 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 122.998 0.519 . . . . 0.0 110.448 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.5 t -52.58 -53.66 19.17 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 123.686 0.794 . . . . 0.0 109.567 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -59.16 -48.06 83.01 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.722 0.809 . . . . 0.0 111.379 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.5 m -60.99 -53.73 53.69 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.396 0.678 . . . . 0.0 111.219 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.2 mt -57.82 -56.27 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 123.885 0.874 . . . . 0.0 109.26 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -55.86 -48.67 75.12 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.17 0.588 . . . . 0.0 110.905 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.94 -55.19 30.4 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.232 0.92 . . . . 0.0 112.034 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.75 -55.98 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 117.371 0.585 . . . . 0.0 110.771 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.2 mm -63.0 -37.32 79.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.504 0.721 . . . . 0.0 111.758 -173.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.1 p -54.29 -34.63 61.31 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.975 0.807 . . . . 0.0 112.414 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -89.53 0.56 56.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.624 0.77 . . . . 0.0 112.709 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -72.55 143.22 84.84 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 119.151 0.887 . . . . 0.0 109.186 175.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.47 128.43 21.29 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.943 2.429 . . . . 0.0 110.252 -175.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.38 -35.62 4.94 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-O 118.789 -1.006 . . . . 0.0 112.292 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.9 t -66.65 123.5 19.81 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 CA-C-N 118.219 1.009 . . . . 0.0 109.623 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -96.92 -96.88 0.2 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.1 p -90.08 147.12 23.83 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.237 0.615 . . . . 0.0 109.963 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.3 tt -149.89 142.71 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.835 1.254 . . . . 0.0 108.924 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.31 130.6 25.17 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.859 0.864 . . . . 0.0 109.214 169.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.54 147.75 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 125.399 1.48 . . . . 0.0 108.823 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.2 t -139.32 130.22 26.26 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.012 0.925 . . . . 0.0 110.769 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.0 tp -72.39 -49.91 30.39 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.917 1.287 . . . . 0.0 109.271 170.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.62 67.12 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.65 1.18 . . . . 0.0 111.639 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -89.55 -8.84 51.83 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.272 0.629 . . . . 0.0 111.648 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.9 m 52.24 56.79 7.22 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 125.297 1.439 . . . . 0.0 110.681 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.9 p30 -161.97 172.04 16.64 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.838 0.455 . . . . 0.0 111.513 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.22 119.27 1.97 Allowed Glycine 0 C--N 1.338 0.658 0 C-N-CA 125.577 1.56 . . . . 0.0 109.287 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.5 m -99.44 121.88 41.76 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.2 t -129.48 137.08 57.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 124.366 1.066 . . . . 0.0 110.126 -169.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -112.97 129.87 56.33 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -150.28 169.99 20.07 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -168.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -97.38 114.72 65.24 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.64 1.576 . . . . 0.0 109.548 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -44.85 -41.36 15.18 Favored 'Trans proline' 0 C--N 1.349 0.555 1 C-N-CA 125.452 4.102 . . . . 0.0 114.399 174.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.0 mt -61.53 -32.9 72.97 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.944 0.898 . . . . 0.0 111.903 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.1 mt -105.34 -28.8 10.67 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.069 0.948 . . . . 0.0 112.215 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.7 t -153.16 163.23 40.24 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.837 0.744 . . . . 0.0 110.374 178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.9 p -136.01 165.85 32.62 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 125.723 1.609 . . . . 0.0 109.504 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -53.12 -37.61 79.81 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.448 2.765 . . . . 0.0 112.573 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -67.21 -41.35 85.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.261 1.024 . . . . 0.0 110.46 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.6 m -64.03 -48.05 77.82 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.999 0.52 . . . . 0.0 110.048 177.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.4 mt -59.39 -49.66 76.96 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.937 0.895 . . . . 0.0 110.294 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -50.96 -51.03 56.58 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.317 1.047 . . . . 0.0 110.382 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.13 -46.6 84.98 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.323 0.963 . . . . 0.0 112.248 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.73 92.77 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.49 0.716 . . . . 0.0 111.125 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.5 mt -64.55 -36.41 77.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 123.215 0.606 . . . . 0.0 110.25 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -63.57 -41.46 98.4 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.942 -0.474 . . . . 0.0 110.357 175.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.14 -40.8 98.62 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.74 0.816 . . . . 0.0 111.285 175.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.4 mmm -56.17 -40.25 73.6 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.904 0.482 . . . . 0.0 110.665 173.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.72 54.31 0.26 Allowed Glycine 0 C--N 1.34 0.773 0 C-N-CA 123.973 0.796 . . . . 0.0 111.406 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -140.45 144.3 36.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.123 0.969 . . . . 0.0 108.791 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -70.46 99.23 1.57 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.68 129.05 45.78 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.057 1.343 . . . . 0.0 109.123 -174.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.5 p -137.52 143.87 41.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.31 1.044 . . . . 0.0 109.063 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 61.8 mt . . . . . 0 CA--C 1.53 0.193 0 C-N-CA 122.813 0.445 . . . . 0.0 110.22 -178.945 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.3 p . . . . . 0 CA--C 1.531 0.246 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -137.73 170.88 15.3 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 124.734 1.214 . . . . 0.0 109.816 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -124.15 153.45 41.5 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.497 1.119 . . . . 0.0 109.538 172.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.1 t -147.07 138.47 24.08 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.135 0.974 . . . . 0.0 109.756 -176.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.92 113.06 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.6 mt -113.28 126.2 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -71.15 136.32 48.07 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 177.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.6 mt -129.96 91.15 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -99.42 153.84 18.69 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.452 0.701 . . . . 0.0 109.553 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.1 45.0 12.18 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.853 0.74 . . . . 0.0 112.062 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 54.7 mtt -79.77 153.45 29.18 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 169.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.5 m -84.53 -52.37 6.18 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.756 0.822 . . . . 0.0 109.871 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.2 p -163.8 -178.29 5.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.732 1.213 . . . . 0.0 108.7 -175.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -60.57 -25.51 66.24 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.127 0.971 . . . . 0.0 113.25 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.6 m -54.69 -36.47 64.7 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.713 0.688 . . . . 0.0 111.468 175.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.2 m -61.4 -41.34 96.98 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 122.885 0.474 . . . . 0.0 111.186 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.8 t -53.37 -54.39 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 123.507 0.723 . . . . 0.0 109.322 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -59.77 -45.65 91.6 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.611 0.764 . . . . 0.0 111.361 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.4 m -59.14 -52.22 66.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.261 0.624 . . . . 0.0 111.443 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.6 mt -56.92 -50.98 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.194 0.998 . . . . 0.0 109.573 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -54.43 -56.07 22.45 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.413 0.685 . . . . 0.0 110.751 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.34 -56.35 19.98 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.124 0.868 . . . . 0.0 112.086 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.8 t -59.92 -57.23 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.817 0.847 . . . . 0.0 110.766 -177.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.2 mt -70.6 -32.82 50.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 118.851 -0.595 . . . . 0.0 112.081 -169.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 87.3 p -52.96 -30.75 36.65 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -89.12 -5.84 57.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.557 0.743 . . . . 0.0 112.483 -175.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -75.08 147.78 83.72 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 118.885 0.766 . . . . 0.0 110.229 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -45.29 127.71 9.32 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 124.309 3.34 . . . . 0.0 113.254 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.51 -31.1 5.64 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-O 118.653 -1.082 . . . . 0.0 113.596 176.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.73 136.56 25.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 118.386 1.093 . . . . 0.0 110.098 -175.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -115.67 -100.97 0.43 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.639 1.176 . . . . 0.0 108.224 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 86.5 p -81.53 151.56 27.69 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.709 0.686 . . . . 0.0 110.128 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.24 131.46 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 123.788 0.835 . . . . 0.0 108.939 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -130.69 102.15 5.99 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.179 1.392 . . . . 0.0 108.057 -174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.1 t -100.73 149.88 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.436 1.094 . . . . 0.0 109.021 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.6 t -140.1 129.23 23.67 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.101 0.96 . . . . 0.0 109.753 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.7 tp -70.47 -49.49 48.05 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.458 1.103 . . . . 0.0 109.301 170.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.59 -47.65 66.76 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.712 1.205 . . . . 0.0 111.776 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -89.42 -11.9 41.82 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.199 0.6 . . . . 0.0 111.612 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.7 m 54.04 56.53 6.94 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 125.011 1.325 . . . . 0.0 110.602 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -157.59 170.49 22.27 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.498 0.719 . . . . 0.0 111.279 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -137.36 116.26 1.34 Allowed Glycine 0 C--N 1.337 0.603 0 C-N-CA 126.196 1.855 . . . . 0.0 109.389 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.3 m -99.48 105.92 17.89 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 t -109.25 137.24 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 124.548 1.139 . . . . 0.0 109.214 -173.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -105.56 130.01 53.7 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 169.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -150.42 164.96 34.58 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -168.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -98.08 113.97 64.54 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.158 1.383 . . . . 0.0 109.682 170.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -44.82 -37.43 11.88 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 125.247 3.965 . . . . 0.0 114.873 173.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.1 mt -63.82 -34.18 77.35 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.24 0.616 . . . . 0.0 111.97 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.4 mt -105.64 -27.61 11.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.98 0.912 . . . . 0.0 112.478 -171.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.0 t -151.87 176.27 11.62 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.749 0.704 . . . . 0.0 109.96 176.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.6 p -148.98 163.48 25.31 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.477 1.111 . . . . 0.0 109.717 -175.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -53.16 -36.51 77.43 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.193 2.595 . . . . 0.0 112.678 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -68.03 -44.57 76.17 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.318 1.047 . . . . 0.0 110.355 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.6 m -61.55 -46.93 87.82 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.224 0.609 . . . . 0.0 110.287 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.8 mt -62.31 -45.85 91.37 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.285 1.034 . . . . 0.0 110.764 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -53.64 -46.85 70.68 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.975 0.91 . . . . 0.0 109.968 172.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.56 -45.4 84.59 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.276 0.941 . . . . 0.0 112.268 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.39 -48.54 77.43 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.686 0.743 . . . . 0.0 111.168 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.2 mt -59.62 -45.11 94.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.802 0.841 . . . . 0.0 109.834 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -57.34 -47.85 80.51 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.874 0.87 . . . . 0.0 110.22 176.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -59.48 -41.66 90.3 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.848 0.859 . . . . 0.0 111.525 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.7 mtp -59.3 -41.55 89.26 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.051 0.387 . . . . 0.0 110.731 174.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.29 60.0 0.19 Allowed Glycine 0 C--N 1.34 0.787 0 C-N-CA 123.688 0.661 . . . . 0.0 111.718 169.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -140.35 155.93 46.6 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.018 0.927 . . . . 0.0 109.236 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.17 96.49 3.3 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.75 124.41 44.99 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.901 1.28 . . . . 0.0 109.989 -174.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.0 t -150.29 156.52 41.69 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.097 0.559 . . . . 0.0 109.948 175.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 CA--C 1.533 0.306 0 C-N-CA 123.851 0.86 . . . . 0.0 113.152 -169.33 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.1 p . . . . . 0 CA--C 1.53 0.183 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -140.14 169.85 16.92 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.821 1.248 . . . . 0.0 109.34 175.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -140.3 143.64 35.97 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.462 1.105 . . . . 0.0 108.746 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 t -134.29 141.56 46.99 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.375 1.07 . . . . 0.0 109.824 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.0 t -107.66 106.97 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 175.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.3 mt -102.22 123.66 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -177.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -69.66 128.52 36.76 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 169.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 66.7 mt -127.47 86.58 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -99.95 148.73 24.17 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.067 0.547 . . . . 0.0 110.221 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.21 26.19 16.85 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.672 1.13 . . . . 0.0 112.871 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 68.6 mtm -79.62 136.27 36.79 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.242 1.021 . . . . 0.0 109.366 174.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.3 m -84.48 -46.93 11.14 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.267 1.027 . . . . 0.0 110.748 -173.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.5 p -156.1 177.25 11.64 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.643 0.777 . . . . 0.0 109.474 -175.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -60.69 -24.71 65.85 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.091 0.956 . . . . 0.0 113.091 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.3 m -53.59 -36.2 61.68 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.525 0.602 . . . . 0.0 111.472 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.3 m -60.26 -56.5 20.8 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.8 t -49.9 -52.61 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.464 1.105 . . . . 0.0 110.558 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -57.29 -54.58 45.2 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.366 1.066 . . . . 0.0 111.245 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.5 p -62.31 -49.82 74.09 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.378 0.671 . . . . 0.0 111.523 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 79.1 mt -52.97 -56.17 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 124.285 1.034 . . . . 0.0 109.696 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -57.57 -50.65 72.41 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.134 0.574 . . . . 0.0 110.347 -177.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.77 -51.41 44.95 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.502 1.049 . . . . 0.0 112.374 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.2 t -60.61 -55.18 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.336 0.655 . . . . 0.0 110.329 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.5 mt -64.33 -37.37 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 119.005 -0.522 . . . . 0.0 111.549 -171.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 72.5 m -49.93 -33.73 18.41 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.535 0.734 . . . . 0.0 112.502 173.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -89.39 -12.08 41.37 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.836 0.854 . . . . 0.0 112.06 -174.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -70.33 139.5 87.1 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 119.127 0.876 . . . . 0.0 109.839 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.27 132.82 32.83 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.939 2.426 . . . . 0.0 109.831 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.83 -33.67 6.33 Favored Glycine 0 C--N 1.337 0.605 0 CA-C-O 118.939 -0.923 . . . . 0.0 112.062 -177.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.5 t -70.32 135.3 28.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 CA-C-N 118.113 0.957 . . . . 0.0 109.908 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -111.48 -100.67 0.41 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.961 1.305 . . . . 0.0 107.958 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 59.5 p -86.83 146.16 26.32 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.615 0.766 . . . . 0.0 109.489 176.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.3 tt -150.24 143.89 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 123.624 0.77 . . . . 0.0 109.938 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.45 136.36 41.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 169.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.8 t -124.5 143.24 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.987 1.315 . . . . 0.0 107.691 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.5 t -143.4 130.93 21.14 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.898 0.879 . . . . 0.0 110.191 -174.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.33 -45.69 25.34 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.151 0.981 . . . . 0.0 109.53 174.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.47 -46.67 63.2 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.271 1.028 . . . . 0.0 111.305 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -89.72 -9.62 48.75 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.648 0.779 . . . . 0.0 111.905 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.0 m 52.33 55.59 8.93 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 125.68 1.592 . . . . 0.0 111.076 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -160.87 168.46 24.63 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.173 0.511 . . . . 0.0 111.706 -174.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.12 116.16 1.51 Allowed Glycine 0 CA--C 1.525 0.656 0 C-N-CA 126.232 1.873 . . . . 0.0 108.683 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.7 m -99.31 109.75 22.34 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 176.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.4 t -119.24 122.45 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 124.465 1.106 . . . . 0.0 109.217 -171.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -89.97 131.29 35.95 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 169.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -150.09 165.09 33.84 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -169.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -101.01 113.36 65.8 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.08 1.352 . . . . 0.0 109.262 172.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -43.46 -39.35 9.34 Favored 'Trans proline' 0 C--N 1.347 0.499 1 C-N-CA 125.458 4.105 . . . . 0.0 115.346 173.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.87 -34.93 79.27 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.776 0.43 . . . . 0.0 111.857 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.2 mt -100.6 -29.62 12.23 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.819 0.848 . . . . 0.0 112.423 -172.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.4 t -151.15 174.41 13.25 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.53 0.732 . . . . 0.0 109.731 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.8 p -148.15 162.59 30.3 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 123.893 0.877 . . . . 0.0 110.468 -173.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.02 -34.61 77.99 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.631 2.888 . . . . 0.0 112.41 172.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -63.22 -49.23 75.0 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.024 0.93 . . . . 0.0 110.458 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.6 m -62.35 -45.31 93.78 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.215 0.606 . . . . 0.0 110.402 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.3 mt -60.46 -50.12 74.83 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.813 0.845 . . . . 0.0 110.602 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -55.47 -41.92 73.64 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.035 0.379 . . . . 0.0 110.969 172.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.47 -46.21 52.98 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.205 0.907 . . . . 0.0 111.963 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.8 -48.4 80.78 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.408 0.604 . . . . 0.0 111.133 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.6 mm -60.9 -39.63 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 122.946 0.498 . . . . 0.0 111.279 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.24 -44.62 91.26 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.883 0.873 . . . . 0.0 110.216 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.02 -45.6 92.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.788 0.835 . . . . 0.0 110.905 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.5 mmm -59.78 -44.04 94.11 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.417 0.687 . . . . 0.0 110.626 175.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.8 60.96 0.4 Allowed Glycine 0 C--N 1.341 0.82 0 C-N-CA 124.518 1.056 . . . . 0.0 112.007 171.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -140.1 162.33 35.49 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.923 0.889 . . . . 0.0 109.494 172.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.0 103.85 3.91 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.97 110.05 21.82 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.75 1.62 . . . . 0.0 110.127 -174.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.9 t -150.4 145.88 26.35 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.037 0.381 . . . . 0.0 109.995 175.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.3 mt . . . . . 0 CA--C 1.528 0.133 0 C-N-CA 122.597 0.359 . . . . 0.0 111.589 -174.863 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.7 p . . . . . 0 N--CA 1.456 -0.147 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -142.64 162.45 35.43 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 126.333 1.853 . . . . 0.0 107.968 173.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -121.8 142.76 49.89 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.328 1.051 . . . . 0.0 109.231 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -133.54 133.41 42.1 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.192 0.997 . . . . 0.0 109.396 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.8 t -100.27 109.23 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 172.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.1 mt -99.53 118.4 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -75.8 107.41 7.96 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.2 mt -111.97 96.11 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -174.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -99.57 151.55 21.04 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.257 0.623 . . . . 0.0 109.771 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.09 35.35 12.59 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.185 0.898 . . . . 0.0 112.191 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 38.0 mtt -79.46 134.02 36.53 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 169.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.5 m -84.32 -51.51 6.92 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.424 0.689 . . . . 0.0 110.629 -174.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.8 p -161.0 -172.94 3.66 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.594 0.757 . . . . 0.0 109.647 -175.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -55.15 -32.68 62.29 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.385 1.474 . . . . 0.0 113.79 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.6 p -59.36 -41.15 88.62 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.264 0.484 . . . . 0.0 110.902 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.8 m -62.53 -49.95 73.3 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.916 0.486 . . . . 0.0 110.129 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.5 t -50.2 -52.1 15.67 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 C-N-CA 123.796 0.838 . . . . 0.0 109.889 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -62.04 -42.89 99.66 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.956 0.902 . . . . 0.0 111.845 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.6 m -63.87 -48.9 74.86 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.189 0.595 . . . . 0.0 110.969 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.9 mt -55.33 -58.56 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.974 1.309 . . . . 0.0 109.375 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -61.14 -43.52 98.76 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 117.952 0.342 . . . . 0.0 111.254 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.96 -54.48 33.4 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.367 0.984 . . . . 0.0 111.906 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.76 -51.49 72.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.033 0.933 . . . . 0.0 110.323 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.0 mm -62.92 -33.33 59.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.827 -175.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.5 m -57.04 -21.01 27.91 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 175.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -89.09 -14.09 37.1 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.631 0.65 . . . . 0.0 111.653 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -71.0 134.12 85.68 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -66.05 139.46 56.15 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.563 2.175 . . . . 0.0 109.571 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.32 -32.48 7.1 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-O 118.652 -1.082 . . . . 0.0 112.165 -176.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.5 t -66.17 136.37 26.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 CA-C-N 118.464 1.132 . . . . 0.0 110.198 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -116.67 -96.42 0.47 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.487 1.115 . . . . 0.0 108.606 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.5 p -90.09 147.98 23.3 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.475 0.71 . . . . 0.0 109.889 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 tt -150.41 131.98 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 123.841 0.856 . . . . 0.0 110.1 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.08 110.24 12.3 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.69 1.196 . . . . 0.0 108.494 177.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.7 t -106.06 144.4 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.364 1.066 . . . . 0.0 109.061 176.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.3 t -145.17 131.71 19.82 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.881 0.872 . . . . 0.0 110.609 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 tt -74.28 -45.86 44.96 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.737 1.215 . . . . 0.0 109.581 169.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.28 -46.95 66.1 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.298 1.039 . . . . 0.0 111.471 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -89.6 -10.79 44.67 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.42 0.688 . . . . 0.0 111.676 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.9 m 53.21 55.56 8.64 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 125.435 1.494 . . . . 0.0 110.554 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -156.48 169.3 24.95 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -175.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.41 111.43 0.99 Allowed Glycine 0 CA--C 1.524 0.623 0 C-N-CA 126.292 1.901 . . . . 0.0 108.369 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.5 m -99.08 98.54 9.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.7 t -109.98 127.88 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 124.392 1.077 . . . . 0.0 109.269 -170.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -98.27 129.79 44.98 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 169.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -150.06 163.61 37.7 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.76 0.824 . . . . 0.0 110.975 -169.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -95.35 115.01 65.08 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.396 1.078 . . . . 0.0 109.306 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -45.94 -37.17 16.77 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 124.993 3.795 . . . . 0.0 114.616 173.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.9 mt -63.76 -32.62 74.17 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.717 0.807 . . . . 0.0 112.004 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.8 -41.55 7.21 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.732 0.813 . . . . 0.0 111.281 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 t -142.69 170.47 15.65 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.381 0.672 . . . . 0.0 110.247 -178.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.4 p -138.43 160.95 61.62 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.397 1.079 . . . . 0.0 110.349 -174.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -50.64 -40.39 55.56 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.609 2.873 . . . . 0.0 112.211 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -61.12 -47.21 87.33 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.507 1.123 . . . . 0.0 110.418 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.6 m -60.94 -50.57 72.87 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.506 0.722 . . . . 0.0 110.678 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 50.9 mt -59.25 -50.95 72.05 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.382 1.073 . . . . 0.0 110.354 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -53.87 -49.49 68.4 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 124.115 0.966 . . . . 0.0 110.558 174.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.21 -46.44 62.86 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.518 1.056 . . . . 0.0 111.966 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.32 -51.46 69.87 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.239 0.616 . . . . 0.0 111.228 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.0 mm -66.44 -37.15 79.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 117.838 0.29 . . . . 0.0 111.657 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -60.37 -43.84 96.17 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.277 0.631 . . . . 0.0 109.951 175.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -62.72 -42.73 99.8 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.881 0.872 . . . . 0.0 111.363 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.1 mtp -56.95 -44.65 82.77 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.776 0.43 . . . . 0.0 110.577 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.9 63.1 0.18 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 123.597 0.617 . . . . 0.0 111.947 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -140.41 158.26 44.28 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.047 0.939 . . . . 0.0 108.817 171.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -78.74 87.22 4.64 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.25 116.6 31.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.917 1.287 . . . . 0.0 109.183 -176.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.9 p -138.82 133.22 31.77 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.645 1.178 . . . . 0.0 109.365 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 CA--C 1.529 0.155 0 C-N-CA 122.934 0.494 . . . . 0.0 111.299 -177.693 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 76.1 p . . . . . 0 CA--C 1.529 0.17 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -133.52 159.54 40.13 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 124.676 1.19 . . . . 0.0 109.999 -173.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -113.93 145.54 41.35 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.447 1.099 . . . . 0.0 108.818 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.4 t -139.32 155.35 47.76 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.014 0.926 . . . . 0.0 109.489 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.5 t -120.24 131.37 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.1 mt -128.56 120.24 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -74.79 134.35 41.8 Favored 'General case' 0 C--N 1.337 0.052 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.8 mt -125.65 110.84 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -175.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -99.45 152.87 19.5 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.4 2.14 60.43 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.053 -0.86 . . . . 0.0 112.66 -176.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.3 mtm -79.33 103.3 9.17 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 118.66 1.23 . . . . 0.0 107.94 175.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.4 t -84.47 -29.74 25.81 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.302 0.641 . . . . 0.0 111.803 -173.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.2 p -159.17 179.01 9.4 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.389 0.54 . . . . 0.0 110.589 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -59.33 -26.18 64.8 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.09 1.356 . . . . 0.0 113.25 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.8 m -56.06 -40.84 74.15 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.486 0.585 . . . . 0.0 111.169 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.2 m -63.06 -51.85 65.06 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 122.899 0.48 . . . . 0.0 109.777 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.1 t -50.34 -54.89 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.182 0.993 . . . . 0.0 110.232 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -57.45 -53.9 52.93 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.733 1.213 . . . . 0.0 111.215 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.0 p -60.47 -51.27 70.16 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.123 0.569 . . . . 0.0 111.429 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.9 mt -56.08 -55.09 20.23 Favored 'Isoleucine or valine' 0 C--N 1.339 0.152 0 C-N-CA 123.502 0.721 . . . . 0.0 109.63 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -52.95 -53.13 54.18 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.506 0.722 . . . . 0.0 110.64 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.07 -55.55 30.04 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.184 0.897 . . . . 0.0 112.349 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.43 -53.22 51.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 123.958 0.903 . . . . 0.0 111.057 -175.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.7 mm -63.45 -31.4 52.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.026 0.53 . . . . 0.0 111.269 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.0 t -54.51 -26.09 29.55 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -89.38 -5.25 57.61 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.418 0.687 . . . . 0.0 112.284 -175.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -71.83 144.36 88.03 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 118.76 0.709 . . . . 0.0 109.537 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -64.31 128.07 20.62 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.977 2.452 . . . . 0.0 110.202 -175.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.6 -33.33 6.64 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 118.652 -1.082 . . . . 0.0 112.243 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.15 139.38 20.53 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 CA-C-N 118.192 0.996 . . . . 0.0 110.081 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -119.37 -98.7 0.45 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.666 1.186 . . . . 0.0 108.256 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.8 p -85.15 147.41 26.63 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.2 tt -150.26 134.58 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.753 0.821 . . . . 0.0 109.162 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 89.2 mmt-85 -132.52 109.24 9.64 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.081 1.352 . . . . 0.0 108.373 -177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.0 t -103.68 147.1 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.788 1.235 . . . . 0.0 108.703 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.4 t -140.64 127.85 20.99 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.068 0.947 . . . . 0.0 110.588 -174.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.1 tp -69.34 -49.49 55.16 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.576 1.15 . . . . 0.0 109.437 171.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.4 -46.25 69.64 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.752 1.221 . . . . 0.0 111.687 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -89.46 -11.63 42.46 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.3 0.64 . . . . 0.0 111.582 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.6 m 53.46 54.24 10.39 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 125.367 1.467 . . . . 0.0 110.791 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.4 p30 -158.86 173.1 17.05 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.032 0.533 . . . . 0.0 111.626 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.6 119.3 2.04 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 126.101 1.81 . . . . 0.0 109.333 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.9 m -99.59 117.78 34.71 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 t -122.43 128.7 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 124.278 1.031 . . . . 0.0 109.725 -170.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -95.43 127.14 41.22 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 169.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -150.2 164.68 35.06 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.981 0.512 . . . . 0.0 112.175 -169.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -98.81 115.17 65.9 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.545 1.138 . . . . 0.0 110.136 172.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -44.98 -42.84 15.73 Favored 'Trans proline' 0 C--N 1.348 0.526 1 C-N-CA 125.556 4.171 . . . . 0.0 115.634 176.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.2 mt -68.31 -28.01 66.79 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.627 0.371 . . . . 0.0 111.941 -174.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.2 mt -99.68 -31.21 11.68 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.064 0.946 . . . . 0.0 111.726 -175.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.8 t -153.35 163.86 39.17 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.551 0.614 . . . . 0.0 109.956 176.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.4 p -131.22 163.31 50.25 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 124.834 1.254 . . . . 0.0 109.915 -177.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.88 -40.13 67.1 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.292 2.661 . . . . 0.0 112.419 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -66.76 -40.32 88.2 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.719 0.807 . . . . 0.0 111.601 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.4 m -62.36 -48.1 81.28 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.628 0.371 . . . . 0.0 110.047 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.5 mt -61.27 -47.72 84.71 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.104 0.961 . . . . 0.0 110.596 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -51.6 -50.99 59.12 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.416 1.086 . . . . 0.0 110.087 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.93 -46.34 84.22 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.24 0.924 . . . . 0.0 112.112 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.21 -50.6 71.12 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.45 0.7 . . . . 0.0 111.184 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.4 mt -58.6 -47.39 88.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.387 0.675 . . . . 0.0 109.691 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -55.25 -48.92 73.28 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.747 0.819 . . . . 0.0 110.42 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.5 -38.38 77.55 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.925 1.29 . . . . 0.0 112.472 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -56.03 -37.45 69.24 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 118.428 0.558 . . . . 0.0 111.127 175.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.18 56.09 0.07 OUTLIER Glycine 0 C--N 1.34 0.776 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 171.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -140.39 173.75 11.19 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.949 0.9 . . . . 0.0 110.037 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -108.51 88.27 2.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.43 138.54 36.37 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.99 0.916 . . . . 0.0 110.374 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.0 t -149.48 148.11 29.02 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.287 1.035 . . . . 0.0 109.18 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.8 mt . . . . . 0 CA--C 1.53 0.175 0 C-N-CA 122.693 0.397 . . . . 0.0 111.181 -176.731 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.7 p . . . . . 0 CA--C 1.531 0.229 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -145.18 171.69 14.18 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.073 1.349 . . . . 0.0 109.449 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -136.39 143.3 43.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.829 1.252 . . . . 0.0 108.825 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 t -135.52 153.57 51.68 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.898 1.279 . . . . 0.0 109.012 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.3 t -120.83 135.87 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 171.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.4 mt -130.53 124.87 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -175.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -67.14 131.56 46.05 Favored 'General case' 0 C--N 1.338 0.09 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.3 mt -129.59 98.74 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -99.23 150.83 21.68 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.81 4.42 56.88 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.234 0.921 . . . . 0.0 112.343 -173.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 57.6 mtm -79.02 108.41 12.48 Favored 'General case' 0 C--N 1.343 0.318 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.3 m -84.36 -38.58 20.15 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.542 1.137 . . . . 0.0 110.401 -171.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.7 p -156.91 -178.66 7.53 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.805 0.336 . . . . 0.0 110.502 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -55.39 -30.99 61.45 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.667 1.587 . . . . 0.0 113.416 -178.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 m -54.02 -42.59 69.28 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.409 0.684 . . . . 0.0 111.335 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.0 m -62.65 -53.26 57.19 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 122.912 0.485 . . . . 0.0 109.861 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.0 t -49.91 -54.41 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.462 1.105 . . . . 0.0 110.516 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -60.98 -50.88 71.58 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.409 1.084 . . . . 0.0 111.447 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.9 p -61.4 -51.77 67.38 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.81 0.444 . . . . 0.0 111.291 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.8 mt -52.61 -57.7 3.81 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 C-N-CA 124.052 0.941 . . . . 0.0 109.358 177.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -54.7 -45.47 73.98 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.094 0.557 . . . . 0.0 111.166 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.3 -53.96 34.83 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.337 0.97 . . . . 0.0 112.023 177.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.5 t -65.9 -54.5 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 117.552 0.676 . . . . 0.0 110.725 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.8 -40.65 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 123.545 0.738 . . . . 0.0 111.221 -175.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.2 p -56.6 -26.73 56.4 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -89.17 -6.05 57.25 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.747 0.819 . . . . 0.0 111.938 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -73.3 125.57 90.72 Favored Pre-proline 0 CA--C 1.535 0.384 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.89 124.84 10.53 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.781 2.987 . . . . 0.0 112.35 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.12 -37.83 3.35 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-O 119.033 -0.871 . . . . 0.0 112.056 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.3 t -67.86 127.42 29.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-N 117.873 0.836 . . . . 0.0 110.077 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -98.02 -102.41 0.2 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.744 1.218 . . . . 0.0 108.003 176.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 95.7 p -89.97 155.85 18.83 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.538 0.608 . . . . 0.0 110.247 176.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.9 tt -150.55 144.5 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.103 0.961 . . . . 0.0 109.822 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -140.21 108.81 5.9 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.51 1.124 . . . . 0.0 108.84 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.7 t -98.36 141.77 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.668 1.187 . . . . 0.0 108.534 174.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.6 t -135.4 125.78 26.61 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 123.776 0.83 . . . . 0.0 110.888 -173.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -64.85 -55.64 18.26 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.647 1.179 . . . . 0.0 108.804 171.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.68 -47.5 58.77 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 125.2 1.4 . . . . 0.0 112.275 -176.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -89.35 -9.35 50.74 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.069 0.548 . . . . 0.0 111.698 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.6 m 52.3 54.99 9.8 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 125.315 1.446 . . . . 0.0 110.864 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -158.7 173.79 16.03 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.31 0.644 . . . . 0.0 111.095 -174.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.92 119.35 2.02 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 125.708 1.623 . . . . 0.0 109.308 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.2 m -99.44 116.09 30.78 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 t -127.51 122.52 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 124.072 0.949 . . . . 0.0 109.672 -169.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -90.05 134.3 34.33 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -150.09 168.09 24.92 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.86 0.464 . . . . 0.0 112.235 -171.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -103.41 111.82 65.32 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.179 1.392 . . . . 0.0 109.155 171.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -42.66 -38.22 6.23 Favored 'Trans proline' 0 C--N 1.348 0.51 1 C-N-CA 125.402 4.068 . . . . 0.0 115.282 172.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.79 -35.95 82.28 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.142 0.577 . . . . 0.0 111.794 -177.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.6 mt -102.26 -29.95 11.38 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.036 0.934 . . . . 0.0 112.36 -171.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 t -150.65 173.06 14.58 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.387 0.675 . . . . 0.0 109.915 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.7 p -141.4 162.63 46.3 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 124.516 1.126 . . . . 0.0 109.919 -177.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -52.62 -41.03 71.33 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.253 2.635 . . . . 0.0 112.1 174.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -64.62 -41.92 95.85 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.074 0.95 . . . . 0.0 111.423 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.5 m -63.05 -48.42 78.78 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.964 0.505 . . . . 0.0 110.381 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 54.6 mt -61.1 -48.89 79.6 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.091 0.956 . . . . 0.0 110.319 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.6 ttp85 -52.2 -48.48 65.05 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 124.139 0.976 . . . . 0.0 110.148 172.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.98 -46.73 76.26 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.661 1.125 . . . . 0.0 112.244 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.29 -49.84 75.99 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 117.491 0.646 . . . . 0.0 110.967 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.0 mt -61.2 -42.55 93.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.266 0.626 . . . . 0.0 109.972 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -60.83 -44.79 96.48 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.497 1.119 . . . . 0.0 110.583 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -59.03 -39.0 80.61 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.297 1.039 . . . . 0.0 111.349 177.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.3 mtp -67.33 -7.44 24.63 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 175.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.47 57.18 1.29 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 123.893 0.758 . . . . 0.0 111.483 170.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -140.33 156.35 46.47 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.139 0.976 . . . . 0.0 109.59 174.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -81.27 87.54 6.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 176.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.43 122.47 42.59 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.435 1.094 . . . . 0.0 109.747 -174.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.2 m -144.49 136.53 26.13 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.545 1.138 . . . . 0.0 108.588 -177.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.6 mt . . . . . 0 CA--C 1.532 0.279 0 C-N-CA 122.857 0.463 . . . . 0.0 111.497 -176.556 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 81.9 p . . . . . 0 CA--C 1.53 0.195 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -143.98 169.69 17.35 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.988 0.915 . . . . 0.0 109.411 170.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -140.05 139.98 36.06 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.648 1.179 . . . . 0.0 108.192 173.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 t -137.33 141.44 41.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.035 0.934 . . . . 0.0 109.908 -177.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.5 t -99.72 133.39 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 171.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.3 mt -129.05 118.99 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -73.01 132.47 43.44 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.0 mt -120.55 111.49 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 125.266 1.426 . . . . 0.0 107.679 -175.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -100.74 149.37 23.88 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.487 1.115 . . . . 0.0 109.425 174.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.78 15.11 37.94 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.911 1.243 . . . . 0.0 112.455 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 93.1 mtp -79.69 109.07 13.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.5 m -84.34 -47.11 11.06 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.015 0.926 . . . . 0.0 111.065 -169.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -154.92 177.33 11.42 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.804 0.841 . . . . 0.0 108.821 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -61.2 -21.27 63.67 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -174.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.3 m -55.06 -36.8 65.97 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.361 0.528 . . . . 0.0 111.189 173.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.1 m -64.62 -44.23 91.2 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 122.897 0.479 . . . . 0.0 110.578 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.7 t -54.26 -52.88 34.19 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 123.345 0.658 . . . . 0.0 109.326 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -57.77 -50.19 74.08 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.921 0.888 . . . . 0.0 111.186 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -59.82 -59.32 5.62 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.515 0.726 . . . . 0.0 110.959 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 73.7 mt -52.94 -52.59 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.385 1.074 . . . . 0.0 109.561 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -61.72 -54.76 38.13 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.723 0.409 . . . . 0.0 110.746 -175.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.46 -39.11 95.86 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.731 1.158 . . . . 0.0 113.278 -176.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.8 t -73.7 -57.28 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 117.724 0.762 . . . . 0.0 109.937 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.6 mt -67.9 -28.96 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 118.971 -0.537 . . . . 0.0 111.813 -170.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.2 p -53.45 -28.89 32.74 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.897 0.771 . . . . 0.0 112.726 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -88.98 -17.09 30.15 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.857 0.863 . . . . 0.0 111.614 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -71.41 141.9 86.12 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 118.666 0.666 . . . . 0.0 109.709 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -63.99 140.37 72.22 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.323 2.682 . . . . 0.0 111.165 -170.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.43 -32.93 6.22 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 118.744 -1.031 . . . . 0.0 112.149 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.02 141.73 15.76 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 118.356 1.078 . . . . 0.0 110.125 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -118.39 -109.44 0.36 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.155 1.382 . . . . 0.0 107.526 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.7 p -90.1 94.33 9.74 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.329 1.052 . . . . 0.0 109.067 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.5 tt -89.92 133.94 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 123.932 0.893 . . . . 0.0 109.32 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -129.85 97.17 4.42 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.863 1.265 . . . . 0.0 108.444 -172.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.6 t -95.6 147.76 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.921 0.889 . . . . 0.0 109.927 -176.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.4 t -148.71 127.01 12.18 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.851 0.86 . . . . 0.0 110.198 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.8 tt -73.9 -42.77 60.18 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.011 0.924 . . . . 0.0 109.584 170.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.12 -47.11 72.21 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.543 1.137 . . . . 0.0 111.574 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -89.36 -5.44 57.47 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.362 0.665 . . . . 0.0 111.42 176.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.1 m 53.75 53.55 11.22 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 126.054 1.741 . . . . 0.0 111.165 175.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -161.22 172.08 17.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.284 0.564 . . . . 0.0 112.34 -172.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.71 117.05 2.39 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.1 m -99.37 94.38 6.41 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 t -100.03 120.06 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 124.456 1.103 . . . . 0.0 109.58 -169.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -89.52 132.86 34.85 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 169.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -150.81 171.79 16.64 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -169.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -106.87 111.72 63.65 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 125.548 1.539 . . . . 0.0 108.826 171.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -44.06 -38.02 10.11 Favored 'Trans proline' 0 C--N 1.346 0.422 1 C-N-CA 125.397 4.065 . . . . 0.0 114.893 172.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.2 mt -65.12 -33.69 76.62 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.481 0.712 . . . . 0.0 111.696 -177.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.0 mt -101.07 -33.4 10.16 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.266 1.026 . . . . 0.0 112.048 -172.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -148.95 169.97 19.38 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.526 0.73 . . . . 0.0 109.931 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.9 p -141.3 161.85 50.69 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.533 1.133 . . . . 0.0 109.745 -176.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.79 -42.86 42.79 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.484 2.789 . . . . 0.0 112.835 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -65.51 -39.87 92.35 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.541 0.736 . . . . 0.0 111.793 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.0 m -63.06 -45.26 93.02 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.637 0.375 . . . . 0.0 110.103 176.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.1 mt -65.43 -43.5 90.27 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.268 1.027 . . . . 0.0 110.833 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -53.85 -49.41 68.5 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.865 0.866 . . . . 0.0 109.449 170.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.92 -44.54 71.8 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.7 1.143 . . . . 0.0 112.388 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.29 94.65 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.727 0.811 . . . . 0.0 111.153 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.0 mt -63.7 -43.05 97.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 123.001 0.521 . . . . 0.0 110.226 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -62.57 -38.8 91.53 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.541 0.736 . . . . 0.0 111.349 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -60.94 -43.09 99.18 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.536 0.735 . . . . 0.0 110.616 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.4 mtp -62.36 -47.25 85.01 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 119.392 -0.337 . . . . 0.0 110.556 173.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.05 61.02 0.12 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 123.71 0.671 . . . . 0.0 112.077 170.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -140.33 150.69 44.29 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.58 0.752 . . . . 0.0 109.371 171.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -79.7 93.2 5.5 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.39 133.68 43.36 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.939 0.896 . . . . 0.0 110.39 -174.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.8 p -139.04 132.61 30.43 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.95 1.3 . . . . 0.0 108.825 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.8 mt . . . . . 0 C--O 1.231 0.117 0 C-N-CA 123.268 0.627 . . . . 0.0 110.751 -177.83 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 51.2 p . . . . . 0 CA--C 1.529 0.16 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -142.36 166.27 25.15 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.821 1.648 . . . . 0.0 108.901 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -120.72 143.91 48.51 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.005 1.322 . . . . 0.0 108.486 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 t -142.27 139.66 31.98 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 123.534 0.734 . . . . 0.0 109.892 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.5 t -99.81 118.37 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.4 mm -102.22 130.64 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 174.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -71.58 125.56 27.4 Favored 'General case' 0 N--CA 1.458 -0.065 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 169.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.4 mt -127.58 88.95 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -99.88 159.14 15.3 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.097 0.559 . . . . 0.0 109.755 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.64 21.22 56.71 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 119.285 -0.731 . . . . 0.0 112.759 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 70.1 mtm -79.71 128.55 33.55 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.1 p -84.45 -42.43 15.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.497 0.719 . . . . 0.0 110.983 -174.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.6 p -159.58 179.95 8.44 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.822 0.344 . . . . 0.0 110.73 -174.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -54.09 -31.03 50.69 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.662 1.585 . . . . 0.0 113.57 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m -54.59 -39.02 67.41 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.411 0.684 . . . . 0.0 111.372 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.8 m -63.99 -49.2 73.39 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 122.82 0.448 . . . . 0.0 110.198 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.1 t -52.35 -51.82 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.248 1.019 . . . . 0.0 109.646 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -58.43 -48.26 81.28 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.32 1.448 . . . . 0.0 111.789 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.0 m -60.9 -50.78 72.01 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.944 0.497 . . . . 0.0 110.829 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.5 mt -60.39 -55.44 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 123.619 0.768 . . . . 0.0 110.017 -176.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -57.36 -45.33 84.51 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.493 0.588 . . . . 0.0 110.853 -176.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.44 -61.64 7.25 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 123.79 0.71 . . . . 0.0 111.464 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.81 -56.38 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.067 0.947 . . . . 0.0 110.994 -175.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.0 mm -63.08 -33.73 62.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 118.764 -0.636 . . . . 0.0 111.835 -171.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.4 t -51.07 -35.2 33.6 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -89.38 -5.57 57.34 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.903 -0.57 . . . . 0.0 112.453 -175.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -68.22 147.95 98.28 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 119.417 1.008 . . . . 0.0 110.105 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -45.77 132.15 13.46 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 124.08 3.186 . . . . 0.0 112.738 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.82 -39.33 3.09 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 118.943 -0.921 . . . . 0.0 112.986 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.4 t -67.32 143.22 15.67 Favored 'Isoleucine or valine' 0 C--N 1.341 0.205 0 CA-C-N 118.089 0.944 . . . . 0.0 110.278 -177.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -117.63 -95.33 0.48 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.6 p -90.66 157.5 17.43 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.837 0.855 . . . . 0.0 110.078 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.5 tt -150.7 145.06 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 124.488 1.115 . . . . 0.0 108.601 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -131.98 107.83 8.94 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.128 0.971 . . . . 0.0 109.121 176.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.9 t -97.27 149.56 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.977 1.311 . . . . 0.0 109.047 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.3 t -145.14 123.02 11.96 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.266 0.627 . . . . 0.0 110.173 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.8 tp -67.04 -47.0 72.71 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.745 1.218 . . . . 0.0 109.931 172.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.93 -43.28 66.15 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.677 1.191 . . . . 0.0 111.7 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -89.2 -21.02 23.48 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.375 0.67 . . . . 0.0 111.147 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.9 m 57.48 57.29 4.45 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 125.267 1.427 . . . . 0.0 109.784 -174.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.6 p30 -152.81 171.63 17.96 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.47 0.708 . . . . 0.0 111.578 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -137.26 114.68 1.14 Allowed Glycine 0 C--N 1.337 0.615 0 C-N-CA 126.041 1.781 . . . . 0.0 108.894 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.3 m -99.11 99.9 10.97 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.0 t -103.26 133.17 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 124.817 1.247 . . . . 0.0 109.58 -170.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -103.21 125.17 49.76 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 172.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -150.17 171.02 17.57 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -168.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -101.25 113.22 65.83 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.353 1.461 . . . . 0.0 109.479 172.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -44.18 -40.2 12.34 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 125.17 3.914 . . . . 0.0 114.794 173.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.0 mt -63.19 -34.81 78.45 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.606 0.763 . . . . 0.0 111.703 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.8 mt -99.98 -29.26 12.65 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.107 0.963 . . . . 0.0 112.197 -172.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.7 t -153.07 160.25 42.92 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.645 0.657 . . . . 0.0 110.11 177.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.3 p -125.98 161.88 48.88 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 125.179 1.392 . . . . 0.0 109.658 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.99 -36.12 43.3 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.41 2.74 . . . . 0.0 112.924 172.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -67.94 -44.0 77.83 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.608 1.163 . . . . 0.0 110.717 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.2 m -62.78 -45.71 91.39 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.959 0.504 . . . . 0.0 110.296 176.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.9 mt -61.85 -48.84 78.74 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.699 0.8 . . . . 0.0 110.534 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.2 ttp85 -49.99 -47.45 52.87 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.267 1.027 . . . . 0.0 110.14 171.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.84 -51.09 41.29 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.41 1.005 . . . . 0.0 111.826 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.36 -43.76 96.22 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.769 0.785 . . . . 0.0 111.948 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.8 mm -60.9 -44.12 97.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 118.345 0.521 . . . . 0.0 110.507 176.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -58.98 -43.74 91.47 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.173 0.589 . . . . 0.0 110.17 175.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -60.66 -41.47 95.09 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.98 0.912 . . . . 0.0 111.213 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.4 mtp -61.92 -43.86 97.97 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.238 0.472 . . . . 0.0 110.592 173.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.06 60.7 0.2 Allowed Glycine 0 C--N 1.34 0.805 0 C-N-CA 123.786 0.707 . . . . 0.0 111.887 169.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -140.37 159.36 42.36 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.975 0.91 . . . . 0.0 109.313 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -73.46 98.25 2.72 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.87 127.95 46.0 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.049 1.339 . . . . 0.0 110.021 -173.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.1 m -150.11 152.79 35.3 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.472 1.109 . . . . 0.0 108.521 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 mm? . . . . . 0 CA--C 1.531 0.212 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.724 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.4 p . . . . . 0 CA--C 1.529 0.166 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -145.2 165.75 27.43 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.31 1.444 . . . . 0.0 109.065 173.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -129.26 151.01 50.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.813 1.245 . . . . 0.0 109.025 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.5 t -149.62 153.74 37.54 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 123.784 0.834 . . . . 0.0 109.91 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.57 125.43 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 173.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.3 mt -121.36 121.62 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -67.63 131.12 45.0 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 173.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.1 mt -124.39 108.77 21.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.112 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -99.83 150.5 22.29 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.58 13.17 55.99 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.378 0.989 . . . . 0.0 113.06 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 71.5 mtm -79.58 117.17 20.27 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.711 1.255 . . . . 0.0 108.26 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.4 m -84.15 -43.01 15.41 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.093 0.957 . . . . 0.0 110.387 -172.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.9 p -157.38 -178.94 7.72 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.605 0.362 . . . . 0.0 110.419 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -57.6 -25.92 60.76 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.293 1.437 . . . . 0.0 113.425 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.8 t -57.28 -44.42 83.99 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.229 0.611 . . . . 0.0 110.638 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.0 m -61.27 -51.06 70.51 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.817 0.447 . . . . 0.0 109.916 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.4 t -50.45 -53.05 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.328 1.051 . . . . 0.0 110.229 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -57.02 -51.75 68.02 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.55 1.14 . . . . 0.0 111.15 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.4 m -58.91 -54.37 47.87 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.566 0.746 . . . . 0.0 111.392 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.2 mt -54.08 -56.2 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.46 1.104 . . . . 0.0 109.438 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -55.09 -53.41 56.27 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.14 0.976 . . . . 0.0 110.924 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.47 -53.82 42.01 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.463 1.03 . . . . 0.0 112.296 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.6 t -59.48 -53.42 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.449 0.7 . . . . 0.0 110.392 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.0 mt -63.62 -39.94 87.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.108 0.563 . . . . 0.0 111.237 -174.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.2 t -49.92 -34.68 21.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.99 0.916 . . . . 0.0 112.355 176.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -89.05 -9.8 49.88 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.699 0.8 . . . . 0.0 112.427 -172.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -72.56 137.62 80.59 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 119.341 0.973 . . . . 0.0 109.91 177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.39 136.03 20.0 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.718 2.945 . . . . 0.0 112.259 172.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.69 -43.31 1.83 Allowed Glycine 0 CA--C 1.523 0.541 0 CA-C-O 119.221 -0.766 . . . . 0.0 111.823 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.6 t -69.78 133.72 31.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 CA-C-N 117.76 0.78 . . . . 0.0 109.513 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -107.25 -98.1 0.36 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.9 p -90.15 149.04 22.62 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.546 0.738 . . . . 0.0 109.917 176.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.6 tt -150.53 143.17 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.239 1.016 . . . . 0.0 109.574 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -138.59 118.76 13.52 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.836 1.254 . . . . 0.0 108.342 175.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.19 147.02 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.889 1.275 . . . . 0.0 108.225 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.1 t -139.67 127.5 22.01 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 123.828 0.851 . . . . 0.0 110.749 -174.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp -68.17 -50.5 54.04 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.649 1.179 . . . . 0.0 109.47 171.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.56 -46.29 70.19 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.825 1.25 . . . . 0.0 111.73 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -89.36 -10.55 46.24 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.261 0.624 . . . . 0.0 111.586 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.7 m 53.11 55.18 9.23 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.368 1.467 . . . . 0.0 110.846 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -158.88 171.43 20.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.953 0.501 . . . . 0.0 111.698 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.31 116.06 1.86 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 126.376 1.941 . . . . 0.0 109.162 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.8 m -99.33 112.17 24.4 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.0 t -120.0 136.26 57.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.429 1.092 . . . . 0.0 109.819 -170.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -109.64 128.29 55.13 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 169.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -150.3 173.37 14.05 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -168.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -105.4 112.67 64.82 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.442 1.497 . . . . 0.0 109.483 174.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -41.64 -39.71 4.94 Favored 'Trans proline' 0 C--N 1.348 0.52 1 C-N-CA 125.585 4.19 . . . . 0.0 115.272 171.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.6 -33.12 74.35 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.292 0.637 . . . . 0.0 112.017 -177.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.2 mt -106.39 -31.52 8.54 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.297 1.039 . . . . 0.0 112.293 -171.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 t -150.26 175.43 11.8 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.392 0.677 . . . . 0.0 109.961 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.4 p -149.07 164.62 20.38 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.2 1.0 . . . . 0.0 110.328 -174.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.32 -39.45 86.99 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.449 2.766 . . . . 0.0 112.096 174.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.51 -39.03 81.39 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.634 0.774 . . . . 0.0 111.447 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.6 m -62.93 -46.74 86.35 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 45.8 mt -59.87 -50.46 73.68 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.085 0.954 . . . . 0.0 110.609 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -51.53 -48.4 63.01 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.679 1.191 . . . . 0.0 110.46 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.71 -45.32 93.51 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.452 1.025 . . . . 0.0 112.219 177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.85 -46.48 87.69 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.493 0.717 . . . . 0.0 110.991 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.1 mt -60.02 -44.07 93.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 123.528 0.731 . . . . 0.0 109.97 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -60.99 -42.49 98.51 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.638 0.775 . . . . 0.0 111.075 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -61.7 -43.43 98.87 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.663 0.785 . . . . 0.0 111.119 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.8 mtp -59.64 -45.17 92.79 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.746 0.419 . . . . 0.0 110.442 175.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.83 53.38 0.1 Allowed Glycine 0 C--N 1.341 0.817 0 C-N-CA 123.509 0.576 . . . . 0.0 112.477 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -140.46 133.01 28.67 Favored 'General case' 0 C--N 1.338 0.104 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 172.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -73.01 104.56 4.15 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -103.5 139.85 38.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.157 1.383 . . . . 0.0 110.59 -172.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.8 p -142.3 145.28 33.82 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.525 1.13 . . . . 0.0 108.793 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 52.6 mt . . . . . 0 CA--C 1.531 0.228 0 C-N-CA 122.826 0.45 . . . . 0.0 110.189 -176.226 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 CA--C 1.529 0.157 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -140.27 164.03 31.17 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.663 1.585 . . . . 0.0 108.265 170.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -127.27 150.0 49.76 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.471 1.108 . . . . 0.0 109.278 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -144.72 150.25 36.96 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.029 0.932 . . . . 0.0 109.706 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.0 t -112.5 127.18 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 171.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.0 mt -121.73 121.55 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -80.0 130.75 35.51 Favored 'General case' 0 N--CA 1.458 -0.061 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.8 mt -127.76 96.96 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -172.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -99.67 153.77 18.82 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.17 6.78 53.31 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.505 1.05 . . . . 0.0 112.345 -172.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 63.4 mtm -79.34 120.78 24.27 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.642 1.221 . . . . 0.0 108.474 175.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.5 p -84.4 -40.14 18.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.088 0.955 . . . . 0.0 110.989 -173.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.9 p -159.07 179.78 8.74 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.779 0.431 . . . . 0.0 110.327 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -59.22 -25.99 64.47 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.816 1.247 . . . . 0.0 113.279 -176.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.9 m -53.4 -41.28 65.81 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.488 0.586 . . . . 0.0 111.207 174.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.2 m -63.49 -48.35 77.99 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 123.384 0.674 . . . . 0.0 110.374 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.9 t -54.09 -52.17 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.348 1.059 . . . . 0.0 109.858 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -64.45 -46.38 83.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.904 0.881 . . . . 0.0 111.475 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.2 p -61.51 -47.41 85.73 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.085 0.402 . . . . 0.0 110.601 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.6 mt -56.24 -54.81 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 123.39 0.676 . . . . 0.0 109.613 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -49.95 -57.97 6.42 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.965 0.906 . . . . 0.0 110.204 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.55 -53.26 44.88 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.255 0.931 . . . . 0.0 112.583 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.83 -50.38 75.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.314 0.646 . . . . 0.0 111.116 -174.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.65 -32.65 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.091 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.1 m -55.2 -20.08 9.66 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -89.12 -10.83 45.8 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.866 0.757 . . . . 0.0 112.212 -176.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -73.19 127.21 89.57 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -47.45 128.9 15.67 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.854 3.036 . . . . 0.0 112.569 176.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.24 -33.18 6.74 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-O 118.592 -1.115 . . . . 0.0 112.655 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.6 t -65.27 136.91 25.93 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 CA-C-N 118.208 1.004 . . . . 0.0 110.623 -176.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -119.22 -103.06 0.41 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.34 1.456 . . . . 0.0 108.163 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 82.7 p -80.74 151.96 28.59 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.255 0.479 . . . . 0.0 110.133 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -150.25 138.88 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.248 1.019 . . . . 0.0 108.961 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -138.93 101.22 4.24 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.454 1.501 . . . . 0.0 107.712 -172.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 t -110.5 144.93 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.521 1.128 . . . . 0.0 108.865 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -146.51 130.93 17.64 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.312 0.645 . . . . 0.0 111.127 -175.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.8 tp -70.49 -48.82 53.87 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.882 1.273 . . . . 0.0 109.454 171.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.24 -46.26 69.07 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.759 1.224 . . . . 0.0 111.667 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -89.37 -10.15 47.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.194 0.597 . . . . 0.0 111.493 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.5 m 52.67 58.86 4.93 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.377 1.471 . . . . 0.0 110.488 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -158.42 169.19 25.01 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.203 0.525 . . . . 0.0 111.856 -174.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.82 113.58 1.05 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 126.652 2.073 . . . . 0.0 108.102 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.9 m -99.68 130.83 45.93 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 174.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.7 t -135.02 135.22 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 123.353 0.661 . . . . 0.0 109.766 -171.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -101.11 131.08 47.21 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 169.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -150.49 162.35 40.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.987 0.515 . . . . 0.0 111.99 -170.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -91.59 116.1 65.8 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 124.691 1.196 . . . . 0.0 109.49 170.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -48.59 -36.51 32.14 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 124.575 3.517 . . . . 0.0 114.231 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.4 mt -64.59 -28.95 69.98 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.602 0.761 . . . . 0.0 111.988 -176.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.7 mt -109.8 -28.63 8.7 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.047 0.939 . . . . 0.0 112.401 -172.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 t -152.43 178.63 9.34 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.792 0.724 . . . . 0.0 109.991 176.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.5 p -150.34 163.95 22.34 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.64 1.176 . . . . 0.0 109.756 -174.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.89 -38.49 85.95 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.257 2.638 . . . . 0.0 112.324 174.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -66.07 -45.34 81.66 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.26 1.024 . . . . 0.0 110.357 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 m -61.86 -47.26 85.81 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.185 0.594 . . . . 0.0 110.449 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.5 mt -60.16 -50.16 74.78 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.902 0.881 . . . . 0.0 110.382 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 57.5 ttp85 -52.04 -45.32 64.62 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.872 0.869 . . . . 0.0 110.342 172.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.73 -45.28 69.43 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.517 1.056 . . . . 0.0 112.163 175.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.85 -47.97 82.64 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.759 0.779 . . . . 0.0 111.265 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.1 mm -59.63 -45.53 94.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 122.668 0.387 . . . . 0.0 110.484 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -60.0 -41.81 92.93 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.251 1.02 . . . . 0.0 110.559 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.59 -44.49 96.19 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.952 0.901 . . . . 0.0 111.078 176.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.8 mtp -58.81 -41.55 87.04 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.737 0.415 . . . . 0.0 110.735 175.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.31 61.36 0.25 Allowed Glycine 0 C--N 1.34 0.76 0 C-N-CA 123.829 0.728 . . . . 0.0 112.107 169.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -140.45 155.02 46.84 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 123.955 0.902 . . . . 0.0 109.007 170.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -78.72 94.95 5.18 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.82 126.5 45.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.014 1.326 . . . . 0.0 109.897 -176.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.2 p -136.49 131.7 34.32 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.519 1.128 . . . . 0.0 109.162 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.5 mt . . . . . 0 CA--C 1.531 0.221 0 C-N-CA 123.327 0.651 . . . . 0.0 109.591 179.047 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 46.4 p . . . . . 0 CA--C 1.53 0.18 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -142.08 167.07 22.99 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.604 1.562 . . . . 0.0 108.695 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -129.12 153.8 47.32 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.573 1.149 . . . . 0.0 109.568 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -148.08 144.48 27.89 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.86 0.864 . . . . 0.0 110.073 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.7 t -106.9 107.46 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.7 mt -99.75 116.06 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -76.59 120.77 22.25 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 175.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -114.29 110.77 33.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -174.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -99.58 147.46 25.33 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.062 0.945 . . . . 0.0 108.639 173.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.44 4.98 52.59 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.328 0.966 . . . . 0.0 112.874 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 66.6 mtm -79.46 110.92 15.21 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.72 1.26 . . . . 0.0 107.982 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.8 p -84.4 -39.37 19.1 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.8 0.84 . . . . 0.0 110.965 -173.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.6 p -156.43 -179.47 8.2 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.715 0.293 . . . . 0.0 110.643 -175.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -55.16 -32.59 62.25 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.193 1.397 . . . . 0.0 112.981 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m -52.96 -39.85 63.26 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.416 0.687 . . . . 0.0 111.615 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.7 m -66.8 -48.05 70.16 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 122.858 0.463 . . . . 0.0 110.354 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.7 t -52.77 -55.08 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.046 0.938 . . . . 0.0 109.731 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -54.81 -52.95 61.06 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.141 1.376 . . . . 0.0 110.674 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.8 t -56.53 -55.87 28.44 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.697 0.799 . . . . 0.0 111.132 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.8 mt -57.21 -54.56 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.707 0.803 . . . . 0.0 109.641 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -55.02 -52.4 63.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.029 0.532 . . . . 0.0 110.666 -177.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.13 -51.11 60.34 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.681 1.134 . . . . 0.0 112.414 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.7 t -67.7 -57.24 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 117.801 0.801 . . . . 0.0 110.848 -176.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.4 mm -60.3 -34.54 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.561 0.744 . . . . 0.0 111.538 -173.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.9 p -54.13 -27.86 36.12 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -89.15 -20.04 24.74 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.29 0.636 . . . . 0.0 111.798 -175.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.59 141.72 93.31 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 118.509 0.595 . . . . 0.0 109.906 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -62.13 136.64 61.67 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.485 2.79 . . . . 0.0 111.304 -169.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.95 -40.39 2.45 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-O 118.996 -0.891 . . . . 0.0 111.583 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.2 131.52 33.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-N 118.103 0.952 . . . . 0.0 110.166 -176.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -101.2 -101.5 0.26 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.733 1.213 . . . . 0.0 107.732 173.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.5 p -87.92 151.48 22.79 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.77 0.828 . . . . 0.0 109.908 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.9 tt -150.18 137.92 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 123.907 0.883 . . . . 0.0 109.365 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -130.59 112.84 13.53 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.835 1.254 . . . . 0.0 108.479 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.9 t -101.4 147.92 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.379 1.072 . . . . 0.0 108.496 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.8 t -147.02 127.0 13.61 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.644 0.778 . . . . 0.0 110.463 -175.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.9 tp -70.32 -46.01 65.06 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.801 1.241 . . . . 0.0 109.937 172.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.64 -43.47 65.46 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.655 1.182 . . . . 0.0 111.498 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -89.26 -19.95 24.72 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.579 0.752 . . . . 0.0 111.099 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.5 m 57.43 53.82 7.15 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.478 1.511 . . . . 0.0 110.06 -175.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.9 p30 -153.85 172.93 16.59 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.976 0.511 . . . . 0.0 111.918 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.89 113.89 1.19 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 127.128 2.299 . . . . 0.0 107.96 176.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.0 m -98.96 104.34 16.38 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 t -111.47 133.48 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 124.517 1.127 . . . . 0.0 109.849 -169.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -103.58 133.39 48.68 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 169.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -150.45 170.51 18.91 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -171.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -103.19 112.89 66.04 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 125.586 1.554 . . . . 0.0 109.242 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -43.22 -38.98 8.29 Favored 'Trans proline' 0 C--N 1.348 0.531 1 C-N-CA 125.535 4.157 . . . . 0.0 114.987 173.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.41 -34.72 77.31 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.365 0.666 . . . . 0.0 111.811 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.6 mt -101.88 -32.14 10.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.248 1.019 . . . . 0.0 112.177 -172.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.5 t -152.04 175.83 12.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.185 0.594 . . . . 0.0 110.109 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.6 p -150.13 165.28 17.86 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 124.598 1.159 . . . . 0.0 109.635 -175.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -51.06 -46.18 32.42 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.606 2.871 . . . . 0.0 113.075 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -68.58 -34.67 76.2 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.186 0.594 . . . . 0.0 111.865 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.4 m -65.8 -45.45 82.33 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.126 0.421 . . . . 0.0 109.988 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.7 mt -64.45 -44.58 90.67 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.194 0.998 . . . . 0.0 110.692 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.6 ttp180 -53.78 -50.64 65.63 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.64 0.776 . . . . 0.0 109.18 171.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.74 -44.46 60.57 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.02 1.295 . . . . 0.0 112.565 176.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.09 -44.05 96.79 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.816 0.846 . . . . 0.0 111.09 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.6 mt -65.94 -39.76 85.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.21 0.604 . . . . 0.0 110.388 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -62.63 -38.88 91.98 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.506 0.722 . . . . 0.0 110.928 174.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -62.41 -41.36 98.63 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.321 0.648 . . . . 0.0 110.831 176.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.8 mtp -60.52 -48.39 81.96 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.028 0.376 . . . . 0.0 110.241 172.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.58 60.6 0.1 Allowed Glycine 0 C--N 1.341 0.811 0 C-N-CA 123.706 0.669 . . . . 0.0 111.956 170.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -140.35 149.97 43.38 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.624 0.77 . . . . 0.0 109.756 173.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -80.28 87.13 5.59 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.928 0.891 . . . . 0.0 108.691 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.57 140.8 33.23 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.006 0.923 . . . . 0.0 111.007 -175.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.0 t -150.31 160.15 43.93 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.698 1.199 . . . . 0.0 109.146 174.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 CA--C 1.532 0.251 0 C-N-CA 123.15 0.58 . . . . 0.0 110.205 -177.948 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.5 p . . . . . 0 CA--C 1.53 0.208 0 CA-C-O 120.784 0.326 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -134.22 162.81 31.13 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.14 1.376 . . . . 0.0 109.262 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -125.41 145.53 50.01 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.971 1.308 . . . . 0.0 108.695 176.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.7 t -142.8 145.51 33.3 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.824 0.85 . . . . 0.0 109.625 176.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.5 t -106.51 130.88 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 172.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.4 mt -125.62 125.19 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -69.91 129.38 39.36 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.1 mt -121.63 103.82 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -100.01 150.8 22.07 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.077 0.951 . . . . 0.0 109.407 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.74 26.2 23.13 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.674 1.131 . . . . 0.0 112.099 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 93.4 mtp -85.59 111.55 20.15 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.6 p -84.5 -44.84 13.23 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.492 0.717 . . . . 0.0 111.469 -170.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.9 p -159.05 -179.97 8.51 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.415 0.686 . . . . 0.0 109.721 -175.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -56.22 -29.32 60.83 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.819 1.247 . . . . 0.0 113.204 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.5 m -52.19 -41.18 62.45 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.154 0.582 . . . . 0.0 111.428 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.5 m -64.84 -46.53 81.51 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 122.692 0.397 . . . . 0.0 110.503 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.8 t -53.06 -55.15 13.56 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 C-N-CA 123.489 0.716 . . . . 0.0 109.342 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -56.71 -52.11 66.21 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.563 1.145 . . . . 0.0 111.224 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.9 m -58.99 -56.61 20.01 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.68 0.792 . . . . 0.0 111.222 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.4 mt -56.08 -51.96 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 123.651 0.78 . . . . 0.0 109.401 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -56.51 -53.52 56.52 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.856 0.462 . . . . 0.0 110.68 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.8 -54.55 36.6 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.687 0.66 . . . . 0.0 112.372 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.3 t -62.81 -55.35 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.794 0.838 . . . . 0.0 111.043 -174.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.0 mm -62.33 -37.11 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 118.778 -0.63 . . . . 0.0 110.932 -175.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.8 t -51.86 -35.11 43.67 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 118.798 0.726 . . . . 0.0 112.358 175.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -89.0 -12.18 42.14 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.778 0.831 . . . . 0.0 111.988 -173.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -70.4 143.62 90.77 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 119.016 0.825 . . . . 0.0 109.631 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -62.26 137.76 67.74 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.343 2.695 . . . . 0.0 111.021 -171.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.43 -41.02 2.38 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-O 119.059 -0.856 . . . . 0.0 111.311 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.2 t -70.88 141.39 16.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.199 0 CA-C-N 118.106 0.953 . . . . 0.0 109.442 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -112.91 -94.28 0.46 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.5 p -90.82 155.61 18.64 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.713 0.805 . . . . 0.0 109.787 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.4 tt -150.85 137.17 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.058 0.943 . . . . 0.0 108.47 174.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -117.95 99.46 6.92 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.68 1.592 . . . . 0.0 108.565 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.2 t -94.3 144.9 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.791 0.836 . . . . 0.0 109.601 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.5 t -147.37 122.48 10.15 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.785 0.834 . . . . 0.0 110.14 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.9 tt -70.15 -43.75 70.23 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.187 0.995 . . . . 0.0 109.564 170.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.5 -45.83 69.81 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.216 1.006 . . . . 0.0 111.566 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -89.68 -5.57 56.94 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.48 0.712 . . . . 0.0 111.778 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.0 m 51.8 53.82 11.98 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.679 1.591 . . . . 0.0 111.212 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -159.5 173.42 16.2 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -174.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.65 118.77 1.93 Allowed Glycine 0 C--N 1.339 0.72 0 C-N-CA 126.208 1.861 . . . . 0.0 109.001 174.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.8 m -99.68 97.9 8.8 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.2 t -100.63 132.2 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.698 1.199 . . . . 0.0 110.198 -169.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -105.31 126.56 52.24 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 172.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -150.15 169.17 21.93 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -169.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -102.91 115.77 63.63 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.309 1.443 . . . . 0.0 109.709 175.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -45.17 -41.03 16.58 Favored 'Trans proline' 0 C--N 1.348 0.523 1 C-N-CA 125.806 4.338 . . . . 0.0 115.635 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.1 mt -67.12 -29.69 69.49 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.922 0.489 . . . . 0.0 111.781 -174.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.52 -35.3 9.92 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.872 0.869 . . . . 0.0 110.989 -175.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.4 t -150.79 170.98 17.95 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.538 0.608 . . . . 0.0 110.576 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.5 p -150.03 161.86 29.76 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.995 1.318 . . . . 0.0 109.507 -172.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -50.12 -48.46 19.7 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.684 2.923 . . . . 0.0 113.434 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -58.81 -40.18 83.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.724 0.81 . . . . 0.0 112.044 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 m -66.35 -45.26 80.78 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.247 0.619 . . . . 0.0 109.862 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.4 mt -64.3 -43.32 95.09 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.178 0.991 . . . . 0.0 110.944 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.0 ttp85 -56.3 -48.09 77.37 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.85 0.86 . . . . 0.0 109.573 172.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.11 -41.08 92.45 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.28 0.943 . . . . 0.0 112.571 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.34 -47.41 76.58 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.67 0.788 . . . . 0.0 111.036 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.0 mt -62.83 -41.39 92.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.242 0.617 . . . . 0.0 109.7 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -58.75 -43.58 90.33 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.359 0.664 . . . . 0.0 110.803 175.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.7 -39.5 88.75 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.735 0.814 . . . . 0.0 111.429 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.2 mtp -59.25 -44.8 92.38 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 118.234 0.47 . . . . 0.0 110.593 173.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.93 61.5 0.1 Allowed Glycine 0 C--N 1.341 0.84 0 C-N-CA 123.533 0.587 . . . . 0.0 111.88 169.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -140.5 156.64 46.27 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.98 0.912 . . . . 0.0 109.544 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -79.5 90.46 5.09 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 174.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.47 125.52 45.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.69 1.196 . . . . 0.0 109.774 -174.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.4 p -145.62 135.18 23.25 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.314 1.046 . . . . 0.0 108.949 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.1 mt . . . . . 0 CA--C 1.531 0.231 0 C-N-CA 123.682 0.793 . . . . 0.0 111.866 -176.289 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.4 p . . . . . 0 N--CA 1.457 -0.113 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -135.68 170.41 16.01 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.861 1.665 . . . . 0.0 108.122 172.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -140.13 123.93 17.38 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 t -113.06 134.83 54.35 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.838 1.255 . . . . 0.0 109.22 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.3 t -99.55 125.27 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 169.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.5 mt -120.96 119.73 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -73.92 125.59 28.56 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.8 mt -118.22 107.43 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 125.053 1.341 . . . . 0.0 107.388 -176.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -99.79 135.5 41.12 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.58 0.9 20.07 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.854 1.216 . . . . 0.0 112.791 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.8 mtm -78.6 100.09 6.82 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.4 m -84.33 -36.09 22.8 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.974 1.31 . . . . 0.0 111.235 -169.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.1 p -153.45 179.57 8.66 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.026 0.376 . . . . 0.0 110.285 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -56.29 -30.13 62.08 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.178 1.391 . . . . 0.0 112.931 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 m -55.46 -43.91 75.9 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.434 0.694 . . . . 0.0 111.243 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.1 m -61.76 -53.13 60.16 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.5 t -49.91 -56.22 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.502 1.121 . . . . 0.0 110.146 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -63.34 -46.86 84.65 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.944 0.898 . . . . 0.0 111.586 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.6 p -60.99 -49.97 75.3 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.629 0.372 . . . . 0.0 110.994 -177.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.7 mt -55.88 -55.24 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -52.24 -54.35 32.22 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.792 0.837 . . . . 0.0 111.117 -176.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.14 -52.18 53.65 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 124.117 0.865 . . . . 0.0 112.458 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.2 t -64.03 -49.28 82.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 117.456 0.628 . . . . 0.0 111.044 -174.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.6 mm -64.65 -33.81 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.229 0.612 . . . . 0.0 111.217 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.1 t -53.71 -24.75 15.66 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 177.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -88.53 -8.33 54.99 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.424 0.69 . . . . 0.0 112.121 -172.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -74.06 128.18 86.83 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -46.81 133.84 17.51 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.703 2.935 . . . . 0.0 112.232 175.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.99 -42.11 1.97 Allowed Glycine 0 C--N 1.337 0.593 0 CA-C-O 119.037 -0.868 . . . . 0.0 111.47 -177.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.2 t -67.3 130.47 32.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 CA-C-N 117.846 0.823 . . . . 0.0 109.612 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -105.44 -94.48 0.35 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.4 p -90.05 154.96 19.41 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.482 0.713 . . . . 0.0 109.466 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.6 tt -150.25 135.42 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 37.7 mtt85 -131.56 93.9 3.43 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.66 1.184 . . . . 0.0 108.229 -169.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.2 t -95.29 141.91 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 123.648 0.779 . . . . 0.0 109.21 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.2 t -144.96 125.73 14.28 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.012 0.925 . . . . 0.0 110.283 -175.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 tt -71.43 -44.04 65.6 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.731 1.212 . . . . 0.0 110.039 172.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.05 -43.02 63.59 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.321 1.048 . . . . 0.0 111.449 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -89.4 -20.81 23.5 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.626 0.77 . . . . 0.0 111.141 177.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.7 m 57.76 54.68 6.03 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.646 1.578 . . . . 0.0 109.956 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.9 p30 -154.64 171.27 19.77 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.031 0.533 . . . . 0.0 112.104 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.92 114.34 1.56 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 126.506 2.003 . . . . 0.0 108.15 174.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.9 m -99.42 95.92 7.35 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.9 t -100.73 122.08 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 125.088 1.355 . . . . 0.0 109.12 -171.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -89.83 128.2 36.12 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -150.22 165.28 33.41 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -169.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -101.24 113.7 65.8 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.654 1.182 . . . . 0.0 108.885 171.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -45.57 -38.98 17.14 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.972 3.781 . . . . 0.0 114.884 174.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.0 mt -63.91 -28.9 70.15 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.736 0.814 . . . . 0.0 112.017 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.58 -41.81 7.18 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.08 0.952 . . . . 0.0 110.719 -175.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.8 t -143.83 156.97 44.66 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 123.64 0.776 . . . . 0.0 109.92 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.6 p -117.64 162.67 27.63 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 124.815 1.246 . . . . 0.0 109.9 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.07 -41.77 55.7 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.257 2.638 . . . . 0.0 112.385 171.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -63.36 -41.41 98.84 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.921 0.888 . . . . 0.0 111.872 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.9 m -59.67 -49.18 78.75 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.207 0.458 . . . . 0.0 110.026 176.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.4 mt -62.67 -45.71 91.56 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.021 0.929 . . . . 0.0 110.744 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 65.5 ttp85 -55.05 -50.51 68.91 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.032 0.933 . . . . 0.0 109.886 174.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.8 -42.65 86.19 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.633 1.111 . . . . 0.0 112.253 177.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.28 -39.25 94.05 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 117.446 0.623 . . . . 0.0 111.273 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.3 mt -69.72 -36.66 71.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.969 -0.457 . . . . 0.0 110.583 177.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -59.82 -41.09 90.53 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.83 -0.544 . . . . 0.0 110.273 171.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -63.2 -41.88 99.24 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.121 0.569 . . . . 0.0 111.246 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.7 mmm -57.72 -40.69 80.18 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.12 0.418 . . . . 0.0 110.663 172.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.86 55.77 0.31 Allowed Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.144 0.878 . . . . 0.0 111.622 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -140.44 151.04 44.57 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.752 0.821 . . . . 0.0 109.605 175.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -77.15 94.2 4.04 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.74 134.17 43.03 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.073 1.349 . . . . 0.0 109.639 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.2 t -146.31 140.49 26.49 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.842 0.857 . . . . 0.0 109.498 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.7 mt . . . . . 0 N--CA 1.455 -0.195 0 C-N-CA 123.048 0.539 . . . . 0.0 110.651 -175.876 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.4 p . . . . . 0 N--CA 1.457 -0.104 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -138.44 164.08 30.28 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.747 1.619 . . . . 0.0 108.686 176.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -121.53 144.61 48.62 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.542 1.137 . . . . 0.0 108.986 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.3 t -139.3 143.05 37.71 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.059 0.944 . . . . 0.0 109.445 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.4 t -107.71 116.61 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 172.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.0 mm -99.77 124.14 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 174.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -82.1 111.76 18.53 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 174.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 57.2 mt -107.52 106.09 20.01 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 C-N-CA 124.531 1.132 . . . . 0.0 108.334 -173.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -99.75 128.46 45.84 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.52 -4.66 7.62 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.397 0.999 . . . . 0.0 112.917 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 62.9 mtm -78.56 105.86 10.12 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.9 m -84.45 -34.97 23.33 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.335 1.054 . . . . 0.0 109.99 -173.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 p -158.55 167.63 29.09 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.283 0.633 . . . . 0.0 109.98 -175.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -60.13 -20.97 60.9 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.014 1.325 . . . . 0.0 113.791 -170.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.9 p -52.71 -43.0 65.34 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.715 0.689 . . . . 0.0 110.65 171.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 76.7 m -66.74 -48.22 69.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.528 0.731 . . . . 0.0 110.5 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.7 t -50.79 -53.25 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 123.986 0.915 . . . . 0.0 110.353 176.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -58.24 -50.01 75.07 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.731 1.212 . . . . 0.0 111.107 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.2 m -59.5 -54.54 45.35 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.213 0.605 . . . . 0.0 111.206 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.4 mt -54.53 -54.89 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 124.717 1.207 . . . . 0.0 109.742 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -56.34 -53.11 61.21 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.567 0.747 . . . . 0.0 110.713 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.2 -51.61 45.72 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.525 1.06 . . . . 0.0 112.128 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.0 -54.3 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.349 0.659 . . . . 0.0 110.415 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.41 -36.65 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.002 0.521 . . . . 0.0 111.58 -174.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.9 m -52.27 -30.75 29.33 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.501 0.721 . . . . 0.0 112.767 176.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -89.22 -9.95 48.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.583 0.753 . . . . 0.0 112.242 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -74.66 140.09 74.7 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 118.901 0.773 . . . . 0.0 109.874 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -64.83 137.93 55.74 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.992 2.462 . . . . 0.0 110.131 -175.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.7 -37.39 3.61 Favored Glycine 0 CA--C 1.525 0.656 0 CA-C-O 118.898 -0.946 . . . . 0.0 111.748 -176.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.6 t -67.6 141.16 18.12 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 CA-C-N 117.98 0.89 . . . . 0.0 110.418 -175.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -120.73 -102.85 0.41 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.632 1.173 . . . . 0.0 108.501 176.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.7 p -84.55 147.19 27.15 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.553 0.615 . . . . 0.0 109.807 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -150.22 139.95 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 123.642 0.777 . . . . 0.0 110.055 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.24 101.86 4.99 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.946 1.298 . . . . 0.0 108.498 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -97.54 139.0 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 174.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.2 t -135.23 129.05 33.07 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.176 0.99 . . . . 0.0 110.662 -173.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.1 tp -66.73 -52.97 38.31 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.36 1.064 . . . . 0.0 109.145 170.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.8 -49.03 66.45 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 125.041 1.336 . . . . 0.0 111.908 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -89.3 -6.28 56.87 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.012 0.525 . . . . 0.0 111.861 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.8 m 51.27 53.71 12.43 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.257 1.423 . . . . 0.0 111.229 176.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -156.98 172.17 19.16 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.811 0.444 . . . . 0.0 111.725 -174.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.97 112.38 1.01 Allowed Glycine 0 C--N 1.338 0.667 0 C-N-CA 126.215 1.864 . . . . 0.0 108.982 177.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.9 m -99.04 103.81 15.78 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 t -115.02 127.6 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 124.579 1.151 . . . . 0.0 109.831 -169.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -96.17 132.79 41.22 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 168.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -150.11 166.74 28.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.491 0.716 . . . . 0.0 110.887 -170.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -99.81 113.66 65.22 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.395 1.078 . . . . 0.0 109.062 172.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -43.02 -37.85 6.67 Favored 'Trans proline' 0 C--N 1.349 0.58 1 C-N-CA 125.377 4.051 . . . . 0.0 115.137 172.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.8 mt -63.89 -32.3 73.77 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.449 0.699 . . . . 0.0 111.997 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.72 -43.31 6.5 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.935 0.894 . . . . 0.0 111.076 -174.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.8 t -142.86 176.75 8.83 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.423 0.689 . . . . 0.0 110.315 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.0 p -150.26 162.0 29.06 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 124.271 1.028 . . . . 0.0 110.288 -172.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -53.25 -43.57 56.2 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.645 2.896 . . . . 0.0 112.899 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.17 -34.66 78.58 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.635 0.774 . . . . 0.0 112.183 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.5 m -71.51 -47.08 57.63 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.177 0.591 . . . . 0.0 109.816 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 59.8 mt -59.56 -47.72 84.45 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.903 0.881 . . . . 0.0 110.123 177.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -53.97 -50.04 67.42 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.31 1.044 . . . . 0.0 110.06 172.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.34 -44.84 65.83 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.641 1.115 . . . . 0.0 112.461 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.16 -42.47 98.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.479 0.639 . . . . 0.0 111.106 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.0 mt -66.5 -41.8 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 122.934 0.493 . . . . 0.0 110.526 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -59.49 -41.88 90.84 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.55 0.74 . . . . 0.0 110.563 174.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.22 -44.85 95.65 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.378 0.671 . . . . 0.0 111.098 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.0 mtm -60.87 -36.18 78.54 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.701 0.401 . . . . 0.0 111.215 174.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.68 59.12 0.31 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 123.803 0.716 . . . . 0.0 112.225 169.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -140.3 146.79 38.99 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.923 0.889 . . . . 0.0 108.638 172.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -76.01 90.99 3.04 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.59 132.68 44.77 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.278 1.031 . . . . 0.0 109.886 -177.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.1 m -140.32 152.76 46.09 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.077 1.351 . . . . 0.0 107.646 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 mm? . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.274 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.1 p . . . . . 0 CA--C 1.529 0.138 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -117.32 164.49 14.75 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.376 1.071 . . . . 0.0 108.789 170.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -133.02 146.83 52.1 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.141 0.977 . . . . 0.0 109.717 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.1 t -138.85 142.3 38.62 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.28 1.032 . . . . 0.0 109.518 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.5 t -112.75 102.35 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 175.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.7 mt -99.99 112.98 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -66.05 123.69 20.55 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.1 mt -111.31 125.89 68.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -131.79 151.18 51.85 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.396 0.679 . . . . 0.0 109.861 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.47 36.23 6.62 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.803 1.192 . . . . 0.0 112.095 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -88.67 144.6 26.18 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 117.68 0.74 . . . . 0.0 109.015 174.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.0 p -84.69 -43.73 14.07 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.393 0.677 . . . . 0.0 109.807 177.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.7 p -163.69 -175.51 4.17 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.702 0.801 . . . . 0.0 109.956 -175.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -61.17 -27.64 68.55 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.121 1.369 . . . . 0.0 113.863 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.9 p -59.16 -33.53 71.03 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.638 0.654 . . . . 0.0 111.455 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 80.3 m -60.8 -56.07 25.57 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.154 0.582 . . . . 0.0 109.572 175.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.2 t -53.53 -47.19 60.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.788 1.235 . . . . 0.0 111.08 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -56.47 -52.91 62.94 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.83 0.852 . . . . 0.0 110.679 176.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.5 t -59.15 -51.17 71.18 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.881 0.872 . . . . 0.0 111.259 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.4 mt -52.65 -53.19 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.775 1.23 . . . . 0.0 109.551 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -54.74 -53.16 58.7 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.507 0.723 . . . . 0.0 110.698 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.14 -51.72 48.51 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.389 0.995 . . . . 0.0 112.266 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.0 t -58.94 -52.38 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.728 0.811 . . . . 0.0 110.436 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.24 -37.79 79.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 119.018 -0.515 . . . . 0.0 111.516 -176.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.6 m -52.21 -29.65 23.64 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 177.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -89.22 -8.34 53.73 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.482 0.713 . . . . 0.0 112.416 -175.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -73.84 138.28 76.61 Favored Pre-proline 0 CA--C 1.535 0.365 0 CA-C-N 119.082 0.855 . . . . 0.0 110.254 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -66.47 131.34 26.02 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.858 2.372 . . . . 0.0 109.394 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.24 -39.29 2.96 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-O 118.915 -0.936 . . . . 0.0 111.444 -175.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.6 t -66.43 135.63 28.14 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 117.955 0.878 . . . . 0.0 109.8 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -111.47 -99.62 0.41 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.024 1.329 . . . . 0.0 107.886 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.3 p -90.43 154.66 19.49 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.768 0.827 . . . . 0.0 109.628 172.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 tt -150.6 146.13 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 123.474 0.71 . . . . 0.0 110.447 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -140.1 107.91 5.67 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.837 1.255 . . . . 0.0 107.711 169.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.0 t -98.42 130.65 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 170.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.9 t -124.7 130.83 53.17 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.426 1.09 . . . . 0.0 110.169 -173.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.8 tp -72.56 -48.49 39.67 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.25 1.02 . . . . 0.0 108.936 172.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.85 -47.36 74.28 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.94 1.296 . . . . 0.0 111.626 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -89.3 -7.55 55.15 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.982 0.513 . . . . 0.0 111.525 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.6 m 53.45 54.01 10.76 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 125.234 1.413 . . . . 0.0 111.153 175.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -159.29 169.91 23.02 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.919 -175.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.35 107.2 1.0 Allowed Glycine 0 C--N 1.337 0.596 0 C-N-CA 126.613 2.054 . . . . 0.0 108.614 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.0 m -98.6 96.17 7.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.4 t -109.31 127.49 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 124.587 1.155 . . . . 0.0 108.924 -172.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -97.91 130.7 44.78 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 169.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -150.21 170.7 18.34 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.268 0.627 . . . . 0.0 112.171 -169.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -106.07 114.6 62.36 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.033 1.333 . . . . 0.0 109.477 173.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -44.3 -36.26 9.07 Favored 'Trans proline' 0 C--N 1.348 0.527 1 C-N-CA 125.528 4.152 . . . . 0.0 115.486 174.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.02 -32.36 74.05 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.259 0.624 . . . . 0.0 111.99 -176.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.3 mt -108.17 -29.62 8.83 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.005 0.922 . . . . 0.0 112.371 -171.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.5 t -148.11 175.25 11.18 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.719 0.69 . . . . 0.0 109.615 173.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.8 p -146.94 163.39 28.92 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 123.65 0.78 . . . . 0.0 110.33 -175.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -52.08 -41.99 61.54 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.475 2.783 . . . . 0.0 112.012 173.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -67.82 -39.62 83.89 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.724 0.81 . . . . 0.0 111.474 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.8 m -61.65 -50.36 72.82 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.83 0.452 . . . . 0.0 109.998 176.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 50.8 mt -60.2 -48.13 83.02 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.271 1.029 . . . . 0.0 110.63 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -54.09 -51.2 64.9 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.62 1.168 . . . . 0.0 110.279 175.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.52 -44.73 85.66 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.482 1.039 . . . . 0.0 111.803 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.3 -46.86 86.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.27 0.628 . . . . 0.0 111.354 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -61.34 -39.6 83.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 123.069 0.548 . . . . 0.0 110.093 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.73 -40.68 95.74 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.98 0.512 . . . . 0.0 110.901 177.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -64.01 -43.17 96.44 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.053 0.941 . . . . 0.0 110.982 176.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 79.5 mmm -56.09 -41.39 75.1 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.546 0.738 . . . . 0.0 110.2 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.15 53.5 0.23 Allowed Glycine 0 C--N 1.341 0.859 0 C-N-CA 123.994 0.806 . . . . 0.0 112.02 169.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -140.45 145.61 37.19 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.634 0.774 . . . . 0.0 109.347 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -68.76 100.84 1.22 Allowed 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.39 120.63 40.83 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.194 1.398 . . . . 0.0 109.938 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.2 p -142.32 137.23 30.42 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.653 0.781 . . . . 0.0 109.915 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.5 mt . . . . . 0 CA--C 1.531 0.224 0 C-N-CA 123.213 0.605 . . . . 0.0 110.988 -176.749 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 75.8 mt . . . . . 0 N--CA 1.475 0.815 0 CA-C-O 120.391 0.139 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.5 p -99.63 161.37 13.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.365 1.066 . . . . 0.0 110.308 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -128.47 173.15 10.48 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.799 1.639 . . . . 0.0 108.446 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -137.86 141.07 40.73 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.901 0.88 . . . . 0.0 108.998 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -130.71 135.8 48.16 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 124.376 1.07 . . . . 0.0 109.68 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.8 t -101.05 107.14 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 172.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.2 mt -99.85 121.52 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -75.79 125.7 29.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 57.8 mt -123.36 98.75 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -174.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -99.73 152.57 19.94 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.49 16.83 48.01 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.54 1.067 . . . . 0.0 112.323 -173.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 97.7 mtp -79.86 110.06 14.87 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.3 t -84.58 -37.93 20.56 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.286 0.635 . . . . 0.0 111.776 -173.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.2 p -158.48 179.72 8.87 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.119 0.568 . . . . 0.0 109.884 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -69.09 -13.33 62.37 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -173.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.7 p -59.83 -36.71 77.38 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.074 0.852 . . . . 0.0 110.12 170.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -59.56 -51.73 68.59 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.38 0.672 . . . . 0.0 109.608 174.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.2 t -52.17 -55.4 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.672 0.789 . . . . 0.0 110.234 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -57.61 -52.48 65.24 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.523 1.129 . . . . 0.0 111.647 -177.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.8 p -61.14 -48.95 79.24 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.694 0.398 . . . . 0.0 111.132 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 88.2 mt -59.19 -54.92 27.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.896 0.878 . . . . 0.0 110.233 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -62.21 -37.71 86.4 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.633 0.651 . . . . 0.0 111.194 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.41 -53.99 40.59 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.829 0.728 . . . . 0.0 111.294 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.22 -54.12 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.642 0.777 . . . . 0.0 110.431 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.4 mt -63.2 -39.86 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 122.891 0.476 . . . . 0.0 111.797 -172.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.6 p -55.96 -24.71 39.98 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -89.49 -9.28 50.61 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.076 0.951 . . . . 0.0 112.184 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -70.35 141.52 88.53 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 118.897 0.771 . . . . 0.0 109.693 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.4 132.55 29.65 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.859 2.373 . . . . 0.0 109.842 -177.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.21 -26.82 22.82 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 118.7 -1.055 . . . . 0.0 112.83 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.0 t -68.27 138.66 22.09 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 118.428 1.114 . . . . 0.0 110.149 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -119.95 -102.6 0.41 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.55 1.14 . . . . 0.0 108.89 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.8 p -80.2 150.77 30.01 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 118.362 0.528 . . . . 0.0 109.853 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.3 tt -150.12 139.48 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 123.329 0.652 . . . . 0.0 110.256 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -139.01 97.39 3.3 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.173 1.389 . . . . 0.0 108.602 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.8 t -99.17 142.27 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 124.476 1.11 . . . . 0.0 108.631 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.0 t -139.84 131.98 28.06 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.803 0.841 . . . . 0.0 110.711 -174.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.8 tp -70.42 -51.57 28.55 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.105 1.362 . . . . 0.0 109.112 169.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.39 -47.16 76.27 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.112 1.365 . . . . 0.0 111.889 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -89.3 -7.78 54.67 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.046 0.538 . . . . 0.0 111.236 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.0 m 54.11 56.55 6.89 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.391 1.477 . . . . 0.0 110.932 174.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -161.31 172.83 15.93 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.632 0.373 . . . . 0.0 111.883 -172.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -137.09 112.8 0.96 Allowed Glycine 0 C--N 1.339 0.727 0 C-N-CA 126.276 1.893 . . . . 0.0 109.29 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.5 m -99.43 103.74 15.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.6 t -116.29 123.95 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 124.285 1.034 . . . . 0.0 109.428 -170.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -89.95 132.36 35.37 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 169.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -150.33 163.24 38.82 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.046 0.539 . . . . 0.0 112.097 -171.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -97.39 115.43 65.74 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.728 1.211 . . . . 0.0 109.932 173.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -47.47 -38.41 27.49 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 125.28 3.987 . . . . 0.0 115.894 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 mp -69.92 -29.87 67.14 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.075 0.398 . . . . 0.0 111.368 -174.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.9 mt -99.72 -31.77 11.38 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.095 0.958 . . . . 0.0 111.932 -173.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.7 t -151.59 171.78 17.08 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.377 0.671 . . . . 0.0 109.822 175.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.3 p -141.79 164.2 35.91 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.229 1.012 . . . . 0.0 110.329 -174.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -53.34 -39.48 81.2 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.274 2.649 . . . . 0.0 112.081 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -67.86 -38.96 83.78 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.781 0.833 . . . . 0.0 111.698 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 m -61.83 -50.27 72.97 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.35 0.523 . . . . 0.0 109.863 175.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 61.7 mt -60.61 -53.0 62.73 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.509 1.123 . . . . 0.0 110.578 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -52.29 -46.58 65.97 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.151 1.38 . . . . 0.0 110.197 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.55 -53.41 38.87 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.788 1.185 . . . . 0.0 111.425 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.63 -44.51 90.03 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 117.672 0.736 . . . . 0.0 111.727 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.8 mt -60.77 -44.53 97.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 122.791 0.436 . . . . 0.0 110.015 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -61.35 -40.03 92.76 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.725 0.81 . . . . 0.0 110.824 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -63.82 -41.14 97.93 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.453 1.101 . . . . 0.0 110.999 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.9 mtp -59.49 -45.76 90.76 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.025 0.375 . . . . 0.0 110.267 173.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.48 63.04 0.14 Allowed Glycine 0 C--N 1.341 0.815 0 C-N-CA 123.552 0.596 . . . . 0.0 111.774 169.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -140.42 158.13 44.47 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 124.057 0.943 . . . . 0.0 109.379 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -76.9 93.44 3.76 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.37 121.13 40.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.76 1.224 . . . . 0.0 109.367 -175.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.6 t -148.45 148.26 30.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.891 0.876 . . . . 0.0 108.85 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.1 mt -71.23 152.62 43.15 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 63.0 p -59.88 -38.19 81.48 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.83 0.452 . . . . 0.0 110.621 170.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.0 t70 . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.044 -1.455 . . . . 0.0 108.211 175.782 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.7 tt . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.5 p -134.23 158.8 42.79 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.73 1.212 . . . . 0.0 110.056 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -141.12 173.24 11.67 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.353 1.461 . . . . 0.0 108.898 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -123.98 141.54 51.96 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.651 1.18 . . . . 0.0 108.559 172.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -130.77 130.77 44.15 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.116 0.966 . . . . 0.0 109.489 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 77.6 t -99.9 104.97 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.2 mt -99.98 126.01 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -75.05 129.71 38.07 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 174.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.9 mt -128.18 90.22 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -99.66 161.11 13.81 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.08 21.14 61.52 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 119.246 -0.752 . . . . 0.0 112.533 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 69.9 mtm -79.85 130.01 34.96 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 118.333 1.067 . . . . 0.0 108.389 170.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.4 m -84.43 -46.25 11.87 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.195 0.598 . . . . 0.0 110.573 -173.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 p -165.38 175.78 8.84 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.328 0.651 . . . . 0.0 110.268 -170.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -52.09 -35.71 48.63 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.907 1.283 . . . . 0.0 113.301 -173.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.1 p -50.28 -41.04 50.01 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.903 0.774 . . . . 0.0 111.64 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.2 m -64.28 -49.11 73.12 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.382 0.673 . . . . 0.0 110.58 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.8 t -51.93 -53.86 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.975 0.91 . . . . 0.0 110.346 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -62.49 -43.22 99.36 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.792 0.837 . . . . 0.0 111.547 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.4 t -59.56 -53.4 58.5 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.012 0.525 . . . . 0.0 110.663 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.8 mt -56.39 -52.44 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.342 1.057 . . . . 0.0 109.576 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -52.82 -55.1 25.5 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.449 1.1 . . . . 0.0 110.531 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.09 -53.66 42.9 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.385 0.993 . . . . 0.0 111.9 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.61 -50.55 78.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.423 0.689 . . . . 0.0 110.975 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 76.7 mt -68.67 -41.07 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.648 -175.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.3 p -55.68 -25.15 38.14 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -89.25 -8.51 53.33 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.134 0.974 . . . . 0.0 112.169 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -70.5 140.75 87.42 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 119.116 0.871 . . . . 0.0 110.532 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.1 128.91 20.54 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.674 2.249 . . . . 0.0 109.181 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.82 -39.27 2.97 Favored Glycine 0 C--N 1.336 0.554 0 CA-C-O 119.073 -0.848 . . . . 0.0 111.557 -175.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.0 t -70.37 137.83 23.18 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 CA-C-N 117.881 0.84 . . . . 0.0 109.419 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -114.24 -98.3 0.44 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.313 1.045 . . . . 0.0 108.186 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 86.7 p -90.27 155.43 18.99 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.953 0.501 . . . . 0.0 110.128 176.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.59 143.05 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.186 0.995 . . . . 0.0 109.859 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.36 105.91 8.2 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.686 1.195 . . . . 0.0 108.653 173.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.6 t -98.06 136.42 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 172.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -139.05 126.94 22.2 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.651 0.78 . . . . 0.0 110.451 -176.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.3 tp -69.68 -45.73 67.66 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.455 1.102 . . . . 0.0 109.857 171.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.73 -47.15 67.56 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.458 1.103 . . . . 0.0 111.497 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -89.38 -12.37 40.56 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.293 0.637 . . . . 0.0 111.797 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.3 m 53.44 58.08 5.55 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 125.317 1.447 . . . . 0.0 110.441 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.9 p-10 -156.39 173.36 17.0 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.991 0.516 . . . . 0.0 111.953 -174.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.45 110.97 0.83 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 126.719 2.104 . . . . 0.0 108.015 174.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.8 m -99.24 101.45 12.77 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.8 t -110.96 125.37 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 124.664 1.186 . . . . 0.0 109.424 -169.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -91.26 127.82 36.85 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 169.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -146.77 167.17 24.51 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.442 0.697 . . . . 0.0 111.86 -169.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -105.64 111.14 64.78 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.155 1.382 . . . . 0.0 109.368 174.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -45.31 -37.27 13.81 Favored 'Trans proline' 0 C--N 1.348 0.552 1 C-N-CA 125.44 4.093 . . . . 0.0 116.248 177.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -70.21 -30.61 67.75 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.173 0.442 . . . . 0.0 111.33 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.3 mt -99.96 -32.38 11.0 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.212 1.005 . . . . 0.0 112.042 -172.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.7 t -149.9 170.59 18.46 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.785 0.834 . . . . 0.0 109.428 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.6 p -137.85 162.25 55.41 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 123.967 0.907 . . . . 0.0 110.643 -176.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -53.05 -39.12 80.73 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.321 2.681 . . . . 0.0 112.043 172.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -68.32 -40.04 81.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.779 0.832 . . . . 0.0 111.482 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.3 m -60.37 -50.35 73.94 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.926 0.49 . . . . 0.0 109.941 175.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.1 mt -59.51 -50.12 75.13 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.234 1.014 . . . . 0.0 110.511 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -52.5 -48.71 65.81 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.843 1.257 . . . . 0.0 110.627 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.75 -46.47 89.62 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.319 0.962 . . . . 0.0 111.785 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.74 -44.41 96.28 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.117 0.567 . . . . 0.0 111.467 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.44 -45.26 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.082 0.553 . . . . 0.0 110.075 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -59.42 -42.13 91.14 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.731 0.813 . . . . 0.0 110.696 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -62.44 -44.52 96.23 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.742 0.817 . . . . 0.0 111.217 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.9 mtm -59.91 -36.47 77.04 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.657 0.383 . . . . 0.0 110.898 174.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.0 59.91 0.34 Allowed Glycine 0 C--N 1.341 0.811 0 C-N-CA 123.758 0.694 . . . . 0.0 111.996 169.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -140.38 158.64 43.71 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.898 0.879 . . . . 0.0 109.379 173.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -75.77 94.32 3.27 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.5 112.08 24.34 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.967 1.307 . . . . 0.0 110.084 -172.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.9 p -142.56 133.05 25.07 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.575 0.75 . . . . 0.0 109.757 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.5 mt -64.93 150.24 48.23 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.455 0.702 . . . . 0.0 110.85 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.9 p -68.05 -55.13 13.67 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.405 0.682 . . . . 0.0 110.496 172.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 . . . . . 0 C--O 1.25 1.13 0 C-N-CA 125.543 1.537 . . . . 0.0 110.563 -177.158 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 65.2 mt . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 111.471 0.174 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.9 p -140.41 126.66 19.86 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.601 1.161 . . . . 0.0 108.902 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -142.05 171.66 13.75 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.589 1.155 . . . . 0.0 109.238 173.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -139.99 141.69 36.34 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.327 1.051 . . . . 0.0 108.752 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -131.23 138.27 49.27 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.469 1.107 . . . . 0.0 109.81 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.3 t -106.11 100.54 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 174.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.0 mt -99.76 115.21 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -67.01 124.98 24.56 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.4 mt -113.72 100.8 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 106.662 -1.606 . . . . 0.0 106.662 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -99.67 146.37 26.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.698 0.799 . . . . 0.0 109.465 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.84 27.69 31.07 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.226 0.917 . . . . 0.0 112.839 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 73.2 mtm -80.45 135.42 36.14 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.23 1.015 . . . . 0.0 108.93 170.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.7 m -84.22 -48.0 10.23 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.004 0.922 . . . . 0.0 110.201 -174.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 p -161.06 -178.4 6.74 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.48 0.712 . . . . 0.0 109.618 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -61.23 -23.26 65.51 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.614 1.166 . . . . 0.0 113.321 -176.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.3 m -57.61 -37.99 74.19 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.598 0.635 . . . . 0.0 111.266 174.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.4 m -63.85 -51.81 62.96 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -51.85 -49.49 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.521 1.128 . . . . 0.0 110.552 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -57.95 -47.72 82.09 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.431 1.092 . . . . 0.0 110.998 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.7 t -62.22 -52.55 63.33 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.475 0.71 . . . . 0.0 111.188 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.9 mt -54.7 -56.24 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.962 1.305 . . . . 0.0 109.719 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -59.18 -46.77 87.55 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.445 0.698 . . . . 0.0 110.562 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.82 -48.6 50.53 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.932 1.254 . . . . 0.0 112.162 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.18 -62.56 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 117.507 0.653 . . . . 0.0 110.218 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.2 mt -58.82 -39.12 76.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.978 0.911 . . . . 0.0 112.108 -169.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 77.9 p -49.99 -33.84 19.17 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.846 0.859 . . . . 0.0 113.183 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -89.66 -14.89 33.86 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.605 0.762 . . . . 0.0 112.295 -175.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -71.14 143.66 88.81 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 118.689 0.677 . . . . 0.0 110.662 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -63.06 137.39 61.62 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.241 2.627 . . . . 0.0 110.663 -174.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.51 -35.66 4.57 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 119.128 -0.818 . . . . 0.0 111.793 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.0 t -68.45 128.57 32.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 CA-C-N 118.017 0.909 . . . . 0.0 109.847 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -99.68 -103.47 0.23 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.917 1.287 . . . . 0.0 107.854 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.9 p -87.2 154.12 20.97 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.6 0.76 . . . . 0.0 109.519 173.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.7 tt -150.41 135.24 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 123.172 0.589 . . . . 0.0 109.974 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 -134.68 100.82 4.74 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.916 1.287 . . . . 0.0 108.683 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.8 t -98.76 139.12 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.235 1.014 . . . . 0.0 108.637 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.4 t -135.6 132.18 36.78 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 124.445 1.098 . . . . 0.0 110.646 -173.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.7 tp -72.48 -49.45 33.09 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.318 1.047 . . . . 0.0 109.357 173.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.94 -44.82 78.77 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.08 1.352 . . . . 0.0 111.762 -177.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -89.23 -9.68 49.82 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.234 0.613 . . . . 0.0 111.201 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.1 m 54.44 52.42 12.44 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.61 1.564 . . . . 0.0 111.05 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -157.24 170.41 22.53 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.972 0.415 . . . . 0.0 111.838 -173.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.08 113.67 1.69 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 126.561 2.029 . . . . 0.0 108.658 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.3 m -98.77 93.19 5.94 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.8 t -105.63 120.57 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 124.398 1.079 . . . . 0.0 109.009 -171.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -89.78 133.81 34.51 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 169.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -150.25 166.79 28.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.838 0.455 . . . . 0.0 112.145 -169.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -102.78 113.2 66.04 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 125.255 1.422 . . . . 0.0 108.573 172.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -44.35 -36.1 9.05 Favored 'Trans proline' 0 C--N 1.347 0.467 1 C-N-CA 125.49 4.127 . . . . 0.0 115.077 173.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.6 mt -65.36 -36.6 84.49 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.237 0.615 . . . . 0.0 111.768 -177.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.1 mp -99.65 -34.26 10.28 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.956 0.902 . . . . 0.0 111.59 -171.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.3 t -147.82 177.32 9.42 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.457 0.703 . . . . 0.0 109.952 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.9 p -148.39 163.98 23.94 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 124.085 0.954 . . . . 0.0 110.264 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.4 -40.79 77.07 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.398 2.732 . . . . 0.0 112.078 174.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -67.91 -39.41 83.57 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.6 0.76 . . . . 0.0 111.369 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.7 m -61.5 -49.95 74.68 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.898 0.479 . . . . 0.0 110.068 175.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.0 mt -60.2 -48.79 80.22 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.172 0.989 . . . . 0.0 110.633 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -53.27 -50.09 65.56 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.69 1.196 . . . . 0.0 110.23 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.9 -43.21 92.66 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.523 1.059 . . . . 0.0 112.273 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.92 -42.07 98.67 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.344 0.572 . . . . 0.0 111.12 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.4 mt -66.75 -40.4 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.105 0.562 . . . . 0.0 110.389 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -59.01 -43.36 91.53 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.775 0.43 . . . . 0.0 110.78 172.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.39 -44.48 97.07 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.205 0.602 . . . . 0.0 111.03 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.2 mtm -62.29 -33.78 75.3 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.852 0.461 . . . . 0.0 111.26 174.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.3 56.59 0.42 Allowed Glycine 0 C--N 1.341 0.842 0 C-N-CA 123.814 0.721 . . . . 0.0 112.53 169.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -140.41 150.95 44.51 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.665 0.786 . . . . 0.0 109.424 172.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -75.45 98.63 3.96 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.62 128.24 45.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.68 1.192 . . . . 0.0 109.732 -175.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.3 t -150.08 169.34 21.48 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.145 0.978 . . . . 0.0 108.552 175.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -72.68 169.13 17.27 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.727 0.411 . . . . 0.0 110.183 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.2 p -49.54 -49.67 45.22 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.632 1.173 . . . . 0.0 111.456 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 117.197 -1.383 . . . . 0.0 108.988 171.799 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 54.1 tp . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.6 p -121.01 114.34 21.37 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.77 1.228 . . . . 0.0 109.617 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -126.33 149.9 48.87 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 169.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -119.74 149.04 42.67 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.741 0.816 . . . . 0.0 110.144 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.4 t -145.63 146.93 31.52 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.097 0.959 . . . . 0.0 109.102 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.9 t -113.11 125.61 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 172.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.5 mt -120.33 131.64 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -80.75 122.82 27.62 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 173.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.65 95.79 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -99.29 146.71 25.94 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.442 0.697 . . . . 0.0 109.438 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.1 42.26 7.17 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.12 0.867 . . . . 0.0 112.235 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.1 mtt -79.49 143.47 34.88 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 169.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 64.1 p -84.51 -42.37 15.59 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.597 0.759 . . . . 0.0 110.462 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.4 p -163.63 -179.71 6.6 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.126 0.97 . . . . 0.0 109.24 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -63.04 -24.86 68.11 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.163 0.985 . . . . 0.0 113.164 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m -53.13 -35.03 59.24 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.747 0.703 . . . . 0.0 111.574 174.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.5 m -58.34 -49.0 78.75 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.014 0.526 . . . . 0.0 110.834 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.2 t -50.81 -51.46 20.18 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 C-N-CA 123.773 0.829 . . . . 0.0 109.779 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -57.73 -53.7 55.26 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.928 0.891 . . . . 0.0 110.398 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.5 m -54.98 -46.93 75.15 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.244 0.618 . . . . 0.0 111.801 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 57.1 mt -60.65 -59.22 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 124.078 0.951 . . . . 0.0 109.8 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -60.72 -35.71 77.02 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 118.233 0.469 . . . . 0.0 111.302 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.62 -60.31 9.21 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 124.363 0.982 . . . . 0.0 110.676 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.55 -58.02 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 123.002 0.521 . . . . 0.0 110.139 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.9 mt -60.04 -41.33 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.29 0.636 . . . . 0.0 111.892 -169.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.4 p -54.38 -30.83 53.23 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.727 0.694 . . . . 0.0 112.833 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -89.42 -11.32 43.48 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.529 0.731 . . . . 0.0 112.559 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -68.86 141.31 92.22 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 119.253 0.933 . . . . 0.0 109.752 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.08 131.28 26.48 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.991 2.461 . . . . 0.0 110.083 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.8 -33.24 6.72 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-O 118.711 -1.049 . . . . 0.0 112.181 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.3 t -67.3 139.06 21.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-N 118.256 1.028 . . . . 0.0 110.478 -176.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -121.12 -105.65 0.38 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.317 1.447 . . . . 0.0 108.144 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.0 p -80.03 144.85 32.85 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.652 0.66 . . . . 0.0 110.018 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.29 144.09 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.543 0.737 . . . . 0.0 110.824 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -140.28 131.96 27.28 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.123 1.369 . . . . 0.0 107.728 169.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.9 t -123.97 145.8 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.998 1.319 . . . . 0.0 108.229 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.7 t -139.16 132.82 30.55 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 124.138 0.975 . . . . 0.0 110.776 -173.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.9 tp -74.35 -49.98 20.58 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.72 1.208 . . . . 0.0 109.301 171.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.65 -46.15 67.03 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.732 1.213 . . . . 0.0 111.536 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -89.58 -12.13 40.69 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.427 0.691 . . . . 0.0 111.611 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.6 m 53.13 52.06 14.46 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 125.181 1.393 . . . . 0.0 110.581 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -154.47 172.57 17.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.961 0.504 . . . . 0.0 111.687 -175.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -142.76 116.25 1.01 Allowed Glycine 0 C--N 1.338 0.648 0 C-N-CA 125.644 1.592 . . . . 0.0 109.392 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.5 m -99.55 115.56 29.65 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.4 t -128.23 129.07 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 124.007 0.923 . . . . 0.0 109.755 -170.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -97.87 133.65 42.08 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 168.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -150.47 167.06 28.27 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.332 0.653 . . . . 0.0 111.482 -171.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -101.53 113.88 65.76 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.636 1.174 . . . . 0.0 109.431 173.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -43.37 -39.74 9.3 Favored 'Trans proline' 0 C--N 1.348 0.526 1 C-N-CA 125.603 4.202 . . . . 0.0 115.51 176.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.1 mt -63.98 -34.31 77.7 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.377 0.671 . . . . 0.0 111.81 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.3 mt -102.8 -29.27 11.57 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.912 0.885 . . . . 0.0 112.269 -172.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.8 t -152.55 165.92 33.66 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.415 0.686 . . . . 0.0 109.491 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.0 p -138.75 167.51 19.17 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.592 1.157 . . . . 0.0 110.041 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.35 -38.35 89.0 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.436 2.757 . . . . 0.0 112.181 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -67.08 -38.85 86.47 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.912 0.885 . . . . 0.0 111.508 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.4 m -62.58 -48.75 78.09 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.862 0.465 . . . . 0.0 109.933 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.4 mt -59.0 -53.23 60.8 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.373 1.069 . . . . 0.0 110.302 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 66.0 ttp85 -53.18 -46.02 68.79 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.987 1.315 . . . . 0.0 110.843 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.77 -49.09 77.28 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.489 1.042 . . . . 0.0 111.809 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.07 -46.78 89.28 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 117.385 0.593 . . . . 0.0 111.243 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.0 mt -57.34 -44.16 83.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.653 0.781 . . . . 0.0 110.019 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -61.47 -42.79 99.32 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.812 0.445 . . . . 0.0 110.605 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.14 -39.3 92.13 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.157 0.983 . . . . 0.0 111.926 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 28.8 mtt -55.79 -48.13 75.9 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 118.348 0.522 . . . . 0.0 110.128 173.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.45 58.99 0.13 Allowed Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 174.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -140.08 152.49 46.21 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.384 1.074 . . . . 0.0 108.707 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -72.76 99.98 2.75 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.8 122.29 42.55 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.693 1.197 . . . . 0.0 109.671 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.6 t -150.08 144.19 25.59 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 47.0 mt -66.75 134.56 52.44 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.0 t -90.31 45.69 1.29 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.816 0.846 . . . . 0.0 109.379 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 p30 . . . . . 0 C--O 1.253 1.247 0 C-N-CA 125.428 1.491 . . . . 0.0 108.866 -172.585 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 63.3 mt . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 111.241 0.089 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 43.1 p -137.22 101.57 4.57 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.487 1.115 . . . . 0.0 109.662 -174.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -125.63 169.22 12.71 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.913 1.285 . . . . 0.0 109.106 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -131.76 148.21 52.55 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.553 1.141 . . . . 0.0 109.608 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -146.22 148.69 32.76 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.681 1.192 . . . . 0.0 108.972 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.3 t -120.85 128.08 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.6 mt -122.28 126.84 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -67.8 133.05 48.55 Favored 'General case' 0 CA--C 1.526 0.051 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 172.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.5 mt -131.27 88.78 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -99.8 164.19 12.14 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.81 16.7 69.62 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 119.244 -0.753 . . . . 0.0 112.445 -174.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.1 mtm -79.81 124.9 29.04 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.384 1.092 . . . . 0.0 108.389 170.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.1 p -84.53 -40.9 17.06 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.763 0.825 . . . . 0.0 110.934 -175.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.4 p -158.85 -178.39 7.21 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.893 0.377 . . . . 0.0 110.717 -174.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -57.49 -28.35 63.35 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.623 1.569 . . . . 0.0 113.65 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 m -54.82 -41.28 70.46 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.233 0.613 . . . . 0.0 111.142 175.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.4 m -62.51 -51.47 67.31 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 122.864 0.465 . . . . 0.0 110.016 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.4 t -50.51 -56.35 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.96 0.904 . . . . 0.0 110.14 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -59.77 -50.66 72.94 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.463 1.105 . . . . 0.0 111.488 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.2 p -60.99 -50.39 73.6 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.906 0.482 . . . . 0.0 111.47 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.6 mt -57.75 -52.65 55.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.136 0 C-N-CA 123.353 0.661 . . . . 0.0 109.474 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -54.04 -49.62 68.53 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.289 0.636 . . . . 0.0 110.677 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.15 -54.9 33.87 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.3 0.953 . . . . 0.0 112.309 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.22 -55.47 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.392 0.677 . . . . 0.0 110.613 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.2 mm -64.34 -39.03 84.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 123.55 0.74 . . . . 0.0 111.47 -173.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.7 p -55.02 -30.59 59.87 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.972 0.806 . . . . 0.0 112.69 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -89.41 -3.27 58.49 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.99 0.916 . . . . 0.0 112.267 -175.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -73.12 125.5 90.93 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 119.03 0.832 . . . . 0.0 109.006 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -48.53 118.1 3.1 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.746 2.964 . . . . 0.0 112.128 176.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.37 -36.63 3.54 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 124.042 0.829 . . . . 0.0 111.849 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.7 t -72.66 130.55 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-N 117.87 0.835 . . . . 0.0 109.433 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -90.03 -105.09 0.09 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.0 p -90.62 159.02 16.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.055 1.342 . . . . 0.0 109.852 171.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.8 tt -150.42 134.04 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 123.921 0.888 . . . . 0.0 109.245 173.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -118.28 106.69 13.04 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.866 1.266 . . . . 0.0 108.975 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.2 t -95.35 145.25 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.097 0.959 . . . . 0.0 108.419 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -144.59 128.01 16.92 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.624 0.77 . . . . 0.0 110.461 -177.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.4 tp -70.92 -46.33 62.68 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.558 1.143 . . . . 0.0 110.011 172.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.37 -45.36 65.75 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.397 1.079 . . . . 0.0 111.565 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -89.59 -17.01 29.31 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.557 0.743 . . . . 0.0 111.5 178.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m 54.94 57.73 5.38 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.254 1.422 . . . . 0.0 110.117 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -156.21 173.19 17.2 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.274 0.63 . . . . 0.0 111.627 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.08 116.22 1.7 Allowed Glycine 0 C--N 1.338 0.65 0 C-N-CA 126.438 1.971 . . . . 0.0 108.271 174.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.7 m -99.38 102.52 14.14 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.8 t -108.56 131.55 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 124.428 1.091 . . . . 0.0 110.073 -169.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -101.25 130.6 47.41 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 168.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -150.81 174.79 12.67 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -169.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -115.73 110.36 44.49 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.747 1.619 . . . . 0.0 109.384 174.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -41.58 -38.94 4.42 Favored 'Trans proline' 0 C--N 1.349 0.571 1 C-N-CA 125.999 4.466 . . . . 0.0 115.19 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.1 mt -62.44 -30.71 71.44 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.442 0.697 . . . . 0.0 112.174 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.6 mt -109.52 -36.51 5.95 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.437 1.095 . . . . 0.0 112.018 -171.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.2 t -144.58 171.49 14.3 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.914 0.886 . . . . 0.0 109.303 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.6 p -150.3 161.28 31.23 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 123.215 0.606 . . . . 0.0 110.506 -175.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -49.09 -48.74 17.3 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.947 3.098 . . . . 0.0 113.99 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -66.12 -31.94 73.09 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.257 0.623 . . . . 0.0 112.443 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.0 m -68.11 -48.16 66.23 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 44.4 mt -60.5 -48.46 81.66 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.369 1.068 . . . . 0.0 110.174 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -51.5 -48.99 62.72 Favored 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 124.611 1.165 . . . . 0.0 110.224 172.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.79 -47.1 80.88 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.339 0.971 . . . . 0.0 112.15 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.7 84.16 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.411 0.684 . . . . 0.0 111.212 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.7 mt -61.16 -43.41 96.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.3 0.64 . . . . 0.0 110.048 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -60.82 -41.18 95.21 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.594 0.758 . . . . 0.0 110.719 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.86 -40.97 97.22 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.679 0.791 . . . . 0.0 111.185 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.3 mtp -59.52 -40.45 87.16 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.077 0.399 . . . . 0.0 110.635 173.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.12 62.0 0.22 Allowed Glycine 0 C--N 1.342 0.879 0 C-N-CA 123.712 0.672 . . . . 0.0 111.917 169.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -140.5 160.79 39.22 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.814 0.846 . . . . 0.0 110.02 175.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -77.1 89.62 3.61 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.44 115.15 28.61 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.48 1.112 . . . . 0.0 109.734 -173.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 81.2 p -141.17 148.62 40.3 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 124.17 0.988 . . . . 0.0 108.955 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 52.1 mt -74.46 144.45 44.22 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.086 0.403 . . . . 0.0 110.748 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 p -116.73 -40.7 3.14 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.873 1.269 . . . . 0.0 109.993 169.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.3 t70 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 116.606 -1.664 . . . . 0.0 108.456 175.957 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 56.7 tp . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 119.889 -0.101 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.0 p -140.84 143.88 35.03 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.458 1.103 . . . . 0.0 109.898 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -146.88 163.53 35.81 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.967 1.307 . . . . 0.0 108.983 169.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -125.32 143.56 50.91 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.344 1.458 . . . . 0.0 108.517 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.2 t -150.12 165.68 32.09 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 122.931 0.493 . . . . 0.0 111.072 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.1 t -130.59 134.81 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 170.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.2 mm -113.63 127.34 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 172.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -85.5 122.4 29.58 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 172.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.1 mt -121.98 97.07 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 125.336 1.454 . . . . 0.0 107.691 -169.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -99.79 154.47 18.3 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.959 0.409 . . . . 0.0 110.017 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.55 11.25 51.71 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.734 1.159 . . . . 0.0 112.152 -171.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 98.2 mtp -79.89 116.33 19.98 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.155 0.978 . . . . 0.0 108.597 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.0 p -84.71 -47.85 10.04 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.701 0.801 . . . . 0.0 111.529 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.8 p -153.98 -179.67 8.08 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.09 0.556 . . . . 0.0 110.512 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -58.28 -25.35 61.69 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.343 1.457 . . . . 0.0 113.523 -177.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 t -55.34 -40.63 71.45 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.102 0.561 . . . . 0.0 110.626 174.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.0 m -63.49 -46.97 83.71 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 122.998 0.519 . . . . 0.0 110.448 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.5 t -52.58 -53.66 19.17 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 123.686 0.794 . . . . 0.0 109.567 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -59.16 -48.06 83.01 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.722 0.809 . . . . 0.0 111.379 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.5 m -60.99 -53.73 53.69 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.396 0.678 . . . . 0.0 111.219 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.2 mt -57.82 -56.27 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 123.885 0.874 . . . . 0.0 109.26 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -55.86 -48.67 75.12 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.17 0.588 . . . . 0.0 110.905 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.94 -55.19 30.4 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.232 0.92 . . . . 0.0 112.034 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.75 -55.98 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 117.371 0.585 . . . . 0.0 110.771 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.2 mm -63.0 -37.32 79.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.504 0.721 . . . . 0.0 111.758 -173.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.1 p -54.29 -34.63 61.31 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.975 0.807 . . . . 0.0 112.414 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -89.53 0.56 56.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.624 0.77 . . . . 0.0 112.709 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -72.55 143.22 84.84 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 119.151 0.887 . . . . 0.0 109.186 175.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.47 128.43 21.29 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.943 2.429 . . . . 0.0 110.252 -175.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.38 -35.62 4.94 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-O 118.789 -1.006 . . . . 0.0 112.292 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.9 t -66.65 123.5 19.81 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 CA-C-N 118.219 1.009 . . . . 0.0 109.623 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -96.92 -96.88 0.2 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.1 p -90.08 147.12 23.83 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.237 0.615 . . . . 0.0 109.963 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.3 tt -149.89 142.71 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.835 1.254 . . . . 0.0 108.924 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.31 130.6 25.17 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.859 0.864 . . . . 0.0 109.214 169.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.54 147.75 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 125.399 1.48 . . . . 0.0 108.823 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.2 t -139.32 130.22 26.26 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.012 0.925 . . . . 0.0 110.769 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.0 tp -72.39 -49.91 30.39 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.917 1.287 . . . . 0.0 109.271 170.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.62 67.12 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.65 1.18 . . . . 0.0 111.639 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -89.55 -8.84 51.83 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.272 0.629 . . . . 0.0 111.648 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.9 m 52.24 56.79 7.22 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 125.297 1.439 . . . . 0.0 110.681 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.9 p30 -161.97 172.04 16.64 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.838 0.455 . . . . 0.0 111.513 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.22 119.27 1.97 Allowed Glycine 0 C--N 1.338 0.658 0 C-N-CA 125.577 1.56 . . . . 0.0 109.287 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.5 m -99.44 121.88 41.76 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.2 t -129.48 137.08 57.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 124.366 1.066 . . . . 0.0 110.126 -169.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -112.97 129.87 56.33 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -150.28 169.99 20.07 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -168.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -97.38 114.72 65.24 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.64 1.576 . . . . 0.0 109.548 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -44.85 -41.36 15.18 Favored 'Trans proline' 0 C--N 1.349 0.555 1 C-N-CA 125.452 4.102 . . . . 0.0 114.399 174.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.0 mt -61.53 -32.9 72.97 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.944 0.898 . . . . 0.0 111.903 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.1 mt -105.34 -28.8 10.67 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.069 0.948 . . . . 0.0 112.215 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.7 t -153.16 163.23 40.24 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.837 0.744 . . . . 0.0 110.374 178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.9 p -136.01 165.85 32.62 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 125.723 1.609 . . . . 0.0 109.504 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -53.12 -37.61 79.81 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.448 2.765 . . . . 0.0 112.573 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -67.21 -41.35 85.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.261 1.024 . . . . 0.0 110.46 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.6 m -64.03 -48.05 77.82 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.999 0.52 . . . . 0.0 110.048 177.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.4 mt -59.39 -49.66 76.96 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.937 0.895 . . . . 0.0 110.294 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -50.96 -51.03 56.58 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.317 1.047 . . . . 0.0 110.382 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.13 -46.6 84.98 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.323 0.963 . . . . 0.0 112.248 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.73 92.77 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.49 0.716 . . . . 0.0 111.125 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.5 mt -64.55 -36.41 77.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 123.215 0.606 . . . . 0.0 110.25 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -63.57 -41.46 98.4 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.942 -0.474 . . . . 0.0 110.357 175.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.14 -40.8 98.62 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.74 0.816 . . . . 0.0 111.285 175.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.4 mmm -56.17 -40.25 73.6 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.904 0.482 . . . . 0.0 110.665 173.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.72 54.31 0.26 Allowed Glycine 0 C--N 1.34 0.773 0 C-N-CA 123.973 0.796 . . . . 0.0 111.406 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -140.45 144.3 36.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.123 0.969 . . . . 0.0 108.791 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -70.46 99.23 1.57 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.68 129.05 45.78 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.057 1.343 . . . . 0.0 109.123 -174.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.5 p -137.52 143.87 41.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.31 1.044 . . . . 0.0 109.063 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 61.8 mt -67.53 145.5 54.86 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.813 0.445 . . . . 0.0 110.22 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.5 t -141.2 47.89 1.69 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.118 0.967 . . . . 0.0 109.089 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.237 -1.363 . . . . 0.0 108.522 -175.146 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 110.6 -0.148 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.3 p -99.46 164.06 12.25 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.661 1.185 . . . . 0.0 109.872 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -137.73 170.88 15.3 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 124.734 1.214 . . . . 0.0 109.816 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -124.15 153.45 41.5 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.497 1.119 . . . . 0.0 109.538 172.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.1 t -147.07 138.47 24.08 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.135 0.974 . . . . 0.0 109.756 -176.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.92 113.06 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.6 mt -113.28 126.2 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -71.15 136.32 48.07 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 177.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.6 mt -129.96 91.15 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -99.42 153.84 18.69 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.452 0.701 . . . . 0.0 109.553 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.1 45.0 12.18 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.853 0.74 . . . . 0.0 112.062 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 54.7 mtt -79.77 153.45 29.18 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 169.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.5 m -84.53 -52.37 6.18 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.756 0.822 . . . . 0.0 109.871 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.2 p -163.8 -178.29 5.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.732 1.213 . . . . 0.0 108.7 -175.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -60.57 -25.51 66.24 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.127 0.971 . . . . 0.0 113.25 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.6 m -54.69 -36.47 64.7 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.713 0.688 . . . . 0.0 111.468 175.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.2 m -61.4 -41.34 96.98 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 122.885 0.474 . . . . 0.0 111.186 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.8 t -53.37 -54.39 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 123.507 0.723 . . . . 0.0 109.322 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -59.77 -45.65 91.6 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.611 0.764 . . . . 0.0 111.361 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.4 m -59.14 -52.22 66.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.261 0.624 . . . . 0.0 111.443 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.6 mt -56.92 -50.98 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.194 0.998 . . . . 0.0 109.573 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -54.43 -56.07 22.45 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.413 0.685 . . . . 0.0 110.751 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.34 -56.35 19.98 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.124 0.868 . . . . 0.0 112.086 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.8 t -59.92 -57.23 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.817 0.847 . . . . 0.0 110.766 -177.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.2 mt -70.6 -32.82 50.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 118.851 -0.595 . . . . 0.0 112.081 -169.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 87.3 p -52.96 -30.75 36.65 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -89.12 -5.84 57.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.557 0.743 . . . . 0.0 112.483 -175.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -75.08 147.78 83.72 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 118.885 0.766 . . . . 0.0 110.229 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -45.29 127.71 9.32 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 124.309 3.34 . . . . 0.0 113.254 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.51 -31.1 5.64 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-O 118.653 -1.082 . . . . 0.0 113.596 176.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.73 136.56 25.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 118.386 1.093 . . . . 0.0 110.098 -175.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -115.67 -100.97 0.43 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.639 1.176 . . . . 0.0 108.224 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 86.5 p -81.53 151.56 27.69 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.709 0.686 . . . . 0.0 110.128 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.24 131.46 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 123.788 0.835 . . . . 0.0 108.939 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -130.69 102.15 5.99 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.179 1.392 . . . . 0.0 108.057 -174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.1 t -100.73 149.88 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.436 1.094 . . . . 0.0 109.021 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.6 t -140.1 129.23 23.67 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.101 0.96 . . . . 0.0 109.753 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.7 tp -70.47 -49.49 48.05 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.458 1.103 . . . . 0.0 109.301 170.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.59 -47.65 66.76 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.712 1.205 . . . . 0.0 111.776 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -89.42 -11.9 41.82 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.199 0.6 . . . . 0.0 111.612 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.7 m 54.04 56.53 6.94 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 125.011 1.325 . . . . 0.0 110.602 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -157.59 170.49 22.27 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.498 0.719 . . . . 0.0 111.279 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -137.36 116.26 1.34 Allowed Glycine 0 C--N 1.337 0.603 0 C-N-CA 126.196 1.855 . . . . 0.0 109.389 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.3 m -99.48 105.92 17.89 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 t -109.25 137.24 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 124.548 1.139 . . . . 0.0 109.214 -173.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -105.56 130.01 53.7 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 169.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -150.42 164.96 34.58 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -168.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -98.08 113.97 64.54 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.158 1.383 . . . . 0.0 109.682 170.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -44.82 -37.43 11.88 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 125.247 3.965 . . . . 0.0 114.873 173.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.1 mt -63.82 -34.18 77.35 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.24 0.616 . . . . 0.0 111.97 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.4 mt -105.64 -27.61 11.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.98 0.912 . . . . 0.0 112.478 -171.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.0 t -151.87 176.27 11.62 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.749 0.704 . . . . 0.0 109.96 176.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.6 p -148.98 163.48 25.31 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.477 1.111 . . . . 0.0 109.717 -175.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -53.16 -36.51 77.43 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.193 2.595 . . . . 0.0 112.678 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -68.03 -44.57 76.17 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.318 1.047 . . . . 0.0 110.355 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.6 m -61.55 -46.93 87.82 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.224 0.609 . . . . 0.0 110.287 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.8 mt -62.31 -45.85 91.37 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.285 1.034 . . . . 0.0 110.764 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -53.64 -46.85 70.68 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.975 0.91 . . . . 0.0 109.968 172.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.56 -45.4 84.59 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.276 0.941 . . . . 0.0 112.268 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.39 -48.54 77.43 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.686 0.743 . . . . 0.0 111.168 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.2 mt -59.62 -45.11 94.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.802 0.841 . . . . 0.0 109.834 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -57.34 -47.85 80.51 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.874 0.87 . . . . 0.0 110.22 176.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -59.48 -41.66 90.3 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.848 0.859 . . . . 0.0 111.525 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.7 mtp -59.3 -41.55 89.26 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.051 0.387 . . . . 0.0 110.731 174.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.29 60.0 0.19 Allowed Glycine 0 C--N 1.34 0.787 0 C-N-CA 123.688 0.661 . . . . 0.0 111.718 169.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -140.35 155.93 46.6 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.018 0.927 . . . . 0.0 109.236 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.17 96.49 3.3 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.75 124.41 44.99 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.901 1.28 . . . . 0.0 109.989 -174.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.0 t -150.29 156.52 41.69 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.097 0.559 . . . . 0.0 109.948 175.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.7 mt -84.24 153.39 23.62 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.851 0.86 . . . . 0.0 113.152 -169.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.5 m -142.83 60.49 1.43 Allowed 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 168.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 p30 . . . . . 0 C--O 1.25 1.103 0 CA-C-O 116.95 -1.5 . . . . 0.0 109.073 -170.298 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 86.5 mt . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.1 p -140.25 120.99 14.37 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.197 0.999 . . . . 0.0 109.265 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -140.14 169.85 16.92 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.821 1.248 . . . . 0.0 109.34 175.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -140.3 143.64 35.97 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.462 1.105 . . . . 0.0 108.746 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 t -134.29 141.56 46.99 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.375 1.07 . . . . 0.0 109.824 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.0 t -107.66 106.97 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 175.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.3 mt -102.22 123.66 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -177.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -69.66 128.52 36.76 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 169.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 66.7 mt -127.47 86.58 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -99.95 148.73 24.17 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.067 0.547 . . . . 0.0 110.221 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.21 26.19 16.85 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.672 1.13 . . . . 0.0 112.871 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 68.6 mtm -79.62 136.27 36.79 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.242 1.021 . . . . 0.0 109.366 174.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.3 m -84.48 -46.93 11.14 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.267 1.027 . . . . 0.0 110.748 -173.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.5 p -156.1 177.25 11.64 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.643 0.777 . . . . 0.0 109.474 -175.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -60.69 -24.71 65.85 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.091 0.956 . . . . 0.0 113.091 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.3 m -53.59 -36.2 61.68 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.525 0.602 . . . . 0.0 111.472 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.3 m -60.26 -56.5 20.8 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.8 t -49.9 -52.61 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.464 1.105 . . . . 0.0 110.558 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -57.29 -54.58 45.2 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.366 1.066 . . . . 0.0 111.245 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.5 p -62.31 -49.82 74.09 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.378 0.671 . . . . 0.0 111.523 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 79.1 mt -52.97 -56.17 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 124.285 1.034 . . . . 0.0 109.696 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -57.57 -50.65 72.41 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.134 0.574 . . . . 0.0 110.347 -177.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.77 -51.41 44.95 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.502 1.049 . . . . 0.0 112.374 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.2 t -60.61 -55.18 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.336 0.655 . . . . 0.0 110.329 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.5 mt -64.33 -37.37 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 119.005 -0.522 . . . . 0.0 111.549 -171.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 72.5 m -49.93 -33.73 18.41 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.535 0.734 . . . . 0.0 112.502 173.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -89.39 -12.08 41.37 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.836 0.854 . . . . 0.0 112.06 -174.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -70.33 139.5 87.1 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 119.127 0.876 . . . . 0.0 109.839 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.27 132.82 32.83 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.939 2.426 . . . . 0.0 109.831 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.83 -33.67 6.33 Favored Glycine 0 C--N 1.337 0.605 0 CA-C-O 118.939 -0.923 . . . . 0.0 112.062 -177.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.5 t -70.32 135.3 28.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 CA-C-N 118.113 0.957 . . . . 0.0 109.908 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -111.48 -100.67 0.41 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.961 1.305 . . . . 0.0 107.958 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 59.5 p -86.83 146.16 26.32 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.615 0.766 . . . . 0.0 109.489 176.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.3 tt -150.24 143.89 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 123.624 0.77 . . . . 0.0 109.938 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.45 136.36 41.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 169.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.8 t -124.5 143.24 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.987 1.315 . . . . 0.0 107.691 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.5 t -143.4 130.93 21.14 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.898 0.879 . . . . 0.0 110.191 -174.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.33 -45.69 25.34 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.151 0.981 . . . . 0.0 109.53 174.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.47 -46.67 63.2 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.271 1.028 . . . . 0.0 111.305 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -89.72 -9.62 48.75 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.648 0.779 . . . . 0.0 111.905 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.0 m 52.33 55.59 8.93 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 125.68 1.592 . . . . 0.0 111.076 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -160.87 168.46 24.63 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.173 0.511 . . . . 0.0 111.706 -174.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.12 116.16 1.51 Allowed Glycine 0 CA--C 1.525 0.656 0 C-N-CA 126.232 1.873 . . . . 0.0 108.683 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.7 m -99.31 109.75 22.34 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 176.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.4 t -119.24 122.45 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 124.465 1.106 . . . . 0.0 109.217 -171.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -89.97 131.29 35.95 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 169.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -150.09 165.09 33.84 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -169.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -101.01 113.36 65.8 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.08 1.352 . . . . 0.0 109.262 172.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -43.46 -39.35 9.34 Favored 'Trans proline' 0 C--N 1.347 0.499 1 C-N-CA 125.458 4.105 . . . . 0.0 115.346 173.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.87 -34.93 79.27 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.776 0.43 . . . . 0.0 111.857 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.2 mt -100.6 -29.62 12.23 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.819 0.848 . . . . 0.0 112.423 -172.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.4 t -151.15 174.41 13.25 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.53 0.732 . . . . 0.0 109.731 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.8 p -148.15 162.59 30.3 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 123.893 0.877 . . . . 0.0 110.468 -173.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.02 -34.61 77.99 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.631 2.888 . . . . 0.0 112.41 172.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -63.22 -49.23 75.0 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.024 0.93 . . . . 0.0 110.458 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.6 m -62.35 -45.31 93.78 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.215 0.606 . . . . 0.0 110.402 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.3 mt -60.46 -50.12 74.83 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.813 0.845 . . . . 0.0 110.602 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -55.47 -41.92 73.64 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.035 0.379 . . . . 0.0 110.969 172.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.47 -46.21 52.98 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.205 0.907 . . . . 0.0 111.963 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.8 -48.4 80.78 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.408 0.604 . . . . 0.0 111.133 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.6 mm -60.9 -39.63 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 122.946 0.498 . . . . 0.0 111.279 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.24 -44.62 91.26 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.883 0.873 . . . . 0.0 110.216 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.02 -45.6 92.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.788 0.835 . . . . 0.0 110.905 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.5 mmm -59.78 -44.04 94.11 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.417 0.687 . . . . 0.0 110.626 175.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.8 60.96 0.4 Allowed Glycine 0 C--N 1.341 0.82 0 C-N-CA 124.518 1.056 . . . . 0.0 112.007 171.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -140.1 162.33 35.49 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.923 0.889 . . . . 0.0 109.494 172.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.0 103.85 3.91 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.97 110.05 21.82 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.75 1.62 . . . . 0.0 110.127 -174.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.9 t -150.4 145.88 26.35 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.037 0.381 . . . . 0.0 109.995 175.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.3 mt -74.41 144.59 44.26 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 122.597 0.359 . . . . 0.0 111.589 -174.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.3 t -96.86 -52.43 3.89 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.062 1.345 . . . . 0.0 107.7 169.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.5 p30 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.031 -1.461 . . . . 0.0 109.058 178.259 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 55.4 tp . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 110.676 -0.12 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.7 p -139.67 150.06 44.46 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.06 0.944 . . . . 0.0 109.823 176.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -142.64 162.45 35.43 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 126.333 1.853 . . . . 0.0 107.968 173.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -121.8 142.76 49.89 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.328 1.051 . . . . 0.0 109.231 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -133.54 133.41 42.1 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.192 0.997 . . . . 0.0 109.396 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.8 t -100.27 109.23 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 172.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.1 mt -99.53 118.4 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -75.8 107.41 7.96 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.2 mt -111.97 96.11 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -174.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -99.57 151.55 21.04 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.257 0.623 . . . . 0.0 109.771 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.09 35.35 12.59 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.185 0.898 . . . . 0.0 112.191 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 38.0 mtt -79.46 134.02 36.53 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 169.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.5 m -84.32 -51.51 6.92 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.424 0.689 . . . . 0.0 110.629 -174.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.8 p -161.0 -172.94 3.66 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.594 0.757 . . . . 0.0 109.647 -175.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -55.15 -32.68 62.29 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.385 1.474 . . . . 0.0 113.79 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.6 p -59.36 -41.15 88.62 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.264 0.484 . . . . 0.0 110.902 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.8 m -62.53 -49.95 73.3 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.916 0.486 . . . . 0.0 110.129 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.5 t -50.2 -52.1 15.67 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 C-N-CA 123.796 0.838 . . . . 0.0 109.889 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -62.04 -42.89 99.66 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.956 0.902 . . . . 0.0 111.845 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.6 m -63.87 -48.9 74.86 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.189 0.595 . . . . 0.0 110.969 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.9 mt -55.33 -58.56 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.974 1.309 . . . . 0.0 109.375 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -61.14 -43.52 98.76 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 117.952 0.342 . . . . 0.0 111.254 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.96 -54.48 33.4 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.367 0.984 . . . . 0.0 111.906 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.76 -51.49 72.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.033 0.933 . . . . 0.0 110.323 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.0 mm -62.92 -33.33 59.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.827 -175.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.5 m -57.04 -21.01 27.91 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 175.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -89.09 -14.09 37.1 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.631 0.65 . . . . 0.0 111.653 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -71.0 134.12 85.68 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -66.05 139.46 56.15 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.563 2.175 . . . . 0.0 109.571 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.32 -32.48 7.1 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-O 118.652 -1.082 . . . . 0.0 112.165 -176.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.5 t -66.17 136.37 26.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 CA-C-N 118.464 1.132 . . . . 0.0 110.198 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -116.67 -96.42 0.47 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.487 1.115 . . . . 0.0 108.606 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.5 p -90.09 147.98 23.3 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.475 0.71 . . . . 0.0 109.889 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 tt -150.41 131.98 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 123.841 0.856 . . . . 0.0 110.1 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.08 110.24 12.3 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.69 1.196 . . . . 0.0 108.494 177.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.7 t -106.06 144.4 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.364 1.066 . . . . 0.0 109.061 176.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.3 t -145.17 131.71 19.82 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.881 0.872 . . . . 0.0 110.609 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 tt -74.28 -45.86 44.96 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.737 1.215 . . . . 0.0 109.581 169.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.28 -46.95 66.1 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.298 1.039 . . . . 0.0 111.471 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -89.6 -10.79 44.67 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.42 0.688 . . . . 0.0 111.676 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.9 m 53.21 55.56 8.64 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 125.435 1.494 . . . . 0.0 110.554 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -156.48 169.3 24.95 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -175.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.41 111.43 0.99 Allowed Glycine 0 CA--C 1.524 0.623 0 C-N-CA 126.292 1.901 . . . . 0.0 108.369 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.5 m -99.08 98.54 9.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.7 t -109.98 127.88 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 124.392 1.077 . . . . 0.0 109.269 -170.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -98.27 129.79 44.98 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 169.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -150.06 163.61 37.7 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.76 0.824 . . . . 0.0 110.975 -169.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -95.35 115.01 65.08 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.396 1.078 . . . . 0.0 109.306 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -45.94 -37.17 16.77 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 124.993 3.795 . . . . 0.0 114.616 173.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.9 mt -63.76 -32.62 74.17 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.717 0.807 . . . . 0.0 112.004 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.8 -41.55 7.21 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.732 0.813 . . . . 0.0 111.281 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 t -142.69 170.47 15.65 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.381 0.672 . . . . 0.0 110.247 -178.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.4 p -138.43 160.95 61.62 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.397 1.079 . . . . 0.0 110.349 -174.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -50.64 -40.39 55.56 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.609 2.873 . . . . 0.0 112.211 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -61.12 -47.21 87.33 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.507 1.123 . . . . 0.0 110.418 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.6 m -60.94 -50.57 72.87 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.506 0.722 . . . . 0.0 110.678 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 50.9 mt -59.25 -50.95 72.05 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.382 1.073 . . . . 0.0 110.354 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -53.87 -49.49 68.4 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 124.115 0.966 . . . . 0.0 110.558 174.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.21 -46.44 62.86 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.518 1.056 . . . . 0.0 111.966 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.32 -51.46 69.87 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.239 0.616 . . . . 0.0 111.228 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.0 mm -66.44 -37.15 79.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 117.838 0.29 . . . . 0.0 111.657 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -60.37 -43.84 96.17 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.277 0.631 . . . . 0.0 109.951 175.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -62.72 -42.73 99.8 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.881 0.872 . . . . 0.0 111.363 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.1 mtp -56.95 -44.65 82.77 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.776 0.43 . . . . 0.0 110.577 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.9 63.1 0.18 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 123.597 0.617 . . . . 0.0 111.947 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -140.41 158.26 44.28 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.047 0.939 . . . . 0.0 108.817 171.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -78.74 87.22 4.64 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.25 116.6 31.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.917 1.287 . . . . 0.0 109.183 -176.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.9 p -138.82 133.22 31.77 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.645 1.178 . . . . 0.0 109.365 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.1 mt -69.09 145.81 53.11 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.934 0.494 . . . . 0.0 111.299 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 67.9 p -73.3 -50.34 22.66 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 169.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 C--O 1.251 1.159 0 C-N-CA 125.688 1.595 . . . . 0.0 111.041 175.946 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 75.1 mt . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 120.374 0.131 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 76.1 p -99.34 156.42 17.01 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.609 1.164 . . . . 0.0 109.158 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -133.52 159.54 40.13 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 124.676 1.19 . . . . 0.0 109.999 -173.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -113.93 145.54 41.35 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.447 1.099 . . . . 0.0 108.818 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.4 t -139.32 155.35 47.76 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.014 0.926 . . . . 0.0 109.489 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.5 t -120.24 131.37 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.1 mt -128.56 120.24 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -74.79 134.35 41.8 Favored 'General case' 0 C--N 1.337 0.052 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.8 mt -125.65 110.84 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -175.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -99.45 152.87 19.5 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.4 2.14 60.43 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.053 -0.86 . . . . 0.0 112.66 -176.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.3 mtm -79.33 103.3 9.17 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 118.66 1.23 . . . . 0.0 107.94 175.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.4 t -84.47 -29.74 25.81 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.302 0.641 . . . . 0.0 111.803 -173.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.2 p -159.17 179.01 9.4 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.389 0.54 . . . . 0.0 110.589 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -59.33 -26.18 64.8 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.09 1.356 . . . . 0.0 113.25 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.8 m -56.06 -40.84 74.15 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.486 0.585 . . . . 0.0 111.169 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.2 m -63.06 -51.85 65.06 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 122.899 0.48 . . . . 0.0 109.777 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.1 t -50.34 -54.89 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.182 0.993 . . . . 0.0 110.232 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -57.45 -53.9 52.93 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.733 1.213 . . . . 0.0 111.215 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.0 p -60.47 -51.27 70.16 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.123 0.569 . . . . 0.0 111.429 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.9 mt -56.08 -55.09 20.23 Favored 'Isoleucine or valine' 0 C--N 1.339 0.152 0 C-N-CA 123.502 0.721 . . . . 0.0 109.63 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -52.95 -53.13 54.18 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.506 0.722 . . . . 0.0 110.64 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.07 -55.55 30.04 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.184 0.897 . . . . 0.0 112.349 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.43 -53.22 51.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 123.958 0.903 . . . . 0.0 111.057 -175.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.7 mm -63.45 -31.4 52.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.026 0.53 . . . . 0.0 111.269 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.0 t -54.51 -26.09 29.55 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -89.38 -5.25 57.61 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.418 0.687 . . . . 0.0 112.284 -175.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -71.83 144.36 88.03 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 118.76 0.709 . . . . 0.0 109.537 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -64.31 128.07 20.62 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.977 2.452 . . . . 0.0 110.202 -175.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.6 -33.33 6.64 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 118.652 -1.082 . . . . 0.0 112.243 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.15 139.38 20.53 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 CA-C-N 118.192 0.996 . . . . 0.0 110.081 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -119.37 -98.7 0.45 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.666 1.186 . . . . 0.0 108.256 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.8 p -85.15 147.41 26.63 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.2 tt -150.26 134.58 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.753 0.821 . . . . 0.0 109.162 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 89.2 mmt-85 -132.52 109.24 9.64 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.081 1.352 . . . . 0.0 108.373 -177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.0 t -103.68 147.1 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.788 1.235 . . . . 0.0 108.703 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.4 t -140.64 127.85 20.99 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.068 0.947 . . . . 0.0 110.588 -174.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.1 tp -69.34 -49.49 55.16 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.576 1.15 . . . . 0.0 109.437 171.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.4 -46.25 69.64 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.752 1.221 . . . . 0.0 111.687 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -89.46 -11.63 42.46 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.3 0.64 . . . . 0.0 111.582 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.6 m 53.46 54.24 10.39 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 125.367 1.467 . . . . 0.0 110.791 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.4 p30 -158.86 173.1 17.05 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.032 0.533 . . . . 0.0 111.626 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.6 119.3 2.04 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 126.101 1.81 . . . . 0.0 109.333 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.9 m -99.59 117.78 34.71 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 t -122.43 128.7 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 124.278 1.031 . . . . 0.0 109.725 -170.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -95.43 127.14 41.22 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 169.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -150.2 164.68 35.06 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.981 0.512 . . . . 0.0 112.175 -169.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -98.81 115.17 65.9 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.545 1.138 . . . . 0.0 110.136 172.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -44.98 -42.84 15.73 Favored 'Trans proline' 0 C--N 1.348 0.526 1 C-N-CA 125.556 4.171 . . . . 0.0 115.634 176.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.2 mt -68.31 -28.01 66.79 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.627 0.371 . . . . 0.0 111.941 -174.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.2 mt -99.68 -31.21 11.68 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.064 0.946 . . . . 0.0 111.726 -175.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.8 t -153.35 163.86 39.17 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.551 0.614 . . . . 0.0 109.956 176.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.4 p -131.22 163.31 50.25 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 124.834 1.254 . . . . 0.0 109.915 -177.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.88 -40.13 67.1 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.292 2.661 . . . . 0.0 112.419 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -66.76 -40.32 88.2 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.719 0.807 . . . . 0.0 111.601 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.4 m -62.36 -48.1 81.28 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.628 0.371 . . . . 0.0 110.047 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.5 mt -61.27 -47.72 84.71 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.104 0.961 . . . . 0.0 110.596 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -51.6 -50.99 59.12 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.416 1.086 . . . . 0.0 110.087 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.93 -46.34 84.22 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.24 0.924 . . . . 0.0 112.112 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.21 -50.6 71.12 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.45 0.7 . . . . 0.0 111.184 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.4 mt -58.6 -47.39 88.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.387 0.675 . . . . 0.0 109.691 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -55.25 -48.92 73.28 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.747 0.819 . . . . 0.0 110.42 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.5 -38.38 77.55 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.925 1.29 . . . . 0.0 112.472 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -56.03 -37.45 69.24 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 118.428 0.558 . . . . 0.0 111.127 175.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.18 56.09 0.07 OUTLIER Glycine 0 C--N 1.34 0.776 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 171.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -140.39 173.75 11.19 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.949 0.9 . . . . 0.0 110.037 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -108.51 88.27 2.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.43 138.54 36.37 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.99 0.916 . . . . 0.0 110.374 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.0 t -149.48 148.11 29.02 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.287 1.035 . . . . 0.0 109.18 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.8 mt -65.39 152.25 44.34 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.693 0.397 . . . . 0.0 111.181 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.4 t -139.15 38.43 2.11 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.11 1.364 . . . . 0.0 108.577 172.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.9 t70 . . . . . 0 C--O 1.251 1.155 0 C-N-CA 125.4 1.48 . . . . 0.0 107.941 -171.276 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 120.335 0.112 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.7 p -140.21 128.08 21.98 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.126 0.97 . . . . 0.0 109.226 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -145.18 171.69 14.18 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.073 1.349 . . . . 0.0 109.449 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -136.39 143.3 43.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.829 1.252 . . . . 0.0 108.825 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 t -135.52 153.57 51.68 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.898 1.279 . . . . 0.0 109.012 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.3 t -120.83 135.87 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 171.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.4 mt -130.53 124.87 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -175.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -67.14 131.56 46.05 Favored 'General case' 0 C--N 1.338 0.09 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.3 mt -129.59 98.74 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -99.23 150.83 21.68 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.81 4.42 56.88 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.234 0.921 . . . . 0.0 112.343 -173.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 57.6 mtm -79.02 108.41 12.48 Favored 'General case' 0 C--N 1.343 0.318 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.3 m -84.36 -38.58 20.15 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.542 1.137 . . . . 0.0 110.401 -171.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.7 p -156.91 -178.66 7.53 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.805 0.336 . . . . 0.0 110.502 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -55.39 -30.99 61.45 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.667 1.587 . . . . 0.0 113.416 -178.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 m -54.02 -42.59 69.28 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.409 0.684 . . . . 0.0 111.335 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.0 m -62.65 -53.26 57.19 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 122.912 0.485 . . . . 0.0 109.861 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.0 t -49.91 -54.41 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.462 1.105 . . . . 0.0 110.516 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -60.98 -50.88 71.58 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.409 1.084 . . . . 0.0 111.447 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.9 p -61.4 -51.77 67.38 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.81 0.444 . . . . 0.0 111.291 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.8 mt -52.61 -57.7 3.81 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 C-N-CA 124.052 0.941 . . . . 0.0 109.358 177.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -54.7 -45.47 73.98 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.094 0.557 . . . . 0.0 111.166 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.3 -53.96 34.83 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.337 0.97 . . . . 0.0 112.023 177.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.5 t -65.9 -54.5 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 117.552 0.676 . . . . 0.0 110.725 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.8 -40.65 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 123.545 0.738 . . . . 0.0 111.221 -175.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.2 p -56.6 -26.73 56.4 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -89.17 -6.05 57.25 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.747 0.819 . . . . 0.0 111.938 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -73.3 125.57 90.72 Favored Pre-proline 0 CA--C 1.535 0.384 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.89 124.84 10.53 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.781 2.987 . . . . 0.0 112.35 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.12 -37.83 3.35 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-O 119.033 -0.871 . . . . 0.0 112.056 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.3 t -67.86 127.42 29.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-N 117.873 0.836 . . . . 0.0 110.077 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -98.02 -102.41 0.2 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.744 1.218 . . . . 0.0 108.003 176.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 95.7 p -89.97 155.85 18.83 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.538 0.608 . . . . 0.0 110.247 176.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.9 tt -150.55 144.5 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.103 0.961 . . . . 0.0 109.822 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -140.21 108.81 5.9 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.51 1.124 . . . . 0.0 108.84 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.7 t -98.36 141.77 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.668 1.187 . . . . 0.0 108.534 174.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.6 t -135.4 125.78 26.61 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 123.776 0.83 . . . . 0.0 110.888 -173.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -64.85 -55.64 18.26 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.647 1.179 . . . . 0.0 108.804 171.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.68 -47.5 58.77 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 125.2 1.4 . . . . 0.0 112.275 -176.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -89.35 -9.35 50.74 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.069 0.548 . . . . 0.0 111.698 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.6 m 52.3 54.99 9.8 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 125.315 1.446 . . . . 0.0 110.864 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -158.7 173.79 16.03 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.31 0.644 . . . . 0.0 111.095 -174.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.92 119.35 2.02 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 125.708 1.623 . . . . 0.0 109.308 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.2 m -99.44 116.09 30.78 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 t -127.51 122.52 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 124.072 0.949 . . . . 0.0 109.672 -169.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -90.05 134.3 34.33 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -150.09 168.09 24.92 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.86 0.464 . . . . 0.0 112.235 -171.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -103.41 111.82 65.32 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.179 1.392 . . . . 0.0 109.155 171.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -42.66 -38.22 6.23 Favored 'Trans proline' 0 C--N 1.348 0.51 1 C-N-CA 125.402 4.068 . . . . 0.0 115.282 172.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.79 -35.95 82.28 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.142 0.577 . . . . 0.0 111.794 -177.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.6 mt -102.26 -29.95 11.38 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.036 0.934 . . . . 0.0 112.36 -171.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 t -150.65 173.06 14.58 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.387 0.675 . . . . 0.0 109.915 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.7 p -141.4 162.63 46.3 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 124.516 1.126 . . . . 0.0 109.919 -177.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -52.62 -41.03 71.33 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.253 2.635 . . . . 0.0 112.1 174.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -64.62 -41.92 95.85 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.074 0.95 . . . . 0.0 111.423 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.5 m -63.05 -48.42 78.78 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.964 0.505 . . . . 0.0 110.381 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 54.6 mt -61.1 -48.89 79.6 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.091 0.956 . . . . 0.0 110.319 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.6 ttp85 -52.2 -48.48 65.05 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 124.139 0.976 . . . . 0.0 110.148 172.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.98 -46.73 76.26 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.661 1.125 . . . . 0.0 112.244 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.29 -49.84 75.99 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 117.491 0.646 . . . . 0.0 110.967 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.0 mt -61.2 -42.55 93.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.266 0.626 . . . . 0.0 109.972 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -60.83 -44.79 96.48 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.497 1.119 . . . . 0.0 110.583 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -59.03 -39.0 80.61 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.297 1.039 . . . . 0.0 111.349 177.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.3 mtp -67.33 -7.44 24.63 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 175.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.47 57.18 1.29 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 123.893 0.758 . . . . 0.0 111.483 170.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -140.33 156.35 46.47 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.139 0.976 . . . . 0.0 109.59 174.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -81.27 87.54 6.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 176.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.43 122.47 42.59 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.435 1.094 . . . . 0.0 109.747 -174.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.2 m -144.49 136.53 26.13 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.545 1.138 . . . . 0.0 108.588 -177.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.6 mt -63.67 136.7 57.69 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.857 0.463 . . . . 0.0 111.497 -176.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.1 m -89.51 -52.65 4.91 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 169.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 C--O 1.25 1.129 0 C-N-CA 125.333 1.453 . . . . 0.0 109.008 -179.695 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 46.1 tp . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 81.9 p -136.66 123.22 20.94 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.432 1.093 . . . . 0.0 109.458 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -143.98 169.69 17.35 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.988 0.915 . . . . 0.0 109.411 170.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -140.05 139.98 36.06 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.648 1.179 . . . . 0.0 108.192 173.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 t -137.33 141.44 41.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.035 0.934 . . . . 0.0 109.908 -177.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.5 t -99.72 133.39 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 171.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.3 mt -129.05 118.99 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -73.01 132.47 43.44 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.0 mt -120.55 111.49 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 125.266 1.426 . . . . 0.0 107.679 -175.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -100.74 149.37 23.88 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.487 1.115 . . . . 0.0 109.425 174.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.78 15.11 37.94 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.911 1.243 . . . . 0.0 112.455 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 93.1 mtp -79.69 109.07 13.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.5 m -84.34 -47.11 11.06 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.015 0.926 . . . . 0.0 111.065 -169.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -154.92 177.33 11.42 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.804 0.841 . . . . 0.0 108.821 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -61.2 -21.27 63.67 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -174.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.3 m -55.06 -36.8 65.97 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.361 0.528 . . . . 0.0 111.189 173.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.1 m -64.62 -44.23 91.2 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 122.897 0.479 . . . . 0.0 110.578 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.7 t -54.26 -52.88 34.19 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 123.345 0.658 . . . . 0.0 109.326 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -57.77 -50.19 74.08 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.921 0.888 . . . . 0.0 111.186 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -59.82 -59.32 5.62 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.515 0.726 . . . . 0.0 110.959 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 73.7 mt -52.94 -52.59 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.385 1.074 . . . . 0.0 109.561 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -61.72 -54.76 38.13 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.723 0.409 . . . . 0.0 110.746 -175.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.46 -39.11 95.86 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.731 1.158 . . . . 0.0 113.278 -176.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.8 t -73.7 -57.28 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 117.724 0.762 . . . . 0.0 109.937 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.6 mt -67.9 -28.96 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 118.971 -0.537 . . . . 0.0 111.813 -170.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.2 p -53.45 -28.89 32.74 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.897 0.771 . . . . 0.0 112.726 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -88.98 -17.09 30.15 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.857 0.863 . . . . 0.0 111.614 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -71.41 141.9 86.12 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 118.666 0.666 . . . . 0.0 109.709 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -63.99 140.37 72.22 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.323 2.682 . . . . 0.0 111.165 -170.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.43 -32.93 6.22 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 118.744 -1.031 . . . . 0.0 112.149 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.02 141.73 15.76 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 118.356 1.078 . . . . 0.0 110.125 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -118.39 -109.44 0.36 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.155 1.382 . . . . 0.0 107.526 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.7 p -90.1 94.33 9.74 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.329 1.052 . . . . 0.0 109.067 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.5 tt -89.92 133.94 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 123.932 0.893 . . . . 0.0 109.32 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -129.85 97.17 4.42 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.863 1.265 . . . . 0.0 108.444 -172.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.6 t -95.6 147.76 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.921 0.889 . . . . 0.0 109.927 -176.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.4 t -148.71 127.01 12.18 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.851 0.86 . . . . 0.0 110.198 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.8 tt -73.9 -42.77 60.18 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.011 0.924 . . . . 0.0 109.584 170.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.12 -47.11 72.21 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.543 1.137 . . . . 0.0 111.574 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -89.36 -5.44 57.47 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.362 0.665 . . . . 0.0 111.42 176.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.1 m 53.75 53.55 11.22 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 126.054 1.741 . . . . 0.0 111.165 175.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -161.22 172.08 17.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.284 0.564 . . . . 0.0 112.34 -172.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.71 117.05 2.39 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.1 m -99.37 94.38 6.41 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 t -100.03 120.06 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 124.456 1.103 . . . . 0.0 109.58 -169.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -89.52 132.86 34.85 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 169.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -150.81 171.79 16.64 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -169.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -106.87 111.72 63.65 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 125.548 1.539 . . . . 0.0 108.826 171.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -44.06 -38.02 10.11 Favored 'Trans proline' 0 C--N 1.346 0.422 1 C-N-CA 125.397 4.065 . . . . 0.0 114.893 172.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.2 mt -65.12 -33.69 76.62 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.481 0.712 . . . . 0.0 111.696 -177.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.0 mt -101.07 -33.4 10.16 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.266 1.026 . . . . 0.0 112.048 -172.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -148.95 169.97 19.38 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.526 0.73 . . . . 0.0 109.931 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.9 p -141.3 161.85 50.69 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.533 1.133 . . . . 0.0 109.745 -176.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.79 -42.86 42.79 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.484 2.789 . . . . 0.0 112.835 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -65.51 -39.87 92.35 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.541 0.736 . . . . 0.0 111.793 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.0 m -63.06 -45.26 93.02 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.637 0.375 . . . . 0.0 110.103 176.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.1 mt -65.43 -43.5 90.27 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.268 1.027 . . . . 0.0 110.833 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -53.85 -49.41 68.5 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.865 0.866 . . . . 0.0 109.449 170.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.92 -44.54 71.8 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.7 1.143 . . . . 0.0 112.388 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.29 94.65 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.727 0.811 . . . . 0.0 111.153 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.0 mt -63.7 -43.05 97.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 123.001 0.521 . . . . 0.0 110.226 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -62.57 -38.8 91.53 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.541 0.736 . . . . 0.0 111.349 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -60.94 -43.09 99.18 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.536 0.735 . . . . 0.0 110.616 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.4 mtp -62.36 -47.25 85.01 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 119.392 -0.337 . . . . 0.0 110.556 173.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.05 61.02 0.12 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 123.71 0.671 . . . . 0.0 112.077 170.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -140.33 150.69 44.29 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.58 0.752 . . . . 0.0 109.371 171.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -79.7 93.2 5.5 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.39 133.68 43.36 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.939 0.896 . . . . 0.0 110.39 -174.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.8 p -139.04 132.61 30.43 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.95 1.3 . . . . 0.0 108.825 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.8 mt -62.52 131.31 48.68 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.268 0.627 . . . . 0.0 110.751 -177.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.4 m -93.73 -44.88 7.94 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 169.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 117.238 -1.363 . . . . 0.0 108.804 171.77 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 83.5 mt . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 111.186 0.069 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 51.2 p -140.05 153.92 46.92 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.359 1.064 . . . . 0.0 109.751 177.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -142.36 166.27 25.15 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.821 1.648 . . . . 0.0 108.901 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -120.72 143.91 48.51 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.005 1.322 . . . . 0.0 108.486 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 t -142.27 139.66 31.98 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 123.534 0.734 . . . . 0.0 109.892 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.5 t -99.81 118.37 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.4 mm -102.22 130.64 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 174.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -71.58 125.56 27.4 Favored 'General case' 0 N--CA 1.458 -0.065 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 169.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.4 mt -127.58 88.95 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -99.88 159.14 15.3 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.097 0.559 . . . . 0.0 109.755 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.64 21.22 56.71 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 119.285 -0.731 . . . . 0.0 112.759 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 70.1 mtm -79.71 128.55 33.55 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.1 p -84.45 -42.43 15.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.497 0.719 . . . . 0.0 110.983 -174.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.6 p -159.58 179.95 8.44 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.822 0.344 . . . . 0.0 110.73 -174.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -54.09 -31.03 50.69 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.662 1.585 . . . . 0.0 113.57 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m -54.59 -39.02 67.41 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.411 0.684 . . . . 0.0 111.372 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.8 m -63.99 -49.2 73.39 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 122.82 0.448 . . . . 0.0 110.198 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.1 t -52.35 -51.82 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.248 1.019 . . . . 0.0 109.646 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -58.43 -48.26 81.28 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.32 1.448 . . . . 0.0 111.789 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.0 m -60.9 -50.78 72.01 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.944 0.497 . . . . 0.0 110.829 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.5 mt -60.39 -55.44 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 123.619 0.768 . . . . 0.0 110.017 -176.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -57.36 -45.33 84.51 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.493 0.588 . . . . 0.0 110.853 -176.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.44 -61.64 7.25 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 123.79 0.71 . . . . 0.0 111.464 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.81 -56.38 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.067 0.947 . . . . 0.0 110.994 -175.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.0 mm -63.08 -33.73 62.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 118.764 -0.636 . . . . 0.0 111.835 -171.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.4 t -51.07 -35.2 33.6 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -89.38 -5.57 57.34 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.903 -0.57 . . . . 0.0 112.453 -175.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -68.22 147.95 98.28 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 119.417 1.008 . . . . 0.0 110.105 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -45.77 132.15 13.46 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 124.08 3.186 . . . . 0.0 112.738 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.82 -39.33 3.09 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 118.943 -0.921 . . . . 0.0 112.986 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.4 t -67.32 143.22 15.67 Favored 'Isoleucine or valine' 0 C--N 1.341 0.205 0 CA-C-N 118.089 0.944 . . . . 0.0 110.278 -177.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -117.63 -95.33 0.48 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.6 p -90.66 157.5 17.43 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.837 0.855 . . . . 0.0 110.078 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.5 tt -150.7 145.06 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 124.488 1.115 . . . . 0.0 108.601 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -131.98 107.83 8.94 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.128 0.971 . . . . 0.0 109.121 176.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.9 t -97.27 149.56 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.977 1.311 . . . . 0.0 109.047 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.3 t -145.14 123.02 11.96 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.266 0.627 . . . . 0.0 110.173 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.8 tp -67.04 -47.0 72.71 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.745 1.218 . . . . 0.0 109.931 172.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.93 -43.28 66.15 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.677 1.191 . . . . 0.0 111.7 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -89.2 -21.02 23.48 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.375 0.67 . . . . 0.0 111.147 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.9 m 57.48 57.29 4.45 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 125.267 1.427 . . . . 0.0 109.784 -174.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.6 p30 -152.81 171.63 17.96 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.47 0.708 . . . . 0.0 111.578 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -137.26 114.68 1.14 Allowed Glycine 0 C--N 1.337 0.615 0 C-N-CA 126.041 1.781 . . . . 0.0 108.894 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.3 m -99.11 99.9 10.97 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.0 t -103.26 133.17 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 124.817 1.247 . . . . 0.0 109.58 -170.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -103.21 125.17 49.76 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 172.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -150.17 171.02 17.57 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -168.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -101.25 113.22 65.83 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.353 1.461 . . . . 0.0 109.479 172.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -44.18 -40.2 12.34 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 125.17 3.914 . . . . 0.0 114.794 173.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.0 mt -63.19 -34.81 78.45 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.606 0.763 . . . . 0.0 111.703 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.8 mt -99.98 -29.26 12.65 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.107 0.963 . . . . 0.0 112.197 -172.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.7 t -153.07 160.25 42.92 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.645 0.657 . . . . 0.0 110.11 177.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.3 p -125.98 161.88 48.88 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 125.179 1.392 . . . . 0.0 109.658 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.99 -36.12 43.3 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.41 2.74 . . . . 0.0 112.924 172.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -67.94 -44.0 77.83 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.608 1.163 . . . . 0.0 110.717 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.2 m -62.78 -45.71 91.39 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.959 0.504 . . . . 0.0 110.296 176.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.9 mt -61.85 -48.84 78.74 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.699 0.8 . . . . 0.0 110.534 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.2 ttp85 -49.99 -47.45 52.87 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.267 1.027 . . . . 0.0 110.14 171.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.84 -51.09 41.29 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.41 1.005 . . . . 0.0 111.826 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.36 -43.76 96.22 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.769 0.785 . . . . 0.0 111.948 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.8 mm -60.9 -44.12 97.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 118.345 0.521 . . . . 0.0 110.507 176.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -58.98 -43.74 91.47 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.173 0.589 . . . . 0.0 110.17 175.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -60.66 -41.47 95.09 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.98 0.912 . . . . 0.0 111.213 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.4 mtp -61.92 -43.86 97.97 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.238 0.472 . . . . 0.0 110.592 173.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.06 60.7 0.2 Allowed Glycine 0 C--N 1.34 0.805 0 C-N-CA 123.786 0.707 . . . . 0.0 111.887 169.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -140.37 159.36 42.36 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.975 0.91 . . . . 0.0 109.313 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -73.46 98.25 2.72 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.87 127.95 46.0 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.049 1.339 . . . . 0.0 110.021 -173.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.1 m -150.11 152.79 35.3 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.472 1.109 . . . . 0.0 108.521 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -75.27 124.37 26.96 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 t -91.29 -59.91 2.03 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 171.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.6 t70 . . . . . 0 C--O 1.249 1.051 0 C-N-CA 125.373 1.469 . . . . 0.0 107.819 178.592 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 120.328 0.109 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.4 p -140.39 133.08 28.88 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.273 1.029 . . . . 0.0 109.64 176.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -145.2 165.75 27.43 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.31 1.444 . . . . 0.0 109.065 173.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -129.26 151.01 50.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.813 1.245 . . . . 0.0 109.025 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.5 t -149.62 153.74 37.54 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 123.784 0.834 . . . . 0.0 109.91 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.57 125.43 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 173.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.3 mt -121.36 121.62 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -67.63 131.12 45.0 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 173.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.1 mt -124.39 108.77 21.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.112 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -99.83 150.5 22.29 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.58 13.17 55.99 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.378 0.989 . . . . 0.0 113.06 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 71.5 mtm -79.58 117.17 20.27 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.711 1.255 . . . . 0.0 108.26 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.4 m -84.15 -43.01 15.41 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.093 0.957 . . . . 0.0 110.387 -172.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.9 p -157.38 -178.94 7.72 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.605 0.362 . . . . 0.0 110.419 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -57.6 -25.92 60.76 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.293 1.437 . . . . 0.0 113.425 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.8 t -57.28 -44.42 83.99 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.229 0.611 . . . . 0.0 110.638 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.0 m -61.27 -51.06 70.51 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.817 0.447 . . . . 0.0 109.916 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.4 t -50.45 -53.05 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.328 1.051 . . . . 0.0 110.229 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -57.02 -51.75 68.02 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.55 1.14 . . . . 0.0 111.15 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.4 m -58.91 -54.37 47.87 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.566 0.746 . . . . 0.0 111.392 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.2 mt -54.08 -56.2 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.46 1.104 . . . . 0.0 109.438 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -55.09 -53.41 56.27 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.14 0.976 . . . . 0.0 110.924 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.47 -53.82 42.01 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.463 1.03 . . . . 0.0 112.296 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.6 t -59.48 -53.42 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.449 0.7 . . . . 0.0 110.392 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.0 mt -63.62 -39.94 87.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.108 0.563 . . . . 0.0 111.237 -174.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.2 t -49.92 -34.68 21.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.99 0.916 . . . . 0.0 112.355 176.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -89.05 -9.8 49.88 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.699 0.8 . . . . 0.0 112.427 -172.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -72.56 137.62 80.59 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 119.341 0.973 . . . . 0.0 109.91 177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.39 136.03 20.0 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.718 2.945 . . . . 0.0 112.259 172.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.69 -43.31 1.83 Allowed Glycine 0 CA--C 1.523 0.541 0 CA-C-O 119.221 -0.766 . . . . 0.0 111.823 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.6 t -69.78 133.72 31.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 CA-C-N 117.76 0.78 . . . . 0.0 109.513 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -107.25 -98.1 0.36 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.9 p -90.15 149.04 22.62 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.546 0.738 . . . . 0.0 109.917 176.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.6 tt -150.53 143.17 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.239 1.016 . . . . 0.0 109.574 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -138.59 118.76 13.52 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.836 1.254 . . . . 0.0 108.342 175.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.19 147.02 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.889 1.275 . . . . 0.0 108.225 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.1 t -139.67 127.5 22.01 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 123.828 0.851 . . . . 0.0 110.749 -174.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp -68.17 -50.5 54.04 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.649 1.179 . . . . 0.0 109.47 171.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.56 -46.29 70.19 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.825 1.25 . . . . 0.0 111.73 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -89.36 -10.55 46.24 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.261 0.624 . . . . 0.0 111.586 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.7 m 53.11 55.18 9.23 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.368 1.467 . . . . 0.0 110.846 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -158.88 171.43 20.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.953 0.501 . . . . 0.0 111.698 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.31 116.06 1.86 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 126.376 1.941 . . . . 0.0 109.162 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.8 m -99.33 112.17 24.4 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.0 t -120.0 136.26 57.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.429 1.092 . . . . 0.0 109.819 -170.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -109.64 128.29 55.13 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 169.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -150.3 173.37 14.05 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -168.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -105.4 112.67 64.82 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.442 1.497 . . . . 0.0 109.483 174.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -41.64 -39.71 4.94 Favored 'Trans proline' 0 C--N 1.348 0.52 1 C-N-CA 125.585 4.19 . . . . 0.0 115.272 171.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.6 -33.12 74.35 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.292 0.637 . . . . 0.0 112.017 -177.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.2 mt -106.39 -31.52 8.54 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.297 1.039 . . . . 0.0 112.293 -171.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 t -150.26 175.43 11.8 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.392 0.677 . . . . 0.0 109.961 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.4 p -149.07 164.62 20.38 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.2 1.0 . . . . 0.0 110.328 -174.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.32 -39.45 86.99 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.449 2.766 . . . . 0.0 112.096 174.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.51 -39.03 81.39 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.634 0.774 . . . . 0.0 111.447 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.6 m -62.93 -46.74 86.35 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 45.8 mt -59.87 -50.46 73.68 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.085 0.954 . . . . 0.0 110.609 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -51.53 -48.4 63.01 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.679 1.191 . . . . 0.0 110.46 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.71 -45.32 93.51 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.452 1.025 . . . . 0.0 112.219 177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.85 -46.48 87.69 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.493 0.717 . . . . 0.0 110.991 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.1 mt -60.02 -44.07 93.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 123.528 0.731 . . . . 0.0 109.97 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -60.99 -42.49 98.51 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.638 0.775 . . . . 0.0 111.075 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -61.7 -43.43 98.87 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.663 0.785 . . . . 0.0 111.119 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.8 mtp -59.64 -45.17 92.79 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.746 0.419 . . . . 0.0 110.442 175.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.83 53.38 0.1 Allowed Glycine 0 C--N 1.341 0.817 0 C-N-CA 123.509 0.576 . . . . 0.0 112.477 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -140.46 133.01 28.67 Favored 'General case' 0 C--N 1.338 0.104 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 172.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -73.01 104.56 4.15 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -103.5 139.85 38.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.157 1.383 . . . . 0.0 110.59 -172.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.8 p -142.3 145.28 33.82 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.525 1.13 . . . . 0.0 108.793 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 52.6 mt -71.93 127.35 32.29 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.826 0.45 . . . . 0.0 110.189 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.82 -51.99 7.15 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 171.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.0 t70 . . . . . 0 C--O 1.249 1.071 0 C-N-CA 125.499 1.52 . . . . 0.0 108.09 179.822 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 47.1 tp . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 110.622 -0.14 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.1 p -140.03 142.7 36.21 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.282 1.033 . . . . 0.0 110.112 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -140.27 164.03 31.17 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.663 1.585 . . . . 0.0 108.265 170.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -127.27 150.0 49.76 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.471 1.108 . . . . 0.0 109.278 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -144.72 150.25 36.96 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.029 0.932 . . . . 0.0 109.706 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.0 t -112.5 127.18 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 171.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.0 mt -121.73 121.55 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -80.0 130.75 35.51 Favored 'General case' 0 N--CA 1.458 -0.061 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.8 mt -127.76 96.96 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -172.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -99.67 153.77 18.82 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.17 6.78 53.31 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.505 1.05 . . . . 0.0 112.345 -172.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 63.4 mtm -79.34 120.78 24.27 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.642 1.221 . . . . 0.0 108.474 175.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.5 p -84.4 -40.14 18.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.088 0.955 . . . . 0.0 110.989 -173.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.9 p -159.07 179.78 8.74 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.779 0.431 . . . . 0.0 110.327 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -59.22 -25.99 64.47 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.816 1.247 . . . . 0.0 113.279 -176.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.9 m -53.4 -41.28 65.81 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.488 0.586 . . . . 0.0 111.207 174.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.2 m -63.49 -48.35 77.99 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 123.384 0.674 . . . . 0.0 110.374 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.9 t -54.09 -52.17 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.348 1.059 . . . . 0.0 109.858 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -64.45 -46.38 83.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.904 0.881 . . . . 0.0 111.475 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.2 p -61.51 -47.41 85.73 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.085 0.402 . . . . 0.0 110.601 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.6 mt -56.24 -54.81 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 123.39 0.676 . . . . 0.0 109.613 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -49.95 -57.97 6.42 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.965 0.906 . . . . 0.0 110.204 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.55 -53.26 44.88 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.255 0.931 . . . . 0.0 112.583 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.83 -50.38 75.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.314 0.646 . . . . 0.0 111.116 -174.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.65 -32.65 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.091 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.1 m -55.2 -20.08 9.66 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -89.12 -10.83 45.8 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.866 0.757 . . . . 0.0 112.212 -176.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -73.19 127.21 89.57 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -47.45 128.9 15.67 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.854 3.036 . . . . 0.0 112.569 176.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.24 -33.18 6.74 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-O 118.592 -1.115 . . . . 0.0 112.655 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.6 t -65.27 136.91 25.93 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 CA-C-N 118.208 1.004 . . . . 0.0 110.623 -176.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -119.22 -103.06 0.41 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.34 1.456 . . . . 0.0 108.163 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 82.7 p -80.74 151.96 28.59 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.255 0.479 . . . . 0.0 110.133 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -150.25 138.88 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.248 1.019 . . . . 0.0 108.961 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -138.93 101.22 4.24 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.454 1.501 . . . . 0.0 107.712 -172.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 t -110.5 144.93 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.521 1.128 . . . . 0.0 108.865 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -146.51 130.93 17.64 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.312 0.645 . . . . 0.0 111.127 -175.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.8 tp -70.49 -48.82 53.87 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.882 1.273 . . . . 0.0 109.454 171.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.24 -46.26 69.07 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.759 1.224 . . . . 0.0 111.667 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -89.37 -10.15 47.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.194 0.597 . . . . 0.0 111.493 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.5 m 52.67 58.86 4.93 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.377 1.471 . . . . 0.0 110.488 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -158.42 169.19 25.01 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.203 0.525 . . . . 0.0 111.856 -174.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.82 113.58 1.05 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 126.652 2.073 . . . . 0.0 108.102 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.9 m -99.68 130.83 45.93 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 174.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.7 t -135.02 135.22 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 123.353 0.661 . . . . 0.0 109.766 -171.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -101.11 131.08 47.21 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 169.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -150.49 162.35 40.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.987 0.515 . . . . 0.0 111.99 -170.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -91.59 116.1 65.8 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 124.691 1.196 . . . . 0.0 109.49 170.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -48.59 -36.51 32.14 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 124.575 3.517 . . . . 0.0 114.231 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.4 mt -64.59 -28.95 69.98 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.602 0.761 . . . . 0.0 111.988 -176.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.7 mt -109.8 -28.63 8.7 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.047 0.939 . . . . 0.0 112.401 -172.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 t -152.43 178.63 9.34 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.792 0.724 . . . . 0.0 109.991 176.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.5 p -150.34 163.95 22.34 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.64 1.176 . . . . 0.0 109.756 -174.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.89 -38.49 85.95 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.257 2.638 . . . . 0.0 112.324 174.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -66.07 -45.34 81.66 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.26 1.024 . . . . 0.0 110.357 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 m -61.86 -47.26 85.81 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.185 0.594 . . . . 0.0 110.449 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.5 mt -60.16 -50.16 74.78 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.902 0.881 . . . . 0.0 110.382 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 57.5 ttp85 -52.04 -45.32 64.62 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.872 0.869 . . . . 0.0 110.342 172.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.73 -45.28 69.43 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.517 1.056 . . . . 0.0 112.163 175.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.85 -47.97 82.64 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.759 0.779 . . . . 0.0 111.265 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.1 mm -59.63 -45.53 94.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 122.668 0.387 . . . . 0.0 110.484 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -60.0 -41.81 92.93 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.251 1.02 . . . . 0.0 110.559 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.59 -44.49 96.19 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.952 0.901 . . . . 0.0 111.078 176.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.8 mtp -58.81 -41.55 87.04 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.737 0.415 . . . . 0.0 110.735 175.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.31 61.36 0.25 Allowed Glycine 0 C--N 1.34 0.76 0 C-N-CA 123.829 0.728 . . . . 0.0 112.107 169.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -140.45 155.02 46.84 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 123.955 0.902 . . . . 0.0 109.007 170.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -78.72 94.95 5.18 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.82 126.5 45.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.014 1.326 . . . . 0.0 109.897 -176.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.2 p -136.49 131.7 34.32 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.519 1.128 . . . . 0.0 109.162 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.5 mt -62.75 124.22 20.45 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.327 0.651 . . . . 0.0 109.591 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.6 t -97.39 -52.69 3.71 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.975 0.91 . . . . 0.0 109.605 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 117.069 -1.443 . . . . 0.0 108.847 -177.893 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.3 tt . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 46.4 p -139.73 161.21 38.09 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.52 1.128 . . . . 0.0 110.074 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -142.08 167.07 22.99 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.604 1.562 . . . . 0.0 108.695 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -129.12 153.8 47.32 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.573 1.149 . . . . 0.0 109.568 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -148.08 144.48 27.89 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.86 0.864 . . . . 0.0 110.073 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.7 t -106.9 107.46 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.7 mt -99.75 116.06 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -76.59 120.77 22.25 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 175.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -114.29 110.77 33.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -174.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -99.58 147.46 25.33 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.062 0.945 . . . . 0.0 108.639 173.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.44 4.98 52.59 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.328 0.966 . . . . 0.0 112.874 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 66.6 mtm -79.46 110.92 15.21 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.72 1.26 . . . . 0.0 107.982 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.8 p -84.4 -39.37 19.1 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.8 0.84 . . . . 0.0 110.965 -173.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.6 p -156.43 -179.47 8.2 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.715 0.293 . . . . 0.0 110.643 -175.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -55.16 -32.59 62.25 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.193 1.397 . . . . 0.0 112.981 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m -52.96 -39.85 63.26 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.416 0.687 . . . . 0.0 111.615 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.7 m -66.8 -48.05 70.16 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 122.858 0.463 . . . . 0.0 110.354 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.7 t -52.77 -55.08 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.046 0.938 . . . . 0.0 109.731 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -54.81 -52.95 61.06 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.141 1.376 . . . . 0.0 110.674 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.8 t -56.53 -55.87 28.44 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.697 0.799 . . . . 0.0 111.132 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.8 mt -57.21 -54.56 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.707 0.803 . . . . 0.0 109.641 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -55.02 -52.4 63.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.029 0.532 . . . . 0.0 110.666 -177.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.13 -51.11 60.34 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.681 1.134 . . . . 0.0 112.414 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.7 t -67.7 -57.24 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 117.801 0.801 . . . . 0.0 110.848 -176.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.4 mm -60.3 -34.54 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.561 0.744 . . . . 0.0 111.538 -173.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.9 p -54.13 -27.86 36.12 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -89.15 -20.04 24.74 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.29 0.636 . . . . 0.0 111.798 -175.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.59 141.72 93.31 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 118.509 0.595 . . . . 0.0 109.906 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -62.13 136.64 61.67 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.485 2.79 . . . . 0.0 111.304 -169.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.95 -40.39 2.45 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-O 118.996 -0.891 . . . . 0.0 111.583 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.2 131.52 33.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-N 118.103 0.952 . . . . 0.0 110.166 -176.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -101.2 -101.5 0.26 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.733 1.213 . . . . 0.0 107.732 173.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.5 p -87.92 151.48 22.79 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.77 0.828 . . . . 0.0 109.908 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.9 tt -150.18 137.92 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 123.907 0.883 . . . . 0.0 109.365 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -130.59 112.84 13.53 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.835 1.254 . . . . 0.0 108.479 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.9 t -101.4 147.92 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.379 1.072 . . . . 0.0 108.496 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.8 t -147.02 127.0 13.61 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.644 0.778 . . . . 0.0 110.463 -175.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.9 tp -70.32 -46.01 65.06 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.801 1.241 . . . . 0.0 109.937 172.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.64 -43.47 65.46 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.655 1.182 . . . . 0.0 111.498 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -89.26 -19.95 24.72 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.579 0.752 . . . . 0.0 111.099 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.5 m 57.43 53.82 7.15 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.478 1.511 . . . . 0.0 110.06 -175.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.9 p30 -153.85 172.93 16.59 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.976 0.511 . . . . 0.0 111.918 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.89 113.89 1.19 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 127.128 2.299 . . . . 0.0 107.96 176.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.0 m -98.96 104.34 16.38 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 t -111.47 133.48 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 124.517 1.127 . . . . 0.0 109.849 -169.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -103.58 133.39 48.68 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 169.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -150.45 170.51 18.91 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -171.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -103.19 112.89 66.04 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 125.586 1.554 . . . . 0.0 109.242 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -43.22 -38.98 8.29 Favored 'Trans proline' 0 C--N 1.348 0.531 1 C-N-CA 125.535 4.157 . . . . 0.0 114.987 173.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.41 -34.72 77.31 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.365 0.666 . . . . 0.0 111.811 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.6 mt -101.88 -32.14 10.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.248 1.019 . . . . 0.0 112.177 -172.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.5 t -152.04 175.83 12.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.185 0.594 . . . . 0.0 110.109 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.6 p -150.13 165.28 17.86 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 124.598 1.159 . . . . 0.0 109.635 -175.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -51.06 -46.18 32.42 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.606 2.871 . . . . 0.0 113.075 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -68.58 -34.67 76.2 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.186 0.594 . . . . 0.0 111.865 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.4 m -65.8 -45.45 82.33 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.126 0.421 . . . . 0.0 109.988 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.7 mt -64.45 -44.58 90.67 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.194 0.998 . . . . 0.0 110.692 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.6 ttp180 -53.78 -50.64 65.63 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.64 0.776 . . . . 0.0 109.18 171.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.74 -44.46 60.57 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.02 1.295 . . . . 0.0 112.565 176.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.09 -44.05 96.79 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.816 0.846 . . . . 0.0 111.09 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.6 mt -65.94 -39.76 85.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.21 0.604 . . . . 0.0 110.388 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -62.63 -38.88 91.98 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.506 0.722 . . . . 0.0 110.928 174.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -62.41 -41.36 98.63 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.321 0.648 . . . . 0.0 110.831 176.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.8 mtp -60.52 -48.39 81.96 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.028 0.376 . . . . 0.0 110.241 172.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.58 60.6 0.1 Allowed Glycine 0 C--N 1.341 0.811 0 C-N-CA 123.706 0.669 . . . . 0.0 111.956 170.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -140.35 149.97 43.38 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.624 0.77 . . . . 0.0 109.756 173.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -80.28 87.13 5.59 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.928 0.891 . . . . 0.0 108.691 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.57 140.8 33.23 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.006 0.923 . . . . 0.0 111.007 -175.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.0 t -150.31 160.15 43.93 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.698 1.199 . . . . 0.0 109.146 174.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -82.69 162.19 21.89 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.15 0.58 . . . . 0.0 110.205 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 71.1 m -79.28 69.03 5.42 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.391 0.676 . . . . 0.0 109.58 172.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 117.142 -1.409 . . . . 0.0 108.709 179.965 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 75.3 mt . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 120.41 0.148 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.5 p -99.53 166.57 11.09 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.788 1.235 . . . . 0.0 110.19 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -134.22 162.81 31.13 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.14 1.376 . . . . 0.0 109.262 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -125.41 145.53 50.01 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.971 1.308 . . . . 0.0 108.695 176.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.7 t -142.8 145.51 33.3 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.824 0.85 . . . . 0.0 109.625 176.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.5 t -106.51 130.88 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 172.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.4 mt -125.62 125.19 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -69.91 129.38 39.36 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.1 mt -121.63 103.82 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -100.01 150.8 22.07 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.077 0.951 . . . . 0.0 109.407 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.74 26.2 23.13 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.674 1.131 . . . . 0.0 112.099 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 93.4 mtp -85.59 111.55 20.15 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.6 p -84.5 -44.84 13.23 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.492 0.717 . . . . 0.0 111.469 -170.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.9 p -159.05 -179.97 8.51 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.415 0.686 . . . . 0.0 109.721 -175.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -56.22 -29.32 60.83 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.819 1.247 . . . . 0.0 113.204 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.5 m -52.19 -41.18 62.45 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.154 0.582 . . . . 0.0 111.428 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.5 m -64.84 -46.53 81.51 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 122.692 0.397 . . . . 0.0 110.503 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.8 t -53.06 -55.15 13.56 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 C-N-CA 123.489 0.716 . . . . 0.0 109.342 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -56.71 -52.11 66.21 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.563 1.145 . . . . 0.0 111.224 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.9 m -58.99 -56.61 20.01 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.68 0.792 . . . . 0.0 111.222 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.4 mt -56.08 -51.96 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 123.651 0.78 . . . . 0.0 109.401 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -56.51 -53.52 56.52 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.856 0.462 . . . . 0.0 110.68 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.8 -54.55 36.6 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.687 0.66 . . . . 0.0 112.372 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.3 t -62.81 -55.35 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.794 0.838 . . . . 0.0 111.043 -174.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.0 mm -62.33 -37.11 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 118.778 -0.63 . . . . 0.0 110.932 -175.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.8 t -51.86 -35.11 43.67 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 118.798 0.726 . . . . 0.0 112.358 175.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -89.0 -12.18 42.14 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.778 0.831 . . . . 0.0 111.988 -173.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -70.4 143.62 90.77 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 119.016 0.825 . . . . 0.0 109.631 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -62.26 137.76 67.74 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.343 2.695 . . . . 0.0 111.021 -171.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.43 -41.02 2.38 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-O 119.059 -0.856 . . . . 0.0 111.311 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.2 t -70.88 141.39 16.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.199 0 CA-C-N 118.106 0.953 . . . . 0.0 109.442 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -112.91 -94.28 0.46 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.5 p -90.82 155.61 18.64 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.713 0.805 . . . . 0.0 109.787 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.4 tt -150.85 137.17 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.058 0.943 . . . . 0.0 108.47 174.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -117.95 99.46 6.92 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.68 1.592 . . . . 0.0 108.565 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.2 t -94.3 144.9 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.791 0.836 . . . . 0.0 109.601 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.5 t -147.37 122.48 10.15 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.785 0.834 . . . . 0.0 110.14 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.9 tt -70.15 -43.75 70.23 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.187 0.995 . . . . 0.0 109.564 170.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.5 -45.83 69.81 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.216 1.006 . . . . 0.0 111.566 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -89.68 -5.57 56.94 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.48 0.712 . . . . 0.0 111.778 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.0 m 51.8 53.82 11.98 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.679 1.591 . . . . 0.0 111.212 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -159.5 173.42 16.2 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -174.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.65 118.77 1.93 Allowed Glycine 0 C--N 1.339 0.72 0 C-N-CA 126.208 1.861 . . . . 0.0 109.001 174.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.8 m -99.68 97.9 8.8 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.2 t -100.63 132.2 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.698 1.199 . . . . 0.0 110.198 -169.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -105.31 126.56 52.24 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 172.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -150.15 169.17 21.93 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -169.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -102.91 115.77 63.63 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.309 1.443 . . . . 0.0 109.709 175.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -45.17 -41.03 16.58 Favored 'Trans proline' 0 C--N 1.348 0.523 1 C-N-CA 125.806 4.338 . . . . 0.0 115.635 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.1 mt -67.12 -29.69 69.49 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.922 0.489 . . . . 0.0 111.781 -174.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.52 -35.3 9.92 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.872 0.869 . . . . 0.0 110.989 -175.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.4 t -150.79 170.98 17.95 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.538 0.608 . . . . 0.0 110.576 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.5 p -150.03 161.86 29.76 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.995 1.318 . . . . 0.0 109.507 -172.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -50.12 -48.46 19.7 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.684 2.923 . . . . 0.0 113.434 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -58.81 -40.18 83.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.724 0.81 . . . . 0.0 112.044 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 m -66.35 -45.26 80.78 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.247 0.619 . . . . 0.0 109.862 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.4 mt -64.3 -43.32 95.09 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.178 0.991 . . . . 0.0 110.944 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.0 ttp85 -56.3 -48.09 77.37 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.85 0.86 . . . . 0.0 109.573 172.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.11 -41.08 92.45 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.28 0.943 . . . . 0.0 112.571 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.34 -47.41 76.58 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.67 0.788 . . . . 0.0 111.036 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.0 mt -62.83 -41.39 92.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.242 0.617 . . . . 0.0 109.7 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -58.75 -43.58 90.33 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.359 0.664 . . . . 0.0 110.803 175.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.7 -39.5 88.75 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.735 0.814 . . . . 0.0 111.429 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.2 mtp -59.25 -44.8 92.38 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 118.234 0.47 . . . . 0.0 110.593 173.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.93 61.5 0.1 Allowed Glycine 0 C--N 1.341 0.84 0 C-N-CA 123.533 0.587 . . . . 0.0 111.88 169.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -140.5 156.64 46.27 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.98 0.912 . . . . 0.0 109.544 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -79.5 90.46 5.09 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 174.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.47 125.52 45.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.69 1.196 . . . . 0.0 109.774 -174.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.4 p -145.62 135.18 23.25 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.314 1.046 . . . . 0.0 108.949 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.3 141.12 56.6 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.682 0.793 . . . . 0.0 111.866 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.0 m -84.24 -41.91 16.44 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 169.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 . . . . . 0 C--O 1.251 1.132 0 CA-C-O 117.062 -1.447 . . . . 0.0 110.135 177.067 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.4 p -128.99 141.76 51.15 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.655 1.182 . . . . 0.0 109.48 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -135.68 170.41 16.01 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.861 1.665 . . . . 0.0 108.122 172.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -140.13 123.93 17.38 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 t -113.06 134.83 54.35 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.838 1.255 . . . . 0.0 109.22 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.3 t -99.55 125.27 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 169.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.5 mt -120.96 119.73 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -73.92 125.59 28.56 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.8 mt -118.22 107.43 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 125.053 1.341 . . . . 0.0 107.388 -176.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -99.79 135.5 41.12 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.58 0.9 20.07 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.854 1.216 . . . . 0.0 112.791 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.8 mtm -78.6 100.09 6.82 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.4 m -84.33 -36.09 22.8 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.974 1.31 . . . . 0.0 111.235 -169.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.1 p -153.45 179.57 8.66 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.026 0.376 . . . . 0.0 110.285 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -56.29 -30.13 62.08 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.178 1.391 . . . . 0.0 112.931 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 m -55.46 -43.91 75.9 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.434 0.694 . . . . 0.0 111.243 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.1 m -61.76 -53.13 60.16 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.5 t -49.91 -56.22 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.502 1.121 . . . . 0.0 110.146 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -63.34 -46.86 84.65 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.944 0.898 . . . . 0.0 111.586 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.6 p -60.99 -49.97 75.3 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.629 0.372 . . . . 0.0 110.994 -177.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.7 mt -55.88 -55.24 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -52.24 -54.35 32.22 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.792 0.837 . . . . 0.0 111.117 -176.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.14 -52.18 53.65 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 124.117 0.865 . . . . 0.0 112.458 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.2 t -64.03 -49.28 82.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 117.456 0.628 . . . . 0.0 111.044 -174.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.6 mm -64.65 -33.81 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.229 0.612 . . . . 0.0 111.217 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.1 t -53.71 -24.75 15.66 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 177.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -88.53 -8.33 54.99 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.424 0.69 . . . . 0.0 112.121 -172.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -74.06 128.18 86.83 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -46.81 133.84 17.51 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.703 2.935 . . . . 0.0 112.232 175.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.99 -42.11 1.97 Allowed Glycine 0 C--N 1.337 0.593 0 CA-C-O 119.037 -0.868 . . . . 0.0 111.47 -177.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.2 t -67.3 130.47 32.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 CA-C-N 117.846 0.823 . . . . 0.0 109.612 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -105.44 -94.48 0.35 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.4 p -90.05 154.96 19.41 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.482 0.713 . . . . 0.0 109.466 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.6 tt -150.25 135.42 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 37.7 mtt85 -131.56 93.9 3.43 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.66 1.184 . . . . 0.0 108.229 -169.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.2 t -95.29 141.91 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 123.648 0.779 . . . . 0.0 109.21 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.2 t -144.96 125.73 14.28 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.012 0.925 . . . . 0.0 110.283 -175.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 tt -71.43 -44.04 65.6 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.731 1.212 . . . . 0.0 110.039 172.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.05 -43.02 63.59 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.321 1.048 . . . . 0.0 111.449 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -89.4 -20.81 23.5 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.626 0.77 . . . . 0.0 111.141 177.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.7 m 57.76 54.68 6.03 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.646 1.578 . . . . 0.0 109.956 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.9 p30 -154.64 171.27 19.77 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.031 0.533 . . . . 0.0 112.104 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.92 114.34 1.56 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 126.506 2.003 . . . . 0.0 108.15 174.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.9 m -99.42 95.92 7.35 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.9 t -100.73 122.08 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 125.088 1.355 . . . . 0.0 109.12 -171.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -89.83 128.2 36.12 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -150.22 165.28 33.41 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -169.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -101.24 113.7 65.8 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.654 1.182 . . . . 0.0 108.885 171.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -45.57 -38.98 17.14 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.972 3.781 . . . . 0.0 114.884 174.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.0 mt -63.91 -28.9 70.15 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.736 0.814 . . . . 0.0 112.017 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.58 -41.81 7.18 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.08 0.952 . . . . 0.0 110.719 -175.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.8 t -143.83 156.97 44.66 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 123.64 0.776 . . . . 0.0 109.92 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.6 p -117.64 162.67 27.63 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 124.815 1.246 . . . . 0.0 109.9 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.07 -41.77 55.7 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.257 2.638 . . . . 0.0 112.385 171.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -63.36 -41.41 98.84 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.921 0.888 . . . . 0.0 111.872 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.9 m -59.67 -49.18 78.75 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.207 0.458 . . . . 0.0 110.026 176.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.4 mt -62.67 -45.71 91.56 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.021 0.929 . . . . 0.0 110.744 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 65.5 ttp85 -55.05 -50.51 68.91 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.032 0.933 . . . . 0.0 109.886 174.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.8 -42.65 86.19 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.633 1.111 . . . . 0.0 112.253 177.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.28 -39.25 94.05 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 117.446 0.623 . . . . 0.0 111.273 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.3 mt -69.72 -36.66 71.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.969 -0.457 . . . . 0.0 110.583 177.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -59.82 -41.09 90.53 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.83 -0.544 . . . . 0.0 110.273 171.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -63.2 -41.88 99.24 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.121 0.569 . . . . 0.0 111.246 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.7 mmm -57.72 -40.69 80.18 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.12 0.418 . . . . 0.0 110.663 172.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.86 55.77 0.31 Allowed Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.144 0.878 . . . . 0.0 111.622 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -140.44 151.04 44.57 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.752 0.821 . . . . 0.0 109.605 175.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -77.15 94.2 4.04 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.74 134.17 43.03 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.073 1.349 . . . . 0.0 109.639 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.2 t -146.31 140.49 26.49 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.842 0.857 . . . . 0.0 109.498 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.7 mt -69.75 134.68 48.88 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.048 0.539 . . . . 0.0 110.651 -175.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.0 m -92.05 -41.27 10.61 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 169.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.187 -1.387 . . . . 0.0 109.307 172.802 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.6 tt . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.4 p -139.5 154.97 47.81 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.424 1.09 . . . . 0.0 110.161 -178.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -138.44 164.08 30.28 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.747 1.619 . . . . 0.0 108.686 176.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -121.53 144.61 48.62 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.542 1.137 . . . . 0.0 108.986 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.3 t -139.3 143.05 37.71 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.059 0.944 . . . . 0.0 109.445 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.4 t -107.71 116.61 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 172.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.0 mm -99.77 124.14 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 174.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -82.1 111.76 18.53 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 174.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 57.2 mt -107.52 106.09 20.01 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 C-N-CA 124.531 1.132 . . . . 0.0 108.334 -173.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -99.75 128.46 45.84 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.52 -4.66 7.62 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.397 0.999 . . . . 0.0 112.917 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 62.9 mtm -78.56 105.86 10.12 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.9 m -84.45 -34.97 23.33 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.335 1.054 . . . . 0.0 109.99 -173.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 p -158.55 167.63 29.09 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.283 0.633 . . . . 0.0 109.98 -175.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -60.13 -20.97 60.9 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.014 1.325 . . . . 0.0 113.791 -170.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.9 p -52.71 -43.0 65.34 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.715 0.689 . . . . 0.0 110.65 171.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 76.7 m -66.74 -48.22 69.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.528 0.731 . . . . 0.0 110.5 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.7 t -50.79 -53.25 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 123.986 0.915 . . . . 0.0 110.353 176.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -58.24 -50.01 75.07 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.731 1.212 . . . . 0.0 111.107 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.2 m -59.5 -54.54 45.35 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.213 0.605 . . . . 0.0 111.206 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.4 mt -54.53 -54.89 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 124.717 1.207 . . . . 0.0 109.742 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -56.34 -53.11 61.21 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.567 0.747 . . . . 0.0 110.713 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.2 -51.61 45.72 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.525 1.06 . . . . 0.0 112.128 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.0 -54.3 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.349 0.659 . . . . 0.0 110.415 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.41 -36.65 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.002 0.521 . . . . 0.0 111.58 -174.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.9 m -52.27 -30.75 29.33 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.501 0.721 . . . . 0.0 112.767 176.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -89.22 -9.95 48.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.583 0.753 . . . . 0.0 112.242 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -74.66 140.09 74.7 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 118.901 0.773 . . . . 0.0 109.874 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -64.83 137.93 55.74 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.992 2.462 . . . . 0.0 110.131 -175.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.7 -37.39 3.61 Favored Glycine 0 CA--C 1.525 0.656 0 CA-C-O 118.898 -0.946 . . . . 0.0 111.748 -176.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.6 t -67.6 141.16 18.12 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 CA-C-N 117.98 0.89 . . . . 0.0 110.418 -175.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -120.73 -102.85 0.41 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.632 1.173 . . . . 0.0 108.501 176.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.7 p -84.55 147.19 27.15 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.553 0.615 . . . . 0.0 109.807 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -150.22 139.95 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 123.642 0.777 . . . . 0.0 110.055 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.24 101.86 4.99 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.946 1.298 . . . . 0.0 108.498 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -97.54 139.0 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 174.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.2 t -135.23 129.05 33.07 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.176 0.99 . . . . 0.0 110.662 -173.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.1 tp -66.73 -52.97 38.31 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.36 1.064 . . . . 0.0 109.145 170.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.8 -49.03 66.45 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 125.041 1.336 . . . . 0.0 111.908 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -89.3 -6.28 56.87 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.012 0.525 . . . . 0.0 111.861 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.8 m 51.27 53.71 12.43 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.257 1.423 . . . . 0.0 111.229 176.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -156.98 172.17 19.16 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.811 0.444 . . . . 0.0 111.725 -174.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.97 112.38 1.01 Allowed Glycine 0 C--N 1.338 0.667 0 C-N-CA 126.215 1.864 . . . . 0.0 108.982 177.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.9 m -99.04 103.81 15.78 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 t -115.02 127.6 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 124.579 1.151 . . . . 0.0 109.831 -169.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -96.17 132.79 41.22 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 168.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -150.11 166.74 28.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.491 0.716 . . . . 0.0 110.887 -170.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -99.81 113.66 65.22 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.395 1.078 . . . . 0.0 109.062 172.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -43.02 -37.85 6.67 Favored 'Trans proline' 0 C--N 1.349 0.58 1 C-N-CA 125.377 4.051 . . . . 0.0 115.137 172.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.8 mt -63.89 -32.3 73.77 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.449 0.699 . . . . 0.0 111.997 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.72 -43.31 6.5 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.935 0.894 . . . . 0.0 111.076 -174.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.8 t -142.86 176.75 8.83 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.423 0.689 . . . . 0.0 110.315 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.0 p -150.26 162.0 29.06 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 124.271 1.028 . . . . 0.0 110.288 -172.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -53.25 -43.57 56.2 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.645 2.896 . . . . 0.0 112.899 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.17 -34.66 78.58 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.635 0.774 . . . . 0.0 112.183 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.5 m -71.51 -47.08 57.63 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.177 0.591 . . . . 0.0 109.816 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 59.8 mt -59.56 -47.72 84.45 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.903 0.881 . . . . 0.0 110.123 177.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -53.97 -50.04 67.42 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.31 1.044 . . . . 0.0 110.06 172.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.34 -44.84 65.83 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.641 1.115 . . . . 0.0 112.461 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.16 -42.47 98.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.479 0.639 . . . . 0.0 111.106 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.0 mt -66.5 -41.8 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 122.934 0.493 . . . . 0.0 110.526 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -59.49 -41.88 90.84 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.55 0.74 . . . . 0.0 110.563 174.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.22 -44.85 95.65 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.378 0.671 . . . . 0.0 111.098 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.0 mtm -60.87 -36.18 78.54 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.701 0.401 . . . . 0.0 111.215 174.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.68 59.12 0.31 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 123.803 0.716 . . . . 0.0 112.225 169.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -140.3 146.79 38.99 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.923 0.889 . . . . 0.0 108.638 172.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -76.01 90.99 3.04 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.59 132.68 44.77 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.278 1.031 . . . . 0.0 109.886 -177.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.1 m -140.32 152.76 46.09 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.077 1.351 . . . . 0.0 107.646 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -68.35 145.7 53.93 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.9 p -59.1 -45.3 91.21 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.572 0.349 . . . . 0.0 110.334 169.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 116.933 -1.508 . . . . 0.0 109.2 176.188 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 50.1 tp . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 110.571 -0.159 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.1 p -124.3 103.23 8.1 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.915 1.286 . . . . 0.0 109.914 -172.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -117.32 164.49 14.75 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.376 1.071 . . . . 0.0 108.789 170.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -133.02 146.83 52.1 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.141 0.977 . . . . 0.0 109.717 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.1 t -138.85 142.3 38.62 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.28 1.032 . . . . 0.0 109.518 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.5 t -112.75 102.35 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 175.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.7 mt -99.99 112.98 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -66.05 123.69 20.55 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.1 mt -111.31 125.89 68.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -131.79 151.18 51.85 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.396 0.679 . . . . 0.0 109.861 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.47 36.23 6.62 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.803 1.192 . . . . 0.0 112.095 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -88.67 144.6 26.18 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 117.68 0.74 . . . . 0.0 109.015 174.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.0 p -84.69 -43.73 14.07 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.393 0.677 . . . . 0.0 109.807 177.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.7 p -163.69 -175.51 4.17 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.702 0.801 . . . . 0.0 109.956 -175.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -61.17 -27.64 68.55 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.121 1.369 . . . . 0.0 113.863 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.9 p -59.16 -33.53 71.03 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.638 0.654 . . . . 0.0 111.455 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 80.3 m -60.8 -56.07 25.57 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.154 0.582 . . . . 0.0 109.572 175.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.2 t -53.53 -47.19 60.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.788 1.235 . . . . 0.0 111.08 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -56.47 -52.91 62.94 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.83 0.852 . . . . 0.0 110.679 176.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.5 t -59.15 -51.17 71.18 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.881 0.872 . . . . 0.0 111.259 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.4 mt -52.65 -53.19 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.775 1.23 . . . . 0.0 109.551 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -54.74 -53.16 58.7 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.507 0.723 . . . . 0.0 110.698 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.14 -51.72 48.51 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.389 0.995 . . . . 0.0 112.266 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.0 t -58.94 -52.38 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.728 0.811 . . . . 0.0 110.436 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.24 -37.79 79.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 119.018 -0.515 . . . . 0.0 111.516 -176.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.6 m -52.21 -29.65 23.64 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 177.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -89.22 -8.34 53.73 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.482 0.713 . . . . 0.0 112.416 -175.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -73.84 138.28 76.61 Favored Pre-proline 0 CA--C 1.535 0.365 0 CA-C-N 119.082 0.855 . . . . 0.0 110.254 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -66.47 131.34 26.02 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.858 2.372 . . . . 0.0 109.394 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.24 -39.29 2.96 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-O 118.915 -0.936 . . . . 0.0 111.444 -175.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.6 t -66.43 135.63 28.14 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 117.955 0.878 . . . . 0.0 109.8 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -111.47 -99.62 0.41 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.024 1.329 . . . . 0.0 107.886 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.3 p -90.43 154.66 19.49 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.768 0.827 . . . . 0.0 109.628 172.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 tt -150.6 146.13 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 123.474 0.71 . . . . 0.0 110.447 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -140.1 107.91 5.67 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.837 1.255 . . . . 0.0 107.711 169.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.0 t -98.42 130.65 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 170.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.9 t -124.7 130.83 53.17 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.426 1.09 . . . . 0.0 110.169 -173.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.8 tp -72.56 -48.49 39.67 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.25 1.02 . . . . 0.0 108.936 172.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.85 -47.36 74.28 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.94 1.296 . . . . 0.0 111.626 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -89.3 -7.55 55.15 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.982 0.513 . . . . 0.0 111.525 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.6 m 53.45 54.01 10.76 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 125.234 1.413 . . . . 0.0 111.153 175.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -159.29 169.91 23.02 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.919 -175.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.35 107.2 1.0 Allowed Glycine 0 C--N 1.337 0.596 0 C-N-CA 126.613 2.054 . . . . 0.0 108.614 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.0 m -98.6 96.17 7.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.4 t -109.31 127.49 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 124.587 1.155 . . . . 0.0 108.924 -172.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -97.91 130.7 44.78 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 169.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -150.21 170.7 18.34 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.268 0.627 . . . . 0.0 112.171 -169.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -106.07 114.6 62.36 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.033 1.333 . . . . 0.0 109.477 173.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -44.3 -36.26 9.07 Favored 'Trans proline' 0 C--N 1.348 0.527 1 C-N-CA 125.528 4.152 . . . . 0.0 115.486 174.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.02 -32.36 74.05 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.259 0.624 . . . . 0.0 111.99 -176.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.3 mt -108.17 -29.62 8.83 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.005 0.922 . . . . 0.0 112.371 -171.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.5 t -148.11 175.25 11.18 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.719 0.69 . . . . 0.0 109.615 173.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.8 p -146.94 163.39 28.92 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 123.65 0.78 . . . . 0.0 110.33 -175.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -52.08 -41.99 61.54 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.475 2.783 . . . . 0.0 112.012 173.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -67.82 -39.62 83.89 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.724 0.81 . . . . 0.0 111.474 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.8 m -61.65 -50.36 72.82 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.83 0.452 . . . . 0.0 109.998 176.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 50.8 mt -60.2 -48.13 83.02 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.271 1.029 . . . . 0.0 110.63 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -54.09 -51.2 64.9 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.62 1.168 . . . . 0.0 110.279 175.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.52 -44.73 85.66 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.482 1.039 . . . . 0.0 111.803 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.3 -46.86 86.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.27 0.628 . . . . 0.0 111.354 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -61.34 -39.6 83.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 123.069 0.548 . . . . 0.0 110.093 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.73 -40.68 95.74 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.98 0.512 . . . . 0.0 110.901 177.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -64.01 -43.17 96.44 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.053 0.941 . . . . 0.0 110.982 176.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 79.5 mmm -56.09 -41.39 75.1 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.546 0.738 . . . . 0.0 110.2 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.15 53.5 0.23 Allowed Glycine 0 C--N 1.341 0.859 0 C-N-CA 123.994 0.806 . . . . 0.0 112.02 169.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -140.45 145.61 37.19 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.634 0.774 . . . . 0.0 109.347 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -68.76 100.84 1.22 Allowed 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.39 120.63 40.83 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.194 1.398 . . . . 0.0 109.938 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.2 p -142.32 137.23 30.42 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.653 0.781 . . . . 0.0 109.915 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.5 mt -73.82 137.97 44.16 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.213 0.605 . . . . 0.0 110.988 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.5 m -77.61 -43.73 30.61 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 168.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 C--O 1.251 1.173 0 C-N-CA 125.765 1.626 . . . . 0.0 110.315 -179.219 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.5 p . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 121.036 0.446 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -128.47 173.15 10.48 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.799 1.639 . . . . 0.0 108.446 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -137.86 141.07 40.73 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.901 0.88 . . . . 0.0 108.998 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -130.71 135.8 48.16 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 124.376 1.07 . . . . 0.0 109.68 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.8 t -101.05 107.14 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 172.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.2 mt -99.85 121.52 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -75.79 125.7 29.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 57.8 mt -123.36 98.75 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -174.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -99.73 152.57 19.94 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.49 16.83 48.01 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.54 1.067 . . . . 0.0 112.323 -173.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 97.7 mtp -79.86 110.06 14.87 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.3 t -84.58 -37.93 20.56 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.286 0.635 . . . . 0.0 111.776 -173.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.2 p -158.48 179.72 8.87 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.119 0.568 . . . . 0.0 109.884 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -69.09 -13.33 62.37 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -173.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.7 p -59.83 -36.71 77.38 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.074 0.852 . . . . 0.0 110.12 170.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -59.56 -51.73 68.59 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.38 0.672 . . . . 0.0 109.608 174.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.2 t -52.17 -55.4 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.672 0.789 . . . . 0.0 110.234 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -57.61 -52.48 65.24 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.523 1.129 . . . . 0.0 111.647 -177.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.8 p -61.14 -48.95 79.24 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.694 0.398 . . . . 0.0 111.132 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 88.2 mt -59.19 -54.92 27.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.896 0.878 . . . . 0.0 110.233 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -62.21 -37.71 86.4 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.633 0.651 . . . . 0.0 111.194 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.41 -53.99 40.59 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.829 0.728 . . . . 0.0 111.294 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.22 -54.12 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.642 0.777 . . . . 0.0 110.431 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.4 mt -63.2 -39.86 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 122.891 0.476 . . . . 0.0 111.797 -172.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.6 p -55.96 -24.71 39.98 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -89.49 -9.28 50.61 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.076 0.951 . . . . 0.0 112.184 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -70.35 141.52 88.53 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 118.897 0.771 . . . . 0.0 109.693 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.4 132.55 29.65 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.859 2.373 . . . . 0.0 109.842 -177.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.21 -26.82 22.82 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 118.7 -1.055 . . . . 0.0 112.83 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.0 t -68.27 138.66 22.09 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 118.428 1.114 . . . . 0.0 110.149 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -119.95 -102.6 0.41 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.55 1.14 . . . . 0.0 108.89 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.8 p -80.2 150.77 30.01 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 118.362 0.528 . . . . 0.0 109.853 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.3 tt -150.12 139.48 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 123.329 0.652 . . . . 0.0 110.256 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -139.01 97.39 3.3 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.173 1.389 . . . . 0.0 108.602 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.8 t -99.17 142.27 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 124.476 1.11 . . . . 0.0 108.631 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.0 t -139.84 131.98 28.06 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.803 0.841 . . . . 0.0 110.711 -174.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.8 tp -70.42 -51.57 28.55 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.105 1.362 . . . . 0.0 109.112 169.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.39 -47.16 76.27 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.112 1.365 . . . . 0.0 111.889 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -89.3 -7.78 54.67 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.046 0.538 . . . . 0.0 111.236 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.0 m 54.11 56.55 6.89 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.391 1.477 . . . . 0.0 110.932 174.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -161.31 172.83 15.93 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.632 0.373 . . . . 0.0 111.883 -172.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -137.09 112.8 0.96 Allowed Glycine 0 C--N 1.339 0.727 0 C-N-CA 126.276 1.893 . . . . 0.0 109.29 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.5 m -99.43 103.74 15.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.6 t -116.29 123.95 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 124.285 1.034 . . . . 0.0 109.428 -170.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -89.95 132.36 35.37 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 169.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -150.33 163.24 38.82 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.046 0.539 . . . . 0.0 112.097 -171.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -97.39 115.43 65.74 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.728 1.211 . . . . 0.0 109.932 173.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -47.47 -38.41 27.49 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 125.28 3.987 . . . . 0.0 115.894 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 mp -69.92 -29.87 67.14 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.075 0.398 . . . . 0.0 111.368 -174.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.9 mt -99.72 -31.77 11.38 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.095 0.958 . . . . 0.0 111.932 -173.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.7 t -151.59 171.78 17.08 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.377 0.671 . . . . 0.0 109.822 175.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.3 p -141.79 164.2 35.91 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.229 1.012 . . . . 0.0 110.329 -174.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -53.34 -39.48 81.2 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.274 2.649 . . . . 0.0 112.081 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -67.86 -38.96 83.78 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.781 0.833 . . . . 0.0 111.698 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 m -61.83 -50.27 72.97 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.35 0.523 . . . . 0.0 109.863 175.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 61.7 mt -60.61 -53.0 62.73 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.509 1.123 . . . . 0.0 110.578 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -52.29 -46.58 65.97 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.151 1.38 . . . . 0.0 110.197 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.55 -53.41 38.87 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.788 1.185 . . . . 0.0 111.425 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.63 -44.51 90.03 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 117.672 0.736 . . . . 0.0 111.727 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.8 mt -60.77 -44.53 97.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 122.791 0.436 . . . . 0.0 110.015 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -61.35 -40.03 92.76 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.725 0.81 . . . . 0.0 110.824 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -63.82 -41.14 97.93 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.453 1.101 . . . . 0.0 110.999 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.9 mtp -59.49 -45.76 90.76 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.025 0.375 . . . . 0.0 110.267 173.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.48 63.04 0.14 Allowed Glycine 0 C--N 1.341 0.815 0 C-N-CA 123.552 0.596 . . . . 0.0 111.774 169.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -140.42 158.13 44.47 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 124.057 0.943 . . . . 0.0 109.379 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -76.9 93.44 3.76 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.37 121.13 40.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.76 1.224 . . . . 0.0 109.367 -175.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.6 t -148.45 148.26 30.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.891 0.876 . . . . 0.0 108.85 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.1 mt . . . . . 0 CA--C 1.531 0.235 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -178.394 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.5 p . . . . . 0 CA--C 1.528 0.128 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -141.12 173.24 11.67 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.353 1.461 . . . . 0.0 108.898 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -123.98 141.54 51.96 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.651 1.18 . . . . 0.0 108.559 172.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -130.77 130.77 44.15 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.116 0.966 . . . . 0.0 109.489 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 77.6 t -99.9 104.97 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.2 mt -99.98 126.01 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -75.05 129.71 38.07 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 174.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.9 mt -128.18 90.22 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -99.66 161.11 13.81 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.08 21.14 61.52 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 119.246 -0.752 . . . . 0.0 112.533 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 69.9 mtm -79.85 130.01 34.96 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 118.333 1.067 . . . . 0.0 108.389 170.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.4 m -84.43 -46.25 11.87 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.195 0.598 . . . . 0.0 110.573 -173.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 p -165.38 175.78 8.84 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.328 0.651 . . . . 0.0 110.268 -170.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -52.09 -35.71 48.63 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.907 1.283 . . . . 0.0 113.301 -173.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.1 p -50.28 -41.04 50.01 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.903 0.774 . . . . 0.0 111.64 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.2 m -64.28 -49.11 73.12 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.382 0.673 . . . . 0.0 110.58 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.8 t -51.93 -53.86 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.975 0.91 . . . . 0.0 110.346 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -62.49 -43.22 99.36 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.792 0.837 . . . . 0.0 111.547 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.4 t -59.56 -53.4 58.5 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.012 0.525 . . . . 0.0 110.663 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.8 mt -56.39 -52.44 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.342 1.057 . . . . 0.0 109.576 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -52.82 -55.1 25.5 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.449 1.1 . . . . 0.0 110.531 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.09 -53.66 42.9 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.385 0.993 . . . . 0.0 111.9 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.61 -50.55 78.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.423 0.689 . . . . 0.0 110.975 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 76.7 mt -68.67 -41.07 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.648 -175.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.3 p -55.68 -25.15 38.14 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -89.25 -8.51 53.33 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.134 0.974 . . . . 0.0 112.169 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -70.5 140.75 87.42 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 119.116 0.871 . . . . 0.0 110.532 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.1 128.91 20.54 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.674 2.249 . . . . 0.0 109.181 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.82 -39.27 2.97 Favored Glycine 0 C--N 1.336 0.554 0 CA-C-O 119.073 -0.848 . . . . 0.0 111.557 -175.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.0 t -70.37 137.83 23.18 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 CA-C-N 117.881 0.84 . . . . 0.0 109.419 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -114.24 -98.3 0.44 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.313 1.045 . . . . 0.0 108.186 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 86.7 p -90.27 155.43 18.99 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.953 0.501 . . . . 0.0 110.128 176.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.59 143.05 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.186 0.995 . . . . 0.0 109.859 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.36 105.91 8.2 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.686 1.195 . . . . 0.0 108.653 173.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.6 t -98.06 136.42 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 172.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -139.05 126.94 22.2 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.651 0.78 . . . . 0.0 110.451 -176.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.3 tp -69.68 -45.73 67.66 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.455 1.102 . . . . 0.0 109.857 171.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.73 -47.15 67.56 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.458 1.103 . . . . 0.0 111.497 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -89.38 -12.37 40.56 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.293 0.637 . . . . 0.0 111.797 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.3 m 53.44 58.08 5.55 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 125.317 1.447 . . . . 0.0 110.441 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.9 p-10 -156.39 173.36 17.0 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.991 0.516 . . . . 0.0 111.953 -174.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.45 110.97 0.83 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 126.719 2.104 . . . . 0.0 108.015 174.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.8 m -99.24 101.45 12.77 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.8 t -110.96 125.37 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 124.664 1.186 . . . . 0.0 109.424 -169.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -91.26 127.82 36.85 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 169.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -146.77 167.17 24.51 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.442 0.697 . . . . 0.0 111.86 -169.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -105.64 111.14 64.78 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.155 1.382 . . . . 0.0 109.368 174.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -45.31 -37.27 13.81 Favored 'Trans proline' 0 C--N 1.348 0.552 1 C-N-CA 125.44 4.093 . . . . 0.0 116.248 177.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -70.21 -30.61 67.75 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.173 0.442 . . . . 0.0 111.33 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.3 mt -99.96 -32.38 11.0 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.212 1.005 . . . . 0.0 112.042 -172.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.7 t -149.9 170.59 18.46 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.785 0.834 . . . . 0.0 109.428 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.6 p -137.85 162.25 55.41 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 123.967 0.907 . . . . 0.0 110.643 -176.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -53.05 -39.12 80.73 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.321 2.681 . . . . 0.0 112.043 172.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -68.32 -40.04 81.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.779 0.832 . . . . 0.0 111.482 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.3 m -60.37 -50.35 73.94 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.926 0.49 . . . . 0.0 109.941 175.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.1 mt -59.51 -50.12 75.13 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.234 1.014 . . . . 0.0 110.511 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -52.5 -48.71 65.81 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.843 1.257 . . . . 0.0 110.627 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.75 -46.47 89.62 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.319 0.962 . . . . 0.0 111.785 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.74 -44.41 96.28 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.117 0.567 . . . . 0.0 111.467 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.44 -45.26 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.082 0.553 . . . . 0.0 110.075 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -59.42 -42.13 91.14 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.731 0.813 . . . . 0.0 110.696 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -62.44 -44.52 96.23 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.742 0.817 . . . . 0.0 111.217 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.9 mtm -59.91 -36.47 77.04 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.657 0.383 . . . . 0.0 110.898 174.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.0 59.91 0.34 Allowed Glycine 0 C--N 1.341 0.811 0 C-N-CA 123.758 0.694 . . . . 0.0 111.996 169.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -140.38 158.64 43.71 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.898 0.879 . . . . 0.0 109.379 173.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -75.77 94.32 3.27 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.5 112.08 24.34 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.967 1.307 . . . . 0.0 110.084 -172.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.9 p -142.56 133.05 25.07 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.575 0.75 . . . . 0.0 109.757 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.5 mt . . . . . 0 CA--C 1.532 0.288 0 C-N-CA 123.455 0.702 . . . . 0.0 110.85 -179.767 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.9 p . . . . . 0 CA--C 1.53 0.184 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -142.05 171.66 13.75 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.589 1.155 . . . . 0.0 109.238 173.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -139.99 141.69 36.34 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.327 1.051 . . . . 0.0 108.752 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -131.23 138.27 49.27 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.469 1.107 . . . . 0.0 109.81 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.3 t -106.11 100.54 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 174.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.0 mt -99.76 115.21 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -67.01 124.98 24.56 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.4 mt -113.72 100.8 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 106.662 -1.606 . . . . 0.0 106.662 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -99.67 146.37 26.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.698 0.799 . . . . 0.0 109.465 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.84 27.69 31.07 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.226 0.917 . . . . 0.0 112.839 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 73.2 mtm -80.45 135.42 36.14 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.23 1.015 . . . . 0.0 108.93 170.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.7 m -84.22 -48.0 10.23 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.004 0.922 . . . . 0.0 110.201 -174.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 p -161.06 -178.4 6.74 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.48 0.712 . . . . 0.0 109.618 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -61.23 -23.26 65.51 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.614 1.166 . . . . 0.0 113.321 -176.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.3 m -57.61 -37.99 74.19 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.598 0.635 . . . . 0.0 111.266 174.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.4 m -63.85 -51.81 62.96 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -51.85 -49.49 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.521 1.128 . . . . 0.0 110.552 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -57.95 -47.72 82.09 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.431 1.092 . . . . 0.0 110.998 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.7 t -62.22 -52.55 63.33 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.475 0.71 . . . . 0.0 111.188 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.9 mt -54.7 -56.24 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.962 1.305 . . . . 0.0 109.719 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -59.18 -46.77 87.55 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.445 0.698 . . . . 0.0 110.562 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.82 -48.6 50.53 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.932 1.254 . . . . 0.0 112.162 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.18 -62.56 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 117.507 0.653 . . . . 0.0 110.218 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.2 mt -58.82 -39.12 76.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.978 0.911 . . . . 0.0 112.108 -169.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 77.9 p -49.99 -33.84 19.17 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.846 0.859 . . . . 0.0 113.183 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -89.66 -14.89 33.86 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.605 0.762 . . . . 0.0 112.295 -175.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -71.14 143.66 88.81 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 118.689 0.677 . . . . 0.0 110.662 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -63.06 137.39 61.62 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.241 2.627 . . . . 0.0 110.663 -174.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.51 -35.66 4.57 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 119.128 -0.818 . . . . 0.0 111.793 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.0 t -68.45 128.57 32.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 CA-C-N 118.017 0.909 . . . . 0.0 109.847 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -99.68 -103.47 0.23 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.917 1.287 . . . . 0.0 107.854 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.9 p -87.2 154.12 20.97 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.6 0.76 . . . . 0.0 109.519 173.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.7 tt -150.41 135.24 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 123.172 0.589 . . . . 0.0 109.974 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 -134.68 100.82 4.74 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.916 1.287 . . . . 0.0 108.683 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.8 t -98.76 139.12 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.235 1.014 . . . . 0.0 108.637 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.4 t -135.6 132.18 36.78 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 124.445 1.098 . . . . 0.0 110.646 -173.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.7 tp -72.48 -49.45 33.09 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.318 1.047 . . . . 0.0 109.357 173.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.94 -44.82 78.77 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.08 1.352 . . . . 0.0 111.762 -177.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -89.23 -9.68 49.82 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.234 0.613 . . . . 0.0 111.201 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.1 m 54.44 52.42 12.44 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.61 1.564 . . . . 0.0 111.05 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -157.24 170.41 22.53 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.972 0.415 . . . . 0.0 111.838 -173.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.08 113.67 1.69 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 126.561 2.029 . . . . 0.0 108.658 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.3 m -98.77 93.19 5.94 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.8 t -105.63 120.57 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 124.398 1.079 . . . . 0.0 109.009 -171.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -89.78 133.81 34.51 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 169.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -150.25 166.79 28.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.838 0.455 . . . . 0.0 112.145 -169.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -102.78 113.2 66.04 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 125.255 1.422 . . . . 0.0 108.573 172.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -44.35 -36.1 9.05 Favored 'Trans proline' 0 C--N 1.347 0.467 1 C-N-CA 125.49 4.127 . . . . 0.0 115.077 173.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.6 mt -65.36 -36.6 84.49 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.237 0.615 . . . . 0.0 111.768 -177.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.1 mp -99.65 -34.26 10.28 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.956 0.902 . . . . 0.0 111.59 -171.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.3 t -147.82 177.32 9.42 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.457 0.703 . . . . 0.0 109.952 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.9 p -148.39 163.98 23.94 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 124.085 0.954 . . . . 0.0 110.264 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.4 -40.79 77.07 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.398 2.732 . . . . 0.0 112.078 174.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -67.91 -39.41 83.57 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.6 0.76 . . . . 0.0 111.369 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.7 m -61.5 -49.95 74.68 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.898 0.479 . . . . 0.0 110.068 175.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.0 mt -60.2 -48.79 80.22 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.172 0.989 . . . . 0.0 110.633 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -53.27 -50.09 65.56 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.69 1.196 . . . . 0.0 110.23 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.9 -43.21 92.66 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.523 1.059 . . . . 0.0 112.273 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.92 -42.07 98.67 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.344 0.572 . . . . 0.0 111.12 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.4 mt -66.75 -40.4 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.105 0.562 . . . . 0.0 110.389 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -59.01 -43.36 91.53 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.775 0.43 . . . . 0.0 110.78 172.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.39 -44.48 97.07 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.205 0.602 . . . . 0.0 111.03 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.2 mtm -62.29 -33.78 75.3 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.852 0.461 . . . . 0.0 111.26 174.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.3 56.59 0.42 Allowed Glycine 0 C--N 1.341 0.842 0 C-N-CA 123.814 0.721 . . . . 0.0 112.53 169.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -140.41 150.95 44.51 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.665 0.786 . . . . 0.0 109.424 172.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -75.45 98.63 3.96 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.62 128.24 45.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.68 1.192 . . . . 0.0 109.732 -175.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.3 t -150.08 169.34 21.48 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.145 0.978 . . . . 0.0 108.552 175.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 CA--C 1.534 0.332 0 C-N-CA 122.727 0.411 . . . . 0.0 110.183 -178.463 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.6 p . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -126.33 149.9 48.87 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 169.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -119.74 149.04 42.67 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.741 0.816 . . . . 0.0 110.144 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.4 t -145.63 146.93 31.52 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.097 0.959 . . . . 0.0 109.102 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.9 t -113.11 125.61 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 172.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.5 mt -120.33 131.64 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -80.75 122.82 27.62 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 173.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.65 95.79 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -99.29 146.71 25.94 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.442 0.697 . . . . 0.0 109.438 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.1 42.26 7.17 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.12 0.867 . . . . 0.0 112.235 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.1 mtt -79.49 143.47 34.88 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 169.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 64.1 p -84.51 -42.37 15.59 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.597 0.759 . . . . 0.0 110.462 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.4 p -163.63 -179.71 6.6 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.126 0.97 . . . . 0.0 109.24 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -63.04 -24.86 68.11 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.163 0.985 . . . . 0.0 113.164 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m -53.13 -35.03 59.24 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.747 0.703 . . . . 0.0 111.574 174.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.5 m -58.34 -49.0 78.75 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.014 0.526 . . . . 0.0 110.834 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.2 t -50.81 -51.46 20.18 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 C-N-CA 123.773 0.829 . . . . 0.0 109.779 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -57.73 -53.7 55.26 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.928 0.891 . . . . 0.0 110.398 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.5 m -54.98 -46.93 75.15 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.244 0.618 . . . . 0.0 111.801 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 57.1 mt -60.65 -59.22 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 124.078 0.951 . . . . 0.0 109.8 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -60.72 -35.71 77.02 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 118.233 0.469 . . . . 0.0 111.302 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.62 -60.31 9.21 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 124.363 0.982 . . . . 0.0 110.676 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.55 -58.02 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 123.002 0.521 . . . . 0.0 110.139 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.9 mt -60.04 -41.33 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.29 0.636 . . . . 0.0 111.892 -169.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.4 p -54.38 -30.83 53.23 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.727 0.694 . . . . 0.0 112.833 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -89.42 -11.32 43.48 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.529 0.731 . . . . 0.0 112.559 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -68.86 141.31 92.22 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 119.253 0.933 . . . . 0.0 109.752 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.08 131.28 26.48 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.991 2.461 . . . . 0.0 110.083 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.8 -33.24 6.72 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-O 118.711 -1.049 . . . . 0.0 112.181 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.3 t -67.3 139.06 21.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-N 118.256 1.028 . . . . 0.0 110.478 -176.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -121.12 -105.65 0.38 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.317 1.447 . . . . 0.0 108.144 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.0 p -80.03 144.85 32.85 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.652 0.66 . . . . 0.0 110.018 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.29 144.09 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.543 0.737 . . . . 0.0 110.824 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -140.28 131.96 27.28 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.123 1.369 . . . . 0.0 107.728 169.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.9 t -123.97 145.8 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.998 1.319 . . . . 0.0 108.229 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.7 t -139.16 132.82 30.55 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 124.138 0.975 . . . . 0.0 110.776 -173.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.9 tp -74.35 -49.98 20.58 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.72 1.208 . . . . 0.0 109.301 171.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.65 -46.15 67.03 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.732 1.213 . . . . 0.0 111.536 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -89.58 -12.13 40.69 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.427 0.691 . . . . 0.0 111.611 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.6 m 53.13 52.06 14.46 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 125.181 1.393 . . . . 0.0 110.581 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -154.47 172.57 17.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.961 0.504 . . . . 0.0 111.687 -175.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -142.76 116.25 1.01 Allowed Glycine 0 C--N 1.338 0.648 0 C-N-CA 125.644 1.592 . . . . 0.0 109.392 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.5 m -99.55 115.56 29.65 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.4 t -128.23 129.07 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 124.007 0.923 . . . . 0.0 109.755 -170.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -97.87 133.65 42.08 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 168.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -150.47 167.06 28.27 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.332 0.653 . . . . 0.0 111.482 -171.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -101.53 113.88 65.76 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.636 1.174 . . . . 0.0 109.431 173.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -43.37 -39.74 9.3 Favored 'Trans proline' 0 C--N 1.348 0.526 1 C-N-CA 125.603 4.202 . . . . 0.0 115.51 176.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.1 mt -63.98 -34.31 77.7 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.377 0.671 . . . . 0.0 111.81 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.3 mt -102.8 -29.27 11.57 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.912 0.885 . . . . 0.0 112.269 -172.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.8 t -152.55 165.92 33.66 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.415 0.686 . . . . 0.0 109.491 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.0 p -138.75 167.51 19.17 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.592 1.157 . . . . 0.0 110.041 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.35 -38.35 89.0 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.436 2.757 . . . . 0.0 112.181 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -67.08 -38.85 86.47 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.912 0.885 . . . . 0.0 111.508 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.4 m -62.58 -48.75 78.09 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.862 0.465 . . . . 0.0 109.933 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.4 mt -59.0 -53.23 60.8 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.373 1.069 . . . . 0.0 110.302 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 66.0 ttp85 -53.18 -46.02 68.79 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.987 1.315 . . . . 0.0 110.843 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.77 -49.09 77.28 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.489 1.042 . . . . 0.0 111.809 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.07 -46.78 89.28 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 117.385 0.593 . . . . 0.0 111.243 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.0 mt -57.34 -44.16 83.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.653 0.781 . . . . 0.0 110.019 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -61.47 -42.79 99.32 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.812 0.445 . . . . 0.0 110.605 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.14 -39.3 92.13 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.157 0.983 . . . . 0.0 111.926 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 28.8 mtt -55.79 -48.13 75.9 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 118.348 0.522 . . . . 0.0 110.128 173.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.45 58.99 0.13 Allowed Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 174.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -140.08 152.49 46.21 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.384 1.074 . . . . 0.0 108.707 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -72.76 99.98 2.75 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.8 122.29 42.55 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.693 1.197 . . . . 0.0 109.671 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.6 t -150.08 144.19 25.59 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 47.0 mt . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.698 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 43.1 p . . . . . 0 CA--C 1.532 0.251 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -125.63 169.22 12.71 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.913 1.285 . . . . 0.0 109.106 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -131.76 148.21 52.55 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.553 1.141 . . . . 0.0 109.608 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -146.22 148.69 32.76 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.681 1.192 . . . . 0.0 108.972 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.3 t -120.85 128.08 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.6 mt -122.28 126.84 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -67.8 133.05 48.55 Favored 'General case' 0 CA--C 1.526 0.051 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 172.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.5 mt -131.27 88.78 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -99.8 164.19 12.14 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.81 16.7 69.62 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 119.244 -0.753 . . . . 0.0 112.445 -174.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.1 mtm -79.81 124.9 29.04 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.384 1.092 . . . . 0.0 108.389 170.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.1 p -84.53 -40.9 17.06 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.763 0.825 . . . . 0.0 110.934 -175.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.4 p -158.85 -178.39 7.21 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.893 0.377 . . . . 0.0 110.717 -174.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -57.49 -28.35 63.35 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.623 1.569 . . . . 0.0 113.65 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 m -54.82 -41.28 70.46 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.233 0.613 . . . . 0.0 111.142 175.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.4 m -62.51 -51.47 67.31 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 122.864 0.465 . . . . 0.0 110.016 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.4 t -50.51 -56.35 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.96 0.904 . . . . 0.0 110.14 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -59.77 -50.66 72.94 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.463 1.105 . . . . 0.0 111.488 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.2 p -60.99 -50.39 73.6 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.906 0.482 . . . . 0.0 111.47 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.6 mt -57.75 -52.65 55.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.136 0 C-N-CA 123.353 0.661 . . . . 0.0 109.474 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -54.04 -49.62 68.53 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.289 0.636 . . . . 0.0 110.677 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.15 -54.9 33.87 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.3 0.953 . . . . 0.0 112.309 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.22 -55.47 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.392 0.677 . . . . 0.0 110.613 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.2 mm -64.34 -39.03 84.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 123.55 0.74 . . . . 0.0 111.47 -173.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.7 p -55.02 -30.59 59.87 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.972 0.806 . . . . 0.0 112.69 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -89.41 -3.27 58.49 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.99 0.916 . . . . 0.0 112.267 -175.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -73.12 125.5 90.93 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 119.03 0.832 . . . . 0.0 109.006 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -48.53 118.1 3.1 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.746 2.964 . . . . 0.0 112.128 176.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.37 -36.63 3.54 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 124.042 0.829 . . . . 0.0 111.849 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.7 t -72.66 130.55 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-N 117.87 0.835 . . . . 0.0 109.433 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -90.03 -105.09 0.09 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.0 p -90.62 159.02 16.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.055 1.342 . . . . 0.0 109.852 171.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.8 tt -150.42 134.04 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 123.921 0.888 . . . . 0.0 109.245 173.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -118.28 106.69 13.04 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.866 1.266 . . . . 0.0 108.975 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.2 t -95.35 145.25 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.097 0.959 . . . . 0.0 108.419 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -144.59 128.01 16.92 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.624 0.77 . . . . 0.0 110.461 -177.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.4 tp -70.92 -46.33 62.68 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.558 1.143 . . . . 0.0 110.011 172.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.37 -45.36 65.75 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.397 1.079 . . . . 0.0 111.565 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -89.59 -17.01 29.31 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.557 0.743 . . . . 0.0 111.5 178.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m 54.94 57.73 5.38 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.254 1.422 . . . . 0.0 110.117 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -156.21 173.19 17.2 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.274 0.63 . . . . 0.0 111.627 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.08 116.22 1.7 Allowed Glycine 0 C--N 1.338 0.65 0 C-N-CA 126.438 1.971 . . . . 0.0 108.271 174.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.7 m -99.38 102.52 14.14 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.8 t -108.56 131.55 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 124.428 1.091 . . . . 0.0 110.073 -169.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -101.25 130.6 47.41 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 168.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -150.81 174.79 12.67 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -169.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -115.73 110.36 44.49 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.747 1.619 . . . . 0.0 109.384 174.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -41.58 -38.94 4.42 Favored 'Trans proline' 0 C--N 1.349 0.571 1 C-N-CA 125.999 4.466 . . . . 0.0 115.19 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.1 mt -62.44 -30.71 71.44 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.442 0.697 . . . . 0.0 112.174 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.6 mt -109.52 -36.51 5.95 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.437 1.095 . . . . 0.0 112.018 -171.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.2 t -144.58 171.49 14.3 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.914 0.886 . . . . 0.0 109.303 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.6 p -150.3 161.28 31.23 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 123.215 0.606 . . . . 0.0 110.506 -175.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -49.09 -48.74 17.3 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.947 3.098 . . . . 0.0 113.99 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -66.12 -31.94 73.09 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.257 0.623 . . . . 0.0 112.443 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.0 m -68.11 -48.16 66.23 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 44.4 mt -60.5 -48.46 81.66 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.369 1.068 . . . . 0.0 110.174 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -51.5 -48.99 62.72 Favored 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 124.611 1.165 . . . . 0.0 110.224 172.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.79 -47.1 80.88 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.339 0.971 . . . . 0.0 112.15 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.7 84.16 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.411 0.684 . . . . 0.0 111.212 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.7 mt -61.16 -43.41 96.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.3 0.64 . . . . 0.0 110.048 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -60.82 -41.18 95.21 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.594 0.758 . . . . 0.0 110.719 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.86 -40.97 97.22 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.679 0.791 . . . . 0.0 111.185 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.3 mtp -59.52 -40.45 87.16 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.077 0.399 . . . . 0.0 110.635 173.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.12 62.0 0.22 Allowed Glycine 0 C--N 1.342 0.879 0 C-N-CA 123.712 0.672 . . . . 0.0 111.917 169.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -140.5 160.79 39.22 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.814 0.846 . . . . 0.0 110.02 175.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -77.1 89.62 3.61 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.44 115.15 28.61 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.48 1.112 . . . . 0.0 109.734 -173.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 81.2 p -141.17 148.62 40.3 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 124.17 0.988 . . . . 0.0 108.955 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 52.1 mt . . . . . 0 CA--C 1.531 0.232 0 CA-C-N 118.086 0.403 . . . . 0.0 110.748 -178.956 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.0 p . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -146.88 163.53 35.81 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.967 1.307 . . . . 0.0 108.983 169.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -125.32 143.56 50.91 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.344 1.458 . . . . 0.0 108.517 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.2 t -150.12 165.68 32.09 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 122.931 0.493 . . . . 0.0 111.072 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.1 t -130.59 134.81 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 170.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.2 mm -113.63 127.34 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 172.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -85.5 122.4 29.58 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 172.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.1 mt -121.98 97.07 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 125.336 1.454 . . . . 0.0 107.691 -169.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -99.79 154.47 18.3 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.959 0.409 . . . . 0.0 110.017 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.55 11.25 51.71 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.734 1.159 . . . . 0.0 112.152 -171.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 98.2 mtp -79.89 116.33 19.98 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.155 0.978 . . . . 0.0 108.597 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.0 p -84.71 -47.85 10.04 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.701 0.801 . . . . 0.0 111.529 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.8 p -153.98 -179.67 8.08 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.09 0.556 . . . . 0.0 110.512 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -58.28 -25.35 61.69 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.343 1.457 . . . . 0.0 113.523 -177.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 t -55.34 -40.63 71.45 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.102 0.561 . . . . 0.0 110.626 174.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.0 m -63.49 -46.97 83.71 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 122.998 0.519 . . . . 0.0 110.448 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.5 t -52.58 -53.66 19.17 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 123.686 0.794 . . . . 0.0 109.567 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -59.16 -48.06 83.01 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.722 0.809 . . . . 0.0 111.379 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.5 m -60.99 -53.73 53.69 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.396 0.678 . . . . 0.0 111.219 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.2 mt -57.82 -56.27 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 123.885 0.874 . . . . 0.0 109.26 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -55.86 -48.67 75.12 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.17 0.588 . . . . 0.0 110.905 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.94 -55.19 30.4 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.232 0.92 . . . . 0.0 112.034 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.75 -55.98 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 117.371 0.585 . . . . 0.0 110.771 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.2 mm -63.0 -37.32 79.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.504 0.721 . . . . 0.0 111.758 -173.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.1 p -54.29 -34.63 61.31 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.975 0.807 . . . . 0.0 112.414 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -89.53 0.56 56.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.624 0.77 . . . . 0.0 112.709 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -72.55 143.22 84.84 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 119.151 0.887 . . . . 0.0 109.186 175.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.47 128.43 21.29 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.943 2.429 . . . . 0.0 110.252 -175.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.38 -35.62 4.94 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-O 118.789 -1.006 . . . . 0.0 112.292 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.9 t -66.65 123.5 19.81 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 CA-C-N 118.219 1.009 . . . . 0.0 109.623 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -96.92 -96.88 0.2 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.1 p -90.08 147.12 23.83 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.237 0.615 . . . . 0.0 109.963 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.3 tt -149.89 142.71 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.835 1.254 . . . . 0.0 108.924 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.31 130.6 25.17 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.859 0.864 . . . . 0.0 109.214 169.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.54 147.75 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 125.399 1.48 . . . . 0.0 108.823 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.2 t -139.32 130.22 26.26 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.012 0.925 . . . . 0.0 110.769 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.0 tp -72.39 -49.91 30.39 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.917 1.287 . . . . 0.0 109.271 170.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.62 67.12 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.65 1.18 . . . . 0.0 111.639 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -89.55 -8.84 51.83 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.272 0.629 . . . . 0.0 111.648 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.9 m 52.24 56.79 7.22 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 125.297 1.439 . . . . 0.0 110.681 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.9 p30 -161.97 172.04 16.64 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.838 0.455 . . . . 0.0 111.513 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.22 119.27 1.97 Allowed Glycine 0 C--N 1.338 0.658 0 C-N-CA 125.577 1.56 . . . . 0.0 109.287 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.5 m -99.44 121.88 41.76 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.2 t -129.48 137.08 57.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 124.366 1.066 . . . . 0.0 110.126 -169.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -112.97 129.87 56.33 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -150.28 169.99 20.07 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -168.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -97.38 114.72 65.24 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.64 1.576 . . . . 0.0 109.548 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -44.85 -41.36 15.18 Favored 'Trans proline' 0 C--N 1.349 0.555 1 C-N-CA 125.452 4.102 . . . . 0.0 114.399 174.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.0 mt -61.53 -32.9 72.97 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.944 0.898 . . . . 0.0 111.903 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.1 mt -105.34 -28.8 10.67 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.069 0.948 . . . . 0.0 112.215 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.7 t -153.16 163.23 40.24 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.837 0.744 . . . . 0.0 110.374 178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.9 p -136.01 165.85 32.62 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 125.723 1.609 . . . . 0.0 109.504 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -53.12 -37.61 79.81 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.448 2.765 . . . . 0.0 112.573 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -67.21 -41.35 85.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.261 1.024 . . . . 0.0 110.46 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.6 m -64.03 -48.05 77.82 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.999 0.52 . . . . 0.0 110.048 177.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.4 mt -59.39 -49.66 76.96 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.937 0.895 . . . . 0.0 110.294 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -50.96 -51.03 56.58 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.317 1.047 . . . . 0.0 110.382 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.13 -46.6 84.98 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.323 0.963 . . . . 0.0 112.248 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.73 92.77 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.49 0.716 . . . . 0.0 111.125 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.5 mt -64.55 -36.41 77.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 123.215 0.606 . . . . 0.0 110.25 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -63.57 -41.46 98.4 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.942 -0.474 . . . . 0.0 110.357 175.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.14 -40.8 98.62 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.74 0.816 . . . . 0.0 111.285 175.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.4 mmm -56.17 -40.25 73.6 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.904 0.482 . . . . 0.0 110.665 173.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.72 54.31 0.26 Allowed Glycine 0 C--N 1.34 0.773 0 C-N-CA 123.973 0.796 . . . . 0.0 111.406 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -140.45 144.3 36.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.123 0.969 . . . . 0.0 108.791 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -70.46 99.23 1.57 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.68 129.05 45.78 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.057 1.343 . . . . 0.0 109.123 -174.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.5 p -137.52 143.87 41.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.31 1.044 . . . . 0.0 109.063 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 61.8 mt . . . . . 0 CA--C 1.53 0.193 0 C-N-CA 122.813 0.445 . . . . 0.0 110.22 -178.945 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.3 p . . . . . 0 CA--C 1.531 0.246 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -137.73 170.88 15.3 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 124.734 1.214 . . . . 0.0 109.816 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -124.15 153.45 41.5 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.497 1.119 . . . . 0.0 109.538 172.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.1 t -147.07 138.47 24.08 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.135 0.974 . . . . 0.0 109.756 -176.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.92 113.06 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.6 mt -113.28 126.2 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -71.15 136.32 48.07 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 177.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.6 mt -129.96 91.15 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -99.42 153.84 18.69 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.452 0.701 . . . . 0.0 109.553 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.1 45.0 12.18 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.853 0.74 . . . . 0.0 112.062 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 54.7 mtt -79.77 153.45 29.18 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 169.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.5 m -84.53 -52.37 6.18 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.756 0.822 . . . . 0.0 109.871 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.2 p -163.8 -178.29 5.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.732 1.213 . . . . 0.0 108.7 -175.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -60.57 -25.51 66.24 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.127 0.971 . . . . 0.0 113.25 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.6 m -54.69 -36.47 64.7 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.713 0.688 . . . . 0.0 111.468 175.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.2 m -61.4 -41.34 96.98 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 122.885 0.474 . . . . 0.0 111.186 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.8 t -53.37 -54.39 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 123.507 0.723 . . . . 0.0 109.322 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -59.77 -45.65 91.6 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.611 0.764 . . . . 0.0 111.361 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.4 m -59.14 -52.22 66.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.261 0.624 . . . . 0.0 111.443 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.6 mt -56.92 -50.98 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.194 0.998 . . . . 0.0 109.573 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -54.43 -56.07 22.45 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.413 0.685 . . . . 0.0 110.751 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.34 -56.35 19.98 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.124 0.868 . . . . 0.0 112.086 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.8 t -59.92 -57.23 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.817 0.847 . . . . 0.0 110.766 -177.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.2 mt -70.6 -32.82 50.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 118.851 -0.595 . . . . 0.0 112.081 -169.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 87.3 p -52.96 -30.75 36.65 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -89.12 -5.84 57.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.557 0.743 . . . . 0.0 112.483 -175.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -75.08 147.78 83.72 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 118.885 0.766 . . . . 0.0 110.229 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -45.29 127.71 9.32 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 124.309 3.34 . . . . 0.0 113.254 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.51 -31.1 5.64 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-O 118.653 -1.082 . . . . 0.0 113.596 176.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.73 136.56 25.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 118.386 1.093 . . . . 0.0 110.098 -175.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -115.67 -100.97 0.43 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.639 1.176 . . . . 0.0 108.224 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 86.5 p -81.53 151.56 27.69 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.709 0.686 . . . . 0.0 110.128 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.24 131.46 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 123.788 0.835 . . . . 0.0 108.939 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -130.69 102.15 5.99 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.179 1.392 . . . . 0.0 108.057 -174.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.1 t -100.73 149.88 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.436 1.094 . . . . 0.0 109.021 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.6 t -140.1 129.23 23.67 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.101 0.96 . . . . 0.0 109.753 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.7 tp -70.47 -49.49 48.05 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.458 1.103 . . . . 0.0 109.301 170.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.59 -47.65 66.76 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.712 1.205 . . . . 0.0 111.776 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -89.42 -11.9 41.82 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.199 0.6 . . . . 0.0 111.612 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.7 m 54.04 56.53 6.94 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 125.011 1.325 . . . . 0.0 110.602 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -157.59 170.49 22.27 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.498 0.719 . . . . 0.0 111.279 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -137.36 116.26 1.34 Allowed Glycine 0 C--N 1.337 0.603 0 C-N-CA 126.196 1.855 . . . . 0.0 109.389 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.3 m -99.48 105.92 17.89 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 t -109.25 137.24 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 124.548 1.139 . . . . 0.0 109.214 -173.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -105.56 130.01 53.7 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 169.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -150.42 164.96 34.58 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -168.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -98.08 113.97 64.54 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.158 1.383 . . . . 0.0 109.682 170.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -44.82 -37.43 11.88 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 125.247 3.965 . . . . 0.0 114.873 173.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.1 mt -63.82 -34.18 77.35 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.24 0.616 . . . . 0.0 111.97 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.4 mt -105.64 -27.61 11.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.98 0.912 . . . . 0.0 112.478 -171.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.0 t -151.87 176.27 11.62 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.749 0.704 . . . . 0.0 109.96 176.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.6 p -148.98 163.48 25.31 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.477 1.111 . . . . 0.0 109.717 -175.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -53.16 -36.51 77.43 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.193 2.595 . . . . 0.0 112.678 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -68.03 -44.57 76.17 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.318 1.047 . . . . 0.0 110.355 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.6 m -61.55 -46.93 87.82 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.224 0.609 . . . . 0.0 110.287 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.8 mt -62.31 -45.85 91.37 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.285 1.034 . . . . 0.0 110.764 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -53.64 -46.85 70.68 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.975 0.91 . . . . 0.0 109.968 172.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.56 -45.4 84.59 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.276 0.941 . . . . 0.0 112.268 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.39 -48.54 77.43 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.686 0.743 . . . . 0.0 111.168 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.2 mt -59.62 -45.11 94.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.802 0.841 . . . . 0.0 109.834 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -57.34 -47.85 80.51 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.874 0.87 . . . . 0.0 110.22 176.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -59.48 -41.66 90.3 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.848 0.859 . . . . 0.0 111.525 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.7 mtp -59.3 -41.55 89.26 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.051 0.387 . . . . 0.0 110.731 174.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.29 60.0 0.19 Allowed Glycine 0 C--N 1.34 0.787 0 C-N-CA 123.688 0.661 . . . . 0.0 111.718 169.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -140.35 155.93 46.6 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.018 0.927 . . . . 0.0 109.236 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.17 96.49 3.3 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.75 124.41 44.99 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.901 1.28 . . . . 0.0 109.989 -174.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.0 t -150.29 156.52 41.69 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.097 0.559 . . . . 0.0 109.948 175.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 CA--C 1.533 0.306 0 C-N-CA 123.851 0.86 . . . . 0.0 113.152 -169.33 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.1 p . . . . . 0 CA--C 1.53 0.183 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -140.14 169.85 16.92 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.821 1.248 . . . . 0.0 109.34 175.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -140.3 143.64 35.97 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.462 1.105 . . . . 0.0 108.746 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 t -134.29 141.56 46.99 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.375 1.07 . . . . 0.0 109.824 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.0 t -107.66 106.97 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 175.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.3 mt -102.22 123.66 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -177.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -69.66 128.52 36.76 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 169.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 66.7 mt -127.47 86.58 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -99.95 148.73 24.17 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.067 0.547 . . . . 0.0 110.221 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.21 26.19 16.85 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.672 1.13 . . . . 0.0 112.871 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 68.6 mtm -79.62 136.27 36.79 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.242 1.021 . . . . 0.0 109.366 174.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.3 m -84.48 -46.93 11.14 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.267 1.027 . . . . 0.0 110.748 -173.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.5 p -156.1 177.25 11.64 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.643 0.777 . . . . 0.0 109.474 -175.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -60.69 -24.71 65.85 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.091 0.956 . . . . 0.0 113.091 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.3 m -53.59 -36.2 61.68 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.525 0.602 . . . . 0.0 111.472 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.3 m -60.26 -56.5 20.8 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.8 t -49.9 -52.61 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.464 1.105 . . . . 0.0 110.558 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -57.29 -54.58 45.2 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.366 1.066 . . . . 0.0 111.245 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.5 p -62.31 -49.82 74.09 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.378 0.671 . . . . 0.0 111.523 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 79.1 mt -52.97 -56.17 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 124.285 1.034 . . . . 0.0 109.696 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -57.57 -50.65 72.41 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.134 0.574 . . . . 0.0 110.347 -177.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.77 -51.41 44.95 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.502 1.049 . . . . 0.0 112.374 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.2 t -60.61 -55.18 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.336 0.655 . . . . 0.0 110.329 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.5 mt -64.33 -37.37 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 119.005 -0.522 . . . . 0.0 111.549 -171.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 72.5 m -49.93 -33.73 18.41 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.535 0.734 . . . . 0.0 112.502 173.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -89.39 -12.08 41.37 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.836 0.854 . . . . 0.0 112.06 -174.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -70.33 139.5 87.1 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 119.127 0.876 . . . . 0.0 109.839 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.27 132.82 32.83 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.939 2.426 . . . . 0.0 109.831 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.83 -33.67 6.33 Favored Glycine 0 C--N 1.337 0.605 0 CA-C-O 118.939 -0.923 . . . . 0.0 112.062 -177.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.5 t -70.32 135.3 28.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 CA-C-N 118.113 0.957 . . . . 0.0 109.908 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -111.48 -100.67 0.41 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.961 1.305 . . . . 0.0 107.958 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 59.5 p -86.83 146.16 26.32 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.615 0.766 . . . . 0.0 109.489 176.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.3 tt -150.24 143.89 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 123.624 0.77 . . . . 0.0 109.938 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.45 136.36 41.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 169.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.8 t -124.5 143.24 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.987 1.315 . . . . 0.0 107.691 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.5 t -143.4 130.93 21.14 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.898 0.879 . . . . 0.0 110.191 -174.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.33 -45.69 25.34 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.151 0.981 . . . . 0.0 109.53 174.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.47 -46.67 63.2 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.271 1.028 . . . . 0.0 111.305 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -89.72 -9.62 48.75 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.648 0.779 . . . . 0.0 111.905 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.0 m 52.33 55.59 8.93 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 125.68 1.592 . . . . 0.0 111.076 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -160.87 168.46 24.63 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.173 0.511 . . . . 0.0 111.706 -174.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.12 116.16 1.51 Allowed Glycine 0 CA--C 1.525 0.656 0 C-N-CA 126.232 1.873 . . . . 0.0 108.683 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.7 m -99.31 109.75 22.34 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 176.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.4 t -119.24 122.45 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 124.465 1.106 . . . . 0.0 109.217 -171.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -89.97 131.29 35.95 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 169.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -150.09 165.09 33.84 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -169.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -101.01 113.36 65.8 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.08 1.352 . . . . 0.0 109.262 172.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -43.46 -39.35 9.34 Favored 'Trans proline' 0 C--N 1.347 0.499 1 C-N-CA 125.458 4.105 . . . . 0.0 115.346 173.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.87 -34.93 79.27 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.776 0.43 . . . . 0.0 111.857 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.2 mt -100.6 -29.62 12.23 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.819 0.848 . . . . 0.0 112.423 -172.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.4 t -151.15 174.41 13.25 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.53 0.732 . . . . 0.0 109.731 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.8 p -148.15 162.59 30.3 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 123.893 0.877 . . . . 0.0 110.468 -173.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.02 -34.61 77.99 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.631 2.888 . . . . 0.0 112.41 172.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -63.22 -49.23 75.0 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.024 0.93 . . . . 0.0 110.458 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.6 m -62.35 -45.31 93.78 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.215 0.606 . . . . 0.0 110.402 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.3 mt -60.46 -50.12 74.83 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.813 0.845 . . . . 0.0 110.602 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -55.47 -41.92 73.64 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.035 0.379 . . . . 0.0 110.969 172.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.47 -46.21 52.98 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.205 0.907 . . . . 0.0 111.963 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.8 -48.4 80.78 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.408 0.604 . . . . 0.0 111.133 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.6 mm -60.9 -39.63 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 122.946 0.498 . . . . 0.0 111.279 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.24 -44.62 91.26 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.883 0.873 . . . . 0.0 110.216 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.02 -45.6 92.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.788 0.835 . . . . 0.0 110.905 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.5 mmm -59.78 -44.04 94.11 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.417 0.687 . . . . 0.0 110.626 175.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.8 60.96 0.4 Allowed Glycine 0 C--N 1.341 0.82 0 C-N-CA 124.518 1.056 . . . . 0.0 112.007 171.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -140.1 162.33 35.49 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.923 0.889 . . . . 0.0 109.494 172.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.0 103.85 3.91 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.97 110.05 21.82 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.75 1.62 . . . . 0.0 110.127 -174.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.9 t -150.4 145.88 26.35 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.037 0.381 . . . . 0.0 109.995 175.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.3 mt . . . . . 0 CA--C 1.528 0.133 0 C-N-CA 122.597 0.359 . . . . 0.0 111.589 -174.863 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.7 p . . . . . 0 N--CA 1.456 -0.147 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -142.64 162.45 35.43 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 126.333 1.853 . . . . 0.0 107.968 173.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -121.8 142.76 49.89 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.328 1.051 . . . . 0.0 109.231 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -133.54 133.41 42.1 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.192 0.997 . . . . 0.0 109.396 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.8 t -100.27 109.23 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 172.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.1 mt -99.53 118.4 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -75.8 107.41 7.96 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.2 mt -111.97 96.11 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -174.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -99.57 151.55 21.04 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.257 0.623 . . . . 0.0 109.771 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.09 35.35 12.59 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.185 0.898 . . . . 0.0 112.191 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 38.0 mtt -79.46 134.02 36.53 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 169.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.5 m -84.32 -51.51 6.92 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.424 0.689 . . . . 0.0 110.629 -174.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.8 p -161.0 -172.94 3.66 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.594 0.757 . . . . 0.0 109.647 -175.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -55.15 -32.68 62.29 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.385 1.474 . . . . 0.0 113.79 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.6 p -59.36 -41.15 88.62 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.264 0.484 . . . . 0.0 110.902 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.8 m -62.53 -49.95 73.3 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.916 0.486 . . . . 0.0 110.129 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.5 t -50.2 -52.1 15.67 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 C-N-CA 123.796 0.838 . . . . 0.0 109.889 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -62.04 -42.89 99.66 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.956 0.902 . . . . 0.0 111.845 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.6 m -63.87 -48.9 74.86 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.189 0.595 . . . . 0.0 110.969 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.9 mt -55.33 -58.56 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.974 1.309 . . . . 0.0 109.375 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -61.14 -43.52 98.76 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 117.952 0.342 . . . . 0.0 111.254 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.96 -54.48 33.4 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.367 0.984 . . . . 0.0 111.906 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.76 -51.49 72.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.033 0.933 . . . . 0.0 110.323 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.0 mm -62.92 -33.33 59.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.827 -175.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.5 m -57.04 -21.01 27.91 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 175.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -89.09 -14.09 37.1 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.631 0.65 . . . . 0.0 111.653 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -71.0 134.12 85.68 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -66.05 139.46 56.15 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.563 2.175 . . . . 0.0 109.571 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.32 -32.48 7.1 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-O 118.652 -1.082 . . . . 0.0 112.165 -176.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.5 t -66.17 136.37 26.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 CA-C-N 118.464 1.132 . . . . 0.0 110.198 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -116.67 -96.42 0.47 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.487 1.115 . . . . 0.0 108.606 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.5 p -90.09 147.98 23.3 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.475 0.71 . . . . 0.0 109.889 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 tt -150.41 131.98 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 123.841 0.856 . . . . 0.0 110.1 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.08 110.24 12.3 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.69 1.196 . . . . 0.0 108.494 177.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.7 t -106.06 144.4 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.364 1.066 . . . . 0.0 109.061 176.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.3 t -145.17 131.71 19.82 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.881 0.872 . . . . 0.0 110.609 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 tt -74.28 -45.86 44.96 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.737 1.215 . . . . 0.0 109.581 169.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.28 -46.95 66.1 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.298 1.039 . . . . 0.0 111.471 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -89.6 -10.79 44.67 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.42 0.688 . . . . 0.0 111.676 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.9 m 53.21 55.56 8.64 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 125.435 1.494 . . . . 0.0 110.554 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -156.48 169.3 24.95 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -175.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.41 111.43 0.99 Allowed Glycine 0 CA--C 1.524 0.623 0 C-N-CA 126.292 1.901 . . . . 0.0 108.369 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.5 m -99.08 98.54 9.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.7 t -109.98 127.88 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 124.392 1.077 . . . . 0.0 109.269 -170.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -98.27 129.79 44.98 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 169.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -150.06 163.61 37.7 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.76 0.824 . . . . 0.0 110.975 -169.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -95.35 115.01 65.08 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.396 1.078 . . . . 0.0 109.306 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -45.94 -37.17 16.77 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 124.993 3.795 . . . . 0.0 114.616 173.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.9 mt -63.76 -32.62 74.17 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.717 0.807 . . . . 0.0 112.004 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.8 -41.55 7.21 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.732 0.813 . . . . 0.0 111.281 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 t -142.69 170.47 15.65 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.381 0.672 . . . . 0.0 110.247 -178.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.4 p -138.43 160.95 61.62 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.397 1.079 . . . . 0.0 110.349 -174.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -50.64 -40.39 55.56 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.609 2.873 . . . . 0.0 112.211 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -61.12 -47.21 87.33 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.507 1.123 . . . . 0.0 110.418 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.6 m -60.94 -50.57 72.87 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.506 0.722 . . . . 0.0 110.678 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 50.9 mt -59.25 -50.95 72.05 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.382 1.073 . . . . 0.0 110.354 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -53.87 -49.49 68.4 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 124.115 0.966 . . . . 0.0 110.558 174.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.21 -46.44 62.86 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.518 1.056 . . . . 0.0 111.966 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.32 -51.46 69.87 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.239 0.616 . . . . 0.0 111.228 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.0 mm -66.44 -37.15 79.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 117.838 0.29 . . . . 0.0 111.657 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -60.37 -43.84 96.17 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.277 0.631 . . . . 0.0 109.951 175.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -62.72 -42.73 99.8 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.881 0.872 . . . . 0.0 111.363 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.1 mtp -56.95 -44.65 82.77 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.776 0.43 . . . . 0.0 110.577 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.9 63.1 0.18 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 123.597 0.617 . . . . 0.0 111.947 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -140.41 158.26 44.28 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.047 0.939 . . . . 0.0 108.817 171.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -78.74 87.22 4.64 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.25 116.6 31.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.917 1.287 . . . . 0.0 109.183 -176.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.9 p -138.82 133.22 31.77 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.645 1.178 . . . . 0.0 109.365 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 CA--C 1.529 0.155 0 C-N-CA 122.934 0.494 . . . . 0.0 111.299 -177.693 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 76.1 p . . . . . 0 CA--C 1.529 0.17 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -133.52 159.54 40.13 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 124.676 1.19 . . . . 0.0 109.999 -173.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -113.93 145.54 41.35 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.447 1.099 . . . . 0.0 108.818 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.4 t -139.32 155.35 47.76 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.014 0.926 . . . . 0.0 109.489 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.5 t -120.24 131.37 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.1 mt -128.56 120.24 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -74.79 134.35 41.8 Favored 'General case' 0 C--N 1.337 0.052 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.8 mt -125.65 110.84 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -175.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -99.45 152.87 19.5 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.4 2.14 60.43 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.053 -0.86 . . . . 0.0 112.66 -176.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.3 mtm -79.33 103.3 9.17 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 118.66 1.23 . . . . 0.0 107.94 175.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.4 t -84.47 -29.74 25.81 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.302 0.641 . . . . 0.0 111.803 -173.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.2 p -159.17 179.01 9.4 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.389 0.54 . . . . 0.0 110.589 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -59.33 -26.18 64.8 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.09 1.356 . . . . 0.0 113.25 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.8 m -56.06 -40.84 74.15 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.486 0.585 . . . . 0.0 111.169 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.2 m -63.06 -51.85 65.06 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 122.899 0.48 . . . . 0.0 109.777 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.1 t -50.34 -54.89 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.182 0.993 . . . . 0.0 110.232 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -57.45 -53.9 52.93 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.733 1.213 . . . . 0.0 111.215 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.0 p -60.47 -51.27 70.16 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.123 0.569 . . . . 0.0 111.429 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.9 mt -56.08 -55.09 20.23 Favored 'Isoleucine or valine' 0 C--N 1.339 0.152 0 C-N-CA 123.502 0.721 . . . . 0.0 109.63 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -52.95 -53.13 54.18 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.506 0.722 . . . . 0.0 110.64 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.07 -55.55 30.04 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.184 0.897 . . . . 0.0 112.349 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.43 -53.22 51.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 123.958 0.903 . . . . 0.0 111.057 -175.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.7 mm -63.45 -31.4 52.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.026 0.53 . . . . 0.0 111.269 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.0 t -54.51 -26.09 29.55 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -89.38 -5.25 57.61 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.418 0.687 . . . . 0.0 112.284 -175.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -71.83 144.36 88.03 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 118.76 0.709 . . . . 0.0 109.537 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -64.31 128.07 20.62 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.977 2.452 . . . . 0.0 110.202 -175.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.6 -33.33 6.64 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 118.652 -1.082 . . . . 0.0 112.243 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.15 139.38 20.53 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 CA-C-N 118.192 0.996 . . . . 0.0 110.081 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -119.37 -98.7 0.45 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.666 1.186 . . . . 0.0 108.256 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.8 p -85.15 147.41 26.63 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.2 tt -150.26 134.58 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.753 0.821 . . . . 0.0 109.162 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 89.2 mmt-85 -132.52 109.24 9.64 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.081 1.352 . . . . 0.0 108.373 -177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.0 t -103.68 147.1 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.788 1.235 . . . . 0.0 108.703 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.4 t -140.64 127.85 20.99 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.068 0.947 . . . . 0.0 110.588 -174.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.1 tp -69.34 -49.49 55.16 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.576 1.15 . . . . 0.0 109.437 171.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.4 -46.25 69.64 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.752 1.221 . . . . 0.0 111.687 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -89.46 -11.63 42.46 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.3 0.64 . . . . 0.0 111.582 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.6 m 53.46 54.24 10.39 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 125.367 1.467 . . . . 0.0 110.791 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.4 p30 -158.86 173.1 17.05 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.032 0.533 . . . . 0.0 111.626 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.6 119.3 2.04 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 126.101 1.81 . . . . 0.0 109.333 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.9 m -99.59 117.78 34.71 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 t -122.43 128.7 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 124.278 1.031 . . . . 0.0 109.725 -170.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -95.43 127.14 41.22 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 169.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -150.2 164.68 35.06 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.981 0.512 . . . . 0.0 112.175 -169.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -98.81 115.17 65.9 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.545 1.138 . . . . 0.0 110.136 172.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -44.98 -42.84 15.73 Favored 'Trans proline' 0 C--N 1.348 0.526 1 C-N-CA 125.556 4.171 . . . . 0.0 115.634 176.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.2 mt -68.31 -28.01 66.79 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.627 0.371 . . . . 0.0 111.941 -174.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.2 mt -99.68 -31.21 11.68 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.064 0.946 . . . . 0.0 111.726 -175.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.8 t -153.35 163.86 39.17 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.551 0.614 . . . . 0.0 109.956 176.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.4 p -131.22 163.31 50.25 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 124.834 1.254 . . . . 0.0 109.915 -177.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.88 -40.13 67.1 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.292 2.661 . . . . 0.0 112.419 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -66.76 -40.32 88.2 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.719 0.807 . . . . 0.0 111.601 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.4 m -62.36 -48.1 81.28 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.628 0.371 . . . . 0.0 110.047 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.5 mt -61.27 -47.72 84.71 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.104 0.961 . . . . 0.0 110.596 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -51.6 -50.99 59.12 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.416 1.086 . . . . 0.0 110.087 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.93 -46.34 84.22 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.24 0.924 . . . . 0.0 112.112 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.21 -50.6 71.12 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.45 0.7 . . . . 0.0 111.184 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.4 mt -58.6 -47.39 88.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.387 0.675 . . . . 0.0 109.691 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -55.25 -48.92 73.28 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.747 0.819 . . . . 0.0 110.42 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.5 -38.38 77.55 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.925 1.29 . . . . 0.0 112.472 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -56.03 -37.45 69.24 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 118.428 0.558 . . . . 0.0 111.127 175.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.18 56.09 0.07 OUTLIER Glycine 0 C--N 1.34 0.776 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 171.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -140.39 173.75 11.19 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.949 0.9 . . . . 0.0 110.037 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -108.51 88.27 2.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.43 138.54 36.37 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.99 0.916 . . . . 0.0 110.374 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.0 t -149.48 148.11 29.02 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.287 1.035 . . . . 0.0 109.18 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.8 mt . . . . . 0 CA--C 1.53 0.175 0 C-N-CA 122.693 0.397 . . . . 0.0 111.181 -176.731 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.7 p . . . . . 0 CA--C 1.531 0.229 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -145.18 171.69 14.18 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.073 1.349 . . . . 0.0 109.449 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -136.39 143.3 43.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.829 1.252 . . . . 0.0 108.825 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 t -135.52 153.57 51.68 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.898 1.279 . . . . 0.0 109.012 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.3 t -120.83 135.87 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 171.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.4 mt -130.53 124.87 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -175.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -67.14 131.56 46.05 Favored 'General case' 0 C--N 1.338 0.09 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.3 mt -129.59 98.74 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -99.23 150.83 21.68 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.81 4.42 56.88 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.234 0.921 . . . . 0.0 112.343 -173.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 57.6 mtm -79.02 108.41 12.48 Favored 'General case' 0 C--N 1.343 0.318 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.3 m -84.36 -38.58 20.15 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.542 1.137 . . . . 0.0 110.401 -171.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.7 p -156.91 -178.66 7.53 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.805 0.336 . . . . 0.0 110.502 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -55.39 -30.99 61.45 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.667 1.587 . . . . 0.0 113.416 -178.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 m -54.02 -42.59 69.28 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.409 0.684 . . . . 0.0 111.335 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.0 m -62.65 -53.26 57.19 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 122.912 0.485 . . . . 0.0 109.861 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.0 t -49.91 -54.41 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.462 1.105 . . . . 0.0 110.516 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -60.98 -50.88 71.58 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.409 1.084 . . . . 0.0 111.447 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.9 p -61.4 -51.77 67.38 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.81 0.444 . . . . 0.0 111.291 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.8 mt -52.61 -57.7 3.81 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 C-N-CA 124.052 0.941 . . . . 0.0 109.358 177.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -54.7 -45.47 73.98 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.094 0.557 . . . . 0.0 111.166 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.3 -53.96 34.83 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.337 0.97 . . . . 0.0 112.023 177.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.5 t -65.9 -54.5 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 117.552 0.676 . . . . 0.0 110.725 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.8 -40.65 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 123.545 0.738 . . . . 0.0 111.221 -175.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.2 p -56.6 -26.73 56.4 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -89.17 -6.05 57.25 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.747 0.819 . . . . 0.0 111.938 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -73.3 125.57 90.72 Favored Pre-proline 0 CA--C 1.535 0.384 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.89 124.84 10.53 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.781 2.987 . . . . 0.0 112.35 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.12 -37.83 3.35 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-O 119.033 -0.871 . . . . 0.0 112.056 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.3 t -67.86 127.42 29.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-N 117.873 0.836 . . . . 0.0 110.077 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -98.02 -102.41 0.2 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.744 1.218 . . . . 0.0 108.003 176.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 95.7 p -89.97 155.85 18.83 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.538 0.608 . . . . 0.0 110.247 176.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.9 tt -150.55 144.5 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.103 0.961 . . . . 0.0 109.822 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -140.21 108.81 5.9 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.51 1.124 . . . . 0.0 108.84 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.7 t -98.36 141.77 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.668 1.187 . . . . 0.0 108.534 174.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.6 t -135.4 125.78 26.61 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 123.776 0.83 . . . . 0.0 110.888 -173.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -64.85 -55.64 18.26 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.647 1.179 . . . . 0.0 108.804 171.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.68 -47.5 58.77 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 125.2 1.4 . . . . 0.0 112.275 -176.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -89.35 -9.35 50.74 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.069 0.548 . . . . 0.0 111.698 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.6 m 52.3 54.99 9.8 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 125.315 1.446 . . . . 0.0 110.864 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -158.7 173.79 16.03 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.31 0.644 . . . . 0.0 111.095 -174.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.92 119.35 2.02 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 125.708 1.623 . . . . 0.0 109.308 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.2 m -99.44 116.09 30.78 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 t -127.51 122.52 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 124.072 0.949 . . . . 0.0 109.672 -169.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -90.05 134.3 34.33 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -150.09 168.09 24.92 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.86 0.464 . . . . 0.0 112.235 -171.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -103.41 111.82 65.32 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.179 1.392 . . . . 0.0 109.155 171.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -42.66 -38.22 6.23 Favored 'Trans proline' 0 C--N 1.348 0.51 1 C-N-CA 125.402 4.068 . . . . 0.0 115.282 172.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.79 -35.95 82.28 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.142 0.577 . . . . 0.0 111.794 -177.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.6 mt -102.26 -29.95 11.38 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.036 0.934 . . . . 0.0 112.36 -171.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 t -150.65 173.06 14.58 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.387 0.675 . . . . 0.0 109.915 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.7 p -141.4 162.63 46.3 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 124.516 1.126 . . . . 0.0 109.919 -177.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -52.62 -41.03 71.33 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.253 2.635 . . . . 0.0 112.1 174.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -64.62 -41.92 95.85 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.074 0.95 . . . . 0.0 111.423 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.5 m -63.05 -48.42 78.78 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.964 0.505 . . . . 0.0 110.381 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 54.6 mt -61.1 -48.89 79.6 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.091 0.956 . . . . 0.0 110.319 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.6 ttp85 -52.2 -48.48 65.05 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 124.139 0.976 . . . . 0.0 110.148 172.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.98 -46.73 76.26 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.661 1.125 . . . . 0.0 112.244 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.29 -49.84 75.99 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 117.491 0.646 . . . . 0.0 110.967 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.0 mt -61.2 -42.55 93.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.266 0.626 . . . . 0.0 109.972 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -60.83 -44.79 96.48 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.497 1.119 . . . . 0.0 110.583 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -59.03 -39.0 80.61 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.297 1.039 . . . . 0.0 111.349 177.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.3 mtp -67.33 -7.44 24.63 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 175.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.47 57.18 1.29 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 123.893 0.758 . . . . 0.0 111.483 170.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -140.33 156.35 46.47 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.139 0.976 . . . . 0.0 109.59 174.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -81.27 87.54 6.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 176.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.43 122.47 42.59 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.435 1.094 . . . . 0.0 109.747 -174.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.2 m -144.49 136.53 26.13 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.545 1.138 . . . . 0.0 108.588 -177.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.6 mt . . . . . 0 CA--C 1.532 0.279 0 C-N-CA 122.857 0.463 . . . . 0.0 111.497 -176.556 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 81.9 p . . . . . 0 CA--C 1.53 0.195 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -143.98 169.69 17.35 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.988 0.915 . . . . 0.0 109.411 170.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -140.05 139.98 36.06 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.648 1.179 . . . . 0.0 108.192 173.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 t -137.33 141.44 41.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.035 0.934 . . . . 0.0 109.908 -177.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.5 t -99.72 133.39 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 171.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.3 mt -129.05 118.99 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -73.01 132.47 43.44 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.0 mt -120.55 111.49 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 125.266 1.426 . . . . 0.0 107.679 -175.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -100.74 149.37 23.88 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.487 1.115 . . . . 0.0 109.425 174.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.78 15.11 37.94 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.911 1.243 . . . . 0.0 112.455 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 93.1 mtp -79.69 109.07 13.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.5 m -84.34 -47.11 11.06 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.015 0.926 . . . . 0.0 111.065 -169.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -154.92 177.33 11.42 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.804 0.841 . . . . 0.0 108.821 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -61.2 -21.27 63.67 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -174.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.3 m -55.06 -36.8 65.97 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.361 0.528 . . . . 0.0 111.189 173.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.1 m -64.62 -44.23 91.2 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 122.897 0.479 . . . . 0.0 110.578 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.7 t -54.26 -52.88 34.19 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 123.345 0.658 . . . . 0.0 109.326 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -57.77 -50.19 74.08 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.921 0.888 . . . . 0.0 111.186 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -59.82 -59.32 5.62 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.515 0.726 . . . . 0.0 110.959 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 73.7 mt -52.94 -52.59 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.385 1.074 . . . . 0.0 109.561 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -61.72 -54.76 38.13 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.723 0.409 . . . . 0.0 110.746 -175.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.46 -39.11 95.86 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.731 1.158 . . . . 0.0 113.278 -176.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.8 t -73.7 -57.28 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 117.724 0.762 . . . . 0.0 109.937 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.6 mt -67.9 -28.96 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 118.971 -0.537 . . . . 0.0 111.813 -170.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.2 p -53.45 -28.89 32.74 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.897 0.771 . . . . 0.0 112.726 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -88.98 -17.09 30.15 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.857 0.863 . . . . 0.0 111.614 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -71.41 141.9 86.12 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 118.666 0.666 . . . . 0.0 109.709 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -63.99 140.37 72.22 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.323 2.682 . . . . 0.0 111.165 -170.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.43 -32.93 6.22 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 118.744 -1.031 . . . . 0.0 112.149 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.02 141.73 15.76 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 118.356 1.078 . . . . 0.0 110.125 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -118.39 -109.44 0.36 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.155 1.382 . . . . 0.0 107.526 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.7 p -90.1 94.33 9.74 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.329 1.052 . . . . 0.0 109.067 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.5 tt -89.92 133.94 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 123.932 0.893 . . . . 0.0 109.32 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -129.85 97.17 4.42 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.863 1.265 . . . . 0.0 108.444 -172.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.6 t -95.6 147.76 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.921 0.889 . . . . 0.0 109.927 -176.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.4 t -148.71 127.01 12.18 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.851 0.86 . . . . 0.0 110.198 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.8 tt -73.9 -42.77 60.18 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.011 0.924 . . . . 0.0 109.584 170.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.12 -47.11 72.21 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.543 1.137 . . . . 0.0 111.574 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -89.36 -5.44 57.47 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.362 0.665 . . . . 0.0 111.42 176.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.1 m 53.75 53.55 11.22 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 126.054 1.741 . . . . 0.0 111.165 175.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -161.22 172.08 17.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.284 0.564 . . . . 0.0 112.34 -172.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.71 117.05 2.39 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.1 m -99.37 94.38 6.41 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 t -100.03 120.06 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 124.456 1.103 . . . . 0.0 109.58 -169.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -89.52 132.86 34.85 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 169.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -150.81 171.79 16.64 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -169.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -106.87 111.72 63.65 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 125.548 1.539 . . . . 0.0 108.826 171.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -44.06 -38.02 10.11 Favored 'Trans proline' 0 C--N 1.346 0.422 1 C-N-CA 125.397 4.065 . . . . 0.0 114.893 172.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.2 mt -65.12 -33.69 76.62 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.481 0.712 . . . . 0.0 111.696 -177.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.0 mt -101.07 -33.4 10.16 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.266 1.026 . . . . 0.0 112.048 -172.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -148.95 169.97 19.38 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.526 0.73 . . . . 0.0 109.931 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.9 p -141.3 161.85 50.69 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.533 1.133 . . . . 0.0 109.745 -176.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.79 -42.86 42.79 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.484 2.789 . . . . 0.0 112.835 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -65.51 -39.87 92.35 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.541 0.736 . . . . 0.0 111.793 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.0 m -63.06 -45.26 93.02 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.637 0.375 . . . . 0.0 110.103 176.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.1 mt -65.43 -43.5 90.27 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.268 1.027 . . . . 0.0 110.833 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -53.85 -49.41 68.5 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.865 0.866 . . . . 0.0 109.449 170.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.92 -44.54 71.8 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.7 1.143 . . . . 0.0 112.388 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.29 94.65 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.727 0.811 . . . . 0.0 111.153 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.0 mt -63.7 -43.05 97.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 123.001 0.521 . . . . 0.0 110.226 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -62.57 -38.8 91.53 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.541 0.736 . . . . 0.0 111.349 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -60.94 -43.09 99.18 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.536 0.735 . . . . 0.0 110.616 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.4 mtp -62.36 -47.25 85.01 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 119.392 -0.337 . . . . 0.0 110.556 173.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.05 61.02 0.12 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 123.71 0.671 . . . . 0.0 112.077 170.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -140.33 150.69 44.29 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.58 0.752 . . . . 0.0 109.371 171.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -79.7 93.2 5.5 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.39 133.68 43.36 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.939 0.896 . . . . 0.0 110.39 -174.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.8 p -139.04 132.61 30.43 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.95 1.3 . . . . 0.0 108.825 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.8 mt . . . . . 0 C--O 1.231 0.117 0 C-N-CA 123.268 0.627 . . . . 0.0 110.751 -177.83 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 51.2 p . . . . . 0 CA--C 1.529 0.16 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -142.36 166.27 25.15 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.821 1.648 . . . . 0.0 108.901 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -120.72 143.91 48.51 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.005 1.322 . . . . 0.0 108.486 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 t -142.27 139.66 31.98 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 123.534 0.734 . . . . 0.0 109.892 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.5 t -99.81 118.37 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.4 mm -102.22 130.64 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 174.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -71.58 125.56 27.4 Favored 'General case' 0 N--CA 1.458 -0.065 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 169.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.4 mt -127.58 88.95 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -99.88 159.14 15.3 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.097 0.559 . . . . 0.0 109.755 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.64 21.22 56.71 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 119.285 -0.731 . . . . 0.0 112.759 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 70.1 mtm -79.71 128.55 33.55 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.1 p -84.45 -42.43 15.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.497 0.719 . . . . 0.0 110.983 -174.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.6 p -159.58 179.95 8.44 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.822 0.344 . . . . 0.0 110.73 -174.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -54.09 -31.03 50.69 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.662 1.585 . . . . 0.0 113.57 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m -54.59 -39.02 67.41 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.411 0.684 . . . . 0.0 111.372 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.8 m -63.99 -49.2 73.39 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 122.82 0.448 . . . . 0.0 110.198 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.1 t -52.35 -51.82 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.248 1.019 . . . . 0.0 109.646 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -58.43 -48.26 81.28 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.32 1.448 . . . . 0.0 111.789 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.0 m -60.9 -50.78 72.01 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.944 0.497 . . . . 0.0 110.829 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.5 mt -60.39 -55.44 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 123.619 0.768 . . . . 0.0 110.017 -176.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -57.36 -45.33 84.51 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.493 0.588 . . . . 0.0 110.853 -176.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.44 -61.64 7.25 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 123.79 0.71 . . . . 0.0 111.464 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.81 -56.38 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.067 0.947 . . . . 0.0 110.994 -175.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.0 mm -63.08 -33.73 62.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 118.764 -0.636 . . . . 0.0 111.835 -171.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.4 t -51.07 -35.2 33.6 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -89.38 -5.57 57.34 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.903 -0.57 . . . . 0.0 112.453 -175.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -68.22 147.95 98.28 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 119.417 1.008 . . . . 0.0 110.105 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -45.77 132.15 13.46 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 124.08 3.186 . . . . 0.0 112.738 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.82 -39.33 3.09 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 118.943 -0.921 . . . . 0.0 112.986 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.4 t -67.32 143.22 15.67 Favored 'Isoleucine or valine' 0 C--N 1.341 0.205 0 CA-C-N 118.089 0.944 . . . . 0.0 110.278 -177.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -117.63 -95.33 0.48 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.6 p -90.66 157.5 17.43 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.837 0.855 . . . . 0.0 110.078 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.5 tt -150.7 145.06 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 124.488 1.115 . . . . 0.0 108.601 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -131.98 107.83 8.94 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.128 0.971 . . . . 0.0 109.121 176.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.9 t -97.27 149.56 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.977 1.311 . . . . 0.0 109.047 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.3 t -145.14 123.02 11.96 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.266 0.627 . . . . 0.0 110.173 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.8 tp -67.04 -47.0 72.71 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.745 1.218 . . . . 0.0 109.931 172.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.93 -43.28 66.15 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.677 1.191 . . . . 0.0 111.7 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -89.2 -21.02 23.48 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.375 0.67 . . . . 0.0 111.147 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.9 m 57.48 57.29 4.45 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 125.267 1.427 . . . . 0.0 109.784 -174.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.6 p30 -152.81 171.63 17.96 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.47 0.708 . . . . 0.0 111.578 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -137.26 114.68 1.14 Allowed Glycine 0 C--N 1.337 0.615 0 C-N-CA 126.041 1.781 . . . . 0.0 108.894 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.3 m -99.11 99.9 10.97 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.0 t -103.26 133.17 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 124.817 1.247 . . . . 0.0 109.58 -170.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -103.21 125.17 49.76 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 172.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -150.17 171.02 17.57 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -168.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -101.25 113.22 65.83 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.353 1.461 . . . . 0.0 109.479 172.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -44.18 -40.2 12.34 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 125.17 3.914 . . . . 0.0 114.794 173.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.0 mt -63.19 -34.81 78.45 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.606 0.763 . . . . 0.0 111.703 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.8 mt -99.98 -29.26 12.65 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.107 0.963 . . . . 0.0 112.197 -172.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.7 t -153.07 160.25 42.92 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.645 0.657 . . . . 0.0 110.11 177.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.3 p -125.98 161.88 48.88 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 125.179 1.392 . . . . 0.0 109.658 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.99 -36.12 43.3 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.41 2.74 . . . . 0.0 112.924 172.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -67.94 -44.0 77.83 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.608 1.163 . . . . 0.0 110.717 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.2 m -62.78 -45.71 91.39 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.959 0.504 . . . . 0.0 110.296 176.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.9 mt -61.85 -48.84 78.74 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.699 0.8 . . . . 0.0 110.534 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.2 ttp85 -49.99 -47.45 52.87 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.267 1.027 . . . . 0.0 110.14 171.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.84 -51.09 41.29 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.41 1.005 . . . . 0.0 111.826 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.36 -43.76 96.22 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.769 0.785 . . . . 0.0 111.948 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.8 mm -60.9 -44.12 97.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 118.345 0.521 . . . . 0.0 110.507 176.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -58.98 -43.74 91.47 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.173 0.589 . . . . 0.0 110.17 175.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -60.66 -41.47 95.09 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.98 0.912 . . . . 0.0 111.213 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.4 mtp -61.92 -43.86 97.97 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.238 0.472 . . . . 0.0 110.592 173.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.06 60.7 0.2 Allowed Glycine 0 C--N 1.34 0.805 0 C-N-CA 123.786 0.707 . . . . 0.0 111.887 169.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -140.37 159.36 42.36 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.975 0.91 . . . . 0.0 109.313 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -73.46 98.25 2.72 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.87 127.95 46.0 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.049 1.339 . . . . 0.0 110.021 -173.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.1 m -150.11 152.79 35.3 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.472 1.109 . . . . 0.0 108.521 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 mm? . . . . . 0 CA--C 1.531 0.212 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.724 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.4 p . . . . . 0 CA--C 1.529 0.166 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -145.2 165.75 27.43 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.31 1.444 . . . . 0.0 109.065 173.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -129.26 151.01 50.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.813 1.245 . . . . 0.0 109.025 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.5 t -149.62 153.74 37.54 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 123.784 0.834 . . . . 0.0 109.91 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.57 125.43 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 173.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.3 mt -121.36 121.62 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -67.63 131.12 45.0 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 173.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.1 mt -124.39 108.77 21.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.112 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -99.83 150.5 22.29 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.58 13.17 55.99 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.378 0.989 . . . . 0.0 113.06 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 71.5 mtm -79.58 117.17 20.27 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.711 1.255 . . . . 0.0 108.26 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.4 m -84.15 -43.01 15.41 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.093 0.957 . . . . 0.0 110.387 -172.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.9 p -157.38 -178.94 7.72 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.605 0.362 . . . . 0.0 110.419 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -57.6 -25.92 60.76 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.293 1.437 . . . . 0.0 113.425 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.8 t -57.28 -44.42 83.99 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.229 0.611 . . . . 0.0 110.638 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.0 m -61.27 -51.06 70.51 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.817 0.447 . . . . 0.0 109.916 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.4 t -50.45 -53.05 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.328 1.051 . . . . 0.0 110.229 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -57.02 -51.75 68.02 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.55 1.14 . . . . 0.0 111.15 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.4 m -58.91 -54.37 47.87 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.566 0.746 . . . . 0.0 111.392 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.2 mt -54.08 -56.2 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.46 1.104 . . . . 0.0 109.438 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -55.09 -53.41 56.27 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.14 0.976 . . . . 0.0 110.924 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.47 -53.82 42.01 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.463 1.03 . . . . 0.0 112.296 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.6 t -59.48 -53.42 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.449 0.7 . . . . 0.0 110.392 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.0 mt -63.62 -39.94 87.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.108 0.563 . . . . 0.0 111.237 -174.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.2 t -49.92 -34.68 21.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.99 0.916 . . . . 0.0 112.355 176.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -89.05 -9.8 49.88 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.699 0.8 . . . . 0.0 112.427 -172.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -72.56 137.62 80.59 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 119.341 0.973 . . . . 0.0 109.91 177.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.39 136.03 20.0 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.718 2.945 . . . . 0.0 112.259 172.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.69 -43.31 1.83 Allowed Glycine 0 CA--C 1.523 0.541 0 CA-C-O 119.221 -0.766 . . . . 0.0 111.823 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.6 t -69.78 133.72 31.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 CA-C-N 117.76 0.78 . . . . 0.0 109.513 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -107.25 -98.1 0.36 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.9 p -90.15 149.04 22.62 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.546 0.738 . . . . 0.0 109.917 176.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.6 tt -150.53 143.17 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.239 1.016 . . . . 0.0 109.574 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -138.59 118.76 13.52 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.836 1.254 . . . . 0.0 108.342 175.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.19 147.02 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.889 1.275 . . . . 0.0 108.225 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.1 t -139.67 127.5 22.01 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 123.828 0.851 . . . . 0.0 110.749 -174.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp -68.17 -50.5 54.04 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.649 1.179 . . . . 0.0 109.47 171.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.56 -46.29 70.19 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.825 1.25 . . . . 0.0 111.73 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -89.36 -10.55 46.24 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.261 0.624 . . . . 0.0 111.586 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.7 m 53.11 55.18 9.23 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.368 1.467 . . . . 0.0 110.846 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -158.88 171.43 20.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.953 0.501 . . . . 0.0 111.698 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.31 116.06 1.86 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 126.376 1.941 . . . . 0.0 109.162 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.8 m -99.33 112.17 24.4 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.0 t -120.0 136.26 57.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.429 1.092 . . . . 0.0 109.819 -170.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -109.64 128.29 55.13 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 169.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -150.3 173.37 14.05 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -168.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -105.4 112.67 64.82 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.442 1.497 . . . . 0.0 109.483 174.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -41.64 -39.71 4.94 Favored 'Trans proline' 0 C--N 1.348 0.52 1 C-N-CA 125.585 4.19 . . . . 0.0 115.272 171.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.6 -33.12 74.35 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.292 0.637 . . . . 0.0 112.017 -177.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.2 mt -106.39 -31.52 8.54 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.297 1.039 . . . . 0.0 112.293 -171.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 t -150.26 175.43 11.8 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.392 0.677 . . . . 0.0 109.961 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.4 p -149.07 164.62 20.38 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.2 1.0 . . . . 0.0 110.328 -174.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.32 -39.45 86.99 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.449 2.766 . . . . 0.0 112.096 174.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.51 -39.03 81.39 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.634 0.774 . . . . 0.0 111.447 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.6 m -62.93 -46.74 86.35 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 45.8 mt -59.87 -50.46 73.68 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.085 0.954 . . . . 0.0 110.609 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -51.53 -48.4 63.01 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.679 1.191 . . . . 0.0 110.46 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.71 -45.32 93.51 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.452 1.025 . . . . 0.0 112.219 177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.85 -46.48 87.69 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.493 0.717 . . . . 0.0 110.991 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.1 mt -60.02 -44.07 93.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 123.528 0.731 . . . . 0.0 109.97 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -60.99 -42.49 98.51 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.638 0.775 . . . . 0.0 111.075 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -61.7 -43.43 98.87 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.663 0.785 . . . . 0.0 111.119 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.8 mtp -59.64 -45.17 92.79 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.746 0.419 . . . . 0.0 110.442 175.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.83 53.38 0.1 Allowed Glycine 0 C--N 1.341 0.817 0 C-N-CA 123.509 0.576 . . . . 0.0 112.477 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -140.46 133.01 28.67 Favored 'General case' 0 C--N 1.338 0.104 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 172.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -73.01 104.56 4.15 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -103.5 139.85 38.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.157 1.383 . . . . 0.0 110.59 -172.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.8 p -142.3 145.28 33.82 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.525 1.13 . . . . 0.0 108.793 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 52.6 mt . . . . . 0 CA--C 1.531 0.228 0 C-N-CA 122.826 0.45 . . . . 0.0 110.189 -176.226 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 CA--C 1.529 0.157 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -140.27 164.03 31.17 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.663 1.585 . . . . 0.0 108.265 170.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -127.27 150.0 49.76 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.471 1.108 . . . . 0.0 109.278 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -144.72 150.25 36.96 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.029 0.932 . . . . 0.0 109.706 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.0 t -112.5 127.18 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 171.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.0 mt -121.73 121.55 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -80.0 130.75 35.51 Favored 'General case' 0 N--CA 1.458 -0.061 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.8 mt -127.76 96.96 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -172.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -99.67 153.77 18.82 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.17 6.78 53.31 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.505 1.05 . . . . 0.0 112.345 -172.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 63.4 mtm -79.34 120.78 24.27 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.642 1.221 . . . . 0.0 108.474 175.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.5 p -84.4 -40.14 18.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.088 0.955 . . . . 0.0 110.989 -173.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.9 p -159.07 179.78 8.74 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.779 0.431 . . . . 0.0 110.327 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -59.22 -25.99 64.47 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.816 1.247 . . . . 0.0 113.279 -176.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.9 m -53.4 -41.28 65.81 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.488 0.586 . . . . 0.0 111.207 174.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.2 m -63.49 -48.35 77.99 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 123.384 0.674 . . . . 0.0 110.374 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.9 t -54.09 -52.17 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.348 1.059 . . . . 0.0 109.858 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -64.45 -46.38 83.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.904 0.881 . . . . 0.0 111.475 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.2 p -61.51 -47.41 85.73 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.085 0.402 . . . . 0.0 110.601 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.6 mt -56.24 -54.81 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 123.39 0.676 . . . . 0.0 109.613 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -49.95 -57.97 6.42 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.965 0.906 . . . . 0.0 110.204 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.55 -53.26 44.88 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.255 0.931 . . . . 0.0 112.583 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.83 -50.38 75.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.314 0.646 . . . . 0.0 111.116 -174.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.65 -32.65 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.091 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.1 m -55.2 -20.08 9.66 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -89.12 -10.83 45.8 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.866 0.757 . . . . 0.0 112.212 -176.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -73.19 127.21 89.57 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -47.45 128.9 15.67 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.854 3.036 . . . . 0.0 112.569 176.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.24 -33.18 6.74 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-O 118.592 -1.115 . . . . 0.0 112.655 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.6 t -65.27 136.91 25.93 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 CA-C-N 118.208 1.004 . . . . 0.0 110.623 -176.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -119.22 -103.06 0.41 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.34 1.456 . . . . 0.0 108.163 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 82.7 p -80.74 151.96 28.59 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.255 0.479 . . . . 0.0 110.133 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -150.25 138.88 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.248 1.019 . . . . 0.0 108.961 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -138.93 101.22 4.24 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.454 1.501 . . . . 0.0 107.712 -172.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 t -110.5 144.93 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.521 1.128 . . . . 0.0 108.865 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -146.51 130.93 17.64 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.312 0.645 . . . . 0.0 111.127 -175.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.8 tp -70.49 -48.82 53.87 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.882 1.273 . . . . 0.0 109.454 171.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.24 -46.26 69.07 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.759 1.224 . . . . 0.0 111.667 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -89.37 -10.15 47.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.194 0.597 . . . . 0.0 111.493 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.5 m 52.67 58.86 4.93 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.377 1.471 . . . . 0.0 110.488 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -158.42 169.19 25.01 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.203 0.525 . . . . 0.0 111.856 -174.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.82 113.58 1.05 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 126.652 2.073 . . . . 0.0 108.102 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.9 m -99.68 130.83 45.93 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 174.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.7 t -135.02 135.22 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 123.353 0.661 . . . . 0.0 109.766 -171.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -101.11 131.08 47.21 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 169.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -150.49 162.35 40.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.987 0.515 . . . . 0.0 111.99 -170.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -91.59 116.1 65.8 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 124.691 1.196 . . . . 0.0 109.49 170.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -48.59 -36.51 32.14 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 124.575 3.517 . . . . 0.0 114.231 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.4 mt -64.59 -28.95 69.98 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.602 0.761 . . . . 0.0 111.988 -176.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.7 mt -109.8 -28.63 8.7 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.047 0.939 . . . . 0.0 112.401 -172.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 t -152.43 178.63 9.34 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.792 0.724 . . . . 0.0 109.991 176.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.5 p -150.34 163.95 22.34 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.64 1.176 . . . . 0.0 109.756 -174.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.89 -38.49 85.95 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.257 2.638 . . . . 0.0 112.324 174.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -66.07 -45.34 81.66 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.26 1.024 . . . . 0.0 110.357 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 m -61.86 -47.26 85.81 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.185 0.594 . . . . 0.0 110.449 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.5 mt -60.16 -50.16 74.78 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.902 0.881 . . . . 0.0 110.382 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 57.5 ttp85 -52.04 -45.32 64.62 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.872 0.869 . . . . 0.0 110.342 172.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.73 -45.28 69.43 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.517 1.056 . . . . 0.0 112.163 175.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.85 -47.97 82.64 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.759 0.779 . . . . 0.0 111.265 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.1 mm -59.63 -45.53 94.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 122.668 0.387 . . . . 0.0 110.484 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -60.0 -41.81 92.93 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.251 1.02 . . . . 0.0 110.559 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.59 -44.49 96.19 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.952 0.901 . . . . 0.0 111.078 176.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.8 mtp -58.81 -41.55 87.04 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.737 0.415 . . . . 0.0 110.735 175.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.31 61.36 0.25 Allowed Glycine 0 C--N 1.34 0.76 0 C-N-CA 123.829 0.728 . . . . 0.0 112.107 169.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -140.45 155.02 46.84 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 123.955 0.902 . . . . 0.0 109.007 170.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -78.72 94.95 5.18 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.82 126.5 45.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.014 1.326 . . . . 0.0 109.897 -176.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.2 p -136.49 131.7 34.32 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.519 1.128 . . . . 0.0 109.162 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.5 mt . . . . . 0 CA--C 1.531 0.221 0 C-N-CA 123.327 0.651 . . . . 0.0 109.591 179.047 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 46.4 p . . . . . 0 CA--C 1.53 0.18 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -142.08 167.07 22.99 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.604 1.562 . . . . 0.0 108.695 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -129.12 153.8 47.32 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.573 1.149 . . . . 0.0 109.568 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -148.08 144.48 27.89 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.86 0.864 . . . . 0.0 110.073 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.7 t -106.9 107.46 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.7 mt -99.75 116.06 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -76.59 120.77 22.25 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 175.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -114.29 110.77 33.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -174.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -99.58 147.46 25.33 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.062 0.945 . . . . 0.0 108.639 173.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.44 4.98 52.59 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.328 0.966 . . . . 0.0 112.874 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 66.6 mtm -79.46 110.92 15.21 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.72 1.26 . . . . 0.0 107.982 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.8 p -84.4 -39.37 19.1 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.8 0.84 . . . . 0.0 110.965 -173.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.6 p -156.43 -179.47 8.2 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.715 0.293 . . . . 0.0 110.643 -175.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -55.16 -32.59 62.25 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.193 1.397 . . . . 0.0 112.981 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m -52.96 -39.85 63.26 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.416 0.687 . . . . 0.0 111.615 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.7 m -66.8 -48.05 70.16 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 122.858 0.463 . . . . 0.0 110.354 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.7 t -52.77 -55.08 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.046 0.938 . . . . 0.0 109.731 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -54.81 -52.95 61.06 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.141 1.376 . . . . 0.0 110.674 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.8 t -56.53 -55.87 28.44 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.697 0.799 . . . . 0.0 111.132 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.8 mt -57.21 -54.56 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.707 0.803 . . . . 0.0 109.641 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -55.02 -52.4 63.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.029 0.532 . . . . 0.0 110.666 -177.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.13 -51.11 60.34 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.681 1.134 . . . . 0.0 112.414 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.7 t -67.7 -57.24 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 117.801 0.801 . . . . 0.0 110.848 -176.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.4 mm -60.3 -34.54 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.561 0.744 . . . . 0.0 111.538 -173.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.9 p -54.13 -27.86 36.12 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -89.15 -20.04 24.74 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.29 0.636 . . . . 0.0 111.798 -175.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.59 141.72 93.31 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 118.509 0.595 . . . . 0.0 109.906 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -62.13 136.64 61.67 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.485 2.79 . . . . 0.0 111.304 -169.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.95 -40.39 2.45 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-O 118.996 -0.891 . . . . 0.0 111.583 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.2 131.52 33.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-N 118.103 0.952 . . . . 0.0 110.166 -176.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -101.2 -101.5 0.26 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.733 1.213 . . . . 0.0 107.732 173.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.5 p -87.92 151.48 22.79 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.77 0.828 . . . . 0.0 109.908 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.9 tt -150.18 137.92 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 123.907 0.883 . . . . 0.0 109.365 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -130.59 112.84 13.53 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.835 1.254 . . . . 0.0 108.479 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.9 t -101.4 147.92 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.379 1.072 . . . . 0.0 108.496 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.8 t -147.02 127.0 13.61 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.644 0.778 . . . . 0.0 110.463 -175.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.9 tp -70.32 -46.01 65.06 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.801 1.241 . . . . 0.0 109.937 172.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.64 -43.47 65.46 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.655 1.182 . . . . 0.0 111.498 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -89.26 -19.95 24.72 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.579 0.752 . . . . 0.0 111.099 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.5 m 57.43 53.82 7.15 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.478 1.511 . . . . 0.0 110.06 -175.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.9 p30 -153.85 172.93 16.59 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.976 0.511 . . . . 0.0 111.918 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.89 113.89 1.19 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 127.128 2.299 . . . . 0.0 107.96 176.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.0 m -98.96 104.34 16.38 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 t -111.47 133.48 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 124.517 1.127 . . . . 0.0 109.849 -169.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -103.58 133.39 48.68 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 169.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -150.45 170.51 18.91 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -171.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -103.19 112.89 66.04 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 125.586 1.554 . . . . 0.0 109.242 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -43.22 -38.98 8.29 Favored 'Trans proline' 0 C--N 1.348 0.531 1 C-N-CA 125.535 4.157 . . . . 0.0 114.987 173.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.41 -34.72 77.31 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.365 0.666 . . . . 0.0 111.811 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.6 mt -101.88 -32.14 10.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.248 1.019 . . . . 0.0 112.177 -172.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.5 t -152.04 175.83 12.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.185 0.594 . . . . 0.0 110.109 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.6 p -150.13 165.28 17.86 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 124.598 1.159 . . . . 0.0 109.635 -175.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -51.06 -46.18 32.42 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.606 2.871 . . . . 0.0 113.075 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -68.58 -34.67 76.2 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.186 0.594 . . . . 0.0 111.865 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.4 m -65.8 -45.45 82.33 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.126 0.421 . . . . 0.0 109.988 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.7 mt -64.45 -44.58 90.67 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.194 0.998 . . . . 0.0 110.692 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.6 ttp180 -53.78 -50.64 65.63 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.64 0.776 . . . . 0.0 109.18 171.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.74 -44.46 60.57 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.02 1.295 . . . . 0.0 112.565 176.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.09 -44.05 96.79 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.816 0.846 . . . . 0.0 111.09 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.6 mt -65.94 -39.76 85.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.21 0.604 . . . . 0.0 110.388 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -62.63 -38.88 91.98 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.506 0.722 . . . . 0.0 110.928 174.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -62.41 -41.36 98.63 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.321 0.648 . . . . 0.0 110.831 176.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.8 mtp -60.52 -48.39 81.96 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.028 0.376 . . . . 0.0 110.241 172.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.58 60.6 0.1 Allowed Glycine 0 C--N 1.341 0.811 0 C-N-CA 123.706 0.669 . . . . 0.0 111.956 170.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -140.35 149.97 43.38 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.624 0.77 . . . . 0.0 109.756 173.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -80.28 87.13 5.59 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.928 0.891 . . . . 0.0 108.691 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.57 140.8 33.23 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.006 0.923 . . . . 0.0 111.007 -175.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.0 t -150.31 160.15 43.93 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.698 1.199 . . . . 0.0 109.146 174.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 CA--C 1.532 0.251 0 C-N-CA 123.15 0.58 . . . . 0.0 110.205 -177.948 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.5 p . . . . . 0 CA--C 1.53 0.208 0 CA-C-O 120.784 0.326 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -134.22 162.81 31.13 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.14 1.376 . . . . 0.0 109.262 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -125.41 145.53 50.01 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.971 1.308 . . . . 0.0 108.695 176.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.7 t -142.8 145.51 33.3 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.824 0.85 . . . . 0.0 109.625 176.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.5 t -106.51 130.88 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 172.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.4 mt -125.62 125.19 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -69.91 129.38 39.36 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.1 mt -121.63 103.82 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -100.01 150.8 22.07 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.077 0.951 . . . . 0.0 109.407 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.74 26.2 23.13 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.674 1.131 . . . . 0.0 112.099 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 93.4 mtp -85.59 111.55 20.15 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.6 p -84.5 -44.84 13.23 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.492 0.717 . . . . 0.0 111.469 -170.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.9 p -159.05 -179.97 8.51 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.415 0.686 . . . . 0.0 109.721 -175.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -56.22 -29.32 60.83 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.819 1.247 . . . . 0.0 113.204 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.5 m -52.19 -41.18 62.45 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.154 0.582 . . . . 0.0 111.428 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.5 m -64.84 -46.53 81.51 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 122.692 0.397 . . . . 0.0 110.503 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.8 t -53.06 -55.15 13.56 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 C-N-CA 123.489 0.716 . . . . 0.0 109.342 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -56.71 -52.11 66.21 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.563 1.145 . . . . 0.0 111.224 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.9 m -58.99 -56.61 20.01 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.68 0.792 . . . . 0.0 111.222 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.4 mt -56.08 -51.96 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 123.651 0.78 . . . . 0.0 109.401 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -56.51 -53.52 56.52 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.856 0.462 . . . . 0.0 110.68 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.8 -54.55 36.6 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.687 0.66 . . . . 0.0 112.372 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.3 t -62.81 -55.35 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.794 0.838 . . . . 0.0 111.043 -174.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.0 mm -62.33 -37.11 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 118.778 -0.63 . . . . 0.0 110.932 -175.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.8 t -51.86 -35.11 43.67 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 118.798 0.726 . . . . 0.0 112.358 175.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -89.0 -12.18 42.14 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.778 0.831 . . . . 0.0 111.988 -173.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -70.4 143.62 90.77 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 119.016 0.825 . . . . 0.0 109.631 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -62.26 137.76 67.74 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.343 2.695 . . . . 0.0 111.021 -171.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.43 -41.02 2.38 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-O 119.059 -0.856 . . . . 0.0 111.311 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.2 t -70.88 141.39 16.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.199 0 CA-C-N 118.106 0.953 . . . . 0.0 109.442 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -112.91 -94.28 0.46 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.5 p -90.82 155.61 18.64 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.713 0.805 . . . . 0.0 109.787 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.4 tt -150.85 137.17 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.058 0.943 . . . . 0.0 108.47 174.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -117.95 99.46 6.92 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.68 1.592 . . . . 0.0 108.565 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.2 t -94.3 144.9 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.791 0.836 . . . . 0.0 109.601 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.5 t -147.37 122.48 10.15 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.785 0.834 . . . . 0.0 110.14 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.9 tt -70.15 -43.75 70.23 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.187 0.995 . . . . 0.0 109.564 170.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.5 -45.83 69.81 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.216 1.006 . . . . 0.0 111.566 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -89.68 -5.57 56.94 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.48 0.712 . . . . 0.0 111.778 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.0 m 51.8 53.82 11.98 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.679 1.591 . . . . 0.0 111.212 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -159.5 173.42 16.2 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -174.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.65 118.77 1.93 Allowed Glycine 0 C--N 1.339 0.72 0 C-N-CA 126.208 1.861 . . . . 0.0 109.001 174.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.8 m -99.68 97.9 8.8 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.2 t -100.63 132.2 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.698 1.199 . . . . 0.0 110.198 -169.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -105.31 126.56 52.24 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 172.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -150.15 169.17 21.93 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -169.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -102.91 115.77 63.63 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.309 1.443 . . . . 0.0 109.709 175.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -45.17 -41.03 16.58 Favored 'Trans proline' 0 C--N 1.348 0.523 1 C-N-CA 125.806 4.338 . . . . 0.0 115.635 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.1 mt -67.12 -29.69 69.49 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.922 0.489 . . . . 0.0 111.781 -174.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.52 -35.3 9.92 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.872 0.869 . . . . 0.0 110.989 -175.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.4 t -150.79 170.98 17.95 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.538 0.608 . . . . 0.0 110.576 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.5 p -150.03 161.86 29.76 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.995 1.318 . . . . 0.0 109.507 -172.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -50.12 -48.46 19.7 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.684 2.923 . . . . 0.0 113.434 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -58.81 -40.18 83.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.724 0.81 . . . . 0.0 112.044 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 m -66.35 -45.26 80.78 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.247 0.619 . . . . 0.0 109.862 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.4 mt -64.3 -43.32 95.09 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.178 0.991 . . . . 0.0 110.944 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.0 ttp85 -56.3 -48.09 77.37 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.85 0.86 . . . . 0.0 109.573 172.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.11 -41.08 92.45 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.28 0.943 . . . . 0.0 112.571 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.34 -47.41 76.58 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.67 0.788 . . . . 0.0 111.036 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.0 mt -62.83 -41.39 92.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.242 0.617 . . . . 0.0 109.7 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -58.75 -43.58 90.33 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.359 0.664 . . . . 0.0 110.803 175.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.7 -39.5 88.75 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.735 0.814 . . . . 0.0 111.429 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.2 mtp -59.25 -44.8 92.38 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 118.234 0.47 . . . . 0.0 110.593 173.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.93 61.5 0.1 Allowed Glycine 0 C--N 1.341 0.84 0 C-N-CA 123.533 0.587 . . . . 0.0 111.88 169.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -140.5 156.64 46.27 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.98 0.912 . . . . 0.0 109.544 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -79.5 90.46 5.09 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 174.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.47 125.52 45.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.69 1.196 . . . . 0.0 109.774 -174.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.4 p -145.62 135.18 23.25 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.314 1.046 . . . . 0.0 108.949 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.1 mt . . . . . 0 CA--C 1.531 0.231 0 C-N-CA 123.682 0.793 . . . . 0.0 111.866 -176.289 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.4 p . . . . . 0 N--CA 1.457 -0.113 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -135.68 170.41 16.01 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.861 1.665 . . . . 0.0 108.122 172.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -140.13 123.93 17.38 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 t -113.06 134.83 54.35 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.838 1.255 . . . . 0.0 109.22 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.3 t -99.55 125.27 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 169.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.5 mt -120.96 119.73 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -73.92 125.59 28.56 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.8 mt -118.22 107.43 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 125.053 1.341 . . . . 0.0 107.388 -176.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -99.79 135.5 41.12 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.58 0.9 20.07 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.854 1.216 . . . . 0.0 112.791 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.8 mtm -78.6 100.09 6.82 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.4 m -84.33 -36.09 22.8 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.974 1.31 . . . . 0.0 111.235 -169.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.1 p -153.45 179.57 8.66 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.026 0.376 . . . . 0.0 110.285 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -56.29 -30.13 62.08 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.178 1.391 . . . . 0.0 112.931 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 m -55.46 -43.91 75.9 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.434 0.694 . . . . 0.0 111.243 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.1 m -61.76 -53.13 60.16 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.5 t -49.91 -56.22 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.502 1.121 . . . . 0.0 110.146 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -63.34 -46.86 84.65 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.944 0.898 . . . . 0.0 111.586 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.6 p -60.99 -49.97 75.3 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.629 0.372 . . . . 0.0 110.994 -177.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.7 mt -55.88 -55.24 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -52.24 -54.35 32.22 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.792 0.837 . . . . 0.0 111.117 -176.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.14 -52.18 53.65 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 124.117 0.865 . . . . 0.0 112.458 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.2 t -64.03 -49.28 82.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 117.456 0.628 . . . . 0.0 111.044 -174.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.6 mm -64.65 -33.81 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.229 0.612 . . . . 0.0 111.217 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.1 t -53.71 -24.75 15.66 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 177.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -88.53 -8.33 54.99 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.424 0.69 . . . . 0.0 112.121 -172.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -74.06 128.18 86.83 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -46.81 133.84 17.51 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.703 2.935 . . . . 0.0 112.232 175.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.99 -42.11 1.97 Allowed Glycine 0 C--N 1.337 0.593 0 CA-C-O 119.037 -0.868 . . . . 0.0 111.47 -177.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.2 t -67.3 130.47 32.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 CA-C-N 117.846 0.823 . . . . 0.0 109.612 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -105.44 -94.48 0.35 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.4 p -90.05 154.96 19.41 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.482 0.713 . . . . 0.0 109.466 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.6 tt -150.25 135.42 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 37.7 mtt85 -131.56 93.9 3.43 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.66 1.184 . . . . 0.0 108.229 -169.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.2 t -95.29 141.91 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 123.648 0.779 . . . . 0.0 109.21 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.2 t -144.96 125.73 14.28 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.012 0.925 . . . . 0.0 110.283 -175.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 tt -71.43 -44.04 65.6 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.731 1.212 . . . . 0.0 110.039 172.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.05 -43.02 63.59 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.321 1.048 . . . . 0.0 111.449 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -89.4 -20.81 23.5 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.626 0.77 . . . . 0.0 111.141 177.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.7 m 57.76 54.68 6.03 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.646 1.578 . . . . 0.0 109.956 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.9 p30 -154.64 171.27 19.77 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.031 0.533 . . . . 0.0 112.104 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.92 114.34 1.56 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 126.506 2.003 . . . . 0.0 108.15 174.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.9 m -99.42 95.92 7.35 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.9 t -100.73 122.08 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 125.088 1.355 . . . . 0.0 109.12 -171.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -89.83 128.2 36.12 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -150.22 165.28 33.41 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -169.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -101.24 113.7 65.8 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.654 1.182 . . . . 0.0 108.885 171.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -45.57 -38.98 17.14 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.972 3.781 . . . . 0.0 114.884 174.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.0 mt -63.91 -28.9 70.15 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.736 0.814 . . . . 0.0 112.017 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.58 -41.81 7.18 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.08 0.952 . . . . 0.0 110.719 -175.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.8 t -143.83 156.97 44.66 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 123.64 0.776 . . . . 0.0 109.92 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.6 p -117.64 162.67 27.63 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 124.815 1.246 . . . . 0.0 109.9 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.07 -41.77 55.7 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.257 2.638 . . . . 0.0 112.385 171.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -63.36 -41.41 98.84 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.921 0.888 . . . . 0.0 111.872 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.9 m -59.67 -49.18 78.75 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.207 0.458 . . . . 0.0 110.026 176.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.4 mt -62.67 -45.71 91.56 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.021 0.929 . . . . 0.0 110.744 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 65.5 ttp85 -55.05 -50.51 68.91 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.032 0.933 . . . . 0.0 109.886 174.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.8 -42.65 86.19 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.633 1.111 . . . . 0.0 112.253 177.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.28 -39.25 94.05 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 117.446 0.623 . . . . 0.0 111.273 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.3 mt -69.72 -36.66 71.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.969 -0.457 . . . . 0.0 110.583 177.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -59.82 -41.09 90.53 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.83 -0.544 . . . . 0.0 110.273 171.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -63.2 -41.88 99.24 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.121 0.569 . . . . 0.0 111.246 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.7 mmm -57.72 -40.69 80.18 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.12 0.418 . . . . 0.0 110.663 172.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.86 55.77 0.31 Allowed Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.144 0.878 . . . . 0.0 111.622 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -140.44 151.04 44.57 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.752 0.821 . . . . 0.0 109.605 175.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -77.15 94.2 4.04 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.74 134.17 43.03 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.073 1.349 . . . . 0.0 109.639 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.2 t -146.31 140.49 26.49 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.842 0.857 . . . . 0.0 109.498 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.7 mt . . . . . 0 N--CA 1.455 -0.195 0 C-N-CA 123.048 0.539 . . . . 0.0 110.651 -175.876 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.4 p . . . . . 0 N--CA 1.457 -0.104 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -138.44 164.08 30.28 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.747 1.619 . . . . 0.0 108.686 176.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -121.53 144.61 48.62 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.542 1.137 . . . . 0.0 108.986 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.3 t -139.3 143.05 37.71 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.059 0.944 . . . . 0.0 109.445 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.4 t -107.71 116.61 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 172.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.0 mm -99.77 124.14 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 174.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -82.1 111.76 18.53 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 174.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 57.2 mt -107.52 106.09 20.01 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 C-N-CA 124.531 1.132 . . . . 0.0 108.334 -173.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -99.75 128.46 45.84 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.52 -4.66 7.62 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.397 0.999 . . . . 0.0 112.917 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 62.9 mtm -78.56 105.86 10.12 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.9 m -84.45 -34.97 23.33 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.335 1.054 . . . . 0.0 109.99 -173.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 p -158.55 167.63 29.09 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.283 0.633 . . . . 0.0 109.98 -175.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -60.13 -20.97 60.9 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.014 1.325 . . . . 0.0 113.791 -170.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.9 p -52.71 -43.0 65.34 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.715 0.689 . . . . 0.0 110.65 171.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 76.7 m -66.74 -48.22 69.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.528 0.731 . . . . 0.0 110.5 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.7 t -50.79 -53.25 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 123.986 0.915 . . . . 0.0 110.353 176.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -58.24 -50.01 75.07 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.731 1.212 . . . . 0.0 111.107 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.2 m -59.5 -54.54 45.35 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.213 0.605 . . . . 0.0 111.206 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.4 mt -54.53 -54.89 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 124.717 1.207 . . . . 0.0 109.742 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -56.34 -53.11 61.21 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.567 0.747 . . . . 0.0 110.713 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.2 -51.61 45.72 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.525 1.06 . . . . 0.0 112.128 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.0 -54.3 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.349 0.659 . . . . 0.0 110.415 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.41 -36.65 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.002 0.521 . . . . 0.0 111.58 -174.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.9 m -52.27 -30.75 29.33 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.501 0.721 . . . . 0.0 112.767 176.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -89.22 -9.95 48.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.583 0.753 . . . . 0.0 112.242 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -74.66 140.09 74.7 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 118.901 0.773 . . . . 0.0 109.874 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -64.83 137.93 55.74 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.992 2.462 . . . . 0.0 110.131 -175.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.7 -37.39 3.61 Favored Glycine 0 CA--C 1.525 0.656 0 CA-C-O 118.898 -0.946 . . . . 0.0 111.748 -176.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.6 t -67.6 141.16 18.12 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 CA-C-N 117.98 0.89 . . . . 0.0 110.418 -175.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -120.73 -102.85 0.41 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.632 1.173 . . . . 0.0 108.501 176.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.7 p -84.55 147.19 27.15 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.553 0.615 . . . . 0.0 109.807 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -150.22 139.95 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 123.642 0.777 . . . . 0.0 110.055 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.24 101.86 4.99 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.946 1.298 . . . . 0.0 108.498 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -97.54 139.0 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 174.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.2 t -135.23 129.05 33.07 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.176 0.99 . . . . 0.0 110.662 -173.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.1 tp -66.73 -52.97 38.31 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.36 1.064 . . . . 0.0 109.145 170.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.8 -49.03 66.45 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 125.041 1.336 . . . . 0.0 111.908 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -89.3 -6.28 56.87 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.012 0.525 . . . . 0.0 111.861 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.8 m 51.27 53.71 12.43 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.257 1.423 . . . . 0.0 111.229 176.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -156.98 172.17 19.16 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.811 0.444 . . . . 0.0 111.725 -174.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.97 112.38 1.01 Allowed Glycine 0 C--N 1.338 0.667 0 C-N-CA 126.215 1.864 . . . . 0.0 108.982 177.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.9 m -99.04 103.81 15.78 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 t -115.02 127.6 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 124.579 1.151 . . . . 0.0 109.831 -169.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -96.17 132.79 41.22 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 168.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -150.11 166.74 28.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.491 0.716 . . . . 0.0 110.887 -170.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -99.81 113.66 65.22 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.395 1.078 . . . . 0.0 109.062 172.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -43.02 -37.85 6.67 Favored 'Trans proline' 0 C--N 1.349 0.58 1 C-N-CA 125.377 4.051 . . . . 0.0 115.137 172.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.8 mt -63.89 -32.3 73.77 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.449 0.699 . . . . 0.0 111.997 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.72 -43.31 6.5 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.935 0.894 . . . . 0.0 111.076 -174.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.8 t -142.86 176.75 8.83 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.423 0.689 . . . . 0.0 110.315 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.0 p -150.26 162.0 29.06 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 124.271 1.028 . . . . 0.0 110.288 -172.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -53.25 -43.57 56.2 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.645 2.896 . . . . 0.0 112.899 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.17 -34.66 78.58 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.635 0.774 . . . . 0.0 112.183 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.5 m -71.51 -47.08 57.63 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.177 0.591 . . . . 0.0 109.816 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 59.8 mt -59.56 -47.72 84.45 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.903 0.881 . . . . 0.0 110.123 177.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -53.97 -50.04 67.42 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.31 1.044 . . . . 0.0 110.06 172.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.34 -44.84 65.83 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.641 1.115 . . . . 0.0 112.461 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.16 -42.47 98.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.479 0.639 . . . . 0.0 111.106 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.0 mt -66.5 -41.8 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 122.934 0.493 . . . . 0.0 110.526 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -59.49 -41.88 90.84 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.55 0.74 . . . . 0.0 110.563 174.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.22 -44.85 95.65 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.378 0.671 . . . . 0.0 111.098 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.0 mtm -60.87 -36.18 78.54 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.701 0.401 . . . . 0.0 111.215 174.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.68 59.12 0.31 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 123.803 0.716 . . . . 0.0 112.225 169.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -140.3 146.79 38.99 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.923 0.889 . . . . 0.0 108.638 172.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -76.01 90.99 3.04 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.59 132.68 44.77 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.278 1.031 . . . . 0.0 109.886 -177.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.1 m -140.32 152.76 46.09 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.077 1.351 . . . . 0.0 107.646 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.415 HD22 ' H ' ' A' ' 70' ' ' LEU . 2.2 mm? . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.1 p . . . . . 0 CA--C 1.529 0.138 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -117.32 164.49 14.75 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.376 1.071 . . . . 0.0 108.789 170.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -133.02 146.83 52.1 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.141 0.977 . . . . 0.0 109.717 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.1 t -138.85 142.3 38.62 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.28 1.032 . . . . 0.0 109.518 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.5 t -112.75 102.35 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 175.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.7 mt -99.99 112.98 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -66.05 123.69 20.55 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.1 mt -111.31 125.89 68.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -131.79 151.18 51.85 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.396 0.679 . . . . 0.0 109.861 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.47 36.23 6.62 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.803 1.192 . . . . 0.0 112.095 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -88.67 144.6 26.18 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 117.68 0.74 . . . . 0.0 109.015 174.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.0 p -84.69 -43.73 14.07 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.393 0.677 . . . . 0.0 109.807 177.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.7 p -163.69 -175.51 4.17 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.702 0.801 . . . . 0.0 109.956 -175.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -61.17 -27.64 68.55 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.121 1.369 . . . . 0.0 113.863 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.9 p -59.16 -33.53 71.03 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.638 0.654 . . . . 0.0 111.455 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 80.3 m -60.8 -56.07 25.57 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.154 0.582 . . . . 0.0 109.572 175.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.2 t -53.53 -47.19 60.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.788 1.235 . . . . 0.0 111.08 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -56.47 -52.91 62.94 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.83 0.852 . . . . 0.0 110.679 176.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.5 t -59.15 -51.17 71.18 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.881 0.872 . . . . 0.0 111.259 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.4 mt -52.65 -53.19 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.775 1.23 . . . . 0.0 109.551 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -54.74 -53.16 58.7 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.507 0.723 . . . . 0.0 110.698 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.14 -51.72 48.51 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.389 0.995 . . . . 0.0 112.266 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.0 t -58.94 -52.38 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.728 0.811 . . . . 0.0 110.436 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.24 -37.79 79.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 119.018 -0.515 . . . . 0.0 111.516 -176.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.6 m -52.21 -29.65 23.64 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 177.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -89.22 -8.34 53.73 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.482 0.713 . . . . 0.0 112.416 -175.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -73.84 138.28 76.61 Favored Pre-proline 0 CA--C 1.535 0.365 0 CA-C-N 119.082 0.855 . . . . 0.0 110.254 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -66.47 131.34 26.02 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.858 2.372 . . . . 0.0 109.394 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.24 -39.29 2.96 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-O 118.915 -0.936 . . . . 0.0 111.444 -175.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.6 t -66.43 135.63 28.14 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 117.955 0.878 . . . . 0.0 109.8 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -111.47 -99.62 0.41 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.024 1.329 . . . . 0.0 107.886 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.3 p -90.43 154.66 19.49 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.768 0.827 . . . . 0.0 109.628 172.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 tt -150.6 146.13 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 123.474 0.71 . . . . 0.0 110.447 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -140.1 107.91 5.67 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.837 1.255 . . . . 0.0 107.711 169.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.0 t -98.42 130.65 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 170.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.9 t -124.7 130.83 53.17 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.426 1.09 . . . . 0.0 110.169 -173.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.8 tp -72.56 -48.49 39.67 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.25 1.02 . . . . 0.0 108.936 172.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.85 -47.36 74.28 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.94 1.296 . . . . 0.0 111.626 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -89.3 -7.55 55.15 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.982 0.513 . . . . 0.0 111.525 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.6 m 53.45 54.01 10.76 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 125.234 1.413 . . . . 0.0 111.153 175.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -159.29 169.91 23.02 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.919 -175.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.35 107.2 1.0 Allowed Glycine 0 C--N 1.337 0.596 0 C-N-CA 126.613 2.054 . . . . 0.0 108.614 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.0 m -98.6 96.17 7.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.4 t -109.31 127.49 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 124.587 1.155 . . . . 0.0 108.924 -172.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -97.91 130.7 44.78 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 169.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -150.21 170.7 18.34 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.268 0.627 . . . . 0.0 112.171 -169.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -106.07 114.6 62.36 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.033 1.333 . . . . 0.0 109.477 173.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -44.3 -36.26 9.07 Favored 'Trans proline' 0 C--N 1.348 0.527 1 C-N-CA 125.528 4.152 . . . . 0.0 115.486 174.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.02 -32.36 74.05 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.259 0.624 . . . . 0.0 111.99 -176.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.3 mt -108.17 -29.62 8.83 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.005 0.922 . . . . 0.0 112.371 -171.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.5 t -148.11 175.25 11.18 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.719 0.69 . . . . 0.0 109.615 173.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.8 p -146.94 163.39 28.92 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 123.65 0.78 . . . . 0.0 110.33 -175.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -52.08 -41.99 61.54 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.475 2.783 . . . . 0.0 112.012 173.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -67.82 -39.62 83.89 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.724 0.81 . . . . 0.0 111.474 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.8 m -61.65 -50.36 72.82 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.83 0.452 . . . . 0.0 109.998 176.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 50.8 mt -60.2 -48.13 83.02 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.271 1.029 . . . . 0.0 110.63 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -54.09 -51.2 64.9 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.62 1.168 . . . . 0.0 110.279 175.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.52 -44.73 85.66 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.482 1.039 . . . . 0.0 111.803 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.3 -46.86 86.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.27 0.628 . . . . 0.0 111.354 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -61.34 -39.6 83.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 123.069 0.548 . . . . 0.0 110.093 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.73 -40.68 95.74 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.98 0.512 . . . . 0.0 110.901 177.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -64.01 -43.17 96.44 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.053 0.941 . . . . 0.0 110.982 176.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 79.5 mmm -56.09 -41.39 75.1 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.546 0.738 . . . . 0.0 110.2 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.15 53.5 0.23 Allowed Glycine 0 C--N 1.341 0.859 0 C-N-CA 123.994 0.806 . . . . 0.0 112.02 169.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -140.45 145.61 37.19 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.634 0.774 . . . . 0.0 109.347 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -68.76 100.84 1.22 Allowed 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.39 120.63 40.83 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.194 1.398 . . . . 0.0 109.938 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.2 p -142.32 137.23 30.42 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.653 0.781 . . . . 0.0 109.915 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.5 mt . . . . . 0 CA--C 1.531 0.224 0 C-N-CA 123.213 0.605 . . . . 0.0 110.988 -176.749 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 75.8 mt . . . . . 0 N--CA 1.475 0.815 0 CA-C-O 120.391 0.139 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.5 p -99.63 161.37 13.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.365 1.066 . . . . 0.0 110.308 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -128.47 173.15 10.48 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.799 1.639 . . . . 0.0 108.446 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -137.86 141.07 40.73 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.901 0.88 . . . . 0.0 108.998 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -130.71 135.8 48.16 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 124.376 1.07 . . . . 0.0 109.68 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.8 t -101.05 107.14 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 172.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.2 mt -99.85 121.52 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -75.79 125.7 29.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 57.8 mt -123.36 98.75 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -174.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -99.73 152.57 19.94 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.49 16.83 48.01 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.54 1.067 . . . . 0.0 112.323 -173.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 97.7 mtp -79.86 110.06 14.87 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.3 t -84.58 -37.93 20.56 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.286 0.635 . . . . 0.0 111.776 -173.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.2 p -158.48 179.72 8.87 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.119 0.568 . . . . 0.0 109.884 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -69.09 -13.33 62.37 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -173.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.7 p -59.83 -36.71 77.38 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.074 0.852 . . . . 0.0 110.12 170.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -59.56 -51.73 68.59 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.38 0.672 . . . . 0.0 109.608 174.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.2 t -52.17 -55.4 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.672 0.789 . . . . 0.0 110.234 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -57.61 -52.48 65.24 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.523 1.129 . . . . 0.0 111.647 -177.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.8 p -61.14 -48.95 79.24 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.694 0.398 . . . . 0.0 111.132 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 88.2 mt -59.19 -54.92 27.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.896 0.878 . . . . 0.0 110.233 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -62.21 -37.71 86.4 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.633 0.651 . . . . 0.0 111.194 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.41 -53.99 40.59 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.829 0.728 . . . . 0.0 111.294 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.22 -54.12 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.642 0.777 . . . . 0.0 110.431 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.4 mt -63.2 -39.86 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 122.891 0.476 . . . . 0.0 111.797 -172.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.6 p -55.96 -24.71 39.98 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -89.49 -9.28 50.61 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.076 0.951 . . . . 0.0 112.184 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -70.35 141.52 88.53 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 118.897 0.771 . . . . 0.0 109.693 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.4 132.55 29.65 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.859 2.373 . . . . 0.0 109.842 -177.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.21 -26.82 22.82 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 118.7 -1.055 . . . . 0.0 112.83 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.0 t -68.27 138.66 22.09 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 118.428 1.114 . . . . 0.0 110.149 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -119.95 -102.6 0.41 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.55 1.14 . . . . 0.0 108.89 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.8 p -80.2 150.77 30.01 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 118.362 0.528 . . . . 0.0 109.853 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.3 tt -150.12 139.48 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 123.329 0.652 . . . . 0.0 110.256 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -139.01 97.39 3.3 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.173 1.389 . . . . 0.0 108.602 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.8 t -99.17 142.27 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 124.476 1.11 . . . . 0.0 108.631 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.0 t -139.84 131.98 28.06 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.803 0.841 . . . . 0.0 110.711 -174.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.8 tp -70.42 -51.57 28.55 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.105 1.362 . . . . 0.0 109.112 169.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.39 -47.16 76.27 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.112 1.365 . . . . 0.0 111.889 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -89.3 -7.78 54.67 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.046 0.538 . . . . 0.0 111.236 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.0 m 54.11 56.55 6.89 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.391 1.477 . . . . 0.0 110.932 174.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -161.31 172.83 15.93 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.632 0.373 . . . . 0.0 111.883 -172.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -137.09 112.8 0.96 Allowed Glycine 0 C--N 1.339 0.727 0 C-N-CA 126.276 1.893 . . . . 0.0 109.29 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.5 m -99.43 103.74 15.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.6 t -116.29 123.95 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 124.285 1.034 . . . . 0.0 109.428 -170.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -89.95 132.36 35.37 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 169.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -150.33 163.24 38.82 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.046 0.539 . . . . 0.0 112.097 -171.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -97.39 115.43 65.74 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.728 1.211 . . . . 0.0 109.932 173.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -47.47 -38.41 27.49 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 125.28 3.987 . . . . 0.0 115.894 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 mp -69.92 -29.87 67.14 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.075 0.398 . . . . 0.0 111.368 -174.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.9 mt -99.72 -31.77 11.38 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.095 0.958 . . . . 0.0 111.932 -173.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.7 t -151.59 171.78 17.08 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.377 0.671 . . . . 0.0 109.822 175.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.3 p -141.79 164.2 35.91 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.229 1.012 . . . . 0.0 110.329 -174.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -53.34 -39.48 81.2 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.274 2.649 . . . . 0.0 112.081 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -67.86 -38.96 83.78 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.781 0.833 . . . . 0.0 111.698 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 m -61.83 -50.27 72.97 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.35 0.523 . . . . 0.0 109.863 175.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 61.7 mt -60.61 -53.0 62.73 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.509 1.123 . . . . 0.0 110.578 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -52.29 -46.58 65.97 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.151 1.38 . . . . 0.0 110.197 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.55 -53.41 38.87 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.788 1.185 . . . . 0.0 111.425 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.63 -44.51 90.03 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 117.672 0.736 . . . . 0.0 111.727 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.8 mt -60.77 -44.53 97.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 122.791 0.436 . . . . 0.0 110.015 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -61.35 -40.03 92.76 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.725 0.81 . . . . 0.0 110.824 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -63.82 -41.14 97.93 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.453 1.101 . . . . 0.0 110.999 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.9 mtp -59.49 -45.76 90.76 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.025 0.375 . . . . 0.0 110.267 173.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.48 63.04 0.14 Allowed Glycine 0 C--N 1.341 0.815 0 C-N-CA 123.552 0.596 . . . . 0.0 111.774 169.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -140.42 158.13 44.47 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 124.057 0.943 . . . . 0.0 109.379 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -76.9 93.44 3.76 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.37 121.13 40.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.76 1.224 . . . . 0.0 109.367 -175.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.6 t -148.45 148.26 30.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.891 0.876 . . . . 0.0 108.85 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.1 mt -71.23 152.62 43.15 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 63.0 p -59.88 -38.19 81.48 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.83 0.452 . . . . 0.0 110.621 170.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.0 t70 . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.044 -1.455 . . . . 0.0 108.211 175.782 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.7 tt . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.5 p -134.23 158.8 42.79 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.73 1.212 . . . . 0.0 110.056 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -141.12 173.24 11.67 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.353 1.461 . . . . 0.0 108.898 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -123.98 141.54 51.96 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.651 1.18 . . . . 0.0 108.559 172.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -130.77 130.77 44.15 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.116 0.966 . . . . 0.0 109.489 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 77.6 t -99.9 104.97 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.2 mt -99.98 126.01 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -75.05 129.71 38.07 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 174.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.9 mt -128.18 90.22 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -99.66 161.11 13.81 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.08 21.14 61.52 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 119.246 -0.752 . . . . 0.0 112.533 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 69.9 mtm -79.85 130.01 34.96 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 118.333 1.067 . . . . 0.0 108.389 170.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.4 m -84.43 -46.25 11.87 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.195 0.598 . . . . 0.0 110.573 -173.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 p -165.38 175.78 8.84 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.328 0.651 . . . . 0.0 110.268 -170.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -52.09 -35.71 48.63 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.907 1.283 . . . . 0.0 113.301 -173.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.1 p -50.28 -41.04 50.01 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.903 0.774 . . . . 0.0 111.64 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.2 m -64.28 -49.11 73.12 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.382 0.673 . . . . 0.0 110.58 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.8 t -51.93 -53.86 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.975 0.91 . . . . 0.0 110.346 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -62.49 -43.22 99.36 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.792 0.837 . . . . 0.0 111.547 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.4 t -59.56 -53.4 58.5 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.012 0.525 . . . . 0.0 110.663 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.8 mt -56.39 -52.44 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.342 1.057 . . . . 0.0 109.576 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -52.82 -55.1 25.5 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.449 1.1 . . . . 0.0 110.531 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.09 -53.66 42.9 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.385 0.993 . . . . 0.0 111.9 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.61 -50.55 78.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.423 0.689 . . . . 0.0 110.975 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 76.7 mt -68.67 -41.07 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.648 -175.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.3 p -55.68 -25.15 38.14 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -89.25 -8.51 53.33 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.134 0.974 . . . . 0.0 112.169 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -70.5 140.75 87.42 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 119.116 0.871 . . . . 0.0 110.532 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.1 128.91 20.54 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.674 2.249 . . . . 0.0 109.181 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.82 -39.27 2.97 Favored Glycine 0 C--N 1.336 0.554 0 CA-C-O 119.073 -0.848 . . . . 0.0 111.557 -175.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.0 t -70.37 137.83 23.18 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 CA-C-N 117.881 0.84 . . . . 0.0 109.419 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -114.24 -98.3 0.44 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.313 1.045 . . . . 0.0 108.186 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 86.7 p -90.27 155.43 18.99 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.953 0.501 . . . . 0.0 110.128 176.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.59 143.05 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.186 0.995 . . . . 0.0 109.859 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.36 105.91 8.2 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.686 1.195 . . . . 0.0 108.653 173.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.6 t -98.06 136.42 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 172.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -139.05 126.94 22.2 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.651 0.78 . . . . 0.0 110.451 -176.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.3 tp -69.68 -45.73 67.66 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.455 1.102 . . . . 0.0 109.857 171.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.73 -47.15 67.56 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.458 1.103 . . . . 0.0 111.497 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -89.38 -12.37 40.56 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.293 0.637 . . . . 0.0 111.797 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.3 m 53.44 58.08 5.55 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 125.317 1.447 . . . . 0.0 110.441 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.9 p-10 -156.39 173.36 17.0 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.991 0.516 . . . . 0.0 111.953 -174.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.45 110.97 0.83 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 126.719 2.104 . . . . 0.0 108.015 174.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.8 m -99.24 101.45 12.77 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.8 t -110.96 125.37 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 124.664 1.186 . . . . 0.0 109.424 -169.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -91.26 127.82 36.85 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 169.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -146.77 167.17 24.51 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.442 0.697 . . . . 0.0 111.86 -169.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -105.64 111.14 64.78 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.155 1.382 . . . . 0.0 109.368 174.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -45.31 -37.27 13.81 Favored 'Trans proline' 0 C--N 1.348 0.552 1 C-N-CA 125.44 4.093 . . . . 0.0 116.248 177.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -70.21 -30.61 67.75 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.173 0.442 . . . . 0.0 111.33 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.3 mt -99.96 -32.38 11.0 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.212 1.005 . . . . 0.0 112.042 -172.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.7 t -149.9 170.59 18.46 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.785 0.834 . . . . 0.0 109.428 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.6 p -137.85 162.25 55.41 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 123.967 0.907 . . . . 0.0 110.643 -176.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -53.05 -39.12 80.73 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.321 2.681 . . . . 0.0 112.043 172.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -68.32 -40.04 81.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.779 0.832 . . . . 0.0 111.482 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.3 m -60.37 -50.35 73.94 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.926 0.49 . . . . 0.0 109.941 175.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.1 mt -59.51 -50.12 75.13 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.234 1.014 . . . . 0.0 110.511 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -52.5 -48.71 65.81 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.843 1.257 . . . . 0.0 110.627 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.75 -46.47 89.62 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.319 0.962 . . . . 0.0 111.785 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.74 -44.41 96.28 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.117 0.567 . . . . 0.0 111.467 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.44 -45.26 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.082 0.553 . . . . 0.0 110.075 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -59.42 -42.13 91.14 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.731 0.813 . . . . 0.0 110.696 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -62.44 -44.52 96.23 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.742 0.817 . . . . 0.0 111.217 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.9 mtm -59.91 -36.47 77.04 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.657 0.383 . . . . 0.0 110.898 174.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.0 59.91 0.34 Allowed Glycine 0 C--N 1.341 0.811 0 C-N-CA 123.758 0.694 . . . . 0.0 111.996 169.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -140.38 158.64 43.71 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.898 0.879 . . . . 0.0 109.379 173.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -75.77 94.32 3.27 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.5 112.08 24.34 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.967 1.307 . . . . 0.0 110.084 -172.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.9 p -142.56 133.05 25.07 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.575 0.75 . . . . 0.0 109.757 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.5 mt -64.93 150.24 48.23 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.455 0.702 . . . . 0.0 110.85 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.9 p -68.05 -55.13 13.67 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.405 0.682 . . . . 0.0 110.496 172.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 . . . . . 0 C--O 1.25 1.13 0 C-N-CA 125.543 1.537 . . . . 0.0 110.563 -177.158 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 65.2 mt . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 111.471 0.174 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.9 p -140.41 126.66 19.86 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.601 1.161 . . . . 0.0 108.902 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -142.05 171.66 13.75 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.589 1.155 . . . . 0.0 109.238 173.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -139.99 141.69 36.34 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.327 1.051 . . . . 0.0 108.752 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -131.23 138.27 49.27 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.469 1.107 . . . . 0.0 109.81 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.3 t -106.11 100.54 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 174.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.0 mt -99.76 115.21 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -67.01 124.98 24.56 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.4 mt -113.72 100.8 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 106.662 -1.606 . . . . 0.0 106.662 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -99.67 146.37 26.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.698 0.799 . . . . 0.0 109.465 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.84 27.69 31.07 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.226 0.917 . . . . 0.0 112.839 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 73.2 mtm -80.45 135.42 36.14 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.23 1.015 . . . . 0.0 108.93 170.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.7 m -84.22 -48.0 10.23 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.004 0.922 . . . . 0.0 110.201 -174.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 p -161.06 -178.4 6.74 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.48 0.712 . . . . 0.0 109.618 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -61.23 -23.26 65.51 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.614 1.166 . . . . 0.0 113.321 -176.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.3 m -57.61 -37.99 74.19 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.598 0.635 . . . . 0.0 111.266 174.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.4 m -63.85 -51.81 62.96 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -51.85 -49.49 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.521 1.128 . . . . 0.0 110.552 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -57.95 -47.72 82.09 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.431 1.092 . . . . 0.0 110.998 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.7 t -62.22 -52.55 63.33 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.475 0.71 . . . . 0.0 111.188 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.9 mt -54.7 -56.24 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.962 1.305 . . . . 0.0 109.719 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -59.18 -46.77 87.55 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.445 0.698 . . . . 0.0 110.562 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.82 -48.6 50.53 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.932 1.254 . . . . 0.0 112.162 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.18 -62.56 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 117.507 0.653 . . . . 0.0 110.218 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.2 mt -58.82 -39.12 76.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.978 0.911 . . . . 0.0 112.108 -169.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 77.9 p -49.99 -33.84 19.17 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.846 0.859 . . . . 0.0 113.183 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -89.66 -14.89 33.86 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.605 0.762 . . . . 0.0 112.295 -175.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -71.14 143.66 88.81 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 118.689 0.677 . . . . 0.0 110.662 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -63.06 137.39 61.62 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.241 2.627 . . . . 0.0 110.663 -174.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.51 -35.66 4.57 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 119.128 -0.818 . . . . 0.0 111.793 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.0 t -68.45 128.57 32.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 CA-C-N 118.017 0.909 . . . . 0.0 109.847 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -99.68 -103.47 0.23 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.917 1.287 . . . . 0.0 107.854 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.9 p -87.2 154.12 20.97 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.6 0.76 . . . . 0.0 109.519 173.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.7 tt -150.41 135.24 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 123.172 0.589 . . . . 0.0 109.974 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 -134.68 100.82 4.74 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.916 1.287 . . . . 0.0 108.683 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.8 t -98.76 139.12 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.235 1.014 . . . . 0.0 108.637 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.4 t -135.6 132.18 36.78 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 124.445 1.098 . . . . 0.0 110.646 -173.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.7 tp -72.48 -49.45 33.09 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.318 1.047 . . . . 0.0 109.357 173.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.94 -44.82 78.77 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.08 1.352 . . . . 0.0 111.762 -177.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -89.23 -9.68 49.82 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.234 0.613 . . . . 0.0 111.201 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.1 m 54.44 52.42 12.44 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.61 1.564 . . . . 0.0 111.05 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -157.24 170.41 22.53 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.972 0.415 . . . . 0.0 111.838 -173.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.08 113.67 1.69 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 126.561 2.029 . . . . 0.0 108.658 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.3 m -98.77 93.19 5.94 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.8 t -105.63 120.57 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 124.398 1.079 . . . . 0.0 109.009 -171.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -89.78 133.81 34.51 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 169.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -150.25 166.79 28.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.838 0.455 . . . . 0.0 112.145 -169.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -102.78 113.2 66.04 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 125.255 1.422 . . . . 0.0 108.573 172.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -44.35 -36.1 9.05 Favored 'Trans proline' 0 C--N 1.347 0.467 1 C-N-CA 125.49 4.127 . . . . 0.0 115.077 173.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.6 mt -65.36 -36.6 84.49 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.237 0.615 . . . . 0.0 111.768 -177.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.1 mp -99.65 -34.26 10.28 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.956 0.902 . . . . 0.0 111.59 -171.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.3 t -147.82 177.32 9.42 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.457 0.703 . . . . 0.0 109.952 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.9 p -148.39 163.98 23.94 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 124.085 0.954 . . . . 0.0 110.264 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.4 -40.79 77.07 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.398 2.732 . . . . 0.0 112.078 174.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -67.91 -39.41 83.57 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.6 0.76 . . . . 0.0 111.369 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.7 m -61.5 -49.95 74.68 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.898 0.479 . . . . 0.0 110.068 175.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.0 mt -60.2 -48.79 80.22 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.172 0.989 . . . . 0.0 110.633 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -53.27 -50.09 65.56 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.69 1.196 . . . . 0.0 110.23 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.9 -43.21 92.66 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.523 1.059 . . . . 0.0 112.273 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.92 -42.07 98.67 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.344 0.572 . . . . 0.0 111.12 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.4 mt -66.75 -40.4 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.105 0.562 . . . . 0.0 110.389 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -59.01 -43.36 91.53 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.775 0.43 . . . . 0.0 110.78 172.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.39 -44.48 97.07 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.205 0.602 . . . . 0.0 111.03 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.2 mtm -62.29 -33.78 75.3 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.852 0.461 . . . . 0.0 111.26 174.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.3 56.59 0.42 Allowed Glycine 0 C--N 1.341 0.842 0 C-N-CA 123.814 0.721 . . . . 0.0 112.53 169.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -140.41 150.95 44.51 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.665 0.786 . . . . 0.0 109.424 172.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -75.45 98.63 3.96 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.62 128.24 45.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.68 1.192 . . . . 0.0 109.732 -175.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.3 t -150.08 169.34 21.48 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.145 0.978 . . . . 0.0 108.552 175.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -72.68 169.13 17.27 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.727 0.411 . . . . 0.0 110.183 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.2 p -49.54 -49.67 45.22 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.632 1.173 . . . . 0.0 111.456 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 117.197 -1.383 . . . . 0.0 108.988 171.799 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 54.1 tp . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.6 p -121.01 114.34 21.37 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.77 1.228 . . . . 0.0 109.617 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -126.33 149.9 48.87 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 169.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -119.74 149.04 42.67 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.741 0.816 . . . . 0.0 110.144 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.4 t -145.63 146.93 31.52 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.097 0.959 . . . . 0.0 109.102 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.9 t -113.11 125.61 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 172.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.5 mt -120.33 131.64 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -80.75 122.82 27.62 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 173.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.65 95.79 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -99.29 146.71 25.94 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.442 0.697 . . . . 0.0 109.438 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.1 42.26 7.17 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.12 0.867 . . . . 0.0 112.235 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.1 mtt -79.49 143.47 34.88 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 169.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 64.1 p -84.51 -42.37 15.59 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.597 0.759 . . . . 0.0 110.462 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.4 p -163.63 -179.71 6.6 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.126 0.97 . . . . 0.0 109.24 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -63.04 -24.86 68.11 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.163 0.985 . . . . 0.0 113.164 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m -53.13 -35.03 59.24 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.747 0.703 . . . . 0.0 111.574 174.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.5 m -58.34 -49.0 78.75 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.014 0.526 . . . . 0.0 110.834 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.2 t -50.81 -51.46 20.18 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 C-N-CA 123.773 0.829 . . . . 0.0 109.779 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -57.73 -53.7 55.26 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.928 0.891 . . . . 0.0 110.398 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.5 m -54.98 -46.93 75.15 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.244 0.618 . . . . 0.0 111.801 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 57.1 mt -60.65 -59.22 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 124.078 0.951 . . . . 0.0 109.8 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -60.72 -35.71 77.02 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 118.233 0.469 . . . . 0.0 111.302 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.62 -60.31 9.21 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 124.363 0.982 . . . . 0.0 110.676 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.55 -58.02 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 123.002 0.521 . . . . 0.0 110.139 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.9 mt -60.04 -41.33 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.29 0.636 . . . . 0.0 111.892 -169.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.4 p -54.38 -30.83 53.23 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.727 0.694 . . . . 0.0 112.833 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -89.42 -11.32 43.48 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.529 0.731 . . . . 0.0 112.559 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -68.86 141.31 92.22 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 119.253 0.933 . . . . 0.0 109.752 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.08 131.28 26.48 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.991 2.461 . . . . 0.0 110.083 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.8 -33.24 6.72 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-O 118.711 -1.049 . . . . 0.0 112.181 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.3 t -67.3 139.06 21.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-N 118.256 1.028 . . . . 0.0 110.478 -176.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -121.12 -105.65 0.38 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.317 1.447 . . . . 0.0 108.144 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.0 p -80.03 144.85 32.85 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.652 0.66 . . . . 0.0 110.018 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.29 144.09 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.543 0.737 . . . . 0.0 110.824 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -140.28 131.96 27.28 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.123 1.369 . . . . 0.0 107.728 169.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.9 t -123.97 145.8 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.998 1.319 . . . . 0.0 108.229 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.7 t -139.16 132.82 30.55 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 124.138 0.975 . . . . 0.0 110.776 -173.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.9 tp -74.35 -49.98 20.58 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.72 1.208 . . . . 0.0 109.301 171.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.65 -46.15 67.03 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.732 1.213 . . . . 0.0 111.536 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -89.58 -12.13 40.69 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.427 0.691 . . . . 0.0 111.611 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.6 m 53.13 52.06 14.46 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 125.181 1.393 . . . . 0.0 110.581 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -154.47 172.57 17.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.961 0.504 . . . . 0.0 111.687 -175.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -142.76 116.25 1.01 Allowed Glycine 0 C--N 1.338 0.648 0 C-N-CA 125.644 1.592 . . . . 0.0 109.392 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.5 m -99.55 115.56 29.65 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.4 t -128.23 129.07 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 124.007 0.923 . . . . 0.0 109.755 -170.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -97.87 133.65 42.08 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 168.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -150.47 167.06 28.27 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.332 0.653 . . . . 0.0 111.482 -171.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -101.53 113.88 65.76 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.636 1.174 . . . . 0.0 109.431 173.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -43.37 -39.74 9.3 Favored 'Trans proline' 0 C--N 1.348 0.526 1 C-N-CA 125.603 4.202 . . . . 0.0 115.51 176.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.1 mt -63.98 -34.31 77.7 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.377 0.671 . . . . 0.0 111.81 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.3 mt -102.8 -29.27 11.57 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.912 0.885 . . . . 0.0 112.269 -172.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.8 t -152.55 165.92 33.66 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.415 0.686 . . . . 0.0 109.491 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.0 p -138.75 167.51 19.17 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.592 1.157 . . . . 0.0 110.041 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.35 -38.35 89.0 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.436 2.757 . . . . 0.0 112.181 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -67.08 -38.85 86.47 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.912 0.885 . . . . 0.0 111.508 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.4 m -62.58 -48.75 78.09 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.862 0.465 . . . . 0.0 109.933 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.4 mt -59.0 -53.23 60.8 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.373 1.069 . . . . 0.0 110.302 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 66.0 ttp85 -53.18 -46.02 68.79 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.987 1.315 . . . . 0.0 110.843 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.77 -49.09 77.28 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.489 1.042 . . . . 0.0 111.809 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.07 -46.78 89.28 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 117.385 0.593 . . . . 0.0 111.243 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.0 mt -57.34 -44.16 83.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.653 0.781 . . . . 0.0 110.019 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -61.47 -42.79 99.32 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.812 0.445 . . . . 0.0 110.605 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.14 -39.3 92.13 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.157 0.983 . . . . 0.0 111.926 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 28.8 mtt -55.79 -48.13 75.9 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 118.348 0.522 . . . . 0.0 110.128 173.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.45 58.99 0.13 Allowed Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 174.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -140.08 152.49 46.21 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.384 1.074 . . . . 0.0 108.707 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -72.76 99.98 2.75 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.8 122.29 42.55 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.693 1.197 . . . . 0.0 109.671 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.6 t -150.08 144.19 25.59 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 47.0 mt -66.75 134.56 52.44 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.0 t -90.31 45.69 1.29 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.816 0.846 . . . . 0.0 109.379 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 p30 . . . . . 0 C--O 1.253 1.247 0 C-N-CA 125.428 1.491 . . . . 0.0 108.866 -172.585 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 63.3 mt . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 111.241 0.089 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 43.1 p -137.22 101.57 4.57 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.487 1.115 . . . . 0.0 109.662 -174.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -125.63 169.22 12.71 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.913 1.285 . . . . 0.0 109.106 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -131.76 148.21 52.55 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.553 1.141 . . . . 0.0 109.608 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -146.22 148.69 32.76 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.681 1.192 . . . . 0.0 108.972 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.3 t -120.85 128.08 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.6 mt -122.28 126.84 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -67.8 133.05 48.55 Favored 'General case' 0 CA--C 1.526 0.051 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 172.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.5 mt -131.27 88.78 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -99.8 164.19 12.14 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.81 16.7 69.62 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 119.244 -0.753 . . . . 0.0 112.445 -174.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.1 mtm -79.81 124.9 29.04 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.384 1.092 . . . . 0.0 108.389 170.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.1 p -84.53 -40.9 17.06 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.763 0.825 . . . . 0.0 110.934 -175.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.4 p -158.85 -178.39 7.21 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.893 0.377 . . . . 0.0 110.717 -174.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -57.49 -28.35 63.35 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.623 1.569 . . . . 0.0 113.65 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 m -54.82 -41.28 70.46 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.233 0.613 . . . . 0.0 111.142 175.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.4 m -62.51 -51.47 67.31 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 122.864 0.465 . . . . 0.0 110.016 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.4 t -50.51 -56.35 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.96 0.904 . . . . 0.0 110.14 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -59.77 -50.66 72.94 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.463 1.105 . . . . 0.0 111.488 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.2 p -60.99 -50.39 73.6 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.906 0.482 . . . . 0.0 111.47 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.6 mt -57.75 -52.65 55.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.136 0 C-N-CA 123.353 0.661 . . . . 0.0 109.474 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -54.04 -49.62 68.53 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.289 0.636 . . . . 0.0 110.677 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.15 -54.9 33.87 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.3 0.953 . . . . 0.0 112.309 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.22 -55.47 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.392 0.677 . . . . 0.0 110.613 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.2 mm -64.34 -39.03 84.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 123.55 0.74 . . . . 0.0 111.47 -173.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.7 p -55.02 -30.59 59.87 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.972 0.806 . . . . 0.0 112.69 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -89.41 -3.27 58.49 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.99 0.916 . . . . 0.0 112.267 -175.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -73.12 125.5 90.93 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 119.03 0.832 . . . . 0.0 109.006 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -48.53 118.1 3.1 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.746 2.964 . . . . 0.0 112.128 176.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.37 -36.63 3.54 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 124.042 0.829 . . . . 0.0 111.849 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.7 t -72.66 130.55 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-N 117.87 0.835 . . . . 0.0 109.433 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -90.03 -105.09 0.09 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.0 p -90.62 159.02 16.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.055 1.342 . . . . 0.0 109.852 171.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.8 tt -150.42 134.04 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 123.921 0.888 . . . . 0.0 109.245 173.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -118.28 106.69 13.04 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.866 1.266 . . . . 0.0 108.975 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.2 t -95.35 145.25 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.097 0.959 . . . . 0.0 108.419 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -144.59 128.01 16.92 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.624 0.77 . . . . 0.0 110.461 -177.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.4 tp -70.92 -46.33 62.68 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.558 1.143 . . . . 0.0 110.011 172.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.37 -45.36 65.75 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.397 1.079 . . . . 0.0 111.565 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -89.59 -17.01 29.31 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.557 0.743 . . . . 0.0 111.5 178.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m 54.94 57.73 5.38 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.254 1.422 . . . . 0.0 110.117 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -156.21 173.19 17.2 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.274 0.63 . . . . 0.0 111.627 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.08 116.22 1.7 Allowed Glycine 0 C--N 1.338 0.65 0 C-N-CA 126.438 1.971 . . . . 0.0 108.271 174.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.7 m -99.38 102.52 14.14 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.8 t -108.56 131.55 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 124.428 1.091 . . . . 0.0 110.073 -169.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -101.25 130.6 47.41 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 168.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -150.81 174.79 12.67 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -169.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -115.73 110.36 44.49 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.747 1.619 . . . . 0.0 109.384 174.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -41.58 -38.94 4.42 Favored 'Trans proline' 0 C--N 1.349 0.571 1 C-N-CA 125.999 4.466 . . . . 0.0 115.19 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.1 mt -62.44 -30.71 71.44 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.442 0.697 . . . . 0.0 112.174 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.6 mt -109.52 -36.51 5.95 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.437 1.095 . . . . 0.0 112.018 -171.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.2 t -144.58 171.49 14.3 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.914 0.886 . . . . 0.0 109.303 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.6 p -150.3 161.28 31.23 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 123.215 0.606 . . . . 0.0 110.506 -175.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -49.09 -48.74 17.3 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.947 3.098 . . . . 0.0 113.99 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -66.12 -31.94 73.09 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.257 0.623 . . . . 0.0 112.443 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.0 m -68.11 -48.16 66.23 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 44.4 mt -60.5 -48.46 81.66 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.369 1.068 . . . . 0.0 110.174 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -51.5 -48.99 62.72 Favored 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 124.611 1.165 . . . . 0.0 110.224 172.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.79 -47.1 80.88 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.339 0.971 . . . . 0.0 112.15 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.7 84.16 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.411 0.684 . . . . 0.0 111.212 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.7 mt -61.16 -43.41 96.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.3 0.64 . . . . 0.0 110.048 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -60.82 -41.18 95.21 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.594 0.758 . . . . 0.0 110.719 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.86 -40.97 97.22 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.679 0.791 . . . . 0.0 111.185 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.3 mtp -59.52 -40.45 87.16 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.077 0.399 . . . . 0.0 110.635 173.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.12 62.0 0.22 Allowed Glycine 0 C--N 1.342 0.879 0 C-N-CA 123.712 0.672 . . . . 0.0 111.917 169.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -140.5 160.79 39.22 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.814 0.846 . . . . 0.0 110.02 175.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -77.1 89.62 3.61 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.44 115.15 28.61 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.48 1.112 . . . . 0.0 109.734 -173.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 81.2 p -141.17 148.62 40.3 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 124.17 0.988 . . . . 0.0 108.955 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 52.1 mt -74.46 144.45 44.22 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.086 0.403 . . . . 0.0 110.748 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 p -116.73 -40.7 3.14 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.873 1.269 . . . . 0.0 109.993 169.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.3 t70 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 116.606 -1.664 . . . . 0.0 108.456 175.957 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 56.7 tp . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 119.889 -0.101 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.0 p -140.84 143.88 35.03 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.458 1.103 . . . . 0.0 109.898 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -146.88 163.53 35.81 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.967 1.307 . . . . 0.0 108.983 169.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -125.32 143.56 50.91 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.344 1.458 . . . . 0.0 108.517 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.2 t -150.12 165.68 32.09 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 122.931 0.493 . . . . 0.0 111.072 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.1 t -130.59 134.81 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 170.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.2 mm -113.63 127.34 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 172.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -85.5 122.4 29.58 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 172.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.1 mt -121.98 97.07 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 125.336 1.454 . . . . 0.0 107.691 -169.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -99.79 154.47 18.3 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.959 0.409 . . . . 0.0 110.017 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.55 11.25 51.71 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.734 1.159 . . . . 0.0 112.152 -171.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 98.2 mtp -79.89 116.33 19.98 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.155 0.978 . . . . 0.0 108.597 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.0 p -84.71 -47.85 10.04 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.701 0.801 . . . . 0.0 111.529 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.8 p -153.98 -179.67 8.08 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.09 0.556 . . . . 0.0 110.512 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -58.28 -25.35 61.69 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.343 1.457 . . . . 0.0 113.523 -177.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 t -55.34 -40.63 71.45 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.102 0.561 . . . . 0.0 110.626 174.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.0 m -63.49 -46.97 83.71 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 122.998 0.519 . . . . 0.0 110.448 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.5 t -52.58 -53.66 19.17 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 123.686 0.794 . . . . 0.0 109.567 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -59.16 -48.06 83.01 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.722 0.809 . . . . 0.0 111.379 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.5 m -60.99 -53.73 53.69 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.396 0.678 . . . . 0.0 111.219 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.2 mt -57.82 -56.27 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 123.885 0.874 . . . . 0.0 109.26 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -55.86 -48.67 75.12 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.17 0.588 . . . . 0.0 110.905 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.94 -55.19 30.4 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.232 0.92 . . . . 0.0 112.034 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.75 -55.98 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 117.371 0.585 . . . . 0.0 110.771 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.2 mm -63.0 -37.32 79.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.504 0.721 . . . . 0.0 111.758 -173.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.1 p -54.29 -34.63 61.31 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.975 0.807 . . . . 0.0 112.414 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -89.53 0.56 56.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.624 0.77 . . . . 0.0 112.709 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -72.55 143.22 84.84 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 119.151 0.887 . . . . 0.0 109.186 175.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.47 128.43 21.29 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.943 2.429 . . . . 0.0 110.252 -175.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.38 -35.62 4.94 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-O 118.789 -1.006 . . . . 0.0 112.292 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.9 t -66.65 123.5 19.81 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 CA-C-N 118.219 1.009 . . . . 0.0 109.623 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -96.92 -96.88 0.2 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.1 p -90.08 147.12 23.83 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.237 0.615 . . . . 0.0 109.963 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.3 tt -149.89 142.71 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.835 1.254 . . . . 0.0 108.924 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.31 130.6 25.17 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.859 0.864 . . . . 0.0 109.214 169.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.54 147.75 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 125.399 1.48 . . . . 0.0 108.823 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.2 t -139.32 130.22 26.26 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.012 0.925 . . . . 0.0 110.769 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.0 tp -72.39 -49.91 30.39 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.917 1.287 . . . . 0.0 109.271 170.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.62 67.12 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.65 1.18 . . . . 0.0 111.639 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -89.55 -8.84 51.83 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.272 0.629 . . . . 0.0 111.648 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.9 m 52.24 56.79 7.22 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 125.297 1.439 . . . . 0.0 110.681 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.9 p30 -161.97 172.04 16.64 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.838 0.455 . . . . 0.0 111.513 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.22 119.27 1.97 Allowed Glycine 0 C--N 1.338 0.658 0 C-N-CA 125.577 1.56 . . . . 0.0 109.287 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.5 m -99.44 121.88 41.76 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.2 t -129.48 137.08 57.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 124.366 1.066 . . . . 0.0 110.126 -169.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -112.97 129.87 56.33 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -150.28 169.99 20.07 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -168.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -97.38 114.72 65.24 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.64 1.576 . . . . 0.0 109.548 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -44.85 -41.36 15.18 Favored 'Trans proline' 0 C--N 1.349 0.555 1 C-N-CA 125.452 4.102 . . . . 0.0 114.399 174.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.0 mt -61.53 -32.9 72.97 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.944 0.898 . . . . 0.0 111.903 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.1 mt -105.34 -28.8 10.67 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.069 0.948 . . . . 0.0 112.215 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.7 t -153.16 163.23 40.24 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.837 0.744 . . . . 0.0 110.374 178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.9 p -136.01 165.85 32.62 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 125.723 1.609 . . . . 0.0 109.504 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -53.12 -37.61 79.81 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.448 2.765 . . . . 0.0 112.573 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -67.21 -41.35 85.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.261 1.024 . . . . 0.0 110.46 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.6 m -64.03 -48.05 77.82 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.999 0.52 . . . . 0.0 110.048 177.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.4 mt -59.39 -49.66 76.96 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.937 0.895 . . . . 0.0 110.294 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -50.96 -51.03 56.58 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.317 1.047 . . . . 0.0 110.382 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.13 -46.6 84.98 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.323 0.963 . . . . 0.0 112.248 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.73 92.77 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.49 0.716 . . . . 0.0 111.125 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.5 mt -64.55 -36.41 77.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 123.215 0.606 . . . . 0.0 110.25 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -63.57 -41.46 98.4 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.942 -0.474 . . . . 0.0 110.357 175.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.14 -40.8 98.62 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.74 0.816 . . . . 0.0 111.285 175.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.4 mmm -56.17 -40.25 73.6 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.904 0.482 . . . . 0.0 110.665 173.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.72 54.31 0.26 Allowed Glycine 0 C--N 1.34 0.773 0 C-N-CA 123.973 0.796 . . . . 0.0 111.406 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -140.45 144.3 36.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.123 0.969 . . . . 0.0 108.791 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -70.46 99.23 1.57 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.68 129.05 45.78 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.057 1.343 . . . . 0.0 109.123 -174.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.5 p -137.52 143.87 41.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.31 1.044 . . . . 0.0 109.063 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 61.8 mt -67.53 145.5 54.86 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.813 0.445 . . . . 0.0 110.22 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.5 t -141.2 47.89 1.69 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.118 0.967 . . . . 0.0 109.089 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.237 -1.363 . . . . 0.0 108.522 -175.146 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 110.6 -0.148 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.3 p -99.46 164.06 12.25 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.661 1.185 . . . . 0.0 109.872 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -137.73 170.88 15.3 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 124.734 1.214 . . . . 0.0 109.816 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -124.15 153.45 41.5 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.497 1.119 . . . . 0.0 109.538 172.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.1 t -147.07 138.47 24.08 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.135 0.974 . . . . 0.0 109.756 -176.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.92 113.06 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.6 mt -113.28 126.2 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -71.15 136.32 48.07 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 177.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.6 mt -129.96 91.15 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -99.42 153.84 18.69 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.452 0.701 . . . . 0.0 109.553 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.1 45.0 12.18 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.853 0.74 . . . . 0.0 112.062 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 54.7 mtt -79.77 153.45 29.18 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 169.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.5 m -84.53 -52.37 6.18 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.756 0.822 . . . . 0.0 109.871 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.2 p -163.8 -178.29 5.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.732 1.213 . . . . 0.0 108.7 -175.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -60.57 -25.51 66.24 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.127 0.971 . . . . 0.0 113.25 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.6 m -54.69 -36.47 64.7 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.713 0.688 . . . . 0.0 111.468 175.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.2 m -61.4 -41.34 96.98 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 122.885 0.474 . . . . 0.0 111.186 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.8 t -53.37 -54.39 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 123.507 0.723 . . . . 0.0 109.322 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -59.77 -45.65 91.6 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.611 0.764 . . . . 0.0 111.361 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.4 m -59.14 -52.22 66.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.261 0.624 . . . . 0.0 111.443 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.6 mt -56.92 -50.98 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.194 0.998 . . . . 0.0 109.573 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -54.43 -56.07 22.45 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.413 0.685 . . . . 0.0 110.751 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.34 -56.35 19.98 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.124 0.868 . . . . 0.0 112.086 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.8 t -59.92 -57.23 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.817 0.847 . . . . 0.0 110.766 -177.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.2 mt -70.6 -32.82 50.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 118.851 -0.595 . . . . 0.0 112.081 -169.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 87.3 p -52.96 -30.75 36.65 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -89.12 -5.84 57.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.557 0.743 . . . . 0.0 112.483 -175.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -75.08 147.78 83.72 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 118.885 0.766 . . . . 0.0 110.229 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -45.29 127.71 9.32 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 124.309 3.34 . . . . 0.0 113.254 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.51 -31.1 5.64 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-O 118.653 -1.082 . . . . 0.0 113.596 176.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.73 136.56 25.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 118.386 1.093 . . . . 0.0 110.098 -175.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -115.67 -100.97 0.43 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.639 1.176 . . . . 0.0 108.224 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 86.5 p -81.53 151.56 27.69 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.709 0.686 . . . . 0.0 110.128 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.24 131.46 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 123.788 0.835 . . . . 0.0 108.939 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -130.69 102.15 5.99 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.179 1.392 . . . . 0.0 108.057 -174.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.1 t -100.73 149.88 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.436 1.094 . . . . 0.0 109.021 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.6 t -140.1 129.23 23.67 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.101 0.96 . . . . 0.0 109.753 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.7 tp -70.47 -49.49 48.05 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.458 1.103 . . . . 0.0 109.301 170.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.59 -47.65 66.76 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.712 1.205 . . . . 0.0 111.776 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -89.42 -11.9 41.82 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.199 0.6 . . . . 0.0 111.612 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.7 m 54.04 56.53 6.94 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 125.011 1.325 . . . . 0.0 110.602 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -157.59 170.49 22.27 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.498 0.719 . . . . 0.0 111.279 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -137.36 116.26 1.34 Allowed Glycine 0 C--N 1.337 0.603 0 C-N-CA 126.196 1.855 . . . . 0.0 109.389 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.3 m -99.48 105.92 17.89 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 t -109.25 137.24 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 124.548 1.139 . . . . 0.0 109.214 -173.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -105.56 130.01 53.7 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 169.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -150.42 164.96 34.58 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -168.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -98.08 113.97 64.54 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.158 1.383 . . . . 0.0 109.682 170.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -44.82 -37.43 11.88 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 125.247 3.965 . . . . 0.0 114.873 173.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.1 mt -63.82 -34.18 77.35 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.24 0.616 . . . . 0.0 111.97 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.4 mt -105.64 -27.61 11.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.98 0.912 . . . . 0.0 112.478 -171.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.0 t -151.87 176.27 11.62 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.749 0.704 . . . . 0.0 109.96 176.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.6 p -148.98 163.48 25.31 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.477 1.111 . . . . 0.0 109.717 -175.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -53.16 -36.51 77.43 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.193 2.595 . . . . 0.0 112.678 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -68.03 -44.57 76.17 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.318 1.047 . . . . 0.0 110.355 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.6 m -61.55 -46.93 87.82 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.224 0.609 . . . . 0.0 110.287 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.8 mt -62.31 -45.85 91.37 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.285 1.034 . . . . 0.0 110.764 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -53.64 -46.85 70.68 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.975 0.91 . . . . 0.0 109.968 172.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.56 -45.4 84.59 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.276 0.941 . . . . 0.0 112.268 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.39 -48.54 77.43 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.686 0.743 . . . . 0.0 111.168 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.2 mt -59.62 -45.11 94.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.802 0.841 . . . . 0.0 109.834 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -57.34 -47.85 80.51 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.874 0.87 . . . . 0.0 110.22 176.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -59.48 -41.66 90.3 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.848 0.859 . . . . 0.0 111.525 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.7 mtp -59.3 -41.55 89.26 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.051 0.387 . . . . 0.0 110.731 174.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.29 60.0 0.19 Allowed Glycine 0 C--N 1.34 0.787 0 C-N-CA 123.688 0.661 . . . . 0.0 111.718 169.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -140.35 155.93 46.6 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.018 0.927 . . . . 0.0 109.236 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.17 96.49 3.3 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.75 124.41 44.99 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.901 1.28 . . . . 0.0 109.989 -174.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.0 t -150.29 156.52 41.69 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.097 0.559 . . . . 0.0 109.948 175.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.7 mt -84.24 153.39 23.62 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.851 0.86 . . . . 0.0 113.152 -169.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.5 m -142.83 60.49 1.43 Allowed 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 168.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 p30 . . . . . 0 C--O 1.25 1.103 0 CA-C-O 116.95 -1.5 . . . . 0.0 109.073 -170.298 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 86.5 mt . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.1 p -140.25 120.99 14.37 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.197 0.999 . . . . 0.0 109.265 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -140.14 169.85 16.92 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.821 1.248 . . . . 0.0 109.34 175.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -140.3 143.64 35.97 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.462 1.105 . . . . 0.0 108.746 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 t -134.29 141.56 46.99 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.375 1.07 . . . . 0.0 109.824 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.0 t -107.66 106.97 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 175.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.3 mt -102.22 123.66 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -177.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -69.66 128.52 36.76 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 169.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 66.7 mt -127.47 86.58 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -99.95 148.73 24.17 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.067 0.547 . . . . 0.0 110.221 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.21 26.19 16.85 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.672 1.13 . . . . 0.0 112.871 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 68.6 mtm -79.62 136.27 36.79 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.242 1.021 . . . . 0.0 109.366 174.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.3 m -84.48 -46.93 11.14 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.267 1.027 . . . . 0.0 110.748 -173.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.5 p -156.1 177.25 11.64 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.643 0.777 . . . . 0.0 109.474 -175.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -60.69 -24.71 65.85 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.091 0.956 . . . . 0.0 113.091 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.3 m -53.59 -36.2 61.68 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.525 0.602 . . . . 0.0 111.472 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.3 m -60.26 -56.5 20.8 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.8 t -49.9 -52.61 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.464 1.105 . . . . 0.0 110.558 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -57.29 -54.58 45.2 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.366 1.066 . . . . 0.0 111.245 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.5 p -62.31 -49.82 74.09 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.378 0.671 . . . . 0.0 111.523 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 79.1 mt -52.97 -56.17 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 124.285 1.034 . . . . 0.0 109.696 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -57.57 -50.65 72.41 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.134 0.574 . . . . 0.0 110.347 -177.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.77 -51.41 44.95 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.502 1.049 . . . . 0.0 112.374 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.2 t -60.61 -55.18 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.336 0.655 . . . . 0.0 110.329 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.5 mt -64.33 -37.37 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 119.005 -0.522 . . . . 0.0 111.549 -171.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 72.5 m -49.93 -33.73 18.41 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.535 0.734 . . . . 0.0 112.502 173.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -89.39 -12.08 41.37 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.836 0.854 . . . . 0.0 112.06 -174.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -70.33 139.5 87.1 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 119.127 0.876 . . . . 0.0 109.839 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.27 132.82 32.83 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.939 2.426 . . . . 0.0 109.831 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.83 -33.67 6.33 Favored Glycine 0 C--N 1.337 0.605 0 CA-C-O 118.939 -0.923 . . . . 0.0 112.062 -177.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.5 t -70.32 135.3 28.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 CA-C-N 118.113 0.957 . . . . 0.0 109.908 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -111.48 -100.67 0.41 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.961 1.305 . . . . 0.0 107.958 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 59.5 p -86.83 146.16 26.32 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.615 0.766 . . . . 0.0 109.489 176.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.3 tt -150.24 143.89 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 123.624 0.77 . . . . 0.0 109.938 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.45 136.36 41.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 169.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.8 t -124.5 143.24 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.987 1.315 . . . . 0.0 107.691 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.5 t -143.4 130.93 21.14 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.898 0.879 . . . . 0.0 110.191 -174.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.33 -45.69 25.34 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.151 0.981 . . . . 0.0 109.53 174.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.47 -46.67 63.2 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.271 1.028 . . . . 0.0 111.305 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -89.72 -9.62 48.75 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.648 0.779 . . . . 0.0 111.905 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.0 m 52.33 55.59 8.93 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 125.68 1.592 . . . . 0.0 111.076 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -160.87 168.46 24.63 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.173 0.511 . . . . 0.0 111.706 -174.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.12 116.16 1.51 Allowed Glycine 0 CA--C 1.525 0.656 0 C-N-CA 126.232 1.873 . . . . 0.0 108.683 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.7 m -99.31 109.75 22.34 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 176.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.4 t -119.24 122.45 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 124.465 1.106 . . . . 0.0 109.217 -171.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -89.97 131.29 35.95 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 169.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -150.09 165.09 33.84 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -169.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -101.01 113.36 65.8 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.08 1.352 . . . . 0.0 109.262 172.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -43.46 -39.35 9.34 Favored 'Trans proline' 0 C--N 1.347 0.499 1 C-N-CA 125.458 4.105 . . . . 0.0 115.346 173.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.87 -34.93 79.27 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.776 0.43 . . . . 0.0 111.857 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.2 mt -100.6 -29.62 12.23 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.819 0.848 . . . . 0.0 112.423 -172.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.4 t -151.15 174.41 13.25 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.53 0.732 . . . . 0.0 109.731 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.8 p -148.15 162.59 30.3 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 123.893 0.877 . . . . 0.0 110.468 -173.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.02 -34.61 77.99 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.631 2.888 . . . . 0.0 112.41 172.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -63.22 -49.23 75.0 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.024 0.93 . . . . 0.0 110.458 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.6 m -62.35 -45.31 93.78 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.215 0.606 . . . . 0.0 110.402 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.3 mt -60.46 -50.12 74.83 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.813 0.845 . . . . 0.0 110.602 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -55.47 -41.92 73.64 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.035 0.379 . . . . 0.0 110.969 172.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.47 -46.21 52.98 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.205 0.907 . . . . 0.0 111.963 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.8 -48.4 80.78 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.408 0.604 . . . . 0.0 111.133 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.6 mm -60.9 -39.63 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 122.946 0.498 . . . . 0.0 111.279 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.24 -44.62 91.26 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.883 0.873 . . . . 0.0 110.216 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.02 -45.6 92.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.788 0.835 . . . . 0.0 110.905 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.5 mmm -59.78 -44.04 94.11 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.417 0.687 . . . . 0.0 110.626 175.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.8 60.96 0.4 Allowed Glycine 0 C--N 1.341 0.82 0 C-N-CA 124.518 1.056 . . . . 0.0 112.007 171.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -140.1 162.33 35.49 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.923 0.889 . . . . 0.0 109.494 172.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.0 103.85 3.91 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.97 110.05 21.82 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.75 1.62 . . . . 0.0 110.127 -174.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.9 t -150.4 145.88 26.35 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.037 0.381 . . . . 0.0 109.995 175.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.3 mt -74.41 144.59 44.26 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 122.597 0.359 . . . . 0.0 111.589 -174.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.3 t -96.86 -52.43 3.89 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.062 1.345 . . . . 0.0 107.7 169.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.5 p30 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.031 -1.461 . . . . 0.0 109.058 178.259 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 55.4 tp . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 110.676 -0.12 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.7 p -139.67 150.06 44.46 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.06 0.944 . . . . 0.0 109.823 176.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -142.64 162.45 35.43 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 126.333 1.853 . . . . 0.0 107.968 173.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -121.8 142.76 49.89 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.328 1.051 . . . . 0.0 109.231 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -133.54 133.41 42.1 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.192 0.997 . . . . 0.0 109.396 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.8 t -100.27 109.23 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 172.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.1 mt -99.53 118.4 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -75.8 107.41 7.96 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.2 mt -111.97 96.11 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -174.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -99.57 151.55 21.04 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.257 0.623 . . . . 0.0 109.771 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.09 35.35 12.59 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.185 0.898 . . . . 0.0 112.191 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 38.0 mtt -79.46 134.02 36.53 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 169.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.5 m -84.32 -51.51 6.92 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.424 0.689 . . . . 0.0 110.629 -174.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.8 p -161.0 -172.94 3.66 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.594 0.757 . . . . 0.0 109.647 -175.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -55.15 -32.68 62.29 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.385 1.474 . . . . 0.0 113.79 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.6 p -59.36 -41.15 88.62 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.264 0.484 . . . . 0.0 110.902 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.8 m -62.53 -49.95 73.3 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.916 0.486 . . . . 0.0 110.129 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.5 t -50.2 -52.1 15.67 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 C-N-CA 123.796 0.838 . . . . 0.0 109.889 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -62.04 -42.89 99.66 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.956 0.902 . . . . 0.0 111.845 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.6 m -63.87 -48.9 74.86 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.189 0.595 . . . . 0.0 110.969 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.9 mt -55.33 -58.56 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.974 1.309 . . . . 0.0 109.375 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -61.14 -43.52 98.76 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 117.952 0.342 . . . . 0.0 111.254 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.96 -54.48 33.4 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.367 0.984 . . . . 0.0 111.906 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.76 -51.49 72.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.033 0.933 . . . . 0.0 110.323 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.0 mm -62.92 -33.33 59.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.827 -175.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.5 m -57.04 -21.01 27.91 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 175.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -89.09 -14.09 37.1 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.631 0.65 . . . . 0.0 111.653 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -71.0 134.12 85.68 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -66.05 139.46 56.15 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.563 2.175 . . . . 0.0 109.571 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.32 -32.48 7.1 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-O 118.652 -1.082 . . . . 0.0 112.165 -176.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.5 t -66.17 136.37 26.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 CA-C-N 118.464 1.132 . . . . 0.0 110.198 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -116.67 -96.42 0.47 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.487 1.115 . . . . 0.0 108.606 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.5 p -90.09 147.98 23.3 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.475 0.71 . . . . 0.0 109.889 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 tt -150.41 131.98 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 123.841 0.856 . . . . 0.0 110.1 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.08 110.24 12.3 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.69 1.196 . . . . 0.0 108.494 177.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.7 t -106.06 144.4 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.364 1.066 . . . . 0.0 109.061 176.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.3 t -145.17 131.71 19.82 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.881 0.872 . . . . 0.0 110.609 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 tt -74.28 -45.86 44.96 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.737 1.215 . . . . 0.0 109.581 169.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.28 -46.95 66.1 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.298 1.039 . . . . 0.0 111.471 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -89.6 -10.79 44.67 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.42 0.688 . . . . 0.0 111.676 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.9 m 53.21 55.56 8.64 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 125.435 1.494 . . . . 0.0 110.554 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -156.48 169.3 24.95 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -175.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.41 111.43 0.99 Allowed Glycine 0 CA--C 1.524 0.623 0 C-N-CA 126.292 1.901 . . . . 0.0 108.369 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.5 m -99.08 98.54 9.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.7 t -109.98 127.88 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 124.392 1.077 . . . . 0.0 109.269 -170.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -98.27 129.79 44.98 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 169.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -150.06 163.61 37.7 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.76 0.824 . . . . 0.0 110.975 -169.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -95.35 115.01 65.08 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.396 1.078 . . . . 0.0 109.306 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -45.94 -37.17 16.77 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 124.993 3.795 . . . . 0.0 114.616 173.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.9 mt -63.76 -32.62 74.17 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.717 0.807 . . . . 0.0 112.004 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.8 -41.55 7.21 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.732 0.813 . . . . 0.0 111.281 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 t -142.69 170.47 15.65 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.381 0.672 . . . . 0.0 110.247 -178.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.4 p -138.43 160.95 61.62 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.397 1.079 . . . . 0.0 110.349 -174.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -50.64 -40.39 55.56 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.609 2.873 . . . . 0.0 112.211 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -61.12 -47.21 87.33 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.507 1.123 . . . . 0.0 110.418 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.6 m -60.94 -50.57 72.87 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.506 0.722 . . . . 0.0 110.678 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 50.9 mt -59.25 -50.95 72.05 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.382 1.073 . . . . 0.0 110.354 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -53.87 -49.49 68.4 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 124.115 0.966 . . . . 0.0 110.558 174.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.21 -46.44 62.86 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.518 1.056 . . . . 0.0 111.966 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.32 -51.46 69.87 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.239 0.616 . . . . 0.0 111.228 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.0 mm -66.44 -37.15 79.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 117.838 0.29 . . . . 0.0 111.657 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -60.37 -43.84 96.17 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.277 0.631 . . . . 0.0 109.951 175.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -62.72 -42.73 99.8 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.881 0.872 . . . . 0.0 111.363 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.1 mtp -56.95 -44.65 82.77 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.776 0.43 . . . . 0.0 110.577 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.9 63.1 0.18 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 123.597 0.617 . . . . 0.0 111.947 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -140.41 158.26 44.28 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.047 0.939 . . . . 0.0 108.817 171.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -78.74 87.22 4.64 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.25 116.6 31.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.917 1.287 . . . . 0.0 109.183 -176.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.9 p -138.82 133.22 31.77 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.645 1.178 . . . . 0.0 109.365 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.1 mt -69.09 145.81 53.11 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.934 0.494 . . . . 0.0 111.299 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 67.9 p -73.3 -50.34 22.66 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 169.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 C--O 1.251 1.159 0 C-N-CA 125.688 1.595 . . . . 0.0 111.041 175.946 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 75.1 mt . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 120.374 0.131 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 76.1 p -99.34 156.42 17.01 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.609 1.164 . . . . 0.0 109.158 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -133.52 159.54 40.13 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 124.676 1.19 . . . . 0.0 109.999 -173.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -113.93 145.54 41.35 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.447 1.099 . . . . 0.0 108.818 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.4 t -139.32 155.35 47.76 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.014 0.926 . . . . 0.0 109.489 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.5 t -120.24 131.37 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.1 mt -128.56 120.24 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -74.79 134.35 41.8 Favored 'General case' 0 C--N 1.337 0.052 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.8 mt -125.65 110.84 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -175.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -99.45 152.87 19.5 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.4 2.14 60.43 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.053 -0.86 . . . . 0.0 112.66 -176.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.3 mtm -79.33 103.3 9.17 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 118.66 1.23 . . . . 0.0 107.94 175.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.4 t -84.47 -29.74 25.81 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.302 0.641 . . . . 0.0 111.803 -173.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.2 p -159.17 179.01 9.4 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.389 0.54 . . . . 0.0 110.589 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -59.33 -26.18 64.8 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.09 1.356 . . . . 0.0 113.25 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.8 m -56.06 -40.84 74.15 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.486 0.585 . . . . 0.0 111.169 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.2 m -63.06 -51.85 65.06 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 122.899 0.48 . . . . 0.0 109.777 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.1 t -50.34 -54.89 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.182 0.993 . . . . 0.0 110.232 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -57.45 -53.9 52.93 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.733 1.213 . . . . 0.0 111.215 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.0 p -60.47 -51.27 70.16 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.123 0.569 . . . . 0.0 111.429 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.9 mt -56.08 -55.09 20.23 Favored 'Isoleucine or valine' 0 C--N 1.339 0.152 0 C-N-CA 123.502 0.721 . . . . 0.0 109.63 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -52.95 -53.13 54.18 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.506 0.722 . . . . 0.0 110.64 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.07 -55.55 30.04 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.184 0.897 . . . . 0.0 112.349 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.43 -53.22 51.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 123.958 0.903 . . . . 0.0 111.057 -175.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.7 mm -63.45 -31.4 52.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.026 0.53 . . . . 0.0 111.269 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.0 t -54.51 -26.09 29.55 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -89.38 -5.25 57.61 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.418 0.687 . . . . 0.0 112.284 -175.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -71.83 144.36 88.03 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 118.76 0.709 . . . . 0.0 109.537 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -64.31 128.07 20.62 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.977 2.452 . . . . 0.0 110.202 -175.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.6 -33.33 6.64 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 118.652 -1.082 . . . . 0.0 112.243 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.15 139.38 20.53 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 CA-C-N 118.192 0.996 . . . . 0.0 110.081 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -119.37 -98.7 0.45 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.666 1.186 . . . . 0.0 108.256 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.8 p -85.15 147.41 26.63 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.2 tt -150.26 134.58 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.753 0.821 . . . . 0.0 109.162 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 89.2 mmt-85 -132.52 109.24 9.64 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.081 1.352 . . . . 0.0 108.373 -177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.0 t -103.68 147.1 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.788 1.235 . . . . 0.0 108.703 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.4 t -140.64 127.85 20.99 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.068 0.947 . . . . 0.0 110.588 -174.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.1 tp -69.34 -49.49 55.16 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.576 1.15 . . . . 0.0 109.437 171.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.4 -46.25 69.64 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.752 1.221 . . . . 0.0 111.687 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -89.46 -11.63 42.46 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.3 0.64 . . . . 0.0 111.582 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.6 m 53.46 54.24 10.39 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 125.367 1.467 . . . . 0.0 110.791 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.4 p30 -158.86 173.1 17.05 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.032 0.533 . . . . 0.0 111.626 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.6 119.3 2.04 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 126.101 1.81 . . . . 0.0 109.333 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.9 m -99.59 117.78 34.71 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 t -122.43 128.7 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 124.278 1.031 . . . . 0.0 109.725 -170.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -95.43 127.14 41.22 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 169.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -150.2 164.68 35.06 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.981 0.512 . . . . 0.0 112.175 -169.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -98.81 115.17 65.9 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.545 1.138 . . . . 0.0 110.136 172.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -44.98 -42.84 15.73 Favored 'Trans proline' 0 C--N 1.348 0.526 1 C-N-CA 125.556 4.171 . . . . 0.0 115.634 176.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.2 mt -68.31 -28.01 66.79 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.627 0.371 . . . . 0.0 111.941 -174.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.2 mt -99.68 -31.21 11.68 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.064 0.946 . . . . 0.0 111.726 -175.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.8 t -153.35 163.86 39.17 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.551 0.614 . . . . 0.0 109.956 176.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.4 p -131.22 163.31 50.25 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 124.834 1.254 . . . . 0.0 109.915 -177.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.88 -40.13 67.1 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.292 2.661 . . . . 0.0 112.419 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -66.76 -40.32 88.2 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.719 0.807 . . . . 0.0 111.601 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.4 m -62.36 -48.1 81.28 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.628 0.371 . . . . 0.0 110.047 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.5 mt -61.27 -47.72 84.71 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.104 0.961 . . . . 0.0 110.596 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -51.6 -50.99 59.12 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.416 1.086 . . . . 0.0 110.087 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.93 -46.34 84.22 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.24 0.924 . . . . 0.0 112.112 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.21 -50.6 71.12 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.45 0.7 . . . . 0.0 111.184 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.4 mt -58.6 -47.39 88.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.387 0.675 . . . . 0.0 109.691 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -55.25 -48.92 73.28 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.747 0.819 . . . . 0.0 110.42 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.5 -38.38 77.55 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.925 1.29 . . . . 0.0 112.472 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -56.03 -37.45 69.24 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 118.428 0.558 . . . . 0.0 111.127 175.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.18 56.09 0.07 OUTLIER Glycine 0 C--N 1.34 0.776 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 171.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -140.39 173.75 11.19 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.949 0.9 . . . . 0.0 110.037 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -108.51 88.27 2.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.43 138.54 36.37 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.99 0.916 . . . . 0.0 110.374 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.0 t -149.48 148.11 29.02 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.287 1.035 . . . . 0.0 109.18 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.8 mt -65.39 152.25 44.34 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.693 0.397 . . . . 0.0 111.181 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.4 t -139.15 38.43 2.11 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.11 1.364 . . . . 0.0 108.577 172.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.9 t70 . . . . . 0 C--O 1.251 1.155 0 C-N-CA 125.4 1.48 . . . . 0.0 107.941 -171.276 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 120.335 0.112 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.7 p -140.21 128.08 21.98 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.126 0.97 . . . . 0.0 109.226 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -145.18 171.69 14.18 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.073 1.349 . . . . 0.0 109.449 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -136.39 143.3 43.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.829 1.252 . . . . 0.0 108.825 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 t -135.52 153.57 51.68 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.898 1.279 . . . . 0.0 109.012 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.3 t -120.83 135.87 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 171.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.4 mt -130.53 124.87 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -175.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -67.14 131.56 46.05 Favored 'General case' 0 C--N 1.338 0.09 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.3 mt -129.59 98.74 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -99.23 150.83 21.68 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.81 4.42 56.88 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.234 0.921 . . . . 0.0 112.343 -173.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 57.6 mtm -79.02 108.41 12.48 Favored 'General case' 0 C--N 1.343 0.318 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.3 m -84.36 -38.58 20.15 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.542 1.137 . . . . 0.0 110.401 -171.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.7 p -156.91 -178.66 7.53 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.805 0.336 . . . . 0.0 110.502 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -55.39 -30.99 61.45 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.667 1.587 . . . . 0.0 113.416 -178.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 m -54.02 -42.59 69.28 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.409 0.684 . . . . 0.0 111.335 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.0 m -62.65 -53.26 57.19 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 122.912 0.485 . . . . 0.0 109.861 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.0 t -49.91 -54.41 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.462 1.105 . . . . 0.0 110.516 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -60.98 -50.88 71.58 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.409 1.084 . . . . 0.0 111.447 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.9 p -61.4 -51.77 67.38 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.81 0.444 . . . . 0.0 111.291 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.8 mt -52.61 -57.7 3.81 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 C-N-CA 124.052 0.941 . . . . 0.0 109.358 177.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -54.7 -45.47 73.98 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.094 0.557 . . . . 0.0 111.166 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.3 -53.96 34.83 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.337 0.97 . . . . 0.0 112.023 177.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.5 t -65.9 -54.5 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 117.552 0.676 . . . . 0.0 110.725 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.8 -40.65 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 123.545 0.738 . . . . 0.0 111.221 -175.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.2 p -56.6 -26.73 56.4 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -89.17 -6.05 57.25 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.747 0.819 . . . . 0.0 111.938 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -73.3 125.57 90.72 Favored Pre-proline 0 CA--C 1.535 0.384 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.89 124.84 10.53 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.781 2.987 . . . . 0.0 112.35 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.12 -37.83 3.35 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-O 119.033 -0.871 . . . . 0.0 112.056 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.3 t -67.86 127.42 29.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-N 117.873 0.836 . . . . 0.0 110.077 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -98.02 -102.41 0.2 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.744 1.218 . . . . 0.0 108.003 176.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 95.7 p -89.97 155.85 18.83 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.538 0.608 . . . . 0.0 110.247 176.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.9 tt -150.55 144.5 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.103 0.961 . . . . 0.0 109.822 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -140.21 108.81 5.9 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.51 1.124 . . . . 0.0 108.84 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.7 t -98.36 141.77 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.668 1.187 . . . . 0.0 108.534 174.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.6 t -135.4 125.78 26.61 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 123.776 0.83 . . . . 0.0 110.888 -173.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -64.85 -55.64 18.26 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.647 1.179 . . . . 0.0 108.804 171.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.68 -47.5 58.77 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 125.2 1.4 . . . . 0.0 112.275 -176.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -89.35 -9.35 50.74 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.069 0.548 . . . . 0.0 111.698 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.6 m 52.3 54.99 9.8 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 125.315 1.446 . . . . 0.0 110.864 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -158.7 173.79 16.03 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.31 0.644 . . . . 0.0 111.095 -174.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.92 119.35 2.02 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 125.708 1.623 . . . . 0.0 109.308 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.2 m -99.44 116.09 30.78 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 t -127.51 122.52 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 124.072 0.949 . . . . 0.0 109.672 -169.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -90.05 134.3 34.33 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -150.09 168.09 24.92 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.86 0.464 . . . . 0.0 112.235 -171.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -103.41 111.82 65.32 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.179 1.392 . . . . 0.0 109.155 171.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -42.66 -38.22 6.23 Favored 'Trans proline' 0 C--N 1.348 0.51 1 C-N-CA 125.402 4.068 . . . . 0.0 115.282 172.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.79 -35.95 82.28 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.142 0.577 . . . . 0.0 111.794 -177.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.6 mt -102.26 -29.95 11.38 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.036 0.934 . . . . 0.0 112.36 -171.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 t -150.65 173.06 14.58 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.387 0.675 . . . . 0.0 109.915 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.7 p -141.4 162.63 46.3 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 124.516 1.126 . . . . 0.0 109.919 -177.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -52.62 -41.03 71.33 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.253 2.635 . . . . 0.0 112.1 174.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -64.62 -41.92 95.85 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.074 0.95 . . . . 0.0 111.423 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.5 m -63.05 -48.42 78.78 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.964 0.505 . . . . 0.0 110.381 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 54.6 mt -61.1 -48.89 79.6 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.091 0.956 . . . . 0.0 110.319 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.6 ttp85 -52.2 -48.48 65.05 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 124.139 0.976 . . . . 0.0 110.148 172.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.98 -46.73 76.26 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.661 1.125 . . . . 0.0 112.244 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.29 -49.84 75.99 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 117.491 0.646 . . . . 0.0 110.967 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.0 mt -61.2 -42.55 93.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.266 0.626 . . . . 0.0 109.972 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -60.83 -44.79 96.48 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.497 1.119 . . . . 0.0 110.583 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -59.03 -39.0 80.61 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.297 1.039 . . . . 0.0 111.349 177.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.3 mtp -67.33 -7.44 24.63 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 175.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.47 57.18 1.29 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 123.893 0.758 . . . . 0.0 111.483 170.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -140.33 156.35 46.47 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.139 0.976 . . . . 0.0 109.59 174.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -81.27 87.54 6.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 176.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.43 122.47 42.59 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.435 1.094 . . . . 0.0 109.747 -174.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.2 m -144.49 136.53 26.13 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.545 1.138 . . . . 0.0 108.588 -177.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.6 mt -63.67 136.7 57.69 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.857 0.463 . . . . 0.0 111.497 -176.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.1 m -89.51 -52.65 4.91 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 169.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 C--O 1.25 1.129 0 C-N-CA 125.333 1.453 . . . . 0.0 109.008 -179.695 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 46.1 tp . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 81.9 p -136.66 123.22 20.94 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.432 1.093 . . . . 0.0 109.458 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -143.98 169.69 17.35 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.988 0.915 . . . . 0.0 109.411 170.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -140.05 139.98 36.06 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.648 1.179 . . . . 0.0 108.192 173.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 t -137.33 141.44 41.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.035 0.934 . . . . 0.0 109.908 -177.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.5 t -99.72 133.39 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 171.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.3 mt -129.05 118.99 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -73.01 132.47 43.44 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.0 mt -120.55 111.49 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 125.266 1.426 . . . . 0.0 107.679 -175.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -100.74 149.37 23.88 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.487 1.115 . . . . 0.0 109.425 174.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.78 15.11 37.94 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.911 1.243 . . . . 0.0 112.455 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 93.1 mtp -79.69 109.07 13.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.5 m -84.34 -47.11 11.06 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.015 0.926 . . . . 0.0 111.065 -169.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -154.92 177.33 11.42 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.804 0.841 . . . . 0.0 108.821 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -61.2 -21.27 63.67 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -174.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.3 m -55.06 -36.8 65.97 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.361 0.528 . . . . 0.0 111.189 173.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.1 m -64.62 -44.23 91.2 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 122.897 0.479 . . . . 0.0 110.578 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.7 t -54.26 -52.88 34.19 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 123.345 0.658 . . . . 0.0 109.326 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -57.77 -50.19 74.08 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.921 0.888 . . . . 0.0 111.186 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -59.82 -59.32 5.62 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.515 0.726 . . . . 0.0 110.959 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 73.7 mt -52.94 -52.59 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.385 1.074 . . . . 0.0 109.561 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -61.72 -54.76 38.13 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.723 0.409 . . . . 0.0 110.746 -175.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.46 -39.11 95.86 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.731 1.158 . . . . 0.0 113.278 -176.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.8 t -73.7 -57.28 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 117.724 0.762 . . . . 0.0 109.937 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.6 mt -67.9 -28.96 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 118.971 -0.537 . . . . 0.0 111.813 -170.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.2 p -53.45 -28.89 32.74 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.897 0.771 . . . . 0.0 112.726 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -88.98 -17.09 30.15 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.857 0.863 . . . . 0.0 111.614 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -71.41 141.9 86.12 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 118.666 0.666 . . . . 0.0 109.709 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -63.99 140.37 72.22 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.323 2.682 . . . . 0.0 111.165 -170.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.43 -32.93 6.22 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 118.744 -1.031 . . . . 0.0 112.149 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.02 141.73 15.76 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 118.356 1.078 . . . . 0.0 110.125 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -118.39 -109.44 0.36 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.155 1.382 . . . . 0.0 107.526 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.7 p -90.1 94.33 9.74 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.329 1.052 . . . . 0.0 109.067 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.5 tt -89.92 133.94 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 123.932 0.893 . . . . 0.0 109.32 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -129.85 97.17 4.42 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.863 1.265 . . . . 0.0 108.444 -172.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.6 t -95.6 147.76 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.921 0.889 . . . . 0.0 109.927 -176.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.4 t -148.71 127.01 12.18 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.851 0.86 . . . . 0.0 110.198 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.8 tt -73.9 -42.77 60.18 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.011 0.924 . . . . 0.0 109.584 170.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.12 -47.11 72.21 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.543 1.137 . . . . 0.0 111.574 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -89.36 -5.44 57.47 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.362 0.665 . . . . 0.0 111.42 176.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.1 m 53.75 53.55 11.22 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 126.054 1.741 . . . . 0.0 111.165 175.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -161.22 172.08 17.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.284 0.564 . . . . 0.0 112.34 -172.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.71 117.05 2.39 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.1 m -99.37 94.38 6.41 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 t -100.03 120.06 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 124.456 1.103 . . . . 0.0 109.58 -169.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -89.52 132.86 34.85 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 169.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -150.81 171.79 16.64 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -169.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -106.87 111.72 63.65 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 125.548 1.539 . . . . 0.0 108.826 171.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -44.06 -38.02 10.11 Favored 'Trans proline' 0 C--N 1.346 0.422 1 C-N-CA 125.397 4.065 . . . . 0.0 114.893 172.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.2 mt -65.12 -33.69 76.62 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.481 0.712 . . . . 0.0 111.696 -177.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.0 mt -101.07 -33.4 10.16 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.266 1.026 . . . . 0.0 112.048 -172.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -148.95 169.97 19.38 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.526 0.73 . . . . 0.0 109.931 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.9 p -141.3 161.85 50.69 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.533 1.133 . . . . 0.0 109.745 -176.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.79 -42.86 42.79 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.484 2.789 . . . . 0.0 112.835 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -65.51 -39.87 92.35 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.541 0.736 . . . . 0.0 111.793 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.0 m -63.06 -45.26 93.02 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.637 0.375 . . . . 0.0 110.103 176.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.1 mt -65.43 -43.5 90.27 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.268 1.027 . . . . 0.0 110.833 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -53.85 -49.41 68.5 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.865 0.866 . . . . 0.0 109.449 170.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.92 -44.54 71.8 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.7 1.143 . . . . 0.0 112.388 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.29 94.65 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.727 0.811 . . . . 0.0 111.153 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.0 mt -63.7 -43.05 97.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 123.001 0.521 . . . . 0.0 110.226 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -62.57 -38.8 91.53 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.541 0.736 . . . . 0.0 111.349 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -60.94 -43.09 99.18 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.536 0.735 . . . . 0.0 110.616 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.4 mtp -62.36 -47.25 85.01 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 119.392 -0.337 . . . . 0.0 110.556 173.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.05 61.02 0.12 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 123.71 0.671 . . . . 0.0 112.077 170.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -140.33 150.69 44.29 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.58 0.752 . . . . 0.0 109.371 171.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -79.7 93.2 5.5 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.39 133.68 43.36 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.939 0.896 . . . . 0.0 110.39 -174.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.8 p -139.04 132.61 30.43 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.95 1.3 . . . . 0.0 108.825 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.8 mt -62.52 131.31 48.68 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.268 0.627 . . . . 0.0 110.751 -177.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.4 m -93.73 -44.88 7.94 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 169.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 117.238 -1.363 . . . . 0.0 108.804 171.77 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 83.5 mt . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 111.186 0.069 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 51.2 p -140.05 153.92 46.92 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.359 1.064 . . . . 0.0 109.751 177.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -142.36 166.27 25.15 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.821 1.648 . . . . 0.0 108.901 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -120.72 143.91 48.51 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.005 1.322 . . . . 0.0 108.486 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 t -142.27 139.66 31.98 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 123.534 0.734 . . . . 0.0 109.892 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.5 t -99.81 118.37 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.4 mm -102.22 130.64 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 174.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -71.58 125.56 27.4 Favored 'General case' 0 N--CA 1.458 -0.065 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 169.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.4 mt -127.58 88.95 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -99.88 159.14 15.3 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.097 0.559 . . . . 0.0 109.755 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.64 21.22 56.71 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 119.285 -0.731 . . . . 0.0 112.759 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 70.1 mtm -79.71 128.55 33.55 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.1 p -84.45 -42.43 15.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.497 0.719 . . . . 0.0 110.983 -174.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.6 p -159.58 179.95 8.44 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.822 0.344 . . . . 0.0 110.73 -174.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -54.09 -31.03 50.69 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.662 1.585 . . . . 0.0 113.57 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m -54.59 -39.02 67.41 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.411 0.684 . . . . 0.0 111.372 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.8 m -63.99 -49.2 73.39 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 122.82 0.448 . . . . 0.0 110.198 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.1 t -52.35 -51.82 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.248 1.019 . . . . 0.0 109.646 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -58.43 -48.26 81.28 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.32 1.448 . . . . 0.0 111.789 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.0 m -60.9 -50.78 72.01 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.944 0.497 . . . . 0.0 110.829 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.5 mt -60.39 -55.44 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 123.619 0.768 . . . . 0.0 110.017 -176.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -57.36 -45.33 84.51 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.493 0.588 . . . . 0.0 110.853 -176.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.44 -61.64 7.25 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 123.79 0.71 . . . . 0.0 111.464 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.81 -56.38 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.067 0.947 . . . . 0.0 110.994 -175.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.0 mm -63.08 -33.73 62.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 118.764 -0.636 . . . . 0.0 111.835 -171.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.4 t -51.07 -35.2 33.6 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -89.38 -5.57 57.34 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.903 -0.57 . . . . 0.0 112.453 -175.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -68.22 147.95 98.28 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 119.417 1.008 . . . . 0.0 110.105 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -45.77 132.15 13.46 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 124.08 3.186 . . . . 0.0 112.738 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.82 -39.33 3.09 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 118.943 -0.921 . . . . 0.0 112.986 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.4 t -67.32 143.22 15.67 Favored 'Isoleucine or valine' 0 C--N 1.341 0.205 0 CA-C-N 118.089 0.944 . . . . 0.0 110.278 -177.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -117.63 -95.33 0.48 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.6 p -90.66 157.5 17.43 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.837 0.855 . . . . 0.0 110.078 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.5 tt -150.7 145.06 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 124.488 1.115 . . . . 0.0 108.601 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -131.98 107.83 8.94 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.128 0.971 . . . . 0.0 109.121 176.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.9 t -97.27 149.56 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.977 1.311 . . . . 0.0 109.047 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.3 t -145.14 123.02 11.96 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.266 0.627 . . . . 0.0 110.173 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.8 tp -67.04 -47.0 72.71 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.745 1.218 . . . . 0.0 109.931 172.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.93 -43.28 66.15 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.677 1.191 . . . . 0.0 111.7 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -89.2 -21.02 23.48 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.375 0.67 . . . . 0.0 111.147 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.9 m 57.48 57.29 4.45 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 125.267 1.427 . . . . 0.0 109.784 -174.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.6 p30 -152.81 171.63 17.96 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.47 0.708 . . . . 0.0 111.578 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -137.26 114.68 1.14 Allowed Glycine 0 C--N 1.337 0.615 0 C-N-CA 126.041 1.781 . . . . 0.0 108.894 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.3 m -99.11 99.9 10.97 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.0 t -103.26 133.17 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 124.817 1.247 . . . . 0.0 109.58 -170.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -103.21 125.17 49.76 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 172.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -150.17 171.02 17.57 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -168.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -101.25 113.22 65.83 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.353 1.461 . . . . 0.0 109.479 172.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -44.18 -40.2 12.34 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 125.17 3.914 . . . . 0.0 114.794 173.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.0 mt -63.19 -34.81 78.45 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.606 0.763 . . . . 0.0 111.703 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.8 mt -99.98 -29.26 12.65 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.107 0.963 . . . . 0.0 112.197 -172.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.7 t -153.07 160.25 42.92 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.645 0.657 . . . . 0.0 110.11 177.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.3 p -125.98 161.88 48.88 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 125.179 1.392 . . . . 0.0 109.658 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.99 -36.12 43.3 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.41 2.74 . . . . 0.0 112.924 172.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -67.94 -44.0 77.83 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.608 1.163 . . . . 0.0 110.717 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.2 m -62.78 -45.71 91.39 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.959 0.504 . . . . 0.0 110.296 176.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.9 mt -61.85 -48.84 78.74 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.699 0.8 . . . . 0.0 110.534 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.2 ttp85 -49.99 -47.45 52.87 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.267 1.027 . . . . 0.0 110.14 171.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.84 -51.09 41.29 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.41 1.005 . . . . 0.0 111.826 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.36 -43.76 96.22 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.769 0.785 . . . . 0.0 111.948 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.8 mm -60.9 -44.12 97.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 118.345 0.521 . . . . 0.0 110.507 176.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -58.98 -43.74 91.47 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.173 0.589 . . . . 0.0 110.17 175.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -60.66 -41.47 95.09 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.98 0.912 . . . . 0.0 111.213 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.4 mtp -61.92 -43.86 97.97 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.238 0.472 . . . . 0.0 110.592 173.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.06 60.7 0.2 Allowed Glycine 0 C--N 1.34 0.805 0 C-N-CA 123.786 0.707 . . . . 0.0 111.887 169.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -140.37 159.36 42.36 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.975 0.91 . . . . 0.0 109.313 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -73.46 98.25 2.72 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.87 127.95 46.0 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.049 1.339 . . . . 0.0 110.021 -173.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.1 m -150.11 152.79 35.3 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.472 1.109 . . . . 0.0 108.521 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -75.27 124.37 26.96 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 t -91.29 -59.91 2.03 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 171.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.6 t70 . . . . . 0 C--O 1.249 1.051 0 C-N-CA 125.373 1.469 . . . . 0.0 107.819 178.592 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 120.328 0.109 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.4 p -140.39 133.08 28.88 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.273 1.029 . . . . 0.0 109.64 176.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -145.2 165.75 27.43 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.31 1.444 . . . . 0.0 109.065 173.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -129.26 151.01 50.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.813 1.245 . . . . 0.0 109.025 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.5 t -149.62 153.74 37.54 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 123.784 0.834 . . . . 0.0 109.91 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.57 125.43 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 173.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.3 mt -121.36 121.62 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -67.63 131.12 45.0 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 173.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.1 mt -124.39 108.77 21.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.112 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -99.83 150.5 22.29 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.58 13.17 55.99 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.378 0.989 . . . . 0.0 113.06 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 71.5 mtm -79.58 117.17 20.27 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.711 1.255 . . . . 0.0 108.26 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.4 m -84.15 -43.01 15.41 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.093 0.957 . . . . 0.0 110.387 -172.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.9 p -157.38 -178.94 7.72 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.605 0.362 . . . . 0.0 110.419 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -57.6 -25.92 60.76 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.293 1.437 . . . . 0.0 113.425 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.8 t -57.28 -44.42 83.99 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.229 0.611 . . . . 0.0 110.638 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.0 m -61.27 -51.06 70.51 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.817 0.447 . . . . 0.0 109.916 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.4 t -50.45 -53.05 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.328 1.051 . . . . 0.0 110.229 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -57.02 -51.75 68.02 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.55 1.14 . . . . 0.0 111.15 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.4 m -58.91 -54.37 47.87 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.566 0.746 . . . . 0.0 111.392 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.2 mt -54.08 -56.2 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.46 1.104 . . . . 0.0 109.438 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -55.09 -53.41 56.27 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.14 0.976 . . . . 0.0 110.924 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.47 -53.82 42.01 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.463 1.03 . . . . 0.0 112.296 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.6 t -59.48 -53.42 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.449 0.7 . . . . 0.0 110.392 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.0 mt -63.62 -39.94 87.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.108 0.563 . . . . 0.0 111.237 -174.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.2 t -49.92 -34.68 21.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.99 0.916 . . . . 0.0 112.355 176.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -89.05 -9.8 49.88 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.699 0.8 . . . . 0.0 112.427 -172.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -72.56 137.62 80.59 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 119.341 0.973 . . . . 0.0 109.91 177.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.39 136.03 20.0 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.718 2.945 . . . . 0.0 112.259 172.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.69 -43.31 1.83 Allowed Glycine 0 CA--C 1.523 0.541 0 CA-C-O 119.221 -0.766 . . . . 0.0 111.823 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.6 t -69.78 133.72 31.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 CA-C-N 117.76 0.78 . . . . 0.0 109.513 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -107.25 -98.1 0.36 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.9 p -90.15 149.04 22.62 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.546 0.738 . . . . 0.0 109.917 176.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.6 tt -150.53 143.17 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.239 1.016 . . . . 0.0 109.574 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -138.59 118.76 13.52 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.836 1.254 . . . . 0.0 108.342 175.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.19 147.02 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.889 1.275 . . . . 0.0 108.225 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.1 t -139.67 127.5 22.01 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 123.828 0.851 . . . . 0.0 110.749 -174.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp -68.17 -50.5 54.04 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.649 1.179 . . . . 0.0 109.47 171.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.56 -46.29 70.19 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.825 1.25 . . . . 0.0 111.73 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -89.36 -10.55 46.24 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.261 0.624 . . . . 0.0 111.586 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.7 m 53.11 55.18 9.23 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.368 1.467 . . . . 0.0 110.846 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -158.88 171.43 20.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.953 0.501 . . . . 0.0 111.698 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.31 116.06 1.86 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 126.376 1.941 . . . . 0.0 109.162 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.8 m -99.33 112.17 24.4 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.0 t -120.0 136.26 57.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.429 1.092 . . . . 0.0 109.819 -170.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -109.64 128.29 55.13 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 169.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -150.3 173.37 14.05 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -168.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -105.4 112.67 64.82 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.442 1.497 . . . . 0.0 109.483 174.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -41.64 -39.71 4.94 Favored 'Trans proline' 0 C--N 1.348 0.52 1 C-N-CA 125.585 4.19 . . . . 0.0 115.272 171.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.6 -33.12 74.35 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.292 0.637 . . . . 0.0 112.017 -177.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.2 mt -106.39 -31.52 8.54 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.297 1.039 . . . . 0.0 112.293 -171.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 t -150.26 175.43 11.8 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.392 0.677 . . . . 0.0 109.961 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.4 p -149.07 164.62 20.38 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.2 1.0 . . . . 0.0 110.328 -174.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.32 -39.45 86.99 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.449 2.766 . . . . 0.0 112.096 174.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.51 -39.03 81.39 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.634 0.774 . . . . 0.0 111.447 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.6 m -62.93 -46.74 86.35 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 45.8 mt -59.87 -50.46 73.68 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.085 0.954 . . . . 0.0 110.609 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -51.53 -48.4 63.01 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.679 1.191 . . . . 0.0 110.46 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.71 -45.32 93.51 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.452 1.025 . . . . 0.0 112.219 177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.85 -46.48 87.69 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.493 0.717 . . . . 0.0 110.991 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.1 mt -60.02 -44.07 93.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 123.528 0.731 . . . . 0.0 109.97 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -60.99 -42.49 98.51 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.638 0.775 . . . . 0.0 111.075 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -61.7 -43.43 98.87 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.663 0.785 . . . . 0.0 111.119 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.8 mtp -59.64 -45.17 92.79 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.746 0.419 . . . . 0.0 110.442 175.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.83 53.38 0.1 Allowed Glycine 0 C--N 1.341 0.817 0 C-N-CA 123.509 0.576 . . . . 0.0 112.477 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -140.46 133.01 28.67 Favored 'General case' 0 C--N 1.338 0.104 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 172.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -73.01 104.56 4.15 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -103.5 139.85 38.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.157 1.383 . . . . 0.0 110.59 -172.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.8 p -142.3 145.28 33.82 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.525 1.13 . . . . 0.0 108.793 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 52.6 mt -71.93 127.35 32.29 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.826 0.45 . . . . 0.0 110.189 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.82 -51.99 7.15 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 171.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.0 t70 . . . . . 0 C--O 1.249 1.071 0 C-N-CA 125.499 1.52 . . . . 0.0 108.09 179.822 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 47.1 tp . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 110.622 -0.14 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.1 p -140.03 142.7 36.21 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.282 1.033 . . . . 0.0 110.112 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -140.27 164.03 31.17 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.663 1.585 . . . . 0.0 108.265 170.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -127.27 150.0 49.76 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.471 1.108 . . . . 0.0 109.278 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -144.72 150.25 36.96 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.029 0.932 . . . . 0.0 109.706 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.0 t -112.5 127.18 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 171.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.0 mt -121.73 121.55 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -80.0 130.75 35.51 Favored 'General case' 0 N--CA 1.458 -0.061 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.8 mt -127.76 96.96 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -172.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -99.67 153.77 18.82 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.17 6.78 53.31 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.505 1.05 . . . . 0.0 112.345 -172.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 63.4 mtm -79.34 120.78 24.27 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.642 1.221 . . . . 0.0 108.474 175.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.5 p -84.4 -40.14 18.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.088 0.955 . . . . 0.0 110.989 -173.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.9 p -159.07 179.78 8.74 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.779 0.431 . . . . 0.0 110.327 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -59.22 -25.99 64.47 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.816 1.247 . . . . 0.0 113.279 -176.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.9 m -53.4 -41.28 65.81 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.488 0.586 . . . . 0.0 111.207 174.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.2 m -63.49 -48.35 77.99 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 123.384 0.674 . . . . 0.0 110.374 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.9 t -54.09 -52.17 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.348 1.059 . . . . 0.0 109.858 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -64.45 -46.38 83.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.904 0.881 . . . . 0.0 111.475 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.2 p -61.51 -47.41 85.73 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.085 0.402 . . . . 0.0 110.601 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.6 mt -56.24 -54.81 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 123.39 0.676 . . . . 0.0 109.613 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -49.95 -57.97 6.42 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.965 0.906 . . . . 0.0 110.204 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.55 -53.26 44.88 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.255 0.931 . . . . 0.0 112.583 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.83 -50.38 75.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.314 0.646 . . . . 0.0 111.116 -174.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.65 -32.65 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.091 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.1 m -55.2 -20.08 9.66 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -89.12 -10.83 45.8 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.866 0.757 . . . . 0.0 112.212 -176.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -73.19 127.21 89.57 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -47.45 128.9 15.67 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.854 3.036 . . . . 0.0 112.569 176.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.24 -33.18 6.74 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-O 118.592 -1.115 . . . . 0.0 112.655 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.6 t -65.27 136.91 25.93 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 CA-C-N 118.208 1.004 . . . . 0.0 110.623 -176.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -119.22 -103.06 0.41 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.34 1.456 . . . . 0.0 108.163 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 82.7 p -80.74 151.96 28.59 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.255 0.479 . . . . 0.0 110.133 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -150.25 138.88 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.248 1.019 . . . . 0.0 108.961 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -138.93 101.22 4.24 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.454 1.501 . . . . 0.0 107.712 -172.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 t -110.5 144.93 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.521 1.128 . . . . 0.0 108.865 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -146.51 130.93 17.64 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.312 0.645 . . . . 0.0 111.127 -175.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.8 tp -70.49 -48.82 53.87 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.882 1.273 . . . . 0.0 109.454 171.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.24 -46.26 69.07 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.759 1.224 . . . . 0.0 111.667 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -89.37 -10.15 47.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.194 0.597 . . . . 0.0 111.493 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.5 m 52.67 58.86 4.93 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.377 1.471 . . . . 0.0 110.488 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -158.42 169.19 25.01 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.203 0.525 . . . . 0.0 111.856 -174.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.82 113.58 1.05 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 126.652 2.073 . . . . 0.0 108.102 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.9 m -99.68 130.83 45.93 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 174.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.7 t -135.02 135.22 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 123.353 0.661 . . . . 0.0 109.766 -171.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -101.11 131.08 47.21 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 169.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -150.49 162.35 40.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.987 0.515 . . . . 0.0 111.99 -170.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -91.59 116.1 65.8 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 124.691 1.196 . . . . 0.0 109.49 170.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -48.59 -36.51 32.14 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 124.575 3.517 . . . . 0.0 114.231 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.4 mt -64.59 -28.95 69.98 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.602 0.761 . . . . 0.0 111.988 -176.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.7 mt -109.8 -28.63 8.7 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.047 0.939 . . . . 0.0 112.401 -172.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 t -152.43 178.63 9.34 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.792 0.724 . . . . 0.0 109.991 176.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.5 p -150.34 163.95 22.34 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.64 1.176 . . . . 0.0 109.756 -174.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.89 -38.49 85.95 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.257 2.638 . . . . 0.0 112.324 174.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -66.07 -45.34 81.66 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.26 1.024 . . . . 0.0 110.357 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 m -61.86 -47.26 85.81 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.185 0.594 . . . . 0.0 110.449 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.5 mt -60.16 -50.16 74.78 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.902 0.881 . . . . 0.0 110.382 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 57.5 ttp85 -52.04 -45.32 64.62 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.872 0.869 . . . . 0.0 110.342 172.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.73 -45.28 69.43 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.517 1.056 . . . . 0.0 112.163 175.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.85 -47.97 82.64 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.759 0.779 . . . . 0.0 111.265 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.1 mm -59.63 -45.53 94.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 122.668 0.387 . . . . 0.0 110.484 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -60.0 -41.81 92.93 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.251 1.02 . . . . 0.0 110.559 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.59 -44.49 96.19 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.952 0.901 . . . . 0.0 111.078 176.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.8 mtp -58.81 -41.55 87.04 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.737 0.415 . . . . 0.0 110.735 175.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.31 61.36 0.25 Allowed Glycine 0 C--N 1.34 0.76 0 C-N-CA 123.829 0.728 . . . . 0.0 112.107 169.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -140.45 155.02 46.84 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 123.955 0.902 . . . . 0.0 109.007 170.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -78.72 94.95 5.18 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.82 126.5 45.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.014 1.326 . . . . 0.0 109.897 -176.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.2 p -136.49 131.7 34.32 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.519 1.128 . . . . 0.0 109.162 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.5 mt -62.75 124.22 20.45 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.327 0.651 . . . . 0.0 109.591 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.6 t -97.39 -52.69 3.71 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.975 0.91 . . . . 0.0 109.605 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 117.069 -1.443 . . . . 0.0 108.847 -177.893 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.3 tt . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 46.4 p -139.73 161.21 38.09 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.52 1.128 . . . . 0.0 110.074 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -142.08 167.07 22.99 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.604 1.562 . . . . 0.0 108.695 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -129.12 153.8 47.32 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.573 1.149 . . . . 0.0 109.568 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -148.08 144.48 27.89 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.86 0.864 . . . . 0.0 110.073 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.7 t -106.9 107.46 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.7 mt -99.75 116.06 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -76.59 120.77 22.25 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 175.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -114.29 110.77 33.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -174.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -99.58 147.46 25.33 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.062 0.945 . . . . 0.0 108.639 173.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.44 4.98 52.59 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.328 0.966 . . . . 0.0 112.874 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 66.6 mtm -79.46 110.92 15.21 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.72 1.26 . . . . 0.0 107.982 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.8 p -84.4 -39.37 19.1 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.8 0.84 . . . . 0.0 110.965 -173.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.6 p -156.43 -179.47 8.2 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.715 0.293 . . . . 0.0 110.643 -175.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -55.16 -32.59 62.25 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.193 1.397 . . . . 0.0 112.981 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m -52.96 -39.85 63.26 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.416 0.687 . . . . 0.0 111.615 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.7 m -66.8 -48.05 70.16 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 122.858 0.463 . . . . 0.0 110.354 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.7 t -52.77 -55.08 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.046 0.938 . . . . 0.0 109.731 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -54.81 -52.95 61.06 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.141 1.376 . . . . 0.0 110.674 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.8 t -56.53 -55.87 28.44 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.697 0.799 . . . . 0.0 111.132 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.8 mt -57.21 -54.56 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.707 0.803 . . . . 0.0 109.641 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -55.02 -52.4 63.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.029 0.532 . . . . 0.0 110.666 -177.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.13 -51.11 60.34 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.681 1.134 . . . . 0.0 112.414 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.7 t -67.7 -57.24 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 117.801 0.801 . . . . 0.0 110.848 -176.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.4 mm -60.3 -34.54 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.561 0.744 . . . . 0.0 111.538 -173.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.9 p -54.13 -27.86 36.12 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -89.15 -20.04 24.74 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.29 0.636 . . . . 0.0 111.798 -175.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.59 141.72 93.31 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 118.509 0.595 . . . . 0.0 109.906 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -62.13 136.64 61.67 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.485 2.79 . . . . 0.0 111.304 -169.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.95 -40.39 2.45 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-O 118.996 -0.891 . . . . 0.0 111.583 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.2 131.52 33.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-N 118.103 0.952 . . . . 0.0 110.166 -176.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -101.2 -101.5 0.26 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.733 1.213 . . . . 0.0 107.732 173.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.5 p -87.92 151.48 22.79 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.77 0.828 . . . . 0.0 109.908 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.9 tt -150.18 137.92 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 123.907 0.883 . . . . 0.0 109.365 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -130.59 112.84 13.53 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.835 1.254 . . . . 0.0 108.479 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.9 t -101.4 147.92 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.379 1.072 . . . . 0.0 108.496 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.8 t -147.02 127.0 13.61 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.644 0.778 . . . . 0.0 110.463 -175.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.9 tp -70.32 -46.01 65.06 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.801 1.241 . . . . 0.0 109.937 172.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.64 -43.47 65.46 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.655 1.182 . . . . 0.0 111.498 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -89.26 -19.95 24.72 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.579 0.752 . . . . 0.0 111.099 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.5 m 57.43 53.82 7.15 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.478 1.511 . . . . 0.0 110.06 -175.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.9 p30 -153.85 172.93 16.59 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.976 0.511 . . . . 0.0 111.918 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.89 113.89 1.19 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 127.128 2.299 . . . . 0.0 107.96 176.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.0 m -98.96 104.34 16.38 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 t -111.47 133.48 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 124.517 1.127 . . . . 0.0 109.849 -169.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -103.58 133.39 48.68 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 169.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -150.45 170.51 18.91 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -171.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -103.19 112.89 66.04 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 125.586 1.554 . . . . 0.0 109.242 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -43.22 -38.98 8.29 Favored 'Trans proline' 0 C--N 1.348 0.531 1 C-N-CA 125.535 4.157 . . . . 0.0 114.987 173.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.41 -34.72 77.31 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.365 0.666 . . . . 0.0 111.811 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.6 mt -101.88 -32.14 10.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.248 1.019 . . . . 0.0 112.177 -172.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.5 t -152.04 175.83 12.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.185 0.594 . . . . 0.0 110.109 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.6 p -150.13 165.28 17.86 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 124.598 1.159 . . . . 0.0 109.635 -175.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -51.06 -46.18 32.42 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.606 2.871 . . . . 0.0 113.075 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -68.58 -34.67 76.2 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.186 0.594 . . . . 0.0 111.865 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.4 m -65.8 -45.45 82.33 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.126 0.421 . . . . 0.0 109.988 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.7 mt -64.45 -44.58 90.67 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.194 0.998 . . . . 0.0 110.692 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.6 ttp180 -53.78 -50.64 65.63 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.64 0.776 . . . . 0.0 109.18 171.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.74 -44.46 60.57 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.02 1.295 . . . . 0.0 112.565 176.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.09 -44.05 96.79 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.816 0.846 . . . . 0.0 111.09 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.6 mt -65.94 -39.76 85.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.21 0.604 . . . . 0.0 110.388 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -62.63 -38.88 91.98 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.506 0.722 . . . . 0.0 110.928 174.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -62.41 -41.36 98.63 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.321 0.648 . . . . 0.0 110.831 176.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.8 mtp -60.52 -48.39 81.96 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.028 0.376 . . . . 0.0 110.241 172.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.58 60.6 0.1 Allowed Glycine 0 C--N 1.341 0.811 0 C-N-CA 123.706 0.669 . . . . 0.0 111.956 170.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -140.35 149.97 43.38 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.624 0.77 . . . . 0.0 109.756 173.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -80.28 87.13 5.59 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.928 0.891 . . . . 0.0 108.691 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.57 140.8 33.23 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.006 0.923 . . . . 0.0 111.007 -175.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.0 t -150.31 160.15 43.93 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.698 1.199 . . . . 0.0 109.146 174.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -82.69 162.19 21.89 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.15 0.58 . . . . 0.0 110.205 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 71.1 m -79.28 69.03 5.42 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.391 0.676 . . . . 0.0 109.58 172.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 117.142 -1.409 . . . . 0.0 108.709 179.965 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 75.3 mt . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 120.41 0.148 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.5 p -99.53 166.57 11.09 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.788 1.235 . . . . 0.0 110.19 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -134.22 162.81 31.13 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.14 1.376 . . . . 0.0 109.262 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -125.41 145.53 50.01 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.971 1.308 . . . . 0.0 108.695 176.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.7 t -142.8 145.51 33.3 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.824 0.85 . . . . 0.0 109.625 176.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.5 t -106.51 130.88 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 172.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.4 mt -125.62 125.19 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -69.91 129.38 39.36 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.1 mt -121.63 103.82 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -100.01 150.8 22.07 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.077 0.951 . . . . 0.0 109.407 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.74 26.2 23.13 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.674 1.131 . . . . 0.0 112.099 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 93.4 mtp -85.59 111.55 20.15 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.6 p -84.5 -44.84 13.23 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.492 0.717 . . . . 0.0 111.469 -170.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.9 p -159.05 -179.97 8.51 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.415 0.686 . . . . 0.0 109.721 -175.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -56.22 -29.32 60.83 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.819 1.247 . . . . 0.0 113.204 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.5 m -52.19 -41.18 62.45 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.154 0.582 . . . . 0.0 111.428 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.5 m -64.84 -46.53 81.51 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 122.692 0.397 . . . . 0.0 110.503 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.8 t -53.06 -55.15 13.56 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 C-N-CA 123.489 0.716 . . . . 0.0 109.342 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -56.71 -52.11 66.21 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.563 1.145 . . . . 0.0 111.224 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.9 m -58.99 -56.61 20.01 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.68 0.792 . . . . 0.0 111.222 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.4 mt -56.08 -51.96 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 123.651 0.78 . . . . 0.0 109.401 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -56.51 -53.52 56.52 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.856 0.462 . . . . 0.0 110.68 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.8 -54.55 36.6 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.687 0.66 . . . . 0.0 112.372 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.3 t -62.81 -55.35 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.794 0.838 . . . . 0.0 111.043 -174.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.0 mm -62.33 -37.11 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 118.778 -0.63 . . . . 0.0 110.932 -175.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.8 t -51.86 -35.11 43.67 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 118.798 0.726 . . . . 0.0 112.358 175.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -89.0 -12.18 42.14 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.778 0.831 . . . . 0.0 111.988 -173.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -70.4 143.62 90.77 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 119.016 0.825 . . . . 0.0 109.631 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -62.26 137.76 67.74 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.343 2.695 . . . . 0.0 111.021 -171.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.43 -41.02 2.38 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-O 119.059 -0.856 . . . . 0.0 111.311 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.2 t -70.88 141.39 16.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.199 0 CA-C-N 118.106 0.953 . . . . 0.0 109.442 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -112.91 -94.28 0.46 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.5 p -90.82 155.61 18.64 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.713 0.805 . . . . 0.0 109.787 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.4 tt -150.85 137.17 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.058 0.943 . . . . 0.0 108.47 174.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -117.95 99.46 6.92 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.68 1.592 . . . . 0.0 108.565 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.2 t -94.3 144.9 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.791 0.836 . . . . 0.0 109.601 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.5 t -147.37 122.48 10.15 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.785 0.834 . . . . 0.0 110.14 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.9 tt -70.15 -43.75 70.23 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.187 0.995 . . . . 0.0 109.564 170.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.5 -45.83 69.81 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.216 1.006 . . . . 0.0 111.566 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -89.68 -5.57 56.94 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.48 0.712 . . . . 0.0 111.778 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.0 m 51.8 53.82 11.98 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.679 1.591 . . . . 0.0 111.212 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -159.5 173.42 16.2 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -174.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.65 118.77 1.93 Allowed Glycine 0 C--N 1.339 0.72 0 C-N-CA 126.208 1.861 . . . . 0.0 109.001 174.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.8 m -99.68 97.9 8.8 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.2 t -100.63 132.2 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.698 1.199 . . . . 0.0 110.198 -169.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -105.31 126.56 52.24 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 172.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -150.15 169.17 21.93 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -169.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -102.91 115.77 63.63 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.309 1.443 . . . . 0.0 109.709 175.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -45.17 -41.03 16.58 Favored 'Trans proline' 0 C--N 1.348 0.523 1 C-N-CA 125.806 4.338 . . . . 0.0 115.635 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.1 mt -67.12 -29.69 69.49 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.922 0.489 . . . . 0.0 111.781 -174.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.52 -35.3 9.92 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.872 0.869 . . . . 0.0 110.989 -175.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.4 t -150.79 170.98 17.95 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.538 0.608 . . . . 0.0 110.576 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.5 p -150.03 161.86 29.76 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.995 1.318 . . . . 0.0 109.507 -172.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -50.12 -48.46 19.7 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.684 2.923 . . . . 0.0 113.434 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -58.81 -40.18 83.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.724 0.81 . . . . 0.0 112.044 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 m -66.35 -45.26 80.78 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.247 0.619 . . . . 0.0 109.862 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.4 mt -64.3 -43.32 95.09 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.178 0.991 . . . . 0.0 110.944 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.0 ttp85 -56.3 -48.09 77.37 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.85 0.86 . . . . 0.0 109.573 172.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.11 -41.08 92.45 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.28 0.943 . . . . 0.0 112.571 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.34 -47.41 76.58 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.67 0.788 . . . . 0.0 111.036 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.0 mt -62.83 -41.39 92.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.242 0.617 . . . . 0.0 109.7 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -58.75 -43.58 90.33 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.359 0.664 . . . . 0.0 110.803 175.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.7 -39.5 88.75 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.735 0.814 . . . . 0.0 111.429 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.2 mtp -59.25 -44.8 92.38 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 118.234 0.47 . . . . 0.0 110.593 173.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.93 61.5 0.1 Allowed Glycine 0 C--N 1.341 0.84 0 C-N-CA 123.533 0.587 . . . . 0.0 111.88 169.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -140.5 156.64 46.27 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.98 0.912 . . . . 0.0 109.544 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -79.5 90.46 5.09 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 174.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.47 125.52 45.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.69 1.196 . . . . 0.0 109.774 -174.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.4 p -145.62 135.18 23.25 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.314 1.046 . . . . 0.0 108.949 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.3 141.12 56.6 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.682 0.793 . . . . 0.0 111.866 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.0 m -84.24 -41.91 16.44 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 169.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 . . . . . 0 C--O 1.251 1.132 0 CA-C-O 117.062 -1.447 . . . . 0.0 110.135 177.067 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.4 p -128.99 141.76 51.15 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.655 1.182 . . . . 0.0 109.48 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -135.68 170.41 16.01 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.861 1.665 . . . . 0.0 108.122 172.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -140.13 123.93 17.38 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 t -113.06 134.83 54.35 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.838 1.255 . . . . 0.0 109.22 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.3 t -99.55 125.27 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 169.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.5 mt -120.96 119.73 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -73.92 125.59 28.56 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.8 mt -118.22 107.43 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 125.053 1.341 . . . . 0.0 107.388 -176.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -99.79 135.5 41.12 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.58 0.9 20.07 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.854 1.216 . . . . 0.0 112.791 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.8 mtm -78.6 100.09 6.82 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.4 m -84.33 -36.09 22.8 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.974 1.31 . . . . 0.0 111.235 -169.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.1 p -153.45 179.57 8.66 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.026 0.376 . . . . 0.0 110.285 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -56.29 -30.13 62.08 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.178 1.391 . . . . 0.0 112.931 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 m -55.46 -43.91 75.9 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.434 0.694 . . . . 0.0 111.243 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.1 m -61.76 -53.13 60.16 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.5 t -49.91 -56.22 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.502 1.121 . . . . 0.0 110.146 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -63.34 -46.86 84.65 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.944 0.898 . . . . 0.0 111.586 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.6 p -60.99 -49.97 75.3 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.629 0.372 . . . . 0.0 110.994 -177.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.7 mt -55.88 -55.24 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -52.24 -54.35 32.22 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.792 0.837 . . . . 0.0 111.117 -176.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.14 -52.18 53.65 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 124.117 0.865 . . . . 0.0 112.458 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.2 t -64.03 -49.28 82.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 117.456 0.628 . . . . 0.0 111.044 -174.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.6 mm -64.65 -33.81 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.229 0.612 . . . . 0.0 111.217 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.1 t -53.71 -24.75 15.66 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 177.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -88.53 -8.33 54.99 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.424 0.69 . . . . 0.0 112.121 -172.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -74.06 128.18 86.83 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -46.81 133.84 17.51 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.703 2.935 . . . . 0.0 112.232 175.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.99 -42.11 1.97 Allowed Glycine 0 C--N 1.337 0.593 0 CA-C-O 119.037 -0.868 . . . . 0.0 111.47 -177.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.2 t -67.3 130.47 32.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 CA-C-N 117.846 0.823 . . . . 0.0 109.612 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -105.44 -94.48 0.35 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.4 p -90.05 154.96 19.41 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.482 0.713 . . . . 0.0 109.466 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.6 tt -150.25 135.42 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 37.7 mtt85 -131.56 93.9 3.43 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.66 1.184 . . . . 0.0 108.229 -169.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.2 t -95.29 141.91 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 123.648 0.779 . . . . 0.0 109.21 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.2 t -144.96 125.73 14.28 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.012 0.925 . . . . 0.0 110.283 -175.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 tt -71.43 -44.04 65.6 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.731 1.212 . . . . 0.0 110.039 172.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.05 -43.02 63.59 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.321 1.048 . . . . 0.0 111.449 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -89.4 -20.81 23.5 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.626 0.77 . . . . 0.0 111.141 177.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.7 m 57.76 54.68 6.03 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.646 1.578 . . . . 0.0 109.956 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.9 p30 -154.64 171.27 19.77 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.031 0.533 . . . . 0.0 112.104 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.92 114.34 1.56 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 126.506 2.003 . . . . 0.0 108.15 174.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.9 m -99.42 95.92 7.35 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.9 t -100.73 122.08 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 125.088 1.355 . . . . 0.0 109.12 -171.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -89.83 128.2 36.12 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -150.22 165.28 33.41 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -169.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -101.24 113.7 65.8 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.654 1.182 . . . . 0.0 108.885 171.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -45.57 -38.98 17.14 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.972 3.781 . . . . 0.0 114.884 174.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.0 mt -63.91 -28.9 70.15 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.736 0.814 . . . . 0.0 112.017 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.58 -41.81 7.18 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.08 0.952 . . . . 0.0 110.719 -175.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.8 t -143.83 156.97 44.66 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 123.64 0.776 . . . . 0.0 109.92 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.6 p -117.64 162.67 27.63 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 124.815 1.246 . . . . 0.0 109.9 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.07 -41.77 55.7 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.257 2.638 . . . . 0.0 112.385 171.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -63.36 -41.41 98.84 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.921 0.888 . . . . 0.0 111.872 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.9 m -59.67 -49.18 78.75 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.207 0.458 . . . . 0.0 110.026 176.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.4 mt -62.67 -45.71 91.56 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.021 0.929 . . . . 0.0 110.744 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 65.5 ttp85 -55.05 -50.51 68.91 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.032 0.933 . . . . 0.0 109.886 174.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.8 -42.65 86.19 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.633 1.111 . . . . 0.0 112.253 177.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.28 -39.25 94.05 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 117.446 0.623 . . . . 0.0 111.273 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.3 mt -69.72 -36.66 71.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.969 -0.457 . . . . 0.0 110.583 177.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -59.82 -41.09 90.53 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.83 -0.544 . . . . 0.0 110.273 171.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -63.2 -41.88 99.24 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.121 0.569 . . . . 0.0 111.246 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.7 mmm -57.72 -40.69 80.18 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.12 0.418 . . . . 0.0 110.663 172.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.86 55.77 0.31 Allowed Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.144 0.878 . . . . 0.0 111.622 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -140.44 151.04 44.57 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.752 0.821 . . . . 0.0 109.605 175.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -77.15 94.2 4.04 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.74 134.17 43.03 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.073 1.349 . . . . 0.0 109.639 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.2 t -146.31 140.49 26.49 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.842 0.857 . . . . 0.0 109.498 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.7 mt -69.75 134.68 48.88 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.048 0.539 . . . . 0.0 110.651 -175.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.0 m -92.05 -41.27 10.61 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 169.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.187 -1.387 . . . . 0.0 109.307 172.802 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.6 tt . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.4 p -139.5 154.97 47.81 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.424 1.09 . . . . 0.0 110.161 -178.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -138.44 164.08 30.28 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.747 1.619 . . . . 0.0 108.686 176.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -121.53 144.61 48.62 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.542 1.137 . . . . 0.0 108.986 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.3 t -139.3 143.05 37.71 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.059 0.944 . . . . 0.0 109.445 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.4 t -107.71 116.61 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 172.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.0 mm -99.77 124.14 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 174.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -82.1 111.76 18.53 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 174.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 57.2 mt -107.52 106.09 20.01 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 C-N-CA 124.531 1.132 . . . . 0.0 108.334 -173.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -99.75 128.46 45.84 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.52 -4.66 7.62 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.397 0.999 . . . . 0.0 112.917 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 62.9 mtm -78.56 105.86 10.12 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.9 m -84.45 -34.97 23.33 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.335 1.054 . . . . 0.0 109.99 -173.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 p -158.55 167.63 29.09 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.283 0.633 . . . . 0.0 109.98 -175.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -60.13 -20.97 60.9 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.014 1.325 . . . . 0.0 113.791 -170.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.9 p -52.71 -43.0 65.34 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.715 0.689 . . . . 0.0 110.65 171.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 76.7 m -66.74 -48.22 69.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.528 0.731 . . . . 0.0 110.5 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.7 t -50.79 -53.25 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 123.986 0.915 . . . . 0.0 110.353 176.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -58.24 -50.01 75.07 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.731 1.212 . . . . 0.0 111.107 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.2 m -59.5 -54.54 45.35 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.213 0.605 . . . . 0.0 111.206 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.4 mt -54.53 -54.89 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 124.717 1.207 . . . . 0.0 109.742 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -56.34 -53.11 61.21 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.567 0.747 . . . . 0.0 110.713 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.2 -51.61 45.72 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.525 1.06 . . . . 0.0 112.128 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.0 -54.3 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.349 0.659 . . . . 0.0 110.415 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.41 -36.65 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.002 0.521 . . . . 0.0 111.58 -174.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.9 m -52.27 -30.75 29.33 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.501 0.721 . . . . 0.0 112.767 176.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -89.22 -9.95 48.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.583 0.753 . . . . 0.0 112.242 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -74.66 140.09 74.7 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 118.901 0.773 . . . . 0.0 109.874 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -64.83 137.93 55.74 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.992 2.462 . . . . 0.0 110.131 -175.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.7 -37.39 3.61 Favored Glycine 0 CA--C 1.525 0.656 0 CA-C-O 118.898 -0.946 . . . . 0.0 111.748 -176.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.6 t -67.6 141.16 18.12 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 CA-C-N 117.98 0.89 . . . . 0.0 110.418 -175.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -120.73 -102.85 0.41 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.632 1.173 . . . . 0.0 108.501 176.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.7 p -84.55 147.19 27.15 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.553 0.615 . . . . 0.0 109.807 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -150.22 139.95 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 123.642 0.777 . . . . 0.0 110.055 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.24 101.86 4.99 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.946 1.298 . . . . 0.0 108.498 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -97.54 139.0 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 174.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.2 t -135.23 129.05 33.07 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.176 0.99 . . . . 0.0 110.662 -173.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.1 tp -66.73 -52.97 38.31 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.36 1.064 . . . . 0.0 109.145 170.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.8 -49.03 66.45 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 125.041 1.336 . . . . 0.0 111.908 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -89.3 -6.28 56.87 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.012 0.525 . . . . 0.0 111.861 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.8 m 51.27 53.71 12.43 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.257 1.423 . . . . 0.0 111.229 176.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -156.98 172.17 19.16 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.811 0.444 . . . . 0.0 111.725 -174.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.97 112.38 1.01 Allowed Glycine 0 C--N 1.338 0.667 0 C-N-CA 126.215 1.864 . . . . 0.0 108.982 177.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.9 m -99.04 103.81 15.78 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 t -115.02 127.6 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 124.579 1.151 . . . . 0.0 109.831 -169.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -96.17 132.79 41.22 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 168.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -150.11 166.74 28.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.491 0.716 . . . . 0.0 110.887 -170.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -99.81 113.66 65.22 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.395 1.078 . . . . 0.0 109.062 172.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -43.02 -37.85 6.67 Favored 'Trans proline' 0 C--N 1.349 0.58 1 C-N-CA 125.377 4.051 . . . . 0.0 115.137 172.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.8 mt -63.89 -32.3 73.77 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.449 0.699 . . . . 0.0 111.997 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.72 -43.31 6.5 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.935 0.894 . . . . 0.0 111.076 -174.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.8 t -142.86 176.75 8.83 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.423 0.689 . . . . 0.0 110.315 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.0 p -150.26 162.0 29.06 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 124.271 1.028 . . . . 0.0 110.288 -172.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -53.25 -43.57 56.2 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.645 2.896 . . . . 0.0 112.899 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.17 -34.66 78.58 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.635 0.774 . . . . 0.0 112.183 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.5 m -71.51 -47.08 57.63 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.177 0.591 . . . . 0.0 109.816 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 59.8 mt -59.56 -47.72 84.45 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.903 0.881 . . . . 0.0 110.123 177.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -53.97 -50.04 67.42 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.31 1.044 . . . . 0.0 110.06 172.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.34 -44.84 65.83 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.641 1.115 . . . . 0.0 112.461 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.16 -42.47 98.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.479 0.639 . . . . 0.0 111.106 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.0 mt -66.5 -41.8 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 122.934 0.493 . . . . 0.0 110.526 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -59.49 -41.88 90.84 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.55 0.74 . . . . 0.0 110.563 174.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.22 -44.85 95.65 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.378 0.671 . . . . 0.0 111.098 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.0 mtm -60.87 -36.18 78.54 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.701 0.401 . . . . 0.0 111.215 174.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.68 59.12 0.31 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 123.803 0.716 . . . . 0.0 112.225 169.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -140.3 146.79 38.99 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.923 0.889 . . . . 0.0 108.638 172.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -76.01 90.99 3.04 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.59 132.68 44.77 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.278 1.031 . . . . 0.0 109.886 -177.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.1 m -140.32 152.76 46.09 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.077 1.351 . . . . 0.0 107.646 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.415 HD22 ' H ' ' A' ' 70' ' ' LEU . 2.2 mm? -68.35 145.7 53.93 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.9 p -59.1 -45.3 91.21 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.572 0.349 . . . . 0.0 110.334 169.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 116.933 -1.508 . . . . 0.0 109.2 176.188 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 50.1 tp . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 110.571 -0.159 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.1 p -124.3 103.23 8.1 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.915 1.286 . . . . 0.0 109.914 -172.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -117.32 164.49 14.75 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.376 1.071 . . . . 0.0 108.789 170.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -133.02 146.83 52.1 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.141 0.977 . . . . 0.0 109.717 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.1 t -138.85 142.3 38.62 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.28 1.032 . . . . 0.0 109.518 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.5 t -112.75 102.35 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 175.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.7 mt -99.99 112.98 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -66.05 123.69 20.55 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.1 mt -111.31 125.89 68.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -131.79 151.18 51.85 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.396 0.679 . . . . 0.0 109.861 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.47 36.23 6.62 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.803 1.192 . . . . 0.0 112.095 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -88.67 144.6 26.18 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 117.68 0.74 . . . . 0.0 109.015 174.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.0 p -84.69 -43.73 14.07 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.393 0.677 . . . . 0.0 109.807 177.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.7 p -163.69 -175.51 4.17 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.702 0.801 . . . . 0.0 109.956 -175.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -61.17 -27.64 68.55 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.121 1.369 . . . . 0.0 113.863 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.9 p -59.16 -33.53 71.03 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.638 0.654 . . . . 0.0 111.455 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 80.3 m -60.8 -56.07 25.57 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.154 0.582 . . . . 0.0 109.572 175.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.2 t -53.53 -47.19 60.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.788 1.235 . . . . 0.0 111.08 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -56.47 -52.91 62.94 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.83 0.852 . . . . 0.0 110.679 176.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.5 t -59.15 -51.17 71.18 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.881 0.872 . . . . 0.0 111.259 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.4 mt -52.65 -53.19 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.775 1.23 . . . . 0.0 109.551 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -54.74 -53.16 58.7 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.507 0.723 . . . . 0.0 110.698 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.14 -51.72 48.51 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.389 0.995 . . . . 0.0 112.266 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.0 t -58.94 -52.38 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.728 0.811 . . . . 0.0 110.436 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.24 -37.79 79.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 119.018 -0.515 . . . . 0.0 111.516 -176.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.6 m -52.21 -29.65 23.64 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 177.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -89.22 -8.34 53.73 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.482 0.713 . . . . 0.0 112.416 -175.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -73.84 138.28 76.61 Favored Pre-proline 0 CA--C 1.535 0.365 0 CA-C-N 119.082 0.855 . . . . 0.0 110.254 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -66.47 131.34 26.02 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.858 2.372 . . . . 0.0 109.394 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.24 -39.29 2.96 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-O 118.915 -0.936 . . . . 0.0 111.444 -175.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.6 t -66.43 135.63 28.14 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 117.955 0.878 . . . . 0.0 109.8 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -111.47 -99.62 0.41 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.024 1.329 . . . . 0.0 107.886 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.3 p -90.43 154.66 19.49 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.768 0.827 . . . . 0.0 109.628 172.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 tt -150.6 146.13 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 123.474 0.71 . . . . 0.0 110.447 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -140.1 107.91 5.67 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.837 1.255 . . . . 0.0 107.711 169.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.0 t -98.42 130.65 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 170.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.9 t -124.7 130.83 53.17 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.426 1.09 . . . . 0.0 110.169 -173.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.8 tp -72.56 -48.49 39.67 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.25 1.02 . . . . 0.0 108.936 172.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.85 -47.36 74.28 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.94 1.296 . . . . 0.0 111.626 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -89.3 -7.55 55.15 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.982 0.513 . . . . 0.0 111.525 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.6 m 53.45 54.01 10.76 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 125.234 1.413 . . . . 0.0 111.153 175.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -159.29 169.91 23.02 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.919 -175.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.35 107.2 1.0 Allowed Glycine 0 C--N 1.337 0.596 0 C-N-CA 126.613 2.054 . . . . 0.0 108.614 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.0 m -98.6 96.17 7.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.4 t -109.31 127.49 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 124.587 1.155 . . . . 0.0 108.924 -172.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -97.91 130.7 44.78 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 169.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -150.21 170.7 18.34 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.268 0.627 . . . . 0.0 112.171 -169.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -106.07 114.6 62.36 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.033 1.333 . . . . 0.0 109.477 173.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -44.3 -36.26 9.07 Favored 'Trans proline' 0 C--N 1.348 0.527 1 C-N-CA 125.528 4.152 . . . . 0.0 115.486 174.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.02 -32.36 74.05 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.259 0.624 . . . . 0.0 111.99 -176.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.3 mt -108.17 -29.62 8.83 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.005 0.922 . . . . 0.0 112.371 -171.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.5 t -148.11 175.25 11.18 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.719 0.69 . . . . 0.0 109.615 173.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.8 p -146.94 163.39 28.92 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 123.65 0.78 . . . . 0.0 110.33 -175.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -52.08 -41.99 61.54 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.475 2.783 . . . . 0.0 112.012 173.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -67.82 -39.62 83.89 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.724 0.81 . . . . 0.0 111.474 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.8 m -61.65 -50.36 72.82 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.83 0.452 . . . . 0.0 109.998 176.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 50.8 mt -60.2 -48.13 83.02 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.271 1.029 . . . . 0.0 110.63 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -54.09 -51.2 64.9 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.62 1.168 . . . . 0.0 110.279 175.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.52 -44.73 85.66 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.482 1.039 . . . . 0.0 111.803 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.3 -46.86 86.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.27 0.628 . . . . 0.0 111.354 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -61.34 -39.6 83.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 123.069 0.548 . . . . 0.0 110.093 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.73 -40.68 95.74 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.98 0.512 . . . . 0.0 110.901 177.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -64.01 -43.17 96.44 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.053 0.941 . . . . 0.0 110.982 176.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 79.5 mmm -56.09 -41.39 75.1 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.546 0.738 . . . . 0.0 110.2 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.15 53.5 0.23 Allowed Glycine 0 C--N 1.341 0.859 0 C-N-CA 123.994 0.806 . . . . 0.0 112.02 169.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -140.45 145.61 37.19 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.634 0.774 . . . . 0.0 109.347 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -68.76 100.84 1.22 Allowed 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.39 120.63 40.83 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.194 1.398 . . . . 0.0 109.938 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.2 p -142.32 137.23 30.42 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.653 0.781 . . . . 0.0 109.915 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.5 mt -73.82 137.97 44.16 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.213 0.605 . . . . 0.0 110.988 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.5 m -77.61 -43.73 30.61 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 168.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 C--O 1.251 1.173 0 C-N-CA 125.765 1.626 . . . . 0.0 110.315 -179.219 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.5 p . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 121.036 0.446 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -128.47 173.15 10.48 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.799 1.639 . . . . 0.0 108.446 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -137.86 141.07 40.73 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.901 0.88 . . . . 0.0 108.998 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -130.71 135.8 48.16 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 124.376 1.07 . . . . 0.0 109.68 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.8 t -101.05 107.14 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 172.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.2 mt -99.85 121.52 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -75.79 125.7 29.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 57.8 mt -123.36 98.75 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -174.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -99.73 152.57 19.94 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.49 16.83 48.01 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.54 1.067 . . . . 0.0 112.323 -173.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 97.7 mtp -79.86 110.06 14.87 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.3 t -84.58 -37.93 20.56 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.286 0.635 . . . . 0.0 111.776 -173.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.2 p -158.48 179.72 8.87 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.119 0.568 . . . . 0.0 109.884 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -69.09 -13.33 62.37 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -173.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.7 p -59.83 -36.71 77.38 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.074 0.852 . . . . 0.0 110.12 170.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -59.56 -51.73 68.59 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.38 0.672 . . . . 0.0 109.608 174.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.2 t -52.17 -55.4 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.672 0.789 . . . . 0.0 110.234 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -57.61 -52.48 65.24 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.523 1.129 . . . . 0.0 111.647 -177.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.8 p -61.14 -48.95 79.24 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.694 0.398 . . . . 0.0 111.132 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 88.2 mt -59.19 -54.92 27.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.896 0.878 . . . . 0.0 110.233 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -62.21 -37.71 86.4 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.633 0.651 . . . . 0.0 111.194 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.41 -53.99 40.59 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.829 0.728 . . . . 0.0 111.294 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.22 -54.12 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.642 0.777 . . . . 0.0 110.431 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.4 mt -63.2 -39.86 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 122.891 0.476 . . . . 0.0 111.797 -172.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.6 p -55.96 -24.71 39.98 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -89.49 -9.28 50.61 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.076 0.951 . . . . 0.0 112.184 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -70.35 141.52 88.53 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 118.897 0.771 . . . . 0.0 109.693 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.4 132.55 29.65 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.859 2.373 . . . . 0.0 109.842 -177.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.21 -26.82 22.82 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 118.7 -1.055 . . . . 0.0 112.83 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.0 t -68.27 138.66 22.09 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 118.428 1.114 . . . . 0.0 110.149 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -119.95 -102.6 0.41 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.55 1.14 . . . . 0.0 108.89 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.8 p -80.2 150.77 30.01 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 118.362 0.528 . . . . 0.0 109.853 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.3 tt -150.12 139.48 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 123.329 0.652 . . . . 0.0 110.256 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -139.01 97.39 3.3 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.173 1.389 . . . . 0.0 108.602 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.8 t -99.17 142.27 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 124.476 1.11 . . . . 0.0 108.631 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.0 t -139.84 131.98 28.06 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.803 0.841 . . . . 0.0 110.711 -174.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.8 tp -70.42 -51.57 28.55 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.105 1.362 . . . . 0.0 109.112 169.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.39 -47.16 76.27 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.112 1.365 . . . . 0.0 111.889 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -89.3 -7.78 54.67 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.046 0.538 . . . . 0.0 111.236 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.0 m 54.11 56.55 6.89 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.391 1.477 . . . . 0.0 110.932 174.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -161.31 172.83 15.93 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.632 0.373 . . . . 0.0 111.883 -172.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -137.09 112.8 0.96 Allowed Glycine 0 C--N 1.339 0.727 0 C-N-CA 126.276 1.893 . . . . 0.0 109.29 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.5 m -99.43 103.74 15.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.6 t -116.29 123.95 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 124.285 1.034 . . . . 0.0 109.428 -170.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -89.95 132.36 35.37 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 169.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -150.33 163.24 38.82 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.046 0.539 . . . . 0.0 112.097 -171.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -97.39 115.43 65.74 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.728 1.211 . . . . 0.0 109.932 173.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -47.47 -38.41 27.49 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 125.28 3.987 . . . . 0.0 115.894 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 mp -69.92 -29.87 67.14 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.075 0.398 . . . . 0.0 111.368 -174.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.9 mt -99.72 -31.77 11.38 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.095 0.958 . . . . 0.0 111.932 -173.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.7 t -151.59 171.78 17.08 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.377 0.671 . . . . 0.0 109.822 175.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.3 p -141.79 164.2 35.91 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.229 1.012 . . . . 0.0 110.329 -174.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -53.34 -39.48 81.2 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.274 2.649 . . . . 0.0 112.081 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -67.86 -38.96 83.78 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.781 0.833 . . . . 0.0 111.698 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 m -61.83 -50.27 72.97 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.35 0.523 . . . . 0.0 109.863 175.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 61.7 mt -60.61 -53.0 62.73 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.509 1.123 . . . . 0.0 110.578 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -52.29 -46.58 65.97 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.151 1.38 . . . . 0.0 110.197 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.55 -53.41 38.87 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.788 1.185 . . . . 0.0 111.425 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.63 -44.51 90.03 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 117.672 0.736 . . . . 0.0 111.727 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.8 mt -60.77 -44.53 97.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 122.791 0.436 . . . . 0.0 110.015 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -61.35 -40.03 92.76 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.725 0.81 . . . . 0.0 110.824 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -63.82 -41.14 97.93 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.453 1.101 . . . . 0.0 110.999 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.9 mtp -59.49 -45.76 90.76 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.025 0.375 . . . . 0.0 110.267 173.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.48 63.04 0.14 Allowed Glycine 0 C--N 1.341 0.815 0 C-N-CA 123.552 0.596 . . . . 0.0 111.774 169.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -140.42 158.13 44.47 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 124.057 0.943 . . . . 0.0 109.379 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -76.9 93.44 3.76 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.37 121.13 40.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.76 1.224 . . . . 0.0 109.367 -175.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.6 t -148.45 148.26 30.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.891 0.876 . . . . 0.0 108.85 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.1 mt . . . . . 0 CA--C 1.531 0.235 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -178.394 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.5 p . . . . . 0 CA--C 1.528 0.128 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -141.12 173.24 11.67 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.353 1.461 . . . . 0.0 108.898 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -123.98 141.54 51.96 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.651 1.18 . . . . 0.0 108.559 172.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -130.77 130.77 44.15 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.116 0.966 . . . . 0.0 109.489 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 77.6 t -99.9 104.97 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.2 mt -99.98 126.01 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -75.05 129.71 38.07 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 174.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.9 mt -128.18 90.22 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -99.66 161.11 13.81 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.08 21.14 61.52 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 119.246 -0.752 . . . . 0.0 112.533 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 69.9 mtm -79.85 130.01 34.96 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 118.333 1.067 . . . . 0.0 108.389 170.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.4 m -84.43 -46.25 11.87 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.195 0.598 . . . . 0.0 110.573 -173.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 p -165.38 175.78 8.84 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.328 0.651 . . . . 0.0 110.268 -170.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -52.09 -35.71 48.63 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.907 1.283 . . . . 0.0 113.301 -173.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.1 p -50.28 -41.04 50.01 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.903 0.774 . . . . 0.0 111.64 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.2 m -64.28 -49.11 73.12 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.382 0.673 . . . . 0.0 110.58 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.8 t -51.93 -53.86 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.975 0.91 . . . . 0.0 110.346 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -62.49 -43.22 99.36 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.792 0.837 . . . . 0.0 111.547 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.4 t -59.56 -53.4 58.5 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.012 0.525 . . . . 0.0 110.663 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.8 mt -56.39 -52.44 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.342 1.057 . . . . 0.0 109.576 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -52.82 -55.1 25.5 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.449 1.1 . . . . 0.0 110.531 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.09 -53.66 42.9 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.385 0.993 . . . . 0.0 111.9 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.61 -50.55 78.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.423 0.689 . . . . 0.0 110.975 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 76.7 mt -68.67 -41.07 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.648 -175.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.3 p -55.68 -25.15 38.14 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -89.25 -8.51 53.33 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.134 0.974 . . . . 0.0 112.169 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -70.5 140.75 87.42 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 119.116 0.871 . . . . 0.0 110.532 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.1 128.91 20.54 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.674 2.249 . . . . 0.0 109.181 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.82 -39.27 2.97 Favored Glycine 0 C--N 1.336 0.554 0 CA-C-O 119.073 -0.848 . . . . 0.0 111.557 -175.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.0 t -70.37 137.83 23.18 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 CA-C-N 117.881 0.84 . . . . 0.0 109.419 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -114.24 -98.3 0.44 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.313 1.045 . . . . 0.0 108.186 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 86.7 p -90.27 155.43 18.99 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.953 0.501 . . . . 0.0 110.128 176.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.59 143.05 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.186 0.995 . . . . 0.0 109.859 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.36 105.91 8.2 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.686 1.195 . . . . 0.0 108.653 173.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.6 t -98.06 136.42 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 172.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -139.05 126.94 22.2 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.651 0.78 . . . . 0.0 110.451 -176.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.3 tp -69.68 -45.73 67.66 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.455 1.102 . . . . 0.0 109.857 171.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.73 -47.15 67.56 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.458 1.103 . . . . 0.0 111.497 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -89.38 -12.37 40.56 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.293 0.637 . . . . 0.0 111.797 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.3 m 53.44 58.08 5.55 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 125.317 1.447 . . . . 0.0 110.441 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.9 p-10 -156.39 173.36 17.0 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.991 0.516 . . . . 0.0 111.953 -174.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.45 110.97 0.83 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 126.719 2.104 . . . . 0.0 108.015 174.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.8 m -99.24 101.45 12.77 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.8 t -110.96 125.37 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 124.664 1.186 . . . . 0.0 109.424 -169.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -91.26 127.82 36.85 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 169.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -146.77 167.17 24.51 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.442 0.697 . . . . 0.0 111.86 -169.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -105.64 111.14 64.78 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.155 1.382 . . . . 0.0 109.368 174.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -45.31 -37.27 13.81 Favored 'Trans proline' 0 C--N 1.348 0.552 1 C-N-CA 125.44 4.093 . . . . 0.0 116.248 177.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -70.21 -30.61 67.75 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.173 0.442 . . . . 0.0 111.33 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.3 mt -99.96 -32.38 11.0 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.212 1.005 . . . . 0.0 112.042 -172.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.7 t -149.9 170.59 18.46 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.785 0.834 . . . . 0.0 109.428 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.6 p -137.85 162.25 55.41 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 123.967 0.907 . . . . 0.0 110.643 -176.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -53.05 -39.12 80.73 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.321 2.681 . . . . 0.0 112.043 172.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -68.32 -40.04 81.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.779 0.832 . . . . 0.0 111.482 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.3 m -60.37 -50.35 73.94 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.926 0.49 . . . . 0.0 109.941 175.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.1 mt -59.51 -50.12 75.13 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.234 1.014 . . . . 0.0 110.511 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -52.5 -48.71 65.81 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.843 1.257 . . . . 0.0 110.627 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.75 -46.47 89.62 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.319 0.962 . . . . 0.0 111.785 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.74 -44.41 96.28 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.117 0.567 . . . . 0.0 111.467 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.44 -45.26 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.082 0.553 . . . . 0.0 110.075 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -59.42 -42.13 91.14 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.731 0.813 . . . . 0.0 110.696 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -62.44 -44.52 96.23 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.742 0.817 . . . . 0.0 111.217 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.9 mtm -59.91 -36.47 77.04 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.657 0.383 . . . . 0.0 110.898 174.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.0 59.91 0.34 Allowed Glycine 0 C--N 1.341 0.811 0 C-N-CA 123.758 0.694 . . . . 0.0 111.996 169.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -140.38 158.64 43.71 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.898 0.879 . . . . 0.0 109.379 173.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -75.77 94.32 3.27 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.5 112.08 24.34 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.967 1.307 . . . . 0.0 110.084 -172.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.9 p -142.56 133.05 25.07 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.575 0.75 . . . . 0.0 109.757 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.5 mt . . . . . 0 CA--C 1.532 0.288 0 C-N-CA 123.455 0.702 . . . . 0.0 110.85 -179.767 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.9 p . . . . . 0 CA--C 1.53 0.184 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -142.05 171.66 13.75 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.589 1.155 . . . . 0.0 109.238 173.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -139.99 141.69 36.34 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.327 1.051 . . . . 0.0 108.752 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -131.23 138.27 49.27 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.469 1.107 . . . . 0.0 109.81 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.3 t -106.11 100.54 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 174.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.0 mt -99.76 115.21 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -67.01 124.98 24.56 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.4 mt -113.72 100.8 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 106.662 -1.606 . . . . 0.0 106.662 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -99.67 146.37 26.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.698 0.799 . . . . 0.0 109.465 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.84 27.69 31.07 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.226 0.917 . . . . 0.0 112.839 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 73.2 mtm -80.45 135.42 36.14 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.23 1.015 . . . . 0.0 108.93 170.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.7 m -84.22 -48.0 10.23 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.004 0.922 . . . . 0.0 110.201 -174.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 p -161.06 -178.4 6.74 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.48 0.712 . . . . 0.0 109.618 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -61.23 -23.26 65.51 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.614 1.166 . . . . 0.0 113.321 -176.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.3 m -57.61 -37.99 74.19 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.598 0.635 . . . . 0.0 111.266 174.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.4 m -63.85 -51.81 62.96 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -51.85 -49.49 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.521 1.128 . . . . 0.0 110.552 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -57.95 -47.72 82.09 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.431 1.092 . . . . 0.0 110.998 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.7 t -62.22 -52.55 63.33 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.475 0.71 . . . . 0.0 111.188 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.9 mt -54.7 -56.24 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.962 1.305 . . . . 0.0 109.719 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -59.18 -46.77 87.55 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.445 0.698 . . . . 0.0 110.562 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.82 -48.6 50.53 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.932 1.254 . . . . 0.0 112.162 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.18 -62.56 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 117.507 0.653 . . . . 0.0 110.218 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.2 mt -58.82 -39.12 76.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.978 0.911 . . . . 0.0 112.108 -169.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 77.9 p -49.99 -33.84 19.17 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.846 0.859 . . . . 0.0 113.183 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -89.66 -14.89 33.86 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.605 0.762 . . . . 0.0 112.295 -175.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -71.14 143.66 88.81 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 118.689 0.677 . . . . 0.0 110.662 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -63.06 137.39 61.62 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.241 2.627 . . . . 0.0 110.663 -174.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.51 -35.66 4.57 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 119.128 -0.818 . . . . 0.0 111.793 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.0 t -68.45 128.57 32.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 CA-C-N 118.017 0.909 . . . . 0.0 109.847 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -99.68 -103.47 0.23 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.917 1.287 . . . . 0.0 107.854 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.9 p -87.2 154.12 20.97 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.6 0.76 . . . . 0.0 109.519 173.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.7 tt -150.41 135.24 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 123.172 0.589 . . . . 0.0 109.974 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 -134.68 100.82 4.74 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.916 1.287 . . . . 0.0 108.683 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.8 t -98.76 139.12 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.235 1.014 . . . . 0.0 108.637 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.4 t -135.6 132.18 36.78 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 124.445 1.098 . . . . 0.0 110.646 -173.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.7 tp -72.48 -49.45 33.09 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.318 1.047 . . . . 0.0 109.357 173.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.94 -44.82 78.77 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.08 1.352 . . . . 0.0 111.762 -177.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -89.23 -9.68 49.82 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.234 0.613 . . . . 0.0 111.201 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.1 m 54.44 52.42 12.44 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.61 1.564 . . . . 0.0 111.05 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -157.24 170.41 22.53 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.972 0.415 . . . . 0.0 111.838 -173.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.08 113.67 1.69 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 126.561 2.029 . . . . 0.0 108.658 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.3 m -98.77 93.19 5.94 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.8 t -105.63 120.57 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 124.398 1.079 . . . . 0.0 109.009 -171.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -89.78 133.81 34.51 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 169.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -150.25 166.79 28.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.838 0.455 . . . . 0.0 112.145 -169.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -102.78 113.2 66.04 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 125.255 1.422 . . . . 0.0 108.573 172.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -44.35 -36.1 9.05 Favored 'Trans proline' 0 C--N 1.347 0.467 1 C-N-CA 125.49 4.127 . . . . 0.0 115.077 173.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.6 mt -65.36 -36.6 84.49 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.237 0.615 . . . . 0.0 111.768 -177.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.1 mp -99.65 -34.26 10.28 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.956 0.902 . . . . 0.0 111.59 -171.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.3 t -147.82 177.32 9.42 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.457 0.703 . . . . 0.0 109.952 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.9 p -148.39 163.98 23.94 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 124.085 0.954 . . . . 0.0 110.264 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.4 -40.79 77.07 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.398 2.732 . . . . 0.0 112.078 174.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -67.91 -39.41 83.57 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.6 0.76 . . . . 0.0 111.369 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.7 m -61.5 -49.95 74.68 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.898 0.479 . . . . 0.0 110.068 175.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.0 mt -60.2 -48.79 80.22 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.172 0.989 . . . . 0.0 110.633 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -53.27 -50.09 65.56 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.69 1.196 . . . . 0.0 110.23 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.9 -43.21 92.66 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.523 1.059 . . . . 0.0 112.273 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.92 -42.07 98.67 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.344 0.572 . . . . 0.0 111.12 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.4 mt -66.75 -40.4 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.105 0.562 . . . . 0.0 110.389 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -59.01 -43.36 91.53 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.775 0.43 . . . . 0.0 110.78 172.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.39 -44.48 97.07 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.205 0.602 . . . . 0.0 111.03 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.2 mtm -62.29 -33.78 75.3 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.852 0.461 . . . . 0.0 111.26 174.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.3 56.59 0.42 Allowed Glycine 0 C--N 1.341 0.842 0 C-N-CA 123.814 0.721 . . . . 0.0 112.53 169.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -140.41 150.95 44.51 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.665 0.786 . . . . 0.0 109.424 172.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -75.45 98.63 3.96 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.62 128.24 45.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.68 1.192 . . . . 0.0 109.732 -175.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.3 t -150.08 169.34 21.48 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.145 0.978 . . . . 0.0 108.552 175.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 CA--C 1.534 0.332 0 C-N-CA 122.727 0.411 . . . . 0.0 110.183 -178.463 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.6 p . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -126.33 149.9 48.87 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 169.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -119.74 149.04 42.67 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.741 0.816 . . . . 0.0 110.144 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.4 t -145.63 146.93 31.52 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.097 0.959 . . . . 0.0 109.102 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.9 t -113.11 125.61 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 172.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.5 mt -120.33 131.64 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -80.75 122.82 27.62 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 173.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.65 95.79 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -99.29 146.71 25.94 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.442 0.697 . . . . 0.0 109.438 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.1 42.26 7.17 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.12 0.867 . . . . 0.0 112.235 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.1 mtt -79.49 143.47 34.88 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 169.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 64.1 p -84.51 -42.37 15.59 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.597 0.759 . . . . 0.0 110.462 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.4 p -163.63 -179.71 6.6 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.126 0.97 . . . . 0.0 109.24 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -63.04 -24.86 68.11 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.163 0.985 . . . . 0.0 113.164 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m -53.13 -35.03 59.24 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.747 0.703 . . . . 0.0 111.574 174.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.5 m -58.34 -49.0 78.75 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.014 0.526 . . . . 0.0 110.834 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.2 t -50.81 -51.46 20.18 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 C-N-CA 123.773 0.829 . . . . 0.0 109.779 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -57.73 -53.7 55.26 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.928 0.891 . . . . 0.0 110.398 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.5 m -54.98 -46.93 75.15 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.244 0.618 . . . . 0.0 111.801 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 57.1 mt -60.65 -59.22 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 124.078 0.951 . . . . 0.0 109.8 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -60.72 -35.71 77.02 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 118.233 0.469 . . . . 0.0 111.302 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.62 -60.31 9.21 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 124.363 0.982 . . . . 0.0 110.676 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.55 -58.02 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 123.002 0.521 . . . . 0.0 110.139 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.9 mt -60.04 -41.33 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.29 0.636 . . . . 0.0 111.892 -169.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.4 p -54.38 -30.83 53.23 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.727 0.694 . . . . 0.0 112.833 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -89.42 -11.32 43.48 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.529 0.731 . . . . 0.0 112.559 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -68.86 141.31 92.22 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 119.253 0.933 . . . . 0.0 109.752 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.08 131.28 26.48 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.991 2.461 . . . . 0.0 110.083 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.8 -33.24 6.72 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-O 118.711 -1.049 . . . . 0.0 112.181 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.3 t -67.3 139.06 21.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-N 118.256 1.028 . . . . 0.0 110.478 -176.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -121.12 -105.65 0.38 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.317 1.447 . . . . 0.0 108.144 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.0 p -80.03 144.85 32.85 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.652 0.66 . . . . 0.0 110.018 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.29 144.09 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.543 0.737 . . . . 0.0 110.824 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -140.28 131.96 27.28 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.123 1.369 . . . . 0.0 107.728 169.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.9 t -123.97 145.8 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.998 1.319 . . . . 0.0 108.229 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.7 t -139.16 132.82 30.55 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 124.138 0.975 . . . . 0.0 110.776 -173.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.9 tp -74.35 -49.98 20.58 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.72 1.208 . . . . 0.0 109.301 171.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.65 -46.15 67.03 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.732 1.213 . . . . 0.0 111.536 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -89.58 -12.13 40.69 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.427 0.691 . . . . 0.0 111.611 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.6 m 53.13 52.06 14.46 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 125.181 1.393 . . . . 0.0 110.581 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -154.47 172.57 17.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.961 0.504 . . . . 0.0 111.687 -175.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -142.76 116.25 1.01 Allowed Glycine 0 C--N 1.338 0.648 0 C-N-CA 125.644 1.592 . . . . 0.0 109.392 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.5 m -99.55 115.56 29.65 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.4 t -128.23 129.07 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 124.007 0.923 . . . . 0.0 109.755 -170.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -97.87 133.65 42.08 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 168.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -150.47 167.06 28.27 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.332 0.653 . . . . 0.0 111.482 -171.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -101.53 113.88 65.76 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.636 1.174 . . . . 0.0 109.431 173.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -43.37 -39.74 9.3 Favored 'Trans proline' 0 C--N 1.348 0.526 1 C-N-CA 125.603 4.202 . . . . 0.0 115.51 176.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.1 mt -63.98 -34.31 77.7 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.377 0.671 . . . . 0.0 111.81 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.3 mt -102.8 -29.27 11.57 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.912 0.885 . . . . 0.0 112.269 -172.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.8 t -152.55 165.92 33.66 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.415 0.686 . . . . 0.0 109.491 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.0 p -138.75 167.51 19.17 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.592 1.157 . . . . 0.0 110.041 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.35 -38.35 89.0 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.436 2.757 . . . . 0.0 112.181 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -67.08 -38.85 86.47 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.912 0.885 . . . . 0.0 111.508 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.4 m -62.58 -48.75 78.09 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.862 0.465 . . . . 0.0 109.933 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.4 mt -59.0 -53.23 60.8 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.373 1.069 . . . . 0.0 110.302 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 66.0 ttp85 -53.18 -46.02 68.79 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.987 1.315 . . . . 0.0 110.843 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.77 -49.09 77.28 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.489 1.042 . . . . 0.0 111.809 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.07 -46.78 89.28 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 117.385 0.593 . . . . 0.0 111.243 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.0 mt -57.34 -44.16 83.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.653 0.781 . . . . 0.0 110.019 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -61.47 -42.79 99.32 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.812 0.445 . . . . 0.0 110.605 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.14 -39.3 92.13 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.157 0.983 . . . . 0.0 111.926 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 28.8 mtt -55.79 -48.13 75.9 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 118.348 0.522 . . . . 0.0 110.128 173.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.45 58.99 0.13 Allowed Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 174.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -140.08 152.49 46.21 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.384 1.074 . . . . 0.0 108.707 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -72.76 99.98 2.75 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.8 122.29 42.55 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.693 1.197 . . . . 0.0 109.671 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.6 t -150.08 144.19 25.59 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 47.0 mt . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.698 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 43.1 p . . . . . 0 CA--C 1.532 0.251 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -125.63 169.22 12.71 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.913 1.285 . . . . 0.0 109.106 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -131.76 148.21 52.55 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.553 1.141 . . . . 0.0 109.608 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -146.22 148.69 32.76 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.681 1.192 . . . . 0.0 108.972 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.3 t -120.85 128.08 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.6 mt -122.28 126.84 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -67.8 133.05 48.55 Favored 'General case' 0 CA--C 1.526 0.051 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 172.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.5 mt -131.27 88.78 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -99.8 164.19 12.14 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.81 16.7 69.62 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 119.244 -0.753 . . . . 0.0 112.445 -174.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.1 mtm -79.81 124.9 29.04 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.384 1.092 . . . . 0.0 108.389 170.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.1 p -84.53 -40.9 17.06 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.763 0.825 . . . . 0.0 110.934 -175.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.4 p -158.85 -178.39 7.21 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.893 0.377 . . . . 0.0 110.717 -174.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -57.49 -28.35 63.35 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.623 1.569 . . . . 0.0 113.65 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 m -54.82 -41.28 70.46 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.233 0.613 . . . . 0.0 111.142 175.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.4 m -62.51 -51.47 67.31 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 122.864 0.465 . . . . 0.0 110.016 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.4 t -50.51 -56.35 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.96 0.904 . . . . 0.0 110.14 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -59.77 -50.66 72.94 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.463 1.105 . . . . 0.0 111.488 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.2 p -60.99 -50.39 73.6 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.906 0.482 . . . . 0.0 111.47 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.6 mt -57.75 -52.65 55.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.136 0 C-N-CA 123.353 0.661 . . . . 0.0 109.474 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -54.04 -49.62 68.53 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.289 0.636 . . . . 0.0 110.677 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.15 -54.9 33.87 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.3 0.953 . . . . 0.0 112.309 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.22 -55.47 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.392 0.677 . . . . 0.0 110.613 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.2 mm -64.34 -39.03 84.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 123.55 0.74 . . . . 0.0 111.47 -173.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.7 p -55.02 -30.59 59.87 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.972 0.806 . . . . 0.0 112.69 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -89.41 -3.27 58.49 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.99 0.916 . . . . 0.0 112.267 -175.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -73.12 125.5 90.93 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 119.03 0.832 . . . . 0.0 109.006 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -48.53 118.1 3.1 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.746 2.964 . . . . 0.0 112.128 176.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.37 -36.63 3.54 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 124.042 0.829 . . . . 0.0 111.849 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.7 t -72.66 130.55 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-N 117.87 0.835 . . . . 0.0 109.433 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -90.03 -105.09 0.09 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.0 p -90.62 159.02 16.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.055 1.342 . . . . 0.0 109.852 171.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.8 tt -150.42 134.04 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 123.921 0.888 . . . . 0.0 109.245 173.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -118.28 106.69 13.04 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.866 1.266 . . . . 0.0 108.975 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.2 t -95.35 145.25 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.097 0.959 . . . . 0.0 108.419 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -144.59 128.01 16.92 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.624 0.77 . . . . 0.0 110.461 -177.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.4 tp -70.92 -46.33 62.68 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.558 1.143 . . . . 0.0 110.011 172.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.37 -45.36 65.75 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.397 1.079 . . . . 0.0 111.565 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -89.59 -17.01 29.31 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.557 0.743 . . . . 0.0 111.5 178.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m 54.94 57.73 5.38 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.254 1.422 . . . . 0.0 110.117 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -156.21 173.19 17.2 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.274 0.63 . . . . 0.0 111.627 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.08 116.22 1.7 Allowed Glycine 0 C--N 1.338 0.65 0 C-N-CA 126.438 1.971 . . . . 0.0 108.271 174.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.7 m -99.38 102.52 14.14 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.8 t -108.56 131.55 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 124.428 1.091 . . . . 0.0 110.073 -169.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -101.25 130.6 47.41 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 168.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -150.81 174.79 12.67 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -169.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -115.73 110.36 44.49 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.747 1.619 . . . . 0.0 109.384 174.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -41.58 -38.94 4.42 Favored 'Trans proline' 0 C--N 1.349 0.571 1 C-N-CA 125.999 4.466 . . . . 0.0 115.19 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.1 mt -62.44 -30.71 71.44 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.442 0.697 . . . . 0.0 112.174 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.6 mt -109.52 -36.51 5.95 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.437 1.095 . . . . 0.0 112.018 -171.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.2 t -144.58 171.49 14.3 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.914 0.886 . . . . 0.0 109.303 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.6 p -150.3 161.28 31.23 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 123.215 0.606 . . . . 0.0 110.506 -175.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -49.09 -48.74 17.3 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.947 3.098 . . . . 0.0 113.99 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -66.12 -31.94 73.09 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.257 0.623 . . . . 0.0 112.443 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.0 m -68.11 -48.16 66.23 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 44.4 mt -60.5 -48.46 81.66 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.369 1.068 . . . . 0.0 110.174 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -51.5 -48.99 62.72 Favored 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 124.611 1.165 . . . . 0.0 110.224 172.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.79 -47.1 80.88 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.339 0.971 . . . . 0.0 112.15 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.7 84.16 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.411 0.684 . . . . 0.0 111.212 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.7 mt -61.16 -43.41 96.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.3 0.64 . . . . 0.0 110.048 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -60.82 -41.18 95.21 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.594 0.758 . . . . 0.0 110.719 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.86 -40.97 97.22 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.679 0.791 . . . . 0.0 111.185 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.3 mtp -59.52 -40.45 87.16 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.077 0.399 . . . . 0.0 110.635 173.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.12 62.0 0.22 Allowed Glycine 0 C--N 1.342 0.879 0 C-N-CA 123.712 0.672 . . . . 0.0 111.917 169.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -140.5 160.79 39.22 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.814 0.846 . . . . 0.0 110.02 175.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -77.1 89.62 3.61 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.44 115.15 28.61 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.48 1.112 . . . . 0.0 109.734 -173.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 81.2 p -141.17 148.62 40.3 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 124.17 0.988 . . . . 0.0 108.955 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 52.1 mt . . . . . 0 CA--C 1.531 0.232 0 CA-C-N 118.086 0.403 . . . . 0.0 110.748 -178.956 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.0 p . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -146.88 163.53 35.81 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.967 1.307 . . . . 0.0 108.983 169.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -125.32 143.56 50.91 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.344 1.458 . . . . 0.0 108.517 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.2 t -150.12 165.68 32.09 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 122.931 0.493 . . . . 0.0 111.072 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.1 t -130.59 134.81 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 170.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.2 mm -113.63 127.34 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 172.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -85.5 122.4 29.58 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 172.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.1 mt -121.98 97.07 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 125.336 1.454 . . . . 0.0 107.691 -169.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -99.79 154.47 18.3 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.959 0.409 . . . . 0.0 110.017 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.55 11.25 51.71 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.734 1.159 . . . . 0.0 112.152 -171.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 98.2 mtp -79.89 116.33 19.98 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.155 0.978 . . . . 0.0 108.597 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.0 p -84.71 -47.85 10.04 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.701 0.801 . . . . 0.0 111.529 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.8 p -153.98 -179.67 8.08 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.09 0.556 . . . . 0.0 110.512 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -58.28 -25.35 61.69 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.343 1.457 . . . . 0.0 113.523 -177.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 t -55.34 -40.63 71.45 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.102 0.561 . . . . 0.0 110.626 174.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.0 m -63.49 -46.97 83.71 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 122.998 0.519 . . . . 0.0 110.448 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.5 t -52.58 -53.66 19.17 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 123.686 0.794 . . . . 0.0 109.567 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -59.16 -48.06 83.01 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.722 0.809 . . . . 0.0 111.379 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.5 m -60.99 -53.73 53.69 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.396 0.678 . . . . 0.0 111.219 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.2 mt -57.82 -56.27 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 123.885 0.874 . . . . 0.0 109.26 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -55.86 -48.67 75.12 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.17 0.588 . . . . 0.0 110.905 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.94 -55.19 30.4 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.232 0.92 . . . . 0.0 112.034 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.75 -55.98 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 117.371 0.585 . . . . 0.0 110.771 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.2 mm -63.0 -37.32 79.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.504 0.721 . . . . 0.0 111.758 -173.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.1 p -54.29 -34.63 61.31 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.975 0.807 . . . . 0.0 112.414 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -89.53 0.56 56.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.624 0.77 . . . . 0.0 112.709 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -72.55 143.22 84.84 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 119.151 0.887 . . . . 0.0 109.186 175.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.47 128.43 21.29 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.943 2.429 . . . . 0.0 110.252 -175.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.38 -35.62 4.94 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-O 118.789 -1.006 . . . . 0.0 112.292 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.9 t -66.65 123.5 19.81 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 CA-C-N 118.219 1.009 . . . . 0.0 109.623 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -96.92 -96.88 0.2 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.1 p -90.08 147.12 23.83 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.237 0.615 . . . . 0.0 109.963 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.3 tt -149.89 142.71 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.835 1.254 . . . . 0.0 108.924 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.31 130.6 25.17 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.859 0.864 . . . . 0.0 109.214 169.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.54 147.75 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 125.399 1.48 . . . . 0.0 108.823 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.2 t -139.32 130.22 26.26 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.012 0.925 . . . . 0.0 110.769 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.0 tp -72.39 -49.91 30.39 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.917 1.287 . . . . 0.0 109.271 170.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.62 67.12 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.65 1.18 . . . . 0.0 111.639 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -89.55 -8.84 51.83 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.272 0.629 . . . . 0.0 111.648 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.9 m 52.24 56.79 7.22 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 125.297 1.439 . . . . 0.0 110.681 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.9 p30 -161.97 172.04 16.64 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.838 0.455 . . . . 0.0 111.513 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.22 119.27 1.97 Allowed Glycine 0 C--N 1.338 0.658 0 C-N-CA 125.577 1.56 . . . . 0.0 109.287 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.5 m -99.44 121.88 41.76 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.2 t -129.48 137.08 57.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 124.366 1.066 . . . . 0.0 110.126 -169.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -112.97 129.87 56.33 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -150.28 169.99 20.07 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -168.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -97.38 114.72 65.24 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.64 1.576 . . . . 0.0 109.548 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -44.85 -41.36 15.18 Favored 'Trans proline' 0 C--N 1.349 0.555 1 C-N-CA 125.452 4.102 . . . . 0.0 114.399 174.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.0 mt -61.53 -32.9 72.97 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.944 0.898 . . . . 0.0 111.903 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.1 mt -105.34 -28.8 10.67 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.069 0.948 . . . . 0.0 112.215 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.7 t -153.16 163.23 40.24 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.837 0.744 . . . . 0.0 110.374 178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.9 p -136.01 165.85 32.62 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 125.723 1.609 . . . . 0.0 109.504 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -53.12 -37.61 79.81 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.448 2.765 . . . . 0.0 112.573 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -67.21 -41.35 85.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.261 1.024 . . . . 0.0 110.46 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.6 m -64.03 -48.05 77.82 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.999 0.52 . . . . 0.0 110.048 177.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.4 mt -59.39 -49.66 76.96 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.937 0.895 . . . . 0.0 110.294 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -50.96 -51.03 56.58 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.317 1.047 . . . . 0.0 110.382 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.13 -46.6 84.98 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.323 0.963 . . . . 0.0 112.248 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.73 92.77 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.49 0.716 . . . . 0.0 111.125 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.5 mt -64.55 -36.41 77.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 123.215 0.606 . . . . 0.0 110.25 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -63.57 -41.46 98.4 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.942 -0.474 . . . . 0.0 110.357 175.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.14 -40.8 98.62 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.74 0.816 . . . . 0.0 111.285 175.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.4 mmm -56.17 -40.25 73.6 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.904 0.482 . . . . 0.0 110.665 173.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.72 54.31 0.26 Allowed Glycine 0 C--N 1.34 0.773 0 C-N-CA 123.973 0.796 . . . . 0.0 111.406 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -140.45 144.3 36.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.123 0.969 . . . . 0.0 108.791 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -70.46 99.23 1.57 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.68 129.05 45.78 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.057 1.343 . . . . 0.0 109.123 -174.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.5 p -137.52 143.87 41.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.31 1.044 . . . . 0.0 109.063 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 61.8 mt . . . . . 0 CA--C 1.53 0.193 0 C-N-CA 122.813 0.445 . . . . 0.0 110.22 -178.945 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.3 p . . . . . 0 CA--C 1.531 0.246 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -137.73 170.88 15.3 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 124.734 1.214 . . . . 0.0 109.816 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -124.15 153.45 41.5 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.497 1.119 . . . . 0.0 109.538 172.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.1 t -147.07 138.47 24.08 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.135 0.974 . . . . 0.0 109.756 -176.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.92 113.06 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.6 mt -113.28 126.2 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -71.15 136.32 48.07 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 177.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.6 mt -129.96 91.15 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -99.42 153.84 18.69 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.452 0.701 . . . . 0.0 109.553 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.1 45.0 12.18 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.853 0.74 . . . . 0.0 112.062 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 54.7 mtt -79.77 153.45 29.18 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 169.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.5 m -84.53 -52.37 6.18 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.756 0.822 . . . . 0.0 109.871 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.2 p -163.8 -178.29 5.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.732 1.213 . . . . 0.0 108.7 -175.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -60.57 -25.51 66.24 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.127 0.971 . . . . 0.0 113.25 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.6 m -54.69 -36.47 64.7 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.713 0.688 . . . . 0.0 111.468 175.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.2 m -61.4 -41.34 96.98 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 122.885 0.474 . . . . 0.0 111.186 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.8 t -53.37 -54.39 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 123.507 0.723 . . . . 0.0 109.322 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -59.77 -45.65 91.6 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.611 0.764 . . . . 0.0 111.361 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.4 m -59.14 -52.22 66.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.261 0.624 . . . . 0.0 111.443 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.6 mt -56.92 -50.98 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.194 0.998 . . . . 0.0 109.573 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -54.43 -56.07 22.45 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.413 0.685 . . . . 0.0 110.751 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.34 -56.35 19.98 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.124 0.868 . . . . 0.0 112.086 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.8 t -59.92 -57.23 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.817 0.847 . . . . 0.0 110.766 -177.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.2 mt -70.6 -32.82 50.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 118.851 -0.595 . . . . 0.0 112.081 -169.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 87.3 p -52.96 -30.75 36.65 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -89.12 -5.84 57.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.557 0.743 . . . . 0.0 112.483 -175.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -75.08 147.78 83.72 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 118.885 0.766 . . . . 0.0 110.229 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -45.29 127.71 9.32 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 124.309 3.34 . . . . 0.0 113.254 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.51 -31.1 5.64 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-O 118.653 -1.082 . . . . 0.0 113.596 176.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.73 136.56 25.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 118.386 1.093 . . . . 0.0 110.098 -175.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -115.67 -100.97 0.43 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.639 1.176 . . . . 0.0 108.224 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 86.5 p -81.53 151.56 27.69 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.709 0.686 . . . . 0.0 110.128 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.24 131.46 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 123.788 0.835 . . . . 0.0 108.939 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -130.69 102.15 5.99 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.179 1.392 . . . . 0.0 108.057 -174.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.1 t -100.73 149.88 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.436 1.094 . . . . 0.0 109.021 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.6 t -140.1 129.23 23.67 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.101 0.96 . . . . 0.0 109.753 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.7 tp -70.47 -49.49 48.05 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.458 1.103 . . . . 0.0 109.301 170.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.59 -47.65 66.76 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.712 1.205 . . . . 0.0 111.776 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -89.42 -11.9 41.82 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.199 0.6 . . . . 0.0 111.612 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.7 m 54.04 56.53 6.94 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 125.011 1.325 . . . . 0.0 110.602 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -157.59 170.49 22.27 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.498 0.719 . . . . 0.0 111.279 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -137.36 116.26 1.34 Allowed Glycine 0 C--N 1.337 0.603 0 C-N-CA 126.196 1.855 . . . . 0.0 109.389 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.3 m -99.48 105.92 17.89 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 t -109.25 137.24 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 124.548 1.139 . . . . 0.0 109.214 -173.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -105.56 130.01 53.7 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 169.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -150.42 164.96 34.58 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -168.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -98.08 113.97 64.54 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.158 1.383 . . . . 0.0 109.682 170.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -44.82 -37.43 11.88 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 125.247 3.965 . . . . 0.0 114.873 173.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.1 mt -63.82 -34.18 77.35 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.24 0.616 . . . . 0.0 111.97 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.4 mt -105.64 -27.61 11.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.98 0.912 . . . . 0.0 112.478 -171.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.0 t -151.87 176.27 11.62 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.749 0.704 . . . . 0.0 109.96 176.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.6 p -148.98 163.48 25.31 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.477 1.111 . . . . 0.0 109.717 -175.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -53.16 -36.51 77.43 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.193 2.595 . . . . 0.0 112.678 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -68.03 -44.57 76.17 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.318 1.047 . . . . 0.0 110.355 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.6 m -61.55 -46.93 87.82 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.224 0.609 . . . . 0.0 110.287 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.8 mt -62.31 -45.85 91.37 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.285 1.034 . . . . 0.0 110.764 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -53.64 -46.85 70.68 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.975 0.91 . . . . 0.0 109.968 172.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.56 -45.4 84.59 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.276 0.941 . . . . 0.0 112.268 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.39 -48.54 77.43 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.686 0.743 . . . . 0.0 111.168 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.2 mt -59.62 -45.11 94.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.802 0.841 . . . . 0.0 109.834 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -57.34 -47.85 80.51 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.874 0.87 . . . . 0.0 110.22 176.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -59.48 -41.66 90.3 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.848 0.859 . . . . 0.0 111.525 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.7 mtp -59.3 -41.55 89.26 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.051 0.387 . . . . 0.0 110.731 174.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.29 60.0 0.19 Allowed Glycine 0 C--N 1.34 0.787 0 C-N-CA 123.688 0.661 . . . . 0.0 111.718 169.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -140.35 155.93 46.6 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.018 0.927 . . . . 0.0 109.236 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.17 96.49 3.3 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.75 124.41 44.99 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.901 1.28 . . . . 0.0 109.989 -174.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.0 t -150.29 156.52 41.69 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.097 0.559 . . . . 0.0 109.948 175.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 CA--C 1.533 0.306 0 C-N-CA 123.851 0.86 . . . . 0.0 113.152 -169.33 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.1 p . . . . . 0 CA--C 1.53 0.183 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -140.14 169.85 16.92 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.821 1.248 . . . . 0.0 109.34 175.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -140.3 143.64 35.97 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.462 1.105 . . . . 0.0 108.746 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 t -134.29 141.56 46.99 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.375 1.07 . . . . 0.0 109.824 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.0 t -107.66 106.97 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 175.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.3 mt -102.22 123.66 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -177.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -69.66 128.52 36.76 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 169.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 66.7 mt -127.47 86.58 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -99.95 148.73 24.17 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.067 0.547 . . . . 0.0 110.221 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.21 26.19 16.85 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.672 1.13 . . . . 0.0 112.871 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 68.6 mtm -79.62 136.27 36.79 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.242 1.021 . . . . 0.0 109.366 174.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.3 m -84.48 -46.93 11.14 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.267 1.027 . . . . 0.0 110.748 -173.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.5 p -156.1 177.25 11.64 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.643 0.777 . . . . 0.0 109.474 -175.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -60.69 -24.71 65.85 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.091 0.956 . . . . 0.0 113.091 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.3 m -53.59 -36.2 61.68 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.525 0.602 . . . . 0.0 111.472 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.3 m -60.26 -56.5 20.8 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.8 t -49.9 -52.61 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.464 1.105 . . . . 0.0 110.558 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -57.29 -54.58 45.2 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.366 1.066 . . . . 0.0 111.245 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.5 p -62.31 -49.82 74.09 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.378 0.671 . . . . 0.0 111.523 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 79.1 mt -52.97 -56.17 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 124.285 1.034 . . . . 0.0 109.696 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -57.57 -50.65 72.41 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.134 0.574 . . . . 0.0 110.347 -177.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.77 -51.41 44.95 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.502 1.049 . . . . 0.0 112.374 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.2 t -60.61 -55.18 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.336 0.655 . . . . 0.0 110.329 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.5 mt -64.33 -37.37 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 119.005 -0.522 . . . . 0.0 111.549 -171.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 72.5 m -49.93 -33.73 18.41 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.535 0.734 . . . . 0.0 112.502 173.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -89.39 -12.08 41.37 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.836 0.854 . . . . 0.0 112.06 -174.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -70.33 139.5 87.1 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 119.127 0.876 . . . . 0.0 109.839 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.27 132.82 32.83 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.939 2.426 . . . . 0.0 109.831 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.83 -33.67 6.33 Favored Glycine 0 C--N 1.337 0.605 0 CA-C-O 118.939 -0.923 . . . . 0.0 112.062 -177.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.5 t -70.32 135.3 28.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 CA-C-N 118.113 0.957 . . . . 0.0 109.908 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -111.48 -100.67 0.41 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.961 1.305 . . . . 0.0 107.958 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 59.5 p -86.83 146.16 26.32 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.615 0.766 . . . . 0.0 109.489 176.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.3 tt -150.24 143.89 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 123.624 0.77 . . . . 0.0 109.938 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.45 136.36 41.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 169.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.8 t -124.5 143.24 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.987 1.315 . . . . 0.0 107.691 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.5 t -143.4 130.93 21.14 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.898 0.879 . . . . 0.0 110.191 -174.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.33 -45.69 25.34 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.151 0.981 . . . . 0.0 109.53 174.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.47 -46.67 63.2 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.271 1.028 . . . . 0.0 111.305 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -89.72 -9.62 48.75 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.648 0.779 . . . . 0.0 111.905 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.0 m 52.33 55.59 8.93 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 125.68 1.592 . . . . 0.0 111.076 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -160.87 168.46 24.63 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.173 0.511 . . . . 0.0 111.706 -174.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.12 116.16 1.51 Allowed Glycine 0 CA--C 1.525 0.656 0 C-N-CA 126.232 1.873 . . . . 0.0 108.683 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.7 m -99.31 109.75 22.34 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 176.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.4 t -119.24 122.45 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 124.465 1.106 . . . . 0.0 109.217 -171.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -89.97 131.29 35.95 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 169.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -150.09 165.09 33.84 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -169.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -101.01 113.36 65.8 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.08 1.352 . . . . 0.0 109.262 172.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -43.46 -39.35 9.34 Favored 'Trans proline' 0 C--N 1.347 0.499 1 C-N-CA 125.458 4.105 . . . . 0.0 115.346 173.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.87 -34.93 79.27 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.776 0.43 . . . . 0.0 111.857 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.2 mt -100.6 -29.62 12.23 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.819 0.848 . . . . 0.0 112.423 -172.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.4 t -151.15 174.41 13.25 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.53 0.732 . . . . 0.0 109.731 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.8 p -148.15 162.59 30.3 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 123.893 0.877 . . . . 0.0 110.468 -173.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.02 -34.61 77.99 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.631 2.888 . . . . 0.0 112.41 172.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -63.22 -49.23 75.0 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.024 0.93 . . . . 0.0 110.458 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.6 m -62.35 -45.31 93.78 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.215 0.606 . . . . 0.0 110.402 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.3 mt -60.46 -50.12 74.83 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.813 0.845 . . . . 0.0 110.602 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -55.47 -41.92 73.64 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.035 0.379 . . . . 0.0 110.969 172.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.47 -46.21 52.98 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.205 0.907 . . . . 0.0 111.963 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.8 -48.4 80.78 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.408 0.604 . . . . 0.0 111.133 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.6 mm -60.9 -39.63 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 122.946 0.498 . . . . 0.0 111.279 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.24 -44.62 91.26 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.883 0.873 . . . . 0.0 110.216 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.02 -45.6 92.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.788 0.835 . . . . 0.0 110.905 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.5 mmm -59.78 -44.04 94.11 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.417 0.687 . . . . 0.0 110.626 175.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.8 60.96 0.4 Allowed Glycine 0 C--N 1.341 0.82 0 C-N-CA 124.518 1.056 . . . . 0.0 112.007 171.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -140.1 162.33 35.49 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.923 0.889 . . . . 0.0 109.494 172.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.0 103.85 3.91 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.97 110.05 21.82 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.75 1.62 . . . . 0.0 110.127 -174.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.9 t -150.4 145.88 26.35 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.037 0.381 . . . . 0.0 109.995 175.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.3 mt . . . . . 0 CA--C 1.528 0.133 0 C-N-CA 122.597 0.359 . . . . 0.0 111.589 -174.863 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.7 p . . . . . 0 N--CA 1.456 -0.147 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -142.64 162.45 35.43 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 126.333 1.853 . . . . 0.0 107.968 173.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -121.8 142.76 49.89 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.328 1.051 . . . . 0.0 109.231 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -133.54 133.41 42.1 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.192 0.997 . . . . 0.0 109.396 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.8 t -100.27 109.23 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 172.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.1 mt -99.53 118.4 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -75.8 107.41 7.96 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.2 mt -111.97 96.11 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -174.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -99.57 151.55 21.04 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.257 0.623 . . . . 0.0 109.771 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.09 35.35 12.59 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.185 0.898 . . . . 0.0 112.191 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 38.0 mtt -79.46 134.02 36.53 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 169.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.5 m -84.32 -51.51 6.92 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.424 0.689 . . . . 0.0 110.629 -174.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.8 p -161.0 -172.94 3.66 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.594 0.757 . . . . 0.0 109.647 -175.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -55.15 -32.68 62.29 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.385 1.474 . . . . 0.0 113.79 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.6 p -59.36 -41.15 88.62 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.264 0.484 . . . . 0.0 110.902 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.8 m -62.53 -49.95 73.3 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.916 0.486 . . . . 0.0 110.129 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.5 t -50.2 -52.1 15.67 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 C-N-CA 123.796 0.838 . . . . 0.0 109.889 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -62.04 -42.89 99.66 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.956 0.902 . . . . 0.0 111.845 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.6 m -63.87 -48.9 74.86 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.189 0.595 . . . . 0.0 110.969 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.9 mt -55.33 -58.56 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.974 1.309 . . . . 0.0 109.375 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -61.14 -43.52 98.76 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 117.952 0.342 . . . . 0.0 111.254 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.96 -54.48 33.4 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.367 0.984 . . . . 0.0 111.906 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.76 -51.49 72.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.033 0.933 . . . . 0.0 110.323 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.0 mm -62.92 -33.33 59.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.827 -175.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.5 m -57.04 -21.01 27.91 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 175.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -89.09 -14.09 37.1 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.631 0.65 . . . . 0.0 111.653 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -71.0 134.12 85.68 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -66.05 139.46 56.15 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.563 2.175 . . . . 0.0 109.571 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.32 -32.48 7.1 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-O 118.652 -1.082 . . . . 0.0 112.165 -176.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.5 t -66.17 136.37 26.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 CA-C-N 118.464 1.132 . . . . 0.0 110.198 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -116.67 -96.42 0.47 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.487 1.115 . . . . 0.0 108.606 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.5 p -90.09 147.98 23.3 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.475 0.71 . . . . 0.0 109.889 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 tt -150.41 131.98 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 123.841 0.856 . . . . 0.0 110.1 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.08 110.24 12.3 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.69 1.196 . . . . 0.0 108.494 177.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.7 t -106.06 144.4 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.364 1.066 . . . . 0.0 109.061 176.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.3 t -145.17 131.71 19.82 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.881 0.872 . . . . 0.0 110.609 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 tt -74.28 -45.86 44.96 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.737 1.215 . . . . 0.0 109.581 169.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.28 -46.95 66.1 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.298 1.039 . . . . 0.0 111.471 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -89.6 -10.79 44.67 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.42 0.688 . . . . 0.0 111.676 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.9 m 53.21 55.56 8.64 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 125.435 1.494 . . . . 0.0 110.554 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -156.48 169.3 24.95 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -175.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.41 111.43 0.99 Allowed Glycine 0 CA--C 1.524 0.623 0 C-N-CA 126.292 1.901 . . . . 0.0 108.369 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.5 m -99.08 98.54 9.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.7 t -109.98 127.88 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 124.392 1.077 . . . . 0.0 109.269 -170.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -98.27 129.79 44.98 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 169.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -150.06 163.61 37.7 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.76 0.824 . . . . 0.0 110.975 -169.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -95.35 115.01 65.08 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.396 1.078 . . . . 0.0 109.306 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -45.94 -37.17 16.77 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 124.993 3.795 . . . . 0.0 114.616 173.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.9 mt -63.76 -32.62 74.17 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.717 0.807 . . . . 0.0 112.004 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.8 -41.55 7.21 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.732 0.813 . . . . 0.0 111.281 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 t -142.69 170.47 15.65 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.381 0.672 . . . . 0.0 110.247 -178.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.4 p -138.43 160.95 61.62 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.397 1.079 . . . . 0.0 110.349 -174.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -50.64 -40.39 55.56 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.609 2.873 . . . . 0.0 112.211 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -61.12 -47.21 87.33 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.507 1.123 . . . . 0.0 110.418 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.6 m -60.94 -50.57 72.87 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.506 0.722 . . . . 0.0 110.678 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 50.9 mt -59.25 -50.95 72.05 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.382 1.073 . . . . 0.0 110.354 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -53.87 -49.49 68.4 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 124.115 0.966 . . . . 0.0 110.558 174.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.21 -46.44 62.86 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.518 1.056 . . . . 0.0 111.966 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.32 -51.46 69.87 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.239 0.616 . . . . 0.0 111.228 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.0 mm -66.44 -37.15 79.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 117.838 0.29 . . . . 0.0 111.657 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -60.37 -43.84 96.17 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.277 0.631 . . . . 0.0 109.951 175.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -62.72 -42.73 99.8 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.881 0.872 . . . . 0.0 111.363 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.1 mtp -56.95 -44.65 82.77 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.776 0.43 . . . . 0.0 110.577 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.9 63.1 0.18 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 123.597 0.617 . . . . 0.0 111.947 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -140.41 158.26 44.28 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.047 0.939 . . . . 0.0 108.817 171.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -78.74 87.22 4.64 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.25 116.6 31.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.917 1.287 . . . . 0.0 109.183 -176.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.9 p -138.82 133.22 31.77 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.645 1.178 . . . . 0.0 109.365 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 CA--C 1.529 0.155 0 C-N-CA 122.934 0.494 . . . . 0.0 111.299 -177.693 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 76.1 p . . . . . 0 CA--C 1.529 0.17 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -133.52 159.54 40.13 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 124.676 1.19 . . . . 0.0 109.999 -173.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -113.93 145.54 41.35 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.447 1.099 . . . . 0.0 108.818 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.4 t -139.32 155.35 47.76 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.014 0.926 . . . . 0.0 109.489 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.5 t -120.24 131.37 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.1 mt -128.56 120.24 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -74.79 134.35 41.8 Favored 'General case' 0 C--N 1.337 0.052 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.8 mt -125.65 110.84 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -175.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -99.45 152.87 19.5 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.4 2.14 60.43 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.053 -0.86 . . . . 0.0 112.66 -176.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.3 mtm -79.33 103.3 9.17 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 118.66 1.23 . . . . 0.0 107.94 175.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.4 t -84.47 -29.74 25.81 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.302 0.641 . . . . 0.0 111.803 -173.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.2 p -159.17 179.01 9.4 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.389 0.54 . . . . 0.0 110.589 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -59.33 -26.18 64.8 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.09 1.356 . . . . 0.0 113.25 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.8 m -56.06 -40.84 74.15 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.486 0.585 . . . . 0.0 111.169 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.2 m -63.06 -51.85 65.06 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 122.899 0.48 . . . . 0.0 109.777 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.1 t -50.34 -54.89 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.182 0.993 . . . . 0.0 110.232 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -57.45 -53.9 52.93 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.733 1.213 . . . . 0.0 111.215 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.0 p -60.47 -51.27 70.16 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.123 0.569 . . . . 0.0 111.429 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.9 mt -56.08 -55.09 20.23 Favored 'Isoleucine or valine' 0 C--N 1.339 0.152 0 C-N-CA 123.502 0.721 . . . . 0.0 109.63 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -52.95 -53.13 54.18 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.506 0.722 . . . . 0.0 110.64 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.07 -55.55 30.04 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.184 0.897 . . . . 0.0 112.349 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.43 -53.22 51.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 123.958 0.903 . . . . 0.0 111.057 -175.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.7 mm -63.45 -31.4 52.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.026 0.53 . . . . 0.0 111.269 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.0 t -54.51 -26.09 29.55 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -89.38 -5.25 57.61 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.418 0.687 . . . . 0.0 112.284 -175.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -71.83 144.36 88.03 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 118.76 0.709 . . . . 0.0 109.537 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -64.31 128.07 20.62 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.977 2.452 . . . . 0.0 110.202 -175.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.6 -33.33 6.64 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 118.652 -1.082 . . . . 0.0 112.243 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.15 139.38 20.53 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 CA-C-N 118.192 0.996 . . . . 0.0 110.081 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -119.37 -98.7 0.45 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.666 1.186 . . . . 0.0 108.256 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.8 p -85.15 147.41 26.63 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.2 tt -150.26 134.58 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.753 0.821 . . . . 0.0 109.162 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 89.2 mmt-85 -132.52 109.24 9.64 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.081 1.352 . . . . 0.0 108.373 -177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.0 t -103.68 147.1 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.788 1.235 . . . . 0.0 108.703 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.4 t -140.64 127.85 20.99 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.068 0.947 . . . . 0.0 110.588 -174.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.1 tp -69.34 -49.49 55.16 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.576 1.15 . . . . 0.0 109.437 171.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.4 -46.25 69.64 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.752 1.221 . . . . 0.0 111.687 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -89.46 -11.63 42.46 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.3 0.64 . . . . 0.0 111.582 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.6 m 53.46 54.24 10.39 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 125.367 1.467 . . . . 0.0 110.791 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.4 p30 -158.86 173.1 17.05 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.032 0.533 . . . . 0.0 111.626 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.6 119.3 2.04 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 126.101 1.81 . . . . 0.0 109.333 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.9 m -99.59 117.78 34.71 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 t -122.43 128.7 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 124.278 1.031 . . . . 0.0 109.725 -170.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -95.43 127.14 41.22 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 169.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -150.2 164.68 35.06 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.981 0.512 . . . . 0.0 112.175 -169.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -98.81 115.17 65.9 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.545 1.138 . . . . 0.0 110.136 172.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -44.98 -42.84 15.73 Favored 'Trans proline' 0 C--N 1.348 0.526 1 C-N-CA 125.556 4.171 . . . . 0.0 115.634 176.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.2 mt -68.31 -28.01 66.79 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.627 0.371 . . . . 0.0 111.941 -174.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.2 mt -99.68 -31.21 11.68 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.064 0.946 . . . . 0.0 111.726 -175.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.8 t -153.35 163.86 39.17 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.551 0.614 . . . . 0.0 109.956 176.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.4 p -131.22 163.31 50.25 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 124.834 1.254 . . . . 0.0 109.915 -177.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.88 -40.13 67.1 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.292 2.661 . . . . 0.0 112.419 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -66.76 -40.32 88.2 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.719 0.807 . . . . 0.0 111.601 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.4 m -62.36 -48.1 81.28 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.628 0.371 . . . . 0.0 110.047 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.5 mt -61.27 -47.72 84.71 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.104 0.961 . . . . 0.0 110.596 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -51.6 -50.99 59.12 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.416 1.086 . . . . 0.0 110.087 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.93 -46.34 84.22 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.24 0.924 . . . . 0.0 112.112 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.21 -50.6 71.12 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.45 0.7 . . . . 0.0 111.184 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.4 mt -58.6 -47.39 88.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.387 0.675 . . . . 0.0 109.691 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -55.25 -48.92 73.28 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.747 0.819 . . . . 0.0 110.42 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.5 -38.38 77.55 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.925 1.29 . . . . 0.0 112.472 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -56.03 -37.45 69.24 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 118.428 0.558 . . . . 0.0 111.127 175.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.18 56.09 0.07 OUTLIER Glycine 0 C--N 1.34 0.776 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 171.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -140.39 173.75 11.19 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.949 0.9 . . . . 0.0 110.037 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -108.51 88.27 2.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.43 138.54 36.37 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.99 0.916 . . . . 0.0 110.374 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.0 t -149.48 148.11 29.02 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.287 1.035 . . . . 0.0 109.18 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.8 mt . . . . . 0 CA--C 1.53 0.175 0 C-N-CA 122.693 0.397 . . . . 0.0 111.181 -176.731 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.7 p . . . . . 0 CA--C 1.531 0.229 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -145.18 171.69 14.18 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.073 1.349 . . . . 0.0 109.449 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -136.39 143.3 43.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.829 1.252 . . . . 0.0 108.825 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 t -135.52 153.57 51.68 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.898 1.279 . . . . 0.0 109.012 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.3 t -120.83 135.87 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 171.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.4 mt -130.53 124.87 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -175.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -67.14 131.56 46.05 Favored 'General case' 0 C--N 1.338 0.09 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.3 mt -129.59 98.74 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -99.23 150.83 21.68 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.81 4.42 56.88 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.234 0.921 . . . . 0.0 112.343 -173.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 57.6 mtm -79.02 108.41 12.48 Favored 'General case' 0 C--N 1.343 0.318 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.3 m -84.36 -38.58 20.15 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.542 1.137 . . . . 0.0 110.401 -171.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.7 p -156.91 -178.66 7.53 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.805 0.336 . . . . 0.0 110.502 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -55.39 -30.99 61.45 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.667 1.587 . . . . 0.0 113.416 -178.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 m -54.02 -42.59 69.28 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.409 0.684 . . . . 0.0 111.335 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.0 m -62.65 -53.26 57.19 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 122.912 0.485 . . . . 0.0 109.861 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.0 t -49.91 -54.41 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.462 1.105 . . . . 0.0 110.516 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -60.98 -50.88 71.58 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.409 1.084 . . . . 0.0 111.447 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.9 p -61.4 -51.77 67.38 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.81 0.444 . . . . 0.0 111.291 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.8 mt -52.61 -57.7 3.81 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 C-N-CA 124.052 0.941 . . . . 0.0 109.358 177.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -54.7 -45.47 73.98 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.094 0.557 . . . . 0.0 111.166 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.3 -53.96 34.83 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.337 0.97 . . . . 0.0 112.023 177.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.5 t -65.9 -54.5 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 117.552 0.676 . . . . 0.0 110.725 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.8 -40.65 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 123.545 0.738 . . . . 0.0 111.221 -175.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.2 p -56.6 -26.73 56.4 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -89.17 -6.05 57.25 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.747 0.819 . . . . 0.0 111.938 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -73.3 125.57 90.72 Favored Pre-proline 0 CA--C 1.535 0.384 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.89 124.84 10.53 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.781 2.987 . . . . 0.0 112.35 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.12 -37.83 3.35 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-O 119.033 -0.871 . . . . 0.0 112.056 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.3 t -67.86 127.42 29.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-N 117.873 0.836 . . . . 0.0 110.077 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -98.02 -102.41 0.2 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.744 1.218 . . . . 0.0 108.003 176.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 95.7 p -89.97 155.85 18.83 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.538 0.608 . . . . 0.0 110.247 176.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.9 tt -150.55 144.5 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.103 0.961 . . . . 0.0 109.822 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -140.21 108.81 5.9 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.51 1.124 . . . . 0.0 108.84 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.7 t -98.36 141.77 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.668 1.187 . . . . 0.0 108.534 174.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.6 t -135.4 125.78 26.61 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 123.776 0.83 . . . . 0.0 110.888 -173.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -64.85 -55.64 18.26 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.647 1.179 . . . . 0.0 108.804 171.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.68 -47.5 58.77 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 125.2 1.4 . . . . 0.0 112.275 -176.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -89.35 -9.35 50.74 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.069 0.548 . . . . 0.0 111.698 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.6 m 52.3 54.99 9.8 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 125.315 1.446 . . . . 0.0 110.864 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -158.7 173.79 16.03 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.31 0.644 . . . . 0.0 111.095 -174.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.92 119.35 2.02 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 125.708 1.623 . . . . 0.0 109.308 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.2 m -99.44 116.09 30.78 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 t -127.51 122.52 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 124.072 0.949 . . . . 0.0 109.672 -169.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -90.05 134.3 34.33 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -150.09 168.09 24.92 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.86 0.464 . . . . 0.0 112.235 -171.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -103.41 111.82 65.32 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.179 1.392 . . . . 0.0 109.155 171.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -42.66 -38.22 6.23 Favored 'Trans proline' 0 C--N 1.348 0.51 1 C-N-CA 125.402 4.068 . . . . 0.0 115.282 172.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.79 -35.95 82.28 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.142 0.577 . . . . 0.0 111.794 -177.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.6 mt -102.26 -29.95 11.38 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.036 0.934 . . . . 0.0 112.36 -171.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 t -150.65 173.06 14.58 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.387 0.675 . . . . 0.0 109.915 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.7 p -141.4 162.63 46.3 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 124.516 1.126 . . . . 0.0 109.919 -177.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -52.62 -41.03 71.33 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.253 2.635 . . . . 0.0 112.1 174.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -64.62 -41.92 95.85 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.074 0.95 . . . . 0.0 111.423 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.5 m -63.05 -48.42 78.78 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.964 0.505 . . . . 0.0 110.381 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 54.6 mt -61.1 -48.89 79.6 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.091 0.956 . . . . 0.0 110.319 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.6 ttp85 -52.2 -48.48 65.05 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 124.139 0.976 . . . . 0.0 110.148 172.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.98 -46.73 76.26 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.661 1.125 . . . . 0.0 112.244 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.29 -49.84 75.99 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 117.491 0.646 . . . . 0.0 110.967 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.0 mt -61.2 -42.55 93.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.266 0.626 . . . . 0.0 109.972 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -60.83 -44.79 96.48 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.497 1.119 . . . . 0.0 110.583 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -59.03 -39.0 80.61 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.297 1.039 . . . . 0.0 111.349 177.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.3 mtp -67.33 -7.44 24.63 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 175.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.47 57.18 1.29 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 123.893 0.758 . . . . 0.0 111.483 170.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -140.33 156.35 46.47 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.139 0.976 . . . . 0.0 109.59 174.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -81.27 87.54 6.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 176.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.43 122.47 42.59 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.435 1.094 . . . . 0.0 109.747 -174.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.2 m -144.49 136.53 26.13 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.545 1.138 . . . . 0.0 108.588 -177.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.6 mt . . . . . 0 CA--C 1.532 0.279 0 C-N-CA 122.857 0.463 . . . . 0.0 111.497 -176.556 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 81.9 p . . . . . 0 CA--C 1.53 0.195 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -143.98 169.69 17.35 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.988 0.915 . . . . 0.0 109.411 170.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -140.05 139.98 36.06 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.648 1.179 . . . . 0.0 108.192 173.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 t -137.33 141.44 41.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.035 0.934 . . . . 0.0 109.908 -177.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.5 t -99.72 133.39 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 171.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.3 mt -129.05 118.99 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -73.01 132.47 43.44 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.0 mt -120.55 111.49 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 125.266 1.426 . . . . 0.0 107.679 -175.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -100.74 149.37 23.88 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.487 1.115 . . . . 0.0 109.425 174.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.78 15.11 37.94 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.911 1.243 . . . . 0.0 112.455 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 93.1 mtp -79.69 109.07 13.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.5 m -84.34 -47.11 11.06 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.015 0.926 . . . . 0.0 111.065 -169.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -154.92 177.33 11.42 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.804 0.841 . . . . 0.0 108.821 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -61.2 -21.27 63.67 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -174.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.3 m -55.06 -36.8 65.97 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.361 0.528 . . . . 0.0 111.189 173.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.1 m -64.62 -44.23 91.2 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 122.897 0.479 . . . . 0.0 110.578 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.7 t -54.26 -52.88 34.19 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 123.345 0.658 . . . . 0.0 109.326 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -57.77 -50.19 74.08 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.921 0.888 . . . . 0.0 111.186 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -59.82 -59.32 5.62 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.515 0.726 . . . . 0.0 110.959 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 73.7 mt -52.94 -52.59 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.385 1.074 . . . . 0.0 109.561 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -61.72 -54.76 38.13 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.723 0.409 . . . . 0.0 110.746 -175.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.46 -39.11 95.86 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.731 1.158 . . . . 0.0 113.278 -176.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.8 t -73.7 -57.28 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 117.724 0.762 . . . . 0.0 109.937 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.6 mt -67.9 -28.96 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 118.971 -0.537 . . . . 0.0 111.813 -170.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.2 p -53.45 -28.89 32.74 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.897 0.771 . . . . 0.0 112.726 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -88.98 -17.09 30.15 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.857 0.863 . . . . 0.0 111.614 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -71.41 141.9 86.12 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 118.666 0.666 . . . . 0.0 109.709 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -63.99 140.37 72.22 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.323 2.682 . . . . 0.0 111.165 -170.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.43 -32.93 6.22 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 118.744 -1.031 . . . . 0.0 112.149 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.02 141.73 15.76 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 118.356 1.078 . . . . 0.0 110.125 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -118.39 -109.44 0.36 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.155 1.382 . . . . 0.0 107.526 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.7 p -90.1 94.33 9.74 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.329 1.052 . . . . 0.0 109.067 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.5 tt -89.92 133.94 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 123.932 0.893 . . . . 0.0 109.32 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -129.85 97.17 4.42 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.863 1.265 . . . . 0.0 108.444 -172.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.6 t -95.6 147.76 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.921 0.889 . . . . 0.0 109.927 -176.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.4 t -148.71 127.01 12.18 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.851 0.86 . . . . 0.0 110.198 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.8 tt -73.9 -42.77 60.18 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.011 0.924 . . . . 0.0 109.584 170.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.12 -47.11 72.21 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.543 1.137 . . . . 0.0 111.574 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -89.36 -5.44 57.47 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.362 0.665 . . . . 0.0 111.42 176.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.1 m 53.75 53.55 11.22 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 126.054 1.741 . . . . 0.0 111.165 175.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -161.22 172.08 17.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.284 0.564 . . . . 0.0 112.34 -172.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.71 117.05 2.39 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.1 m -99.37 94.38 6.41 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 t -100.03 120.06 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 124.456 1.103 . . . . 0.0 109.58 -169.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -89.52 132.86 34.85 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 169.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -150.81 171.79 16.64 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -169.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -106.87 111.72 63.65 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 125.548 1.539 . . . . 0.0 108.826 171.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -44.06 -38.02 10.11 Favored 'Trans proline' 0 C--N 1.346 0.422 1 C-N-CA 125.397 4.065 . . . . 0.0 114.893 172.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.2 mt -65.12 -33.69 76.62 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.481 0.712 . . . . 0.0 111.696 -177.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.0 mt -101.07 -33.4 10.16 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.266 1.026 . . . . 0.0 112.048 -172.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -148.95 169.97 19.38 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.526 0.73 . . . . 0.0 109.931 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.9 p -141.3 161.85 50.69 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.533 1.133 . . . . 0.0 109.745 -176.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.79 -42.86 42.79 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.484 2.789 . . . . 0.0 112.835 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -65.51 -39.87 92.35 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.541 0.736 . . . . 0.0 111.793 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.0 m -63.06 -45.26 93.02 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.637 0.375 . . . . 0.0 110.103 176.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.1 mt -65.43 -43.5 90.27 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.268 1.027 . . . . 0.0 110.833 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -53.85 -49.41 68.5 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.865 0.866 . . . . 0.0 109.449 170.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.92 -44.54 71.8 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.7 1.143 . . . . 0.0 112.388 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.29 94.65 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.727 0.811 . . . . 0.0 111.153 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.0 mt -63.7 -43.05 97.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 123.001 0.521 . . . . 0.0 110.226 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -62.57 -38.8 91.53 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.541 0.736 . . . . 0.0 111.349 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -60.94 -43.09 99.18 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.536 0.735 . . . . 0.0 110.616 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.4 mtp -62.36 -47.25 85.01 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 119.392 -0.337 . . . . 0.0 110.556 173.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.05 61.02 0.12 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 123.71 0.671 . . . . 0.0 112.077 170.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -140.33 150.69 44.29 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.58 0.752 . . . . 0.0 109.371 171.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -79.7 93.2 5.5 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.39 133.68 43.36 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.939 0.896 . . . . 0.0 110.39 -174.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.8 p -139.04 132.61 30.43 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.95 1.3 . . . . 0.0 108.825 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.8 mt . . . . . 0 C--O 1.231 0.117 0 C-N-CA 123.268 0.627 . . . . 0.0 110.751 -177.83 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 51.2 p . . . . . 0 CA--C 1.529 0.16 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -142.36 166.27 25.15 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.821 1.648 . . . . 0.0 108.901 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -120.72 143.91 48.51 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.005 1.322 . . . . 0.0 108.486 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 t -142.27 139.66 31.98 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 123.534 0.734 . . . . 0.0 109.892 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.5 t -99.81 118.37 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.4 mm -102.22 130.64 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 174.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -71.58 125.56 27.4 Favored 'General case' 0 N--CA 1.458 -0.065 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 169.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.4 mt -127.58 88.95 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -99.88 159.14 15.3 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.097 0.559 . . . . 0.0 109.755 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.64 21.22 56.71 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 119.285 -0.731 . . . . 0.0 112.759 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 70.1 mtm -79.71 128.55 33.55 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.1 p -84.45 -42.43 15.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.497 0.719 . . . . 0.0 110.983 -174.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.6 p -159.58 179.95 8.44 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.822 0.344 . . . . 0.0 110.73 -174.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -54.09 -31.03 50.69 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.662 1.585 . . . . 0.0 113.57 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m -54.59 -39.02 67.41 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.411 0.684 . . . . 0.0 111.372 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.8 m -63.99 -49.2 73.39 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 122.82 0.448 . . . . 0.0 110.198 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.1 t -52.35 -51.82 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.248 1.019 . . . . 0.0 109.646 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -58.43 -48.26 81.28 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.32 1.448 . . . . 0.0 111.789 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.0 m -60.9 -50.78 72.01 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.944 0.497 . . . . 0.0 110.829 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.5 mt -60.39 -55.44 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 123.619 0.768 . . . . 0.0 110.017 -176.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -57.36 -45.33 84.51 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.493 0.588 . . . . 0.0 110.853 -176.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.44 -61.64 7.25 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 123.79 0.71 . . . . 0.0 111.464 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.81 -56.38 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.067 0.947 . . . . 0.0 110.994 -175.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.0 mm -63.08 -33.73 62.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 118.764 -0.636 . . . . 0.0 111.835 -171.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.4 t -51.07 -35.2 33.6 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -89.38 -5.57 57.34 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.903 -0.57 . . . . 0.0 112.453 -175.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -68.22 147.95 98.28 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 119.417 1.008 . . . . 0.0 110.105 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -45.77 132.15 13.46 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 124.08 3.186 . . . . 0.0 112.738 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.82 -39.33 3.09 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 118.943 -0.921 . . . . 0.0 112.986 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.4 t -67.32 143.22 15.67 Favored 'Isoleucine or valine' 0 C--N 1.341 0.205 0 CA-C-N 118.089 0.944 . . . . 0.0 110.278 -177.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -117.63 -95.33 0.48 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.6 p -90.66 157.5 17.43 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.837 0.855 . . . . 0.0 110.078 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.5 tt -150.7 145.06 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 124.488 1.115 . . . . 0.0 108.601 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -131.98 107.83 8.94 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.128 0.971 . . . . 0.0 109.121 176.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.9 t -97.27 149.56 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.977 1.311 . . . . 0.0 109.047 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.3 t -145.14 123.02 11.96 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.266 0.627 . . . . 0.0 110.173 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.8 tp -67.04 -47.0 72.71 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.745 1.218 . . . . 0.0 109.931 172.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.93 -43.28 66.15 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.677 1.191 . . . . 0.0 111.7 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -89.2 -21.02 23.48 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.375 0.67 . . . . 0.0 111.147 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.9 m 57.48 57.29 4.45 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 125.267 1.427 . . . . 0.0 109.784 -174.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.6 p30 -152.81 171.63 17.96 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.47 0.708 . . . . 0.0 111.578 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -137.26 114.68 1.14 Allowed Glycine 0 C--N 1.337 0.615 0 C-N-CA 126.041 1.781 . . . . 0.0 108.894 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.3 m -99.11 99.9 10.97 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.0 t -103.26 133.17 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 124.817 1.247 . . . . 0.0 109.58 -170.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -103.21 125.17 49.76 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 172.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -150.17 171.02 17.57 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -168.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -101.25 113.22 65.83 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.353 1.461 . . . . 0.0 109.479 172.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -44.18 -40.2 12.34 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 125.17 3.914 . . . . 0.0 114.794 173.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.0 mt -63.19 -34.81 78.45 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.606 0.763 . . . . 0.0 111.703 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.8 mt -99.98 -29.26 12.65 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.107 0.963 . . . . 0.0 112.197 -172.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.7 t -153.07 160.25 42.92 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.645 0.657 . . . . 0.0 110.11 177.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.3 p -125.98 161.88 48.88 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 125.179 1.392 . . . . 0.0 109.658 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.99 -36.12 43.3 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.41 2.74 . . . . 0.0 112.924 172.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -67.94 -44.0 77.83 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.608 1.163 . . . . 0.0 110.717 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.2 m -62.78 -45.71 91.39 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.959 0.504 . . . . 0.0 110.296 176.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.9 mt -61.85 -48.84 78.74 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.699 0.8 . . . . 0.0 110.534 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.2 ttp85 -49.99 -47.45 52.87 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.267 1.027 . . . . 0.0 110.14 171.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.84 -51.09 41.29 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.41 1.005 . . . . 0.0 111.826 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.36 -43.76 96.22 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.769 0.785 . . . . 0.0 111.948 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.8 mm -60.9 -44.12 97.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 118.345 0.521 . . . . 0.0 110.507 176.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -58.98 -43.74 91.47 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.173 0.589 . . . . 0.0 110.17 175.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -60.66 -41.47 95.09 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.98 0.912 . . . . 0.0 111.213 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.4 mtp -61.92 -43.86 97.97 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.238 0.472 . . . . 0.0 110.592 173.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.06 60.7 0.2 Allowed Glycine 0 C--N 1.34 0.805 0 C-N-CA 123.786 0.707 . . . . 0.0 111.887 169.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -140.37 159.36 42.36 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.975 0.91 . . . . 0.0 109.313 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -73.46 98.25 2.72 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.87 127.95 46.0 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.049 1.339 . . . . 0.0 110.021 -173.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.1 m -150.11 152.79 35.3 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.472 1.109 . . . . 0.0 108.521 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 mm? . . . . . 0 CA--C 1.531 0.212 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.724 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.4 p . . . . . 0 CA--C 1.529 0.166 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -145.2 165.75 27.43 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.31 1.444 . . . . 0.0 109.065 173.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -129.26 151.01 50.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.813 1.245 . . . . 0.0 109.025 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.5 t -149.62 153.74 37.54 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 123.784 0.834 . . . . 0.0 109.91 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.57 125.43 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 173.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.3 mt -121.36 121.62 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -67.63 131.12 45.0 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 173.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.1 mt -124.39 108.77 21.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.112 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -99.83 150.5 22.29 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.58 13.17 55.99 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.378 0.989 . . . . 0.0 113.06 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 71.5 mtm -79.58 117.17 20.27 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.711 1.255 . . . . 0.0 108.26 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.4 m -84.15 -43.01 15.41 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.093 0.957 . . . . 0.0 110.387 -172.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.9 p -157.38 -178.94 7.72 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.605 0.362 . . . . 0.0 110.419 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -57.6 -25.92 60.76 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.293 1.437 . . . . 0.0 113.425 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.8 t -57.28 -44.42 83.99 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.229 0.611 . . . . 0.0 110.638 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.0 m -61.27 -51.06 70.51 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.817 0.447 . . . . 0.0 109.916 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.4 t -50.45 -53.05 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.328 1.051 . . . . 0.0 110.229 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -57.02 -51.75 68.02 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.55 1.14 . . . . 0.0 111.15 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.4 m -58.91 -54.37 47.87 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.566 0.746 . . . . 0.0 111.392 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.2 mt -54.08 -56.2 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.46 1.104 . . . . 0.0 109.438 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -55.09 -53.41 56.27 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.14 0.976 . . . . 0.0 110.924 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.47 -53.82 42.01 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.463 1.03 . . . . 0.0 112.296 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.6 t -59.48 -53.42 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.449 0.7 . . . . 0.0 110.392 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.0 mt -63.62 -39.94 87.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.108 0.563 . . . . 0.0 111.237 -174.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.2 t -49.92 -34.68 21.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.99 0.916 . . . . 0.0 112.355 176.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -89.05 -9.8 49.88 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.699 0.8 . . . . 0.0 112.427 -172.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -72.56 137.62 80.59 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 119.341 0.973 . . . . 0.0 109.91 177.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.39 136.03 20.0 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.718 2.945 . . . . 0.0 112.259 172.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.69 -43.31 1.83 Allowed Glycine 0 CA--C 1.523 0.541 0 CA-C-O 119.221 -0.766 . . . . 0.0 111.823 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.6 t -69.78 133.72 31.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 CA-C-N 117.76 0.78 . . . . 0.0 109.513 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -107.25 -98.1 0.36 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.9 p -90.15 149.04 22.62 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.546 0.738 . . . . 0.0 109.917 176.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.6 tt -150.53 143.17 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.239 1.016 . . . . 0.0 109.574 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -138.59 118.76 13.52 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.836 1.254 . . . . 0.0 108.342 175.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.19 147.02 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.889 1.275 . . . . 0.0 108.225 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.1 t -139.67 127.5 22.01 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 123.828 0.851 . . . . 0.0 110.749 -174.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp -68.17 -50.5 54.04 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.649 1.179 . . . . 0.0 109.47 171.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.56 -46.29 70.19 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.825 1.25 . . . . 0.0 111.73 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -89.36 -10.55 46.24 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.261 0.624 . . . . 0.0 111.586 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.7 m 53.11 55.18 9.23 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.368 1.467 . . . . 0.0 110.846 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -158.88 171.43 20.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.953 0.501 . . . . 0.0 111.698 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.31 116.06 1.86 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 126.376 1.941 . . . . 0.0 109.162 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.8 m -99.33 112.17 24.4 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.0 t -120.0 136.26 57.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.429 1.092 . . . . 0.0 109.819 -170.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -109.64 128.29 55.13 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 169.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -150.3 173.37 14.05 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -168.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -105.4 112.67 64.82 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.442 1.497 . . . . 0.0 109.483 174.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -41.64 -39.71 4.94 Favored 'Trans proline' 0 C--N 1.348 0.52 1 C-N-CA 125.585 4.19 . . . . 0.0 115.272 171.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.6 -33.12 74.35 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.292 0.637 . . . . 0.0 112.017 -177.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.2 mt -106.39 -31.52 8.54 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.297 1.039 . . . . 0.0 112.293 -171.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 t -150.26 175.43 11.8 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.392 0.677 . . . . 0.0 109.961 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.4 p -149.07 164.62 20.38 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.2 1.0 . . . . 0.0 110.328 -174.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.32 -39.45 86.99 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.449 2.766 . . . . 0.0 112.096 174.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.51 -39.03 81.39 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.634 0.774 . . . . 0.0 111.447 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.6 m -62.93 -46.74 86.35 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 45.8 mt -59.87 -50.46 73.68 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.085 0.954 . . . . 0.0 110.609 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -51.53 -48.4 63.01 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.679 1.191 . . . . 0.0 110.46 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.71 -45.32 93.51 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.452 1.025 . . . . 0.0 112.219 177.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.85 -46.48 87.69 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.493 0.717 . . . . 0.0 110.991 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.1 mt -60.02 -44.07 93.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 123.528 0.731 . . . . 0.0 109.97 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -60.99 -42.49 98.51 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.638 0.775 . . . . 0.0 111.075 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -61.7 -43.43 98.87 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.663 0.785 . . . . 0.0 111.119 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.8 mtp -59.64 -45.17 92.79 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.746 0.419 . . . . 0.0 110.442 175.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.83 53.38 0.1 Allowed Glycine 0 C--N 1.341 0.817 0 C-N-CA 123.509 0.576 . . . . 0.0 112.477 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -140.46 133.01 28.67 Favored 'General case' 0 C--N 1.338 0.104 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 172.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -73.01 104.56 4.15 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -103.5 139.85 38.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.157 1.383 . . . . 0.0 110.59 -172.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.8 p -142.3 145.28 33.82 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.525 1.13 . . . . 0.0 108.793 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 52.6 mt . . . . . 0 CA--C 1.531 0.228 0 C-N-CA 122.826 0.45 . . . . 0.0 110.189 -176.226 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 CA--C 1.529 0.157 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -140.27 164.03 31.17 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.663 1.585 . . . . 0.0 108.265 170.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -127.27 150.0 49.76 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.471 1.108 . . . . 0.0 109.278 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -144.72 150.25 36.96 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.029 0.932 . . . . 0.0 109.706 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.0 t -112.5 127.18 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 171.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.0 mt -121.73 121.55 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -80.0 130.75 35.51 Favored 'General case' 0 N--CA 1.458 -0.061 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.8 mt -127.76 96.96 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -172.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -99.67 153.77 18.82 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.17 6.78 53.31 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.505 1.05 . . . . 0.0 112.345 -172.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 63.4 mtm -79.34 120.78 24.27 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.642 1.221 . . . . 0.0 108.474 175.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.5 p -84.4 -40.14 18.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.088 0.955 . . . . 0.0 110.989 -173.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.9 p -159.07 179.78 8.74 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.779 0.431 . . . . 0.0 110.327 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -59.22 -25.99 64.47 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.816 1.247 . . . . 0.0 113.279 -176.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.9 m -53.4 -41.28 65.81 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.488 0.586 . . . . 0.0 111.207 174.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.2 m -63.49 -48.35 77.99 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 123.384 0.674 . . . . 0.0 110.374 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.9 t -54.09 -52.17 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.348 1.059 . . . . 0.0 109.858 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -64.45 -46.38 83.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.904 0.881 . . . . 0.0 111.475 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.2 p -61.51 -47.41 85.73 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.085 0.402 . . . . 0.0 110.601 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.6 mt -56.24 -54.81 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 123.39 0.676 . . . . 0.0 109.613 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -49.95 -57.97 6.42 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.965 0.906 . . . . 0.0 110.204 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.55 -53.26 44.88 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.255 0.931 . . . . 0.0 112.583 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.83 -50.38 75.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.314 0.646 . . . . 0.0 111.116 -174.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.65 -32.65 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.091 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.1 m -55.2 -20.08 9.66 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -89.12 -10.83 45.8 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.866 0.757 . . . . 0.0 112.212 -176.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -73.19 127.21 89.57 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -47.45 128.9 15.67 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.854 3.036 . . . . 0.0 112.569 176.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.24 -33.18 6.74 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-O 118.592 -1.115 . . . . 0.0 112.655 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.6 t -65.27 136.91 25.93 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 CA-C-N 118.208 1.004 . . . . 0.0 110.623 -176.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -119.22 -103.06 0.41 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.34 1.456 . . . . 0.0 108.163 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 82.7 p -80.74 151.96 28.59 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.255 0.479 . . . . 0.0 110.133 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -150.25 138.88 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.248 1.019 . . . . 0.0 108.961 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -138.93 101.22 4.24 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.454 1.501 . . . . 0.0 107.712 -172.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 t -110.5 144.93 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.521 1.128 . . . . 0.0 108.865 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -146.51 130.93 17.64 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.312 0.645 . . . . 0.0 111.127 -175.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.8 tp -70.49 -48.82 53.87 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.882 1.273 . . . . 0.0 109.454 171.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.24 -46.26 69.07 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.759 1.224 . . . . 0.0 111.667 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -89.37 -10.15 47.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.194 0.597 . . . . 0.0 111.493 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.5 m 52.67 58.86 4.93 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.377 1.471 . . . . 0.0 110.488 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -158.42 169.19 25.01 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.203 0.525 . . . . 0.0 111.856 -174.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.82 113.58 1.05 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 126.652 2.073 . . . . 0.0 108.102 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.9 m -99.68 130.83 45.93 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 174.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.7 t -135.02 135.22 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 123.353 0.661 . . . . 0.0 109.766 -171.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -101.11 131.08 47.21 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 169.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -150.49 162.35 40.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.987 0.515 . . . . 0.0 111.99 -170.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -91.59 116.1 65.8 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 124.691 1.196 . . . . 0.0 109.49 170.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -48.59 -36.51 32.14 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 124.575 3.517 . . . . 0.0 114.231 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.4 mt -64.59 -28.95 69.98 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.602 0.761 . . . . 0.0 111.988 -176.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.7 mt -109.8 -28.63 8.7 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.047 0.939 . . . . 0.0 112.401 -172.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 t -152.43 178.63 9.34 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.792 0.724 . . . . 0.0 109.991 176.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.5 p -150.34 163.95 22.34 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.64 1.176 . . . . 0.0 109.756 -174.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.89 -38.49 85.95 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.257 2.638 . . . . 0.0 112.324 174.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -66.07 -45.34 81.66 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.26 1.024 . . . . 0.0 110.357 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 m -61.86 -47.26 85.81 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.185 0.594 . . . . 0.0 110.449 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.5 mt -60.16 -50.16 74.78 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.902 0.881 . . . . 0.0 110.382 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 57.5 ttp85 -52.04 -45.32 64.62 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.872 0.869 . . . . 0.0 110.342 172.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.73 -45.28 69.43 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.517 1.056 . . . . 0.0 112.163 175.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.85 -47.97 82.64 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.759 0.779 . . . . 0.0 111.265 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.1 mm -59.63 -45.53 94.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 122.668 0.387 . . . . 0.0 110.484 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -60.0 -41.81 92.93 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.251 1.02 . . . . 0.0 110.559 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.59 -44.49 96.19 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.952 0.901 . . . . 0.0 111.078 176.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.8 mtp -58.81 -41.55 87.04 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.737 0.415 . . . . 0.0 110.735 175.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.31 61.36 0.25 Allowed Glycine 0 C--N 1.34 0.76 0 C-N-CA 123.829 0.728 . . . . 0.0 112.107 169.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -140.45 155.02 46.84 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 123.955 0.902 . . . . 0.0 109.007 170.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -78.72 94.95 5.18 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.82 126.5 45.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.014 1.326 . . . . 0.0 109.897 -176.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.2 p -136.49 131.7 34.32 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.519 1.128 . . . . 0.0 109.162 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.5 mt . . . . . 0 CA--C 1.531 0.221 0 C-N-CA 123.327 0.651 . . . . 0.0 109.591 179.047 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 46.4 p . . . . . 0 CA--C 1.53 0.18 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -142.08 167.07 22.99 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.604 1.562 . . . . 0.0 108.695 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -129.12 153.8 47.32 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.573 1.149 . . . . 0.0 109.568 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -148.08 144.48 27.89 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.86 0.864 . . . . 0.0 110.073 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.7 t -106.9 107.46 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.7 mt -99.75 116.06 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -76.59 120.77 22.25 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 175.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -114.29 110.77 33.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -174.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -99.58 147.46 25.33 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.062 0.945 . . . . 0.0 108.639 173.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.44 4.98 52.59 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.328 0.966 . . . . 0.0 112.874 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 66.6 mtm -79.46 110.92 15.21 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.72 1.26 . . . . 0.0 107.982 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.8 p -84.4 -39.37 19.1 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.8 0.84 . . . . 0.0 110.965 -173.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.6 p -156.43 -179.47 8.2 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.715 0.293 . . . . 0.0 110.643 -175.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -55.16 -32.59 62.25 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.193 1.397 . . . . 0.0 112.981 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m -52.96 -39.85 63.26 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.416 0.687 . . . . 0.0 111.615 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.7 m -66.8 -48.05 70.16 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 122.858 0.463 . . . . 0.0 110.354 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.7 t -52.77 -55.08 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.046 0.938 . . . . 0.0 109.731 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -54.81 -52.95 61.06 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.141 1.376 . . . . 0.0 110.674 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.8 t -56.53 -55.87 28.44 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.697 0.799 . . . . 0.0 111.132 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.8 mt -57.21 -54.56 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.707 0.803 . . . . 0.0 109.641 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -55.02 -52.4 63.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.029 0.532 . . . . 0.0 110.666 -177.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.13 -51.11 60.34 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.681 1.134 . . . . 0.0 112.414 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.7 t -67.7 -57.24 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 117.801 0.801 . . . . 0.0 110.848 -176.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.4 mm -60.3 -34.54 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.561 0.744 . . . . 0.0 111.538 -173.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.9 p -54.13 -27.86 36.12 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -89.15 -20.04 24.74 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.29 0.636 . . . . 0.0 111.798 -175.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.59 141.72 93.31 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 118.509 0.595 . . . . 0.0 109.906 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -62.13 136.64 61.67 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.485 2.79 . . . . 0.0 111.304 -169.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.95 -40.39 2.45 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-O 118.996 -0.891 . . . . 0.0 111.583 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.2 131.52 33.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-N 118.103 0.952 . . . . 0.0 110.166 -176.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -101.2 -101.5 0.26 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.733 1.213 . . . . 0.0 107.732 173.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.5 p -87.92 151.48 22.79 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.77 0.828 . . . . 0.0 109.908 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.9 tt -150.18 137.92 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 123.907 0.883 . . . . 0.0 109.365 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -130.59 112.84 13.53 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.835 1.254 . . . . 0.0 108.479 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.9 t -101.4 147.92 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.379 1.072 . . . . 0.0 108.496 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.8 t -147.02 127.0 13.61 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.644 0.778 . . . . 0.0 110.463 -175.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.9 tp -70.32 -46.01 65.06 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.801 1.241 . . . . 0.0 109.937 172.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.64 -43.47 65.46 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.655 1.182 . . . . 0.0 111.498 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -89.26 -19.95 24.72 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.579 0.752 . . . . 0.0 111.099 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.5 m 57.43 53.82 7.15 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.478 1.511 . . . . 0.0 110.06 -175.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.9 p30 -153.85 172.93 16.59 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.976 0.511 . . . . 0.0 111.918 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.89 113.89 1.19 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 127.128 2.299 . . . . 0.0 107.96 176.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.0 m -98.96 104.34 16.38 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 t -111.47 133.48 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 124.517 1.127 . . . . 0.0 109.849 -169.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -103.58 133.39 48.68 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 169.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -150.45 170.51 18.91 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -171.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -103.19 112.89 66.04 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 125.586 1.554 . . . . 0.0 109.242 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -43.22 -38.98 8.29 Favored 'Trans proline' 0 C--N 1.348 0.531 1 C-N-CA 125.535 4.157 . . . . 0.0 114.987 173.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.41 -34.72 77.31 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.365 0.666 . . . . 0.0 111.811 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.6 mt -101.88 -32.14 10.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.248 1.019 . . . . 0.0 112.177 -172.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.5 t -152.04 175.83 12.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.185 0.594 . . . . 0.0 110.109 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.6 p -150.13 165.28 17.86 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 124.598 1.159 . . . . 0.0 109.635 -175.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -51.06 -46.18 32.42 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.606 2.871 . . . . 0.0 113.075 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -68.58 -34.67 76.2 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.186 0.594 . . . . 0.0 111.865 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.4 m -65.8 -45.45 82.33 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.126 0.421 . . . . 0.0 109.988 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.7 mt -64.45 -44.58 90.67 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.194 0.998 . . . . 0.0 110.692 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.6 ttp180 -53.78 -50.64 65.63 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.64 0.776 . . . . 0.0 109.18 171.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.74 -44.46 60.57 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.02 1.295 . . . . 0.0 112.565 176.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.09 -44.05 96.79 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.816 0.846 . . . . 0.0 111.09 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.6 mt -65.94 -39.76 85.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.21 0.604 . . . . 0.0 110.388 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -62.63 -38.88 91.98 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.506 0.722 . . . . 0.0 110.928 174.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -62.41 -41.36 98.63 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.321 0.648 . . . . 0.0 110.831 176.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.8 mtp -60.52 -48.39 81.96 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.028 0.376 . . . . 0.0 110.241 172.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.58 60.6 0.1 Allowed Glycine 0 C--N 1.341 0.811 0 C-N-CA 123.706 0.669 . . . . 0.0 111.956 170.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -140.35 149.97 43.38 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.624 0.77 . . . . 0.0 109.756 173.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -80.28 87.13 5.59 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.928 0.891 . . . . 0.0 108.691 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.57 140.8 33.23 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.006 0.923 . . . . 0.0 111.007 -175.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.0 t -150.31 160.15 43.93 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.698 1.199 . . . . 0.0 109.146 174.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 CA--C 1.532 0.251 0 C-N-CA 123.15 0.58 . . . . 0.0 110.205 -177.948 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.5 p . . . . . 0 CA--C 1.53 0.208 0 CA-C-O 120.784 0.326 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -134.22 162.81 31.13 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.14 1.376 . . . . 0.0 109.262 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -125.41 145.53 50.01 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.971 1.308 . . . . 0.0 108.695 176.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.7 t -142.8 145.51 33.3 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.824 0.85 . . . . 0.0 109.625 176.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.5 t -106.51 130.88 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 172.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.4 mt -125.62 125.19 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -69.91 129.38 39.36 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.1 mt -121.63 103.82 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -100.01 150.8 22.07 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.077 0.951 . . . . 0.0 109.407 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.74 26.2 23.13 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.674 1.131 . . . . 0.0 112.099 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 93.4 mtp -85.59 111.55 20.15 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.6 p -84.5 -44.84 13.23 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.492 0.717 . . . . 0.0 111.469 -170.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.9 p -159.05 -179.97 8.51 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.415 0.686 . . . . 0.0 109.721 -175.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -56.22 -29.32 60.83 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.819 1.247 . . . . 0.0 113.204 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.5 m -52.19 -41.18 62.45 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.154 0.582 . . . . 0.0 111.428 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.5 m -64.84 -46.53 81.51 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 122.692 0.397 . . . . 0.0 110.503 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.8 t -53.06 -55.15 13.56 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 C-N-CA 123.489 0.716 . . . . 0.0 109.342 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -56.71 -52.11 66.21 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.563 1.145 . . . . 0.0 111.224 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.9 m -58.99 -56.61 20.01 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.68 0.792 . . . . 0.0 111.222 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.4 mt -56.08 -51.96 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 123.651 0.78 . . . . 0.0 109.401 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -56.51 -53.52 56.52 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.856 0.462 . . . . 0.0 110.68 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.8 -54.55 36.6 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.687 0.66 . . . . 0.0 112.372 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.3 t -62.81 -55.35 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.794 0.838 . . . . 0.0 111.043 -174.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.0 mm -62.33 -37.11 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 118.778 -0.63 . . . . 0.0 110.932 -175.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.8 t -51.86 -35.11 43.67 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 118.798 0.726 . . . . 0.0 112.358 175.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -89.0 -12.18 42.14 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.778 0.831 . . . . 0.0 111.988 -173.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -70.4 143.62 90.77 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 119.016 0.825 . . . . 0.0 109.631 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -62.26 137.76 67.74 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.343 2.695 . . . . 0.0 111.021 -171.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.43 -41.02 2.38 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-O 119.059 -0.856 . . . . 0.0 111.311 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.2 t -70.88 141.39 16.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.199 0 CA-C-N 118.106 0.953 . . . . 0.0 109.442 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -112.91 -94.28 0.46 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.5 p -90.82 155.61 18.64 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.713 0.805 . . . . 0.0 109.787 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.4 tt -150.85 137.17 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.058 0.943 . . . . 0.0 108.47 174.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -117.95 99.46 6.92 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.68 1.592 . . . . 0.0 108.565 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.2 t -94.3 144.9 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.791 0.836 . . . . 0.0 109.601 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.5 t -147.37 122.48 10.15 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.785 0.834 . . . . 0.0 110.14 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.9 tt -70.15 -43.75 70.23 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.187 0.995 . . . . 0.0 109.564 170.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.5 -45.83 69.81 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.216 1.006 . . . . 0.0 111.566 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -89.68 -5.57 56.94 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.48 0.712 . . . . 0.0 111.778 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.0 m 51.8 53.82 11.98 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.679 1.591 . . . . 0.0 111.212 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -159.5 173.42 16.2 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -174.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.65 118.77 1.93 Allowed Glycine 0 C--N 1.339 0.72 0 C-N-CA 126.208 1.861 . . . . 0.0 109.001 174.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.8 m -99.68 97.9 8.8 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.2 t -100.63 132.2 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.698 1.199 . . . . 0.0 110.198 -169.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -105.31 126.56 52.24 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 172.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -150.15 169.17 21.93 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -169.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -102.91 115.77 63.63 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.309 1.443 . . . . 0.0 109.709 175.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -45.17 -41.03 16.58 Favored 'Trans proline' 0 C--N 1.348 0.523 1 C-N-CA 125.806 4.338 . . . . 0.0 115.635 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.1 mt -67.12 -29.69 69.49 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.922 0.489 . . . . 0.0 111.781 -174.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.52 -35.3 9.92 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.872 0.869 . . . . 0.0 110.989 -175.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.4 t -150.79 170.98 17.95 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.538 0.608 . . . . 0.0 110.576 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.5 p -150.03 161.86 29.76 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.995 1.318 . . . . 0.0 109.507 -172.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -50.12 -48.46 19.7 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.684 2.923 . . . . 0.0 113.434 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -58.81 -40.18 83.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.724 0.81 . . . . 0.0 112.044 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 m -66.35 -45.26 80.78 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.247 0.619 . . . . 0.0 109.862 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.4 mt -64.3 -43.32 95.09 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.178 0.991 . . . . 0.0 110.944 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.0 ttp85 -56.3 -48.09 77.37 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.85 0.86 . . . . 0.0 109.573 172.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.11 -41.08 92.45 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.28 0.943 . . . . 0.0 112.571 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.34 -47.41 76.58 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.67 0.788 . . . . 0.0 111.036 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.0 mt -62.83 -41.39 92.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.242 0.617 . . . . 0.0 109.7 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -58.75 -43.58 90.33 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.359 0.664 . . . . 0.0 110.803 175.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.7 -39.5 88.75 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.735 0.814 . . . . 0.0 111.429 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.2 mtp -59.25 -44.8 92.38 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 118.234 0.47 . . . . 0.0 110.593 173.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.93 61.5 0.1 Allowed Glycine 0 C--N 1.341 0.84 0 C-N-CA 123.533 0.587 . . . . 0.0 111.88 169.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -140.5 156.64 46.27 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.98 0.912 . . . . 0.0 109.544 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -79.5 90.46 5.09 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 174.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.47 125.52 45.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.69 1.196 . . . . 0.0 109.774 -174.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.4 p -145.62 135.18 23.25 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.314 1.046 . . . . 0.0 108.949 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.1 mt . . . . . 0 CA--C 1.531 0.231 0 C-N-CA 123.682 0.793 . . . . 0.0 111.866 -176.289 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.4 p . . . . . 0 N--CA 1.457 -0.113 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -135.68 170.41 16.01 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.861 1.665 . . . . 0.0 108.122 172.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -140.13 123.93 17.38 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 t -113.06 134.83 54.35 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.838 1.255 . . . . 0.0 109.22 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.3 t -99.55 125.27 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 169.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.5 mt -120.96 119.73 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -73.92 125.59 28.56 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.8 mt -118.22 107.43 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 125.053 1.341 . . . . 0.0 107.388 -176.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -99.79 135.5 41.12 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.58 0.9 20.07 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.854 1.216 . . . . 0.0 112.791 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.8 mtm -78.6 100.09 6.82 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.4 m -84.33 -36.09 22.8 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.974 1.31 . . . . 0.0 111.235 -169.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.1 p -153.45 179.57 8.66 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.026 0.376 . . . . 0.0 110.285 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -56.29 -30.13 62.08 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.178 1.391 . . . . 0.0 112.931 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 m -55.46 -43.91 75.9 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.434 0.694 . . . . 0.0 111.243 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.1 m -61.76 -53.13 60.16 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.5 t -49.91 -56.22 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.502 1.121 . . . . 0.0 110.146 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -63.34 -46.86 84.65 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.944 0.898 . . . . 0.0 111.586 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.6 p -60.99 -49.97 75.3 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.629 0.372 . . . . 0.0 110.994 -177.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.7 mt -55.88 -55.24 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -52.24 -54.35 32.22 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.792 0.837 . . . . 0.0 111.117 -176.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.14 -52.18 53.65 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 124.117 0.865 . . . . 0.0 112.458 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.2 t -64.03 -49.28 82.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 117.456 0.628 . . . . 0.0 111.044 -174.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.6 mm -64.65 -33.81 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.229 0.612 . . . . 0.0 111.217 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.1 t -53.71 -24.75 15.66 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 177.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -88.53 -8.33 54.99 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.424 0.69 . . . . 0.0 112.121 -172.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -74.06 128.18 86.83 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -46.81 133.84 17.51 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.703 2.935 . . . . 0.0 112.232 175.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.99 -42.11 1.97 Allowed Glycine 0 C--N 1.337 0.593 0 CA-C-O 119.037 -0.868 . . . . 0.0 111.47 -177.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.2 t -67.3 130.47 32.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 CA-C-N 117.846 0.823 . . . . 0.0 109.612 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -105.44 -94.48 0.35 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.4 p -90.05 154.96 19.41 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.482 0.713 . . . . 0.0 109.466 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.6 tt -150.25 135.42 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 37.7 mtt85 -131.56 93.9 3.43 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.66 1.184 . . . . 0.0 108.229 -169.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.2 t -95.29 141.91 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 123.648 0.779 . . . . 0.0 109.21 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.2 t -144.96 125.73 14.28 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.012 0.925 . . . . 0.0 110.283 -175.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 tt -71.43 -44.04 65.6 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.731 1.212 . . . . 0.0 110.039 172.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.05 -43.02 63.59 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.321 1.048 . . . . 0.0 111.449 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -89.4 -20.81 23.5 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.626 0.77 . . . . 0.0 111.141 177.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.7 m 57.76 54.68 6.03 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.646 1.578 . . . . 0.0 109.956 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.9 p30 -154.64 171.27 19.77 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.031 0.533 . . . . 0.0 112.104 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.92 114.34 1.56 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 126.506 2.003 . . . . 0.0 108.15 174.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.9 m -99.42 95.92 7.35 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.9 t -100.73 122.08 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 125.088 1.355 . . . . 0.0 109.12 -171.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -89.83 128.2 36.12 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -150.22 165.28 33.41 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -169.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -101.24 113.7 65.8 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.654 1.182 . . . . 0.0 108.885 171.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -45.57 -38.98 17.14 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.972 3.781 . . . . 0.0 114.884 174.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.0 mt -63.91 -28.9 70.15 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.736 0.814 . . . . 0.0 112.017 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.58 -41.81 7.18 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.08 0.952 . . . . 0.0 110.719 -175.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.8 t -143.83 156.97 44.66 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 123.64 0.776 . . . . 0.0 109.92 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.6 p -117.64 162.67 27.63 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 124.815 1.246 . . . . 0.0 109.9 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.07 -41.77 55.7 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.257 2.638 . . . . 0.0 112.385 171.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -63.36 -41.41 98.84 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.921 0.888 . . . . 0.0 111.872 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.9 m -59.67 -49.18 78.75 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.207 0.458 . . . . 0.0 110.026 176.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.4 mt -62.67 -45.71 91.56 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.021 0.929 . . . . 0.0 110.744 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 65.5 ttp85 -55.05 -50.51 68.91 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.032 0.933 . . . . 0.0 109.886 174.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.8 -42.65 86.19 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.633 1.111 . . . . 0.0 112.253 177.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.28 -39.25 94.05 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 117.446 0.623 . . . . 0.0 111.273 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.3 mt -69.72 -36.66 71.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.969 -0.457 . . . . 0.0 110.583 177.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -59.82 -41.09 90.53 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.83 -0.544 . . . . 0.0 110.273 171.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -63.2 -41.88 99.24 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.121 0.569 . . . . 0.0 111.246 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.7 mmm -57.72 -40.69 80.18 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.12 0.418 . . . . 0.0 110.663 172.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.86 55.77 0.31 Allowed Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.144 0.878 . . . . 0.0 111.622 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -140.44 151.04 44.57 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.752 0.821 . . . . 0.0 109.605 175.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -77.15 94.2 4.04 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.74 134.17 43.03 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.073 1.349 . . . . 0.0 109.639 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.2 t -146.31 140.49 26.49 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.842 0.857 . . . . 0.0 109.498 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.7 mt . . . . . 0 N--CA 1.455 -0.195 0 C-N-CA 123.048 0.539 . . . . 0.0 110.651 -175.876 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.4 p . . . . . 0 N--CA 1.457 -0.104 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -138.44 164.08 30.28 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.747 1.619 . . . . 0.0 108.686 176.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -121.53 144.61 48.62 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.542 1.137 . . . . 0.0 108.986 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.3 t -139.3 143.05 37.71 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.059 0.944 . . . . 0.0 109.445 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.4 t -107.71 116.61 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 172.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.0 mm -99.77 124.14 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 174.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -82.1 111.76 18.53 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 174.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 57.2 mt -107.52 106.09 20.01 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 C-N-CA 124.531 1.132 . . . . 0.0 108.334 -173.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -99.75 128.46 45.84 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.52 -4.66 7.62 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.397 0.999 . . . . 0.0 112.917 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 62.9 mtm -78.56 105.86 10.12 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.9 m -84.45 -34.97 23.33 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.335 1.054 . . . . 0.0 109.99 -173.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 p -158.55 167.63 29.09 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.283 0.633 . . . . 0.0 109.98 -175.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -60.13 -20.97 60.9 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.014 1.325 . . . . 0.0 113.791 -170.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.9 p -52.71 -43.0 65.34 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.715 0.689 . . . . 0.0 110.65 171.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 76.7 m -66.74 -48.22 69.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.528 0.731 . . . . 0.0 110.5 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.7 t -50.79 -53.25 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 123.986 0.915 . . . . 0.0 110.353 176.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -58.24 -50.01 75.07 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.731 1.212 . . . . 0.0 111.107 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.2 m -59.5 -54.54 45.35 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.213 0.605 . . . . 0.0 111.206 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.4 mt -54.53 -54.89 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 124.717 1.207 . . . . 0.0 109.742 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -56.34 -53.11 61.21 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.567 0.747 . . . . 0.0 110.713 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.2 -51.61 45.72 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.525 1.06 . . . . 0.0 112.128 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.0 -54.3 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.349 0.659 . . . . 0.0 110.415 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.41 -36.65 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.002 0.521 . . . . 0.0 111.58 -174.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.9 m -52.27 -30.75 29.33 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.501 0.721 . . . . 0.0 112.767 176.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -89.22 -9.95 48.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.583 0.753 . . . . 0.0 112.242 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -74.66 140.09 74.7 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 118.901 0.773 . . . . 0.0 109.874 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -64.83 137.93 55.74 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.992 2.462 . . . . 0.0 110.131 -175.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.7 -37.39 3.61 Favored Glycine 0 CA--C 1.525 0.656 0 CA-C-O 118.898 -0.946 . . . . 0.0 111.748 -176.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.6 t -67.6 141.16 18.12 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 CA-C-N 117.98 0.89 . . . . 0.0 110.418 -175.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -120.73 -102.85 0.41 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.632 1.173 . . . . 0.0 108.501 176.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.7 p -84.55 147.19 27.15 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.553 0.615 . . . . 0.0 109.807 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -150.22 139.95 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 123.642 0.777 . . . . 0.0 110.055 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.24 101.86 4.99 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.946 1.298 . . . . 0.0 108.498 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -97.54 139.0 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 174.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.2 t -135.23 129.05 33.07 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.176 0.99 . . . . 0.0 110.662 -173.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.1 tp -66.73 -52.97 38.31 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.36 1.064 . . . . 0.0 109.145 170.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.8 -49.03 66.45 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 125.041 1.336 . . . . 0.0 111.908 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -89.3 -6.28 56.87 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.012 0.525 . . . . 0.0 111.861 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.8 m 51.27 53.71 12.43 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.257 1.423 . . . . 0.0 111.229 176.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -156.98 172.17 19.16 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.811 0.444 . . . . 0.0 111.725 -174.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.97 112.38 1.01 Allowed Glycine 0 C--N 1.338 0.667 0 C-N-CA 126.215 1.864 . . . . 0.0 108.982 177.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.9 m -99.04 103.81 15.78 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 t -115.02 127.6 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 124.579 1.151 . . . . 0.0 109.831 -169.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -96.17 132.79 41.22 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 168.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -150.11 166.74 28.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.491 0.716 . . . . 0.0 110.887 -170.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -99.81 113.66 65.22 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.395 1.078 . . . . 0.0 109.062 172.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -43.02 -37.85 6.67 Favored 'Trans proline' 0 C--N 1.349 0.58 1 C-N-CA 125.377 4.051 . . . . 0.0 115.137 172.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.8 mt -63.89 -32.3 73.77 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.449 0.699 . . . . 0.0 111.997 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.72 -43.31 6.5 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.935 0.894 . . . . 0.0 111.076 -174.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.8 t -142.86 176.75 8.83 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.423 0.689 . . . . 0.0 110.315 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.0 p -150.26 162.0 29.06 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 124.271 1.028 . . . . 0.0 110.288 -172.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -53.25 -43.57 56.2 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.645 2.896 . . . . 0.0 112.899 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.17 -34.66 78.58 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.635 0.774 . . . . 0.0 112.183 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.5 m -71.51 -47.08 57.63 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.177 0.591 . . . . 0.0 109.816 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 59.8 mt -59.56 -47.72 84.45 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.903 0.881 . . . . 0.0 110.123 177.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -53.97 -50.04 67.42 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.31 1.044 . . . . 0.0 110.06 172.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.34 -44.84 65.83 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.641 1.115 . . . . 0.0 112.461 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.16 -42.47 98.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.479 0.639 . . . . 0.0 111.106 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.0 mt -66.5 -41.8 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 122.934 0.493 . . . . 0.0 110.526 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -59.49 -41.88 90.84 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.55 0.74 . . . . 0.0 110.563 174.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.22 -44.85 95.65 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.378 0.671 . . . . 0.0 111.098 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.0 mtm -60.87 -36.18 78.54 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.701 0.401 . . . . 0.0 111.215 174.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.68 59.12 0.31 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 123.803 0.716 . . . . 0.0 112.225 169.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -140.3 146.79 38.99 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.923 0.889 . . . . 0.0 108.638 172.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -76.01 90.99 3.04 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.59 132.68 44.77 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.278 1.031 . . . . 0.0 109.886 -177.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.1 m -140.32 152.76 46.09 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.077 1.351 . . . . 0.0 107.646 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.415 HD22 ' H ' ' A' ' 70' ' ' LEU . 2.2 mm? . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.1 p . . . . . 0 CA--C 1.529 0.138 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -117.32 164.49 14.75 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.376 1.071 . . . . 0.0 108.789 170.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -133.02 146.83 52.1 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.141 0.977 . . . . 0.0 109.717 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.1 t -138.85 142.3 38.62 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.28 1.032 . . . . 0.0 109.518 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.5 t -112.75 102.35 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 175.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.7 mt -99.99 112.98 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -66.05 123.69 20.55 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.1 mt -111.31 125.89 68.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -131.79 151.18 51.85 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.396 0.679 . . . . 0.0 109.861 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.47 36.23 6.62 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.803 1.192 . . . . 0.0 112.095 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -88.67 144.6 26.18 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 117.68 0.74 . . . . 0.0 109.015 174.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.0 p -84.69 -43.73 14.07 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.393 0.677 . . . . 0.0 109.807 177.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.7 p -163.69 -175.51 4.17 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.702 0.801 . . . . 0.0 109.956 -175.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -61.17 -27.64 68.55 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.121 1.369 . . . . 0.0 113.863 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.9 p -59.16 -33.53 71.03 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.638 0.654 . . . . 0.0 111.455 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 80.3 m -60.8 -56.07 25.57 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.154 0.582 . . . . 0.0 109.572 175.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.2 t -53.53 -47.19 60.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.788 1.235 . . . . 0.0 111.08 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -56.47 -52.91 62.94 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.83 0.852 . . . . 0.0 110.679 176.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.5 t -59.15 -51.17 71.18 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.881 0.872 . . . . 0.0 111.259 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.4 mt -52.65 -53.19 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.775 1.23 . . . . 0.0 109.551 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -54.74 -53.16 58.7 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.507 0.723 . . . . 0.0 110.698 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.14 -51.72 48.51 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.389 0.995 . . . . 0.0 112.266 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.0 t -58.94 -52.38 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.728 0.811 . . . . 0.0 110.436 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.24 -37.79 79.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 119.018 -0.515 . . . . 0.0 111.516 -176.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.6 m -52.21 -29.65 23.64 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 177.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -89.22 -8.34 53.73 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.482 0.713 . . . . 0.0 112.416 -175.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -73.84 138.28 76.61 Favored Pre-proline 0 CA--C 1.535 0.365 0 CA-C-N 119.082 0.855 . . . . 0.0 110.254 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -66.47 131.34 26.02 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.858 2.372 . . . . 0.0 109.394 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.24 -39.29 2.96 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-O 118.915 -0.936 . . . . 0.0 111.444 -175.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.6 t -66.43 135.63 28.14 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 117.955 0.878 . . . . 0.0 109.8 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -111.47 -99.62 0.41 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.024 1.329 . . . . 0.0 107.886 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.3 p -90.43 154.66 19.49 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.768 0.827 . . . . 0.0 109.628 172.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 tt -150.6 146.13 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 123.474 0.71 . . . . 0.0 110.447 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -140.1 107.91 5.67 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.837 1.255 . . . . 0.0 107.711 169.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.0 t -98.42 130.65 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 170.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.9 t -124.7 130.83 53.17 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.426 1.09 . . . . 0.0 110.169 -173.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.8 tp -72.56 -48.49 39.67 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.25 1.02 . . . . 0.0 108.936 172.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.85 -47.36 74.28 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.94 1.296 . . . . 0.0 111.626 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -89.3 -7.55 55.15 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.982 0.513 . . . . 0.0 111.525 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.6 m 53.45 54.01 10.76 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 125.234 1.413 . . . . 0.0 111.153 175.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -159.29 169.91 23.02 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.919 -175.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.35 107.2 1.0 Allowed Glycine 0 C--N 1.337 0.596 0 C-N-CA 126.613 2.054 . . . . 0.0 108.614 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.0 m -98.6 96.17 7.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.4 t -109.31 127.49 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 124.587 1.155 . . . . 0.0 108.924 -172.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -97.91 130.7 44.78 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 169.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -150.21 170.7 18.34 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.268 0.627 . . . . 0.0 112.171 -169.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -106.07 114.6 62.36 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.033 1.333 . . . . 0.0 109.477 173.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -44.3 -36.26 9.07 Favored 'Trans proline' 0 C--N 1.348 0.527 1 C-N-CA 125.528 4.152 . . . . 0.0 115.486 174.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.02 -32.36 74.05 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.259 0.624 . . . . 0.0 111.99 -176.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.3 mt -108.17 -29.62 8.83 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.005 0.922 . . . . 0.0 112.371 -171.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.5 t -148.11 175.25 11.18 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.719 0.69 . . . . 0.0 109.615 173.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.8 p -146.94 163.39 28.92 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 123.65 0.78 . . . . 0.0 110.33 -175.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -52.08 -41.99 61.54 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.475 2.783 . . . . 0.0 112.012 173.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -67.82 -39.62 83.89 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.724 0.81 . . . . 0.0 111.474 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.8 m -61.65 -50.36 72.82 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.83 0.452 . . . . 0.0 109.998 176.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 50.8 mt -60.2 -48.13 83.02 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.271 1.029 . . . . 0.0 110.63 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -54.09 -51.2 64.9 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.62 1.168 . . . . 0.0 110.279 175.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.52 -44.73 85.66 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.482 1.039 . . . . 0.0 111.803 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.3 -46.86 86.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.27 0.628 . . . . 0.0 111.354 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -61.34 -39.6 83.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 123.069 0.548 . . . . 0.0 110.093 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.73 -40.68 95.74 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.98 0.512 . . . . 0.0 110.901 177.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -64.01 -43.17 96.44 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.053 0.941 . . . . 0.0 110.982 176.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 79.5 mmm -56.09 -41.39 75.1 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.546 0.738 . . . . 0.0 110.2 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.15 53.5 0.23 Allowed Glycine 0 C--N 1.341 0.859 0 C-N-CA 123.994 0.806 . . . . 0.0 112.02 169.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -140.45 145.61 37.19 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.634 0.774 . . . . 0.0 109.347 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -68.76 100.84 1.22 Allowed 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.39 120.63 40.83 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.194 1.398 . . . . 0.0 109.938 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.2 p -142.32 137.23 30.42 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.653 0.781 . . . . 0.0 109.915 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.5 mt . . . . . 0 CA--C 1.531 0.224 0 C-N-CA 123.213 0.605 . . . . 0.0 110.988 -176.749 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 75.8 mt . . . . . 0 N--CA 1.475 0.815 0 CA-C-O 120.391 0.139 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.5 p -99.63 161.37 13.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.365 1.066 . . . . 0.0 110.308 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -128.47 173.15 10.48 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.799 1.639 . . . . 0.0 108.446 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -137.86 141.07 40.73 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.901 0.88 . . . . 0.0 108.998 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -130.71 135.8 48.16 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 124.376 1.07 . . . . 0.0 109.68 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.8 t -101.05 107.14 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 172.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.2 mt -99.85 121.52 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -75.79 125.7 29.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 57.8 mt -123.36 98.75 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -174.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -99.73 152.57 19.94 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.49 16.83 48.01 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.54 1.067 . . . . 0.0 112.323 -173.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 97.7 mtp -79.86 110.06 14.87 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.3 t -84.58 -37.93 20.56 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.286 0.635 . . . . 0.0 111.776 -173.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.2 p -158.48 179.72 8.87 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.119 0.568 . . . . 0.0 109.884 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -69.09 -13.33 62.37 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -173.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.7 p -59.83 -36.71 77.38 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.074 0.852 . . . . 0.0 110.12 170.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -59.56 -51.73 68.59 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.38 0.672 . . . . 0.0 109.608 174.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.2 t -52.17 -55.4 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.672 0.789 . . . . 0.0 110.234 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -57.61 -52.48 65.24 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.523 1.129 . . . . 0.0 111.647 -177.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.8 p -61.14 -48.95 79.24 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.694 0.398 . . . . 0.0 111.132 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 88.2 mt -59.19 -54.92 27.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.896 0.878 . . . . 0.0 110.233 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -62.21 -37.71 86.4 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.633 0.651 . . . . 0.0 111.194 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.41 -53.99 40.59 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.829 0.728 . . . . 0.0 111.294 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.22 -54.12 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.642 0.777 . . . . 0.0 110.431 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.4 mt -63.2 -39.86 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 122.891 0.476 . . . . 0.0 111.797 -172.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.6 p -55.96 -24.71 39.98 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -89.49 -9.28 50.61 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.076 0.951 . . . . 0.0 112.184 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -70.35 141.52 88.53 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 118.897 0.771 . . . . 0.0 109.693 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.4 132.55 29.65 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.859 2.373 . . . . 0.0 109.842 -177.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.21 -26.82 22.82 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 118.7 -1.055 . . . . 0.0 112.83 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.0 t -68.27 138.66 22.09 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 118.428 1.114 . . . . 0.0 110.149 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -119.95 -102.6 0.41 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.55 1.14 . . . . 0.0 108.89 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.8 p -80.2 150.77 30.01 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 118.362 0.528 . . . . 0.0 109.853 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.3 tt -150.12 139.48 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 123.329 0.652 . . . . 0.0 110.256 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -139.01 97.39 3.3 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.173 1.389 . . . . 0.0 108.602 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.8 t -99.17 142.27 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 124.476 1.11 . . . . 0.0 108.631 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.0 t -139.84 131.98 28.06 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.803 0.841 . . . . 0.0 110.711 -174.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.8 tp -70.42 -51.57 28.55 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.105 1.362 . . . . 0.0 109.112 169.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.39 -47.16 76.27 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.112 1.365 . . . . 0.0 111.889 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -89.3 -7.78 54.67 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.046 0.538 . . . . 0.0 111.236 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.0 m 54.11 56.55 6.89 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.391 1.477 . . . . 0.0 110.932 174.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -161.31 172.83 15.93 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.632 0.373 . . . . 0.0 111.883 -172.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -137.09 112.8 0.96 Allowed Glycine 0 C--N 1.339 0.727 0 C-N-CA 126.276 1.893 . . . . 0.0 109.29 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.5 m -99.43 103.74 15.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.6 t -116.29 123.95 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 124.285 1.034 . . . . 0.0 109.428 -170.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -89.95 132.36 35.37 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 169.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -150.33 163.24 38.82 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.046 0.539 . . . . 0.0 112.097 -171.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -97.39 115.43 65.74 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.728 1.211 . . . . 0.0 109.932 173.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -47.47 -38.41 27.49 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 125.28 3.987 . . . . 0.0 115.894 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 mp -69.92 -29.87 67.14 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.075 0.398 . . . . 0.0 111.368 -174.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.9 mt -99.72 -31.77 11.38 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.095 0.958 . . . . 0.0 111.932 -173.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.7 t -151.59 171.78 17.08 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.377 0.671 . . . . 0.0 109.822 175.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.3 p -141.79 164.2 35.91 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.229 1.012 . . . . 0.0 110.329 -174.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -53.34 -39.48 81.2 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.274 2.649 . . . . 0.0 112.081 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -67.86 -38.96 83.78 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.781 0.833 . . . . 0.0 111.698 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 m -61.83 -50.27 72.97 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.35 0.523 . . . . 0.0 109.863 175.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 61.7 mt -60.61 -53.0 62.73 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.509 1.123 . . . . 0.0 110.578 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -52.29 -46.58 65.97 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.151 1.38 . . . . 0.0 110.197 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.55 -53.41 38.87 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.788 1.185 . . . . 0.0 111.425 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.63 -44.51 90.03 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 117.672 0.736 . . . . 0.0 111.727 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.8 mt -60.77 -44.53 97.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 122.791 0.436 . . . . 0.0 110.015 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -61.35 -40.03 92.76 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.725 0.81 . . . . 0.0 110.824 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -63.82 -41.14 97.93 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.453 1.101 . . . . 0.0 110.999 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.9 mtp -59.49 -45.76 90.76 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.025 0.375 . . . . 0.0 110.267 173.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.48 63.04 0.14 Allowed Glycine 0 C--N 1.341 0.815 0 C-N-CA 123.552 0.596 . . . . 0.0 111.774 169.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -140.42 158.13 44.47 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 124.057 0.943 . . . . 0.0 109.379 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -76.9 93.44 3.76 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.37 121.13 40.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.76 1.224 . . . . 0.0 109.367 -175.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.6 t -148.45 148.26 30.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.891 0.876 . . . . 0.0 108.85 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.1 mt -71.23 152.62 43.15 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 63.0 p -59.88 -38.19 81.48 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.83 0.452 . . . . 0.0 110.621 170.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.0 t70 . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.044 -1.455 . . . . 0.0 108.211 175.782 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.7 tt . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.5 p -134.23 158.8 42.79 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.73 1.212 . . . . 0.0 110.056 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -141.12 173.24 11.67 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.353 1.461 . . . . 0.0 108.898 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -123.98 141.54 51.96 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.651 1.18 . . . . 0.0 108.559 172.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -130.77 130.77 44.15 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.116 0.966 . . . . 0.0 109.489 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 77.6 t -99.9 104.97 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.2 mt -99.98 126.01 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -75.05 129.71 38.07 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 174.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.9 mt -128.18 90.22 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -99.66 161.11 13.81 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.08 21.14 61.52 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 119.246 -0.752 . . . . 0.0 112.533 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 69.9 mtm -79.85 130.01 34.96 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 118.333 1.067 . . . . 0.0 108.389 170.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.4 m -84.43 -46.25 11.87 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.195 0.598 . . . . 0.0 110.573 -173.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 p -165.38 175.78 8.84 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.328 0.651 . . . . 0.0 110.268 -170.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -52.09 -35.71 48.63 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.907 1.283 . . . . 0.0 113.301 -173.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.1 p -50.28 -41.04 50.01 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.903 0.774 . . . . 0.0 111.64 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.2 m -64.28 -49.11 73.12 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.382 0.673 . . . . 0.0 110.58 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.8 t -51.93 -53.86 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.975 0.91 . . . . 0.0 110.346 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -62.49 -43.22 99.36 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.792 0.837 . . . . 0.0 111.547 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.4 t -59.56 -53.4 58.5 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.012 0.525 . . . . 0.0 110.663 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.8 mt -56.39 -52.44 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.342 1.057 . . . . 0.0 109.576 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -52.82 -55.1 25.5 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.449 1.1 . . . . 0.0 110.531 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.09 -53.66 42.9 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.385 0.993 . . . . 0.0 111.9 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.61 -50.55 78.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.423 0.689 . . . . 0.0 110.975 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 76.7 mt -68.67 -41.07 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.648 -175.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.3 p -55.68 -25.15 38.14 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -89.25 -8.51 53.33 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.134 0.974 . . . . 0.0 112.169 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -70.5 140.75 87.42 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 119.116 0.871 . . . . 0.0 110.532 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.1 128.91 20.54 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.674 2.249 . . . . 0.0 109.181 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.82 -39.27 2.97 Favored Glycine 0 C--N 1.336 0.554 0 CA-C-O 119.073 -0.848 . . . . 0.0 111.557 -175.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.0 t -70.37 137.83 23.18 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 CA-C-N 117.881 0.84 . . . . 0.0 109.419 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -114.24 -98.3 0.44 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.313 1.045 . . . . 0.0 108.186 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 86.7 p -90.27 155.43 18.99 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.953 0.501 . . . . 0.0 110.128 176.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.59 143.05 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.186 0.995 . . . . 0.0 109.859 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.36 105.91 8.2 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.686 1.195 . . . . 0.0 108.653 173.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.6 t -98.06 136.42 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 172.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -139.05 126.94 22.2 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.651 0.78 . . . . 0.0 110.451 -176.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.3 tp -69.68 -45.73 67.66 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.455 1.102 . . . . 0.0 109.857 171.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.73 -47.15 67.56 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.458 1.103 . . . . 0.0 111.497 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -89.38 -12.37 40.56 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.293 0.637 . . . . 0.0 111.797 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.3 m 53.44 58.08 5.55 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 125.317 1.447 . . . . 0.0 110.441 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.9 p-10 -156.39 173.36 17.0 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.991 0.516 . . . . 0.0 111.953 -174.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.45 110.97 0.83 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 126.719 2.104 . . . . 0.0 108.015 174.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.8 m -99.24 101.45 12.77 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.8 t -110.96 125.37 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 124.664 1.186 . . . . 0.0 109.424 -169.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -91.26 127.82 36.85 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 169.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -146.77 167.17 24.51 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.442 0.697 . . . . 0.0 111.86 -169.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -105.64 111.14 64.78 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.155 1.382 . . . . 0.0 109.368 174.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -45.31 -37.27 13.81 Favored 'Trans proline' 0 C--N 1.348 0.552 1 C-N-CA 125.44 4.093 . . . . 0.0 116.248 177.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -70.21 -30.61 67.75 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.173 0.442 . . . . 0.0 111.33 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.3 mt -99.96 -32.38 11.0 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.212 1.005 . . . . 0.0 112.042 -172.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.7 t -149.9 170.59 18.46 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.785 0.834 . . . . 0.0 109.428 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.6 p -137.85 162.25 55.41 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 123.967 0.907 . . . . 0.0 110.643 -176.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -53.05 -39.12 80.73 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.321 2.681 . . . . 0.0 112.043 172.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -68.32 -40.04 81.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.779 0.832 . . . . 0.0 111.482 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.3 m -60.37 -50.35 73.94 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.926 0.49 . . . . 0.0 109.941 175.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.1 mt -59.51 -50.12 75.13 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.234 1.014 . . . . 0.0 110.511 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -52.5 -48.71 65.81 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.843 1.257 . . . . 0.0 110.627 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.75 -46.47 89.62 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.319 0.962 . . . . 0.0 111.785 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.74 -44.41 96.28 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.117 0.567 . . . . 0.0 111.467 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.44 -45.26 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.082 0.553 . . . . 0.0 110.075 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -59.42 -42.13 91.14 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.731 0.813 . . . . 0.0 110.696 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -62.44 -44.52 96.23 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.742 0.817 . . . . 0.0 111.217 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.9 mtm -59.91 -36.47 77.04 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.657 0.383 . . . . 0.0 110.898 174.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.0 59.91 0.34 Allowed Glycine 0 C--N 1.341 0.811 0 C-N-CA 123.758 0.694 . . . . 0.0 111.996 169.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -140.38 158.64 43.71 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.898 0.879 . . . . 0.0 109.379 173.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -75.77 94.32 3.27 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.5 112.08 24.34 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.967 1.307 . . . . 0.0 110.084 -172.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.9 p -142.56 133.05 25.07 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.575 0.75 . . . . 0.0 109.757 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.5 mt -64.93 150.24 48.23 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.455 0.702 . . . . 0.0 110.85 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.9 p -68.05 -55.13 13.67 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.405 0.682 . . . . 0.0 110.496 172.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 . . . . . 0 C--O 1.25 1.13 0 C-N-CA 125.543 1.537 . . . . 0.0 110.563 -177.158 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 65.2 mt . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 111.471 0.174 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.9 p -140.41 126.66 19.86 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.601 1.161 . . . . 0.0 108.902 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -142.05 171.66 13.75 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.589 1.155 . . . . 0.0 109.238 173.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -139.99 141.69 36.34 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.327 1.051 . . . . 0.0 108.752 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -131.23 138.27 49.27 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.469 1.107 . . . . 0.0 109.81 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.3 t -106.11 100.54 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 174.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.0 mt -99.76 115.21 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -67.01 124.98 24.56 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.4 mt -113.72 100.8 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 106.662 -1.606 . . . . 0.0 106.662 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -99.67 146.37 26.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.698 0.799 . . . . 0.0 109.465 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.84 27.69 31.07 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.226 0.917 . . . . 0.0 112.839 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 73.2 mtm -80.45 135.42 36.14 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.23 1.015 . . . . 0.0 108.93 170.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.7 m -84.22 -48.0 10.23 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.004 0.922 . . . . 0.0 110.201 -174.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 p -161.06 -178.4 6.74 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.48 0.712 . . . . 0.0 109.618 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -61.23 -23.26 65.51 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.614 1.166 . . . . 0.0 113.321 -176.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.3 m -57.61 -37.99 74.19 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.598 0.635 . . . . 0.0 111.266 174.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.4 m -63.85 -51.81 62.96 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -51.85 -49.49 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.521 1.128 . . . . 0.0 110.552 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -57.95 -47.72 82.09 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.431 1.092 . . . . 0.0 110.998 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.7 t -62.22 -52.55 63.33 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.475 0.71 . . . . 0.0 111.188 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.9 mt -54.7 -56.24 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.962 1.305 . . . . 0.0 109.719 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -59.18 -46.77 87.55 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.445 0.698 . . . . 0.0 110.562 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.82 -48.6 50.53 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.932 1.254 . . . . 0.0 112.162 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.18 -62.56 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 117.507 0.653 . . . . 0.0 110.218 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.2 mt -58.82 -39.12 76.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.978 0.911 . . . . 0.0 112.108 -169.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 77.9 p -49.99 -33.84 19.17 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.846 0.859 . . . . 0.0 113.183 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -89.66 -14.89 33.86 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.605 0.762 . . . . 0.0 112.295 -175.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -71.14 143.66 88.81 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 118.689 0.677 . . . . 0.0 110.662 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -63.06 137.39 61.62 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.241 2.627 . . . . 0.0 110.663 -174.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.51 -35.66 4.57 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 119.128 -0.818 . . . . 0.0 111.793 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.0 t -68.45 128.57 32.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 CA-C-N 118.017 0.909 . . . . 0.0 109.847 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -99.68 -103.47 0.23 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.917 1.287 . . . . 0.0 107.854 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.9 p -87.2 154.12 20.97 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.6 0.76 . . . . 0.0 109.519 173.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.7 tt -150.41 135.24 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 123.172 0.589 . . . . 0.0 109.974 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 -134.68 100.82 4.74 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.916 1.287 . . . . 0.0 108.683 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.8 t -98.76 139.12 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.235 1.014 . . . . 0.0 108.637 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.4 t -135.6 132.18 36.78 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 124.445 1.098 . . . . 0.0 110.646 -173.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.7 tp -72.48 -49.45 33.09 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.318 1.047 . . . . 0.0 109.357 173.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.94 -44.82 78.77 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.08 1.352 . . . . 0.0 111.762 -177.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -89.23 -9.68 49.82 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.234 0.613 . . . . 0.0 111.201 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.1 m 54.44 52.42 12.44 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.61 1.564 . . . . 0.0 111.05 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -157.24 170.41 22.53 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.972 0.415 . . . . 0.0 111.838 -173.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.08 113.67 1.69 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 126.561 2.029 . . . . 0.0 108.658 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.3 m -98.77 93.19 5.94 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.8 t -105.63 120.57 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 124.398 1.079 . . . . 0.0 109.009 -171.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -89.78 133.81 34.51 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 169.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -150.25 166.79 28.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.838 0.455 . . . . 0.0 112.145 -169.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -102.78 113.2 66.04 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 125.255 1.422 . . . . 0.0 108.573 172.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -44.35 -36.1 9.05 Favored 'Trans proline' 0 C--N 1.347 0.467 1 C-N-CA 125.49 4.127 . . . . 0.0 115.077 173.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.6 mt -65.36 -36.6 84.49 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.237 0.615 . . . . 0.0 111.768 -177.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.1 mp -99.65 -34.26 10.28 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.956 0.902 . . . . 0.0 111.59 -171.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.3 t -147.82 177.32 9.42 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.457 0.703 . . . . 0.0 109.952 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.9 p -148.39 163.98 23.94 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 124.085 0.954 . . . . 0.0 110.264 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.4 -40.79 77.07 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.398 2.732 . . . . 0.0 112.078 174.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -67.91 -39.41 83.57 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.6 0.76 . . . . 0.0 111.369 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.7 m -61.5 -49.95 74.68 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.898 0.479 . . . . 0.0 110.068 175.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.0 mt -60.2 -48.79 80.22 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.172 0.989 . . . . 0.0 110.633 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -53.27 -50.09 65.56 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.69 1.196 . . . . 0.0 110.23 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.9 -43.21 92.66 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.523 1.059 . . . . 0.0 112.273 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.92 -42.07 98.67 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.344 0.572 . . . . 0.0 111.12 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.4 mt -66.75 -40.4 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.105 0.562 . . . . 0.0 110.389 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -59.01 -43.36 91.53 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.775 0.43 . . . . 0.0 110.78 172.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.39 -44.48 97.07 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.205 0.602 . . . . 0.0 111.03 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.2 mtm -62.29 -33.78 75.3 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.852 0.461 . . . . 0.0 111.26 174.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.3 56.59 0.42 Allowed Glycine 0 C--N 1.341 0.842 0 C-N-CA 123.814 0.721 . . . . 0.0 112.53 169.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -140.41 150.95 44.51 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.665 0.786 . . . . 0.0 109.424 172.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -75.45 98.63 3.96 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.62 128.24 45.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.68 1.192 . . . . 0.0 109.732 -175.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.3 t -150.08 169.34 21.48 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.145 0.978 . . . . 0.0 108.552 175.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -72.68 169.13 17.27 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.727 0.411 . . . . 0.0 110.183 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.2 p -49.54 -49.67 45.22 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.632 1.173 . . . . 0.0 111.456 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 117.197 -1.383 . . . . 0.0 108.988 171.799 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 54.1 tp . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.6 p -121.01 114.34 21.37 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.77 1.228 . . . . 0.0 109.617 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -126.33 149.9 48.87 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 169.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -119.74 149.04 42.67 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.741 0.816 . . . . 0.0 110.144 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.4 t -145.63 146.93 31.52 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.097 0.959 . . . . 0.0 109.102 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.9 t -113.11 125.61 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 172.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.5 mt -120.33 131.64 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -80.75 122.82 27.62 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 173.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.65 95.79 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -99.29 146.71 25.94 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.442 0.697 . . . . 0.0 109.438 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.1 42.26 7.17 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.12 0.867 . . . . 0.0 112.235 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.1 mtt -79.49 143.47 34.88 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 169.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 64.1 p -84.51 -42.37 15.59 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.597 0.759 . . . . 0.0 110.462 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.4 p -163.63 -179.71 6.6 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.126 0.97 . . . . 0.0 109.24 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -63.04 -24.86 68.11 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.163 0.985 . . . . 0.0 113.164 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m -53.13 -35.03 59.24 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.747 0.703 . . . . 0.0 111.574 174.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.5 m -58.34 -49.0 78.75 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.014 0.526 . . . . 0.0 110.834 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.2 t -50.81 -51.46 20.18 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 C-N-CA 123.773 0.829 . . . . 0.0 109.779 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -57.73 -53.7 55.26 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.928 0.891 . . . . 0.0 110.398 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.5 m -54.98 -46.93 75.15 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.244 0.618 . . . . 0.0 111.801 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 57.1 mt -60.65 -59.22 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 124.078 0.951 . . . . 0.0 109.8 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -60.72 -35.71 77.02 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 118.233 0.469 . . . . 0.0 111.302 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.62 -60.31 9.21 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 124.363 0.982 . . . . 0.0 110.676 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.55 -58.02 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 123.002 0.521 . . . . 0.0 110.139 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.9 mt -60.04 -41.33 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.29 0.636 . . . . 0.0 111.892 -169.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.4 p -54.38 -30.83 53.23 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.727 0.694 . . . . 0.0 112.833 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -89.42 -11.32 43.48 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.529 0.731 . . . . 0.0 112.559 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -68.86 141.31 92.22 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 119.253 0.933 . . . . 0.0 109.752 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.08 131.28 26.48 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.991 2.461 . . . . 0.0 110.083 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.8 -33.24 6.72 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-O 118.711 -1.049 . . . . 0.0 112.181 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.3 t -67.3 139.06 21.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-N 118.256 1.028 . . . . 0.0 110.478 -176.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -121.12 -105.65 0.38 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.317 1.447 . . . . 0.0 108.144 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.0 p -80.03 144.85 32.85 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.652 0.66 . . . . 0.0 110.018 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.3 tt -150.29 144.09 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.543 0.737 . . . . 0.0 110.824 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -140.28 131.96 27.28 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.123 1.369 . . . . 0.0 107.728 169.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.9 t -123.97 145.8 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.998 1.319 . . . . 0.0 108.229 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.7 t -139.16 132.82 30.55 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 124.138 0.975 . . . . 0.0 110.776 -173.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.9 tp -74.35 -49.98 20.58 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.72 1.208 . . . . 0.0 109.301 171.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.65 -46.15 67.03 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.732 1.213 . . . . 0.0 111.536 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -89.58 -12.13 40.69 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.427 0.691 . . . . 0.0 111.611 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.6 m 53.13 52.06 14.46 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 125.181 1.393 . . . . 0.0 110.581 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -154.47 172.57 17.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.961 0.504 . . . . 0.0 111.687 -175.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -142.76 116.25 1.01 Allowed Glycine 0 C--N 1.338 0.648 0 C-N-CA 125.644 1.592 . . . . 0.0 109.392 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.5 m -99.55 115.56 29.65 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.4 t -128.23 129.07 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 124.007 0.923 . . . . 0.0 109.755 -170.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -97.87 133.65 42.08 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 168.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -150.47 167.06 28.27 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.332 0.653 . . . . 0.0 111.482 -171.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -101.53 113.88 65.76 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.636 1.174 . . . . 0.0 109.431 173.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -43.37 -39.74 9.3 Favored 'Trans proline' 0 C--N 1.348 0.526 1 C-N-CA 125.603 4.202 . . . . 0.0 115.51 176.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.1 mt -63.98 -34.31 77.7 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.377 0.671 . . . . 0.0 111.81 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.3 mt -102.8 -29.27 11.57 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.912 0.885 . . . . 0.0 112.269 -172.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.8 t -152.55 165.92 33.66 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.415 0.686 . . . . 0.0 109.491 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.0 p -138.75 167.51 19.17 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.592 1.157 . . . . 0.0 110.041 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.35 -38.35 89.0 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.436 2.757 . . . . 0.0 112.181 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -67.08 -38.85 86.47 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.912 0.885 . . . . 0.0 111.508 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.4 m -62.58 -48.75 78.09 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.862 0.465 . . . . 0.0 109.933 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.4 mt -59.0 -53.23 60.8 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.373 1.069 . . . . 0.0 110.302 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 66.0 ttp85 -53.18 -46.02 68.79 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.987 1.315 . . . . 0.0 110.843 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.77 -49.09 77.28 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.489 1.042 . . . . 0.0 111.809 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.07 -46.78 89.28 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 117.385 0.593 . . . . 0.0 111.243 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.0 mt -57.34 -44.16 83.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.653 0.781 . . . . 0.0 110.019 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -61.47 -42.79 99.32 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.812 0.445 . . . . 0.0 110.605 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.14 -39.3 92.13 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.157 0.983 . . . . 0.0 111.926 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 28.8 mtt -55.79 -48.13 75.9 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 118.348 0.522 . . . . 0.0 110.128 173.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.45 58.99 0.13 Allowed Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 174.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -140.08 152.49 46.21 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.384 1.074 . . . . 0.0 108.707 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -72.76 99.98 2.75 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.8 122.29 42.55 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.693 1.197 . . . . 0.0 109.671 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.6 t -150.08 144.19 25.59 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 47.0 mt -66.75 134.56 52.44 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.0 t -90.31 45.69 1.29 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.816 0.846 . . . . 0.0 109.379 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 p30 . . . . . 0 C--O 1.253 1.247 0 C-N-CA 125.428 1.491 . . . . 0.0 108.866 -172.585 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 63.3 mt . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 111.241 0.089 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 43.1 p -137.22 101.57 4.57 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.487 1.115 . . . . 0.0 109.662 -174.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -125.63 169.22 12.71 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.913 1.285 . . . . 0.0 109.106 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -131.76 148.21 52.55 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.553 1.141 . . . . 0.0 109.608 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -146.22 148.69 32.76 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.681 1.192 . . . . 0.0 108.972 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.3 t -120.85 128.08 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.6 mt -122.28 126.84 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -67.8 133.05 48.55 Favored 'General case' 0 CA--C 1.526 0.051 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 172.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.5 mt -131.27 88.78 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -99.8 164.19 12.14 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.81 16.7 69.62 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 119.244 -0.753 . . . . 0.0 112.445 -174.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.1 mtm -79.81 124.9 29.04 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.384 1.092 . . . . 0.0 108.389 170.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.1 p -84.53 -40.9 17.06 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.763 0.825 . . . . 0.0 110.934 -175.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.4 p -158.85 -178.39 7.21 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.893 0.377 . . . . 0.0 110.717 -174.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -57.49 -28.35 63.35 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.623 1.569 . . . . 0.0 113.65 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 m -54.82 -41.28 70.46 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.233 0.613 . . . . 0.0 111.142 175.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.4 m -62.51 -51.47 67.31 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 122.864 0.465 . . . . 0.0 110.016 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.4 t -50.51 -56.35 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.96 0.904 . . . . 0.0 110.14 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -59.77 -50.66 72.94 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.463 1.105 . . . . 0.0 111.488 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.2 p -60.99 -50.39 73.6 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.906 0.482 . . . . 0.0 111.47 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.6 mt -57.75 -52.65 55.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.136 0 C-N-CA 123.353 0.661 . . . . 0.0 109.474 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -54.04 -49.62 68.53 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.289 0.636 . . . . 0.0 110.677 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.15 -54.9 33.87 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.3 0.953 . . . . 0.0 112.309 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.22 -55.47 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.392 0.677 . . . . 0.0 110.613 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.2 mm -64.34 -39.03 84.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 123.55 0.74 . . . . 0.0 111.47 -173.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.7 p -55.02 -30.59 59.87 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.972 0.806 . . . . 0.0 112.69 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -89.41 -3.27 58.49 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.99 0.916 . . . . 0.0 112.267 -175.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -73.12 125.5 90.93 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 119.03 0.832 . . . . 0.0 109.006 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -48.53 118.1 3.1 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.746 2.964 . . . . 0.0 112.128 176.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.37 -36.63 3.54 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 124.042 0.829 . . . . 0.0 111.849 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.7 t -72.66 130.55 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-N 117.87 0.835 . . . . 0.0 109.433 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -90.03 -105.09 0.09 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.0 p -90.62 159.02 16.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.055 1.342 . . . . 0.0 109.852 171.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.8 tt -150.42 134.04 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 123.921 0.888 . . . . 0.0 109.245 173.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -118.28 106.69 13.04 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.866 1.266 . . . . 0.0 108.975 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.2 t -95.35 145.25 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.097 0.959 . . . . 0.0 108.419 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -144.59 128.01 16.92 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.624 0.77 . . . . 0.0 110.461 -177.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.4 tp -70.92 -46.33 62.68 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.558 1.143 . . . . 0.0 110.011 172.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.37 -45.36 65.75 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.397 1.079 . . . . 0.0 111.565 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -89.59 -17.01 29.31 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.557 0.743 . . . . 0.0 111.5 178.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m 54.94 57.73 5.38 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.254 1.422 . . . . 0.0 110.117 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -156.21 173.19 17.2 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.274 0.63 . . . . 0.0 111.627 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.08 116.22 1.7 Allowed Glycine 0 C--N 1.338 0.65 0 C-N-CA 126.438 1.971 . . . . 0.0 108.271 174.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.7 m -99.38 102.52 14.14 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.8 t -108.56 131.55 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 124.428 1.091 . . . . 0.0 110.073 -169.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -101.25 130.6 47.41 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 168.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -150.81 174.79 12.67 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -169.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -115.73 110.36 44.49 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.747 1.619 . . . . 0.0 109.384 174.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -41.58 -38.94 4.42 Favored 'Trans proline' 0 C--N 1.349 0.571 1 C-N-CA 125.999 4.466 . . . . 0.0 115.19 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.1 mt -62.44 -30.71 71.44 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.442 0.697 . . . . 0.0 112.174 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.6 mt -109.52 -36.51 5.95 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.437 1.095 . . . . 0.0 112.018 -171.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.2 t -144.58 171.49 14.3 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.914 0.886 . . . . 0.0 109.303 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.6 p -150.3 161.28 31.23 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 123.215 0.606 . . . . 0.0 110.506 -175.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -49.09 -48.74 17.3 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.947 3.098 . . . . 0.0 113.99 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -66.12 -31.94 73.09 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.257 0.623 . . . . 0.0 112.443 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.0 m -68.11 -48.16 66.23 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 44.4 mt -60.5 -48.46 81.66 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.369 1.068 . . . . 0.0 110.174 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -51.5 -48.99 62.72 Favored 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 124.611 1.165 . . . . 0.0 110.224 172.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.79 -47.1 80.88 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.339 0.971 . . . . 0.0 112.15 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.7 84.16 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.411 0.684 . . . . 0.0 111.212 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.7 mt -61.16 -43.41 96.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.3 0.64 . . . . 0.0 110.048 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -60.82 -41.18 95.21 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.594 0.758 . . . . 0.0 110.719 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.86 -40.97 97.22 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.679 0.791 . . . . 0.0 111.185 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.3 mtp -59.52 -40.45 87.16 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.077 0.399 . . . . 0.0 110.635 173.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.12 62.0 0.22 Allowed Glycine 0 C--N 1.342 0.879 0 C-N-CA 123.712 0.672 . . . . 0.0 111.917 169.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -140.5 160.79 39.22 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.814 0.846 . . . . 0.0 110.02 175.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -77.1 89.62 3.61 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.44 115.15 28.61 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.48 1.112 . . . . 0.0 109.734 -173.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 81.2 p -141.17 148.62 40.3 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 124.17 0.988 . . . . 0.0 108.955 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 52.1 mt -74.46 144.45 44.22 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.086 0.403 . . . . 0.0 110.748 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 p -116.73 -40.7 3.14 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.873 1.269 . . . . 0.0 109.993 169.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.3 t70 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 116.606 -1.664 . . . . 0.0 108.456 175.957 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 56.7 tp . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 119.889 -0.101 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.0 p -140.84 143.88 35.03 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.458 1.103 . . . . 0.0 109.898 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -146.88 163.53 35.81 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.967 1.307 . . . . 0.0 108.983 169.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -125.32 143.56 50.91 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.344 1.458 . . . . 0.0 108.517 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.2 t -150.12 165.68 32.09 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 122.931 0.493 . . . . 0.0 111.072 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.1 t -130.59 134.81 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 170.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.2 mm -113.63 127.34 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 172.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -85.5 122.4 29.58 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 172.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.1 mt -121.98 97.07 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 125.336 1.454 . . . . 0.0 107.691 -169.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -99.79 154.47 18.3 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.959 0.409 . . . . 0.0 110.017 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.55 11.25 51.71 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.734 1.159 . . . . 0.0 112.152 -171.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 98.2 mtp -79.89 116.33 19.98 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.155 0.978 . . . . 0.0 108.597 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.0 p -84.71 -47.85 10.04 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.701 0.801 . . . . 0.0 111.529 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.8 p -153.98 -179.67 8.08 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.09 0.556 . . . . 0.0 110.512 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -58.28 -25.35 61.69 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.343 1.457 . . . . 0.0 113.523 -177.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 t -55.34 -40.63 71.45 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.102 0.561 . . . . 0.0 110.626 174.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.0 m -63.49 -46.97 83.71 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 122.998 0.519 . . . . 0.0 110.448 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.5 t -52.58 -53.66 19.17 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 123.686 0.794 . . . . 0.0 109.567 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -59.16 -48.06 83.01 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.722 0.809 . . . . 0.0 111.379 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.5 m -60.99 -53.73 53.69 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.396 0.678 . . . . 0.0 111.219 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.2 mt -57.82 -56.27 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 123.885 0.874 . . . . 0.0 109.26 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -55.86 -48.67 75.12 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.17 0.588 . . . . 0.0 110.905 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.94 -55.19 30.4 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.232 0.92 . . . . 0.0 112.034 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.75 -55.98 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 117.371 0.585 . . . . 0.0 110.771 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.2 mm -63.0 -37.32 79.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.504 0.721 . . . . 0.0 111.758 -173.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.1 p -54.29 -34.63 61.31 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.975 0.807 . . . . 0.0 112.414 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -89.53 0.56 56.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.624 0.77 . . . . 0.0 112.709 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -72.55 143.22 84.84 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 119.151 0.887 . . . . 0.0 109.186 175.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.47 128.43 21.29 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.943 2.429 . . . . 0.0 110.252 -175.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.38 -35.62 4.94 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-O 118.789 -1.006 . . . . 0.0 112.292 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.9 t -66.65 123.5 19.81 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 CA-C-N 118.219 1.009 . . . . 0.0 109.623 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -96.92 -96.88 0.2 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.1 p -90.08 147.12 23.83 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.237 0.615 . . . . 0.0 109.963 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.3 tt -149.89 142.71 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.835 1.254 . . . . 0.0 108.924 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.31 130.6 25.17 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.859 0.864 . . . . 0.0 109.214 169.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.54 147.75 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 125.399 1.48 . . . . 0.0 108.823 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.2 t -139.32 130.22 26.26 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.012 0.925 . . . . 0.0 110.769 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.0 tp -72.39 -49.91 30.39 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.917 1.287 . . . . 0.0 109.271 170.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.62 67.12 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.65 1.18 . . . . 0.0 111.639 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -89.55 -8.84 51.83 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.272 0.629 . . . . 0.0 111.648 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.9 m 52.24 56.79 7.22 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 125.297 1.439 . . . . 0.0 110.681 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.9 p30 -161.97 172.04 16.64 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.838 0.455 . . . . 0.0 111.513 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.22 119.27 1.97 Allowed Glycine 0 C--N 1.338 0.658 0 C-N-CA 125.577 1.56 . . . . 0.0 109.287 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.5 m -99.44 121.88 41.76 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.2 t -129.48 137.08 57.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 124.366 1.066 . . . . 0.0 110.126 -169.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -112.97 129.87 56.33 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -150.28 169.99 20.07 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -168.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -97.38 114.72 65.24 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.64 1.576 . . . . 0.0 109.548 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -44.85 -41.36 15.18 Favored 'Trans proline' 0 C--N 1.349 0.555 1 C-N-CA 125.452 4.102 . . . . 0.0 114.399 174.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.0 mt -61.53 -32.9 72.97 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.944 0.898 . . . . 0.0 111.903 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.1 mt -105.34 -28.8 10.67 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.069 0.948 . . . . 0.0 112.215 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.7 t -153.16 163.23 40.24 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.837 0.744 . . . . 0.0 110.374 178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.9 p -136.01 165.85 32.62 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 125.723 1.609 . . . . 0.0 109.504 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -53.12 -37.61 79.81 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.448 2.765 . . . . 0.0 112.573 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -67.21 -41.35 85.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.261 1.024 . . . . 0.0 110.46 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.6 m -64.03 -48.05 77.82 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.999 0.52 . . . . 0.0 110.048 177.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.4 mt -59.39 -49.66 76.96 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.937 0.895 . . . . 0.0 110.294 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -50.96 -51.03 56.58 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.317 1.047 . . . . 0.0 110.382 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.13 -46.6 84.98 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.323 0.963 . . . . 0.0 112.248 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.73 92.77 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.49 0.716 . . . . 0.0 111.125 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.5 mt -64.55 -36.41 77.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 123.215 0.606 . . . . 0.0 110.25 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -63.57 -41.46 98.4 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.942 -0.474 . . . . 0.0 110.357 175.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.14 -40.8 98.62 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.74 0.816 . . . . 0.0 111.285 175.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.4 mmm -56.17 -40.25 73.6 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.904 0.482 . . . . 0.0 110.665 173.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.72 54.31 0.26 Allowed Glycine 0 C--N 1.34 0.773 0 C-N-CA 123.973 0.796 . . . . 0.0 111.406 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -140.45 144.3 36.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.123 0.969 . . . . 0.0 108.791 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -70.46 99.23 1.57 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.68 129.05 45.78 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.057 1.343 . . . . 0.0 109.123 -174.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.5 p -137.52 143.87 41.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.31 1.044 . . . . 0.0 109.063 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 61.8 mt -67.53 145.5 54.86 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.813 0.445 . . . . 0.0 110.22 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.5 t -141.2 47.89 1.69 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.118 0.967 . . . . 0.0 109.089 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.237 -1.363 . . . . 0.0 108.522 -175.146 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 110.6 -0.148 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.3 p -99.46 164.06 12.25 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.661 1.185 . . . . 0.0 109.872 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -137.73 170.88 15.3 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 124.734 1.214 . . . . 0.0 109.816 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -124.15 153.45 41.5 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.497 1.119 . . . . 0.0 109.538 172.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.1 t -147.07 138.47 24.08 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.135 0.974 . . . . 0.0 109.756 -176.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.92 113.06 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.6 mt -113.28 126.2 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -71.15 136.32 48.07 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 177.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.6 mt -129.96 91.15 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -99.42 153.84 18.69 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.452 0.701 . . . . 0.0 109.553 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.1 45.0 12.18 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.853 0.74 . . . . 0.0 112.062 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 54.7 mtt -79.77 153.45 29.18 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 169.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.5 m -84.53 -52.37 6.18 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.756 0.822 . . . . 0.0 109.871 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.2 p -163.8 -178.29 5.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.732 1.213 . . . . 0.0 108.7 -175.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -60.57 -25.51 66.24 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.127 0.971 . . . . 0.0 113.25 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.6 m -54.69 -36.47 64.7 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.713 0.688 . . . . 0.0 111.468 175.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.2 m -61.4 -41.34 96.98 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 122.885 0.474 . . . . 0.0 111.186 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.8 t -53.37 -54.39 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 123.507 0.723 . . . . 0.0 109.322 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -59.77 -45.65 91.6 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.611 0.764 . . . . 0.0 111.361 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.4 m -59.14 -52.22 66.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.261 0.624 . . . . 0.0 111.443 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.6 mt -56.92 -50.98 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.194 0.998 . . . . 0.0 109.573 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -54.43 -56.07 22.45 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.413 0.685 . . . . 0.0 110.751 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.34 -56.35 19.98 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.124 0.868 . . . . 0.0 112.086 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.8 t -59.92 -57.23 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.817 0.847 . . . . 0.0 110.766 -177.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.2 mt -70.6 -32.82 50.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 118.851 -0.595 . . . . 0.0 112.081 -169.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 87.3 p -52.96 -30.75 36.65 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -89.12 -5.84 57.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.557 0.743 . . . . 0.0 112.483 -175.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -75.08 147.78 83.72 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 118.885 0.766 . . . . 0.0 110.229 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -45.29 127.71 9.32 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 124.309 3.34 . . . . 0.0 113.254 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.51 -31.1 5.64 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-O 118.653 -1.082 . . . . 0.0 113.596 176.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.73 136.56 25.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 118.386 1.093 . . . . 0.0 110.098 -175.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -115.67 -100.97 0.43 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.639 1.176 . . . . 0.0 108.224 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 86.5 p -81.53 151.56 27.69 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.709 0.686 . . . . 0.0 110.128 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.24 131.46 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 123.788 0.835 . . . . 0.0 108.939 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -130.69 102.15 5.99 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.179 1.392 . . . . 0.0 108.057 -174.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.1 t -100.73 149.88 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.436 1.094 . . . . 0.0 109.021 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.6 t -140.1 129.23 23.67 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.101 0.96 . . . . 0.0 109.753 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.7 tp -70.47 -49.49 48.05 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.458 1.103 . . . . 0.0 109.301 170.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.59 -47.65 66.76 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.712 1.205 . . . . 0.0 111.776 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -89.42 -11.9 41.82 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.199 0.6 . . . . 0.0 111.612 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.7 m 54.04 56.53 6.94 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 125.011 1.325 . . . . 0.0 110.602 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -157.59 170.49 22.27 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.498 0.719 . . . . 0.0 111.279 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -137.36 116.26 1.34 Allowed Glycine 0 C--N 1.337 0.603 0 C-N-CA 126.196 1.855 . . . . 0.0 109.389 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.3 m -99.48 105.92 17.89 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 t -109.25 137.24 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 124.548 1.139 . . . . 0.0 109.214 -173.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -105.56 130.01 53.7 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 169.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -150.42 164.96 34.58 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -168.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -98.08 113.97 64.54 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.158 1.383 . . . . 0.0 109.682 170.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -44.82 -37.43 11.88 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 125.247 3.965 . . . . 0.0 114.873 173.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.1 mt -63.82 -34.18 77.35 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.24 0.616 . . . . 0.0 111.97 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.4 mt -105.64 -27.61 11.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.98 0.912 . . . . 0.0 112.478 -171.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.0 t -151.87 176.27 11.62 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.749 0.704 . . . . 0.0 109.96 176.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.6 p -148.98 163.48 25.31 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.477 1.111 . . . . 0.0 109.717 -175.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -53.16 -36.51 77.43 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.193 2.595 . . . . 0.0 112.678 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -68.03 -44.57 76.17 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.318 1.047 . . . . 0.0 110.355 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.6 m -61.55 -46.93 87.82 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.224 0.609 . . . . 0.0 110.287 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.8 mt -62.31 -45.85 91.37 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.285 1.034 . . . . 0.0 110.764 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -53.64 -46.85 70.68 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.975 0.91 . . . . 0.0 109.968 172.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.56 -45.4 84.59 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.276 0.941 . . . . 0.0 112.268 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.39 -48.54 77.43 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.686 0.743 . . . . 0.0 111.168 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.2 mt -59.62 -45.11 94.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.802 0.841 . . . . 0.0 109.834 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -57.34 -47.85 80.51 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.874 0.87 . . . . 0.0 110.22 176.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -59.48 -41.66 90.3 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.848 0.859 . . . . 0.0 111.525 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.7 mtp -59.3 -41.55 89.26 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.051 0.387 . . . . 0.0 110.731 174.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.29 60.0 0.19 Allowed Glycine 0 C--N 1.34 0.787 0 C-N-CA 123.688 0.661 . . . . 0.0 111.718 169.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -140.35 155.93 46.6 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.018 0.927 . . . . 0.0 109.236 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.17 96.49 3.3 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.75 124.41 44.99 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.901 1.28 . . . . 0.0 109.989 -174.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.0 t -150.29 156.52 41.69 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.097 0.559 . . . . 0.0 109.948 175.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.7 mt -84.24 153.39 23.62 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.851 0.86 . . . . 0.0 113.152 -169.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.5 m -142.83 60.49 1.43 Allowed 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 168.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 p30 . . . . . 0 C--O 1.25 1.103 0 CA-C-O 116.95 -1.5 . . . . 0.0 109.073 -170.298 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 86.5 mt . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.1 p -140.25 120.99 14.37 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.197 0.999 . . . . 0.0 109.265 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -140.14 169.85 16.92 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.821 1.248 . . . . 0.0 109.34 175.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -140.3 143.64 35.97 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.462 1.105 . . . . 0.0 108.746 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 t -134.29 141.56 46.99 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.375 1.07 . . . . 0.0 109.824 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.0 t -107.66 106.97 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 175.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.3 mt -102.22 123.66 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -177.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -69.66 128.52 36.76 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 169.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 66.7 mt -127.47 86.58 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -99.95 148.73 24.17 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.067 0.547 . . . . 0.0 110.221 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.21 26.19 16.85 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.672 1.13 . . . . 0.0 112.871 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 68.6 mtm -79.62 136.27 36.79 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.242 1.021 . . . . 0.0 109.366 174.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.3 m -84.48 -46.93 11.14 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.267 1.027 . . . . 0.0 110.748 -173.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.5 p -156.1 177.25 11.64 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.643 0.777 . . . . 0.0 109.474 -175.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -60.69 -24.71 65.85 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.091 0.956 . . . . 0.0 113.091 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.3 m -53.59 -36.2 61.68 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.525 0.602 . . . . 0.0 111.472 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.3 m -60.26 -56.5 20.8 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.8 t -49.9 -52.61 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.464 1.105 . . . . 0.0 110.558 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -57.29 -54.58 45.2 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.366 1.066 . . . . 0.0 111.245 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.5 p -62.31 -49.82 74.09 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.378 0.671 . . . . 0.0 111.523 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 79.1 mt -52.97 -56.17 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 124.285 1.034 . . . . 0.0 109.696 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -57.57 -50.65 72.41 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.134 0.574 . . . . 0.0 110.347 -177.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.77 -51.41 44.95 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.502 1.049 . . . . 0.0 112.374 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.2 t -60.61 -55.18 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.336 0.655 . . . . 0.0 110.329 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.5 mt -64.33 -37.37 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 119.005 -0.522 . . . . 0.0 111.549 -171.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 72.5 m -49.93 -33.73 18.41 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.535 0.734 . . . . 0.0 112.502 173.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -89.39 -12.08 41.37 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.836 0.854 . . . . 0.0 112.06 -174.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -70.33 139.5 87.1 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 119.127 0.876 . . . . 0.0 109.839 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.27 132.82 32.83 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.939 2.426 . . . . 0.0 109.831 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.83 -33.67 6.33 Favored Glycine 0 C--N 1.337 0.605 0 CA-C-O 118.939 -0.923 . . . . 0.0 112.062 -177.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.5 t -70.32 135.3 28.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 CA-C-N 118.113 0.957 . . . . 0.0 109.908 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -111.48 -100.67 0.41 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.961 1.305 . . . . 0.0 107.958 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 59.5 p -86.83 146.16 26.32 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.615 0.766 . . . . 0.0 109.489 176.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.3 tt -150.24 143.89 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 123.624 0.77 . . . . 0.0 109.938 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.45 136.36 41.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 169.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.8 t -124.5 143.24 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.987 1.315 . . . . 0.0 107.691 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.5 t -143.4 130.93 21.14 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.898 0.879 . . . . 0.0 110.191 -174.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.33 -45.69 25.34 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.151 0.981 . . . . 0.0 109.53 174.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.47 -46.67 63.2 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.271 1.028 . . . . 0.0 111.305 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -89.72 -9.62 48.75 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.648 0.779 . . . . 0.0 111.905 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.0 m 52.33 55.59 8.93 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 125.68 1.592 . . . . 0.0 111.076 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -160.87 168.46 24.63 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.173 0.511 . . . . 0.0 111.706 -174.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.12 116.16 1.51 Allowed Glycine 0 CA--C 1.525 0.656 0 C-N-CA 126.232 1.873 . . . . 0.0 108.683 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.7 m -99.31 109.75 22.34 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 176.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.4 t -119.24 122.45 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 124.465 1.106 . . . . 0.0 109.217 -171.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -89.97 131.29 35.95 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 169.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -150.09 165.09 33.84 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -169.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -101.01 113.36 65.8 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.08 1.352 . . . . 0.0 109.262 172.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -43.46 -39.35 9.34 Favored 'Trans proline' 0 C--N 1.347 0.499 1 C-N-CA 125.458 4.105 . . . . 0.0 115.346 173.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.87 -34.93 79.27 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.776 0.43 . . . . 0.0 111.857 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.2 mt -100.6 -29.62 12.23 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.819 0.848 . . . . 0.0 112.423 -172.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.4 t -151.15 174.41 13.25 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.53 0.732 . . . . 0.0 109.731 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.8 p -148.15 162.59 30.3 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 123.893 0.877 . . . . 0.0 110.468 -173.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.02 -34.61 77.99 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.631 2.888 . . . . 0.0 112.41 172.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -63.22 -49.23 75.0 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.024 0.93 . . . . 0.0 110.458 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.6 m -62.35 -45.31 93.78 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.215 0.606 . . . . 0.0 110.402 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.3 mt -60.46 -50.12 74.83 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.813 0.845 . . . . 0.0 110.602 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -55.47 -41.92 73.64 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.035 0.379 . . . . 0.0 110.969 172.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.47 -46.21 52.98 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.205 0.907 . . . . 0.0 111.963 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.8 -48.4 80.78 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.408 0.604 . . . . 0.0 111.133 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.6 mm -60.9 -39.63 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 122.946 0.498 . . . . 0.0 111.279 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.24 -44.62 91.26 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.883 0.873 . . . . 0.0 110.216 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.02 -45.6 92.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.788 0.835 . . . . 0.0 110.905 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.5 mmm -59.78 -44.04 94.11 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.417 0.687 . . . . 0.0 110.626 175.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.8 60.96 0.4 Allowed Glycine 0 C--N 1.341 0.82 0 C-N-CA 124.518 1.056 . . . . 0.0 112.007 171.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -140.1 162.33 35.49 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.923 0.889 . . . . 0.0 109.494 172.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.0 103.85 3.91 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.97 110.05 21.82 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.75 1.62 . . . . 0.0 110.127 -174.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.9 t -150.4 145.88 26.35 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.037 0.381 . . . . 0.0 109.995 175.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.3 mt -74.41 144.59 44.26 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 122.597 0.359 . . . . 0.0 111.589 -174.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.3 t -96.86 -52.43 3.89 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.062 1.345 . . . . 0.0 107.7 169.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.5 p30 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.031 -1.461 . . . . 0.0 109.058 178.259 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 55.4 tp . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 110.676 -0.12 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.7 p -139.67 150.06 44.46 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.06 0.944 . . . . 0.0 109.823 176.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -142.64 162.45 35.43 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 126.333 1.853 . . . . 0.0 107.968 173.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -121.8 142.76 49.89 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.328 1.051 . . . . 0.0 109.231 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -133.54 133.41 42.1 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.192 0.997 . . . . 0.0 109.396 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.8 t -100.27 109.23 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 172.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.1 mt -99.53 118.4 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -75.8 107.41 7.96 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.2 mt -111.97 96.11 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -174.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -99.57 151.55 21.04 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.257 0.623 . . . . 0.0 109.771 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.09 35.35 12.59 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.185 0.898 . . . . 0.0 112.191 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 38.0 mtt -79.46 134.02 36.53 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 169.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.5 m -84.32 -51.51 6.92 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.424 0.689 . . . . 0.0 110.629 -174.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.8 p -161.0 -172.94 3.66 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.594 0.757 . . . . 0.0 109.647 -175.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -55.15 -32.68 62.29 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.385 1.474 . . . . 0.0 113.79 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.6 p -59.36 -41.15 88.62 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.264 0.484 . . . . 0.0 110.902 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.8 m -62.53 -49.95 73.3 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.916 0.486 . . . . 0.0 110.129 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.5 t -50.2 -52.1 15.67 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 C-N-CA 123.796 0.838 . . . . 0.0 109.889 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -62.04 -42.89 99.66 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.956 0.902 . . . . 0.0 111.845 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.6 m -63.87 -48.9 74.86 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.189 0.595 . . . . 0.0 110.969 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.9 mt -55.33 -58.56 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.974 1.309 . . . . 0.0 109.375 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -61.14 -43.52 98.76 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 117.952 0.342 . . . . 0.0 111.254 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.96 -54.48 33.4 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.367 0.984 . . . . 0.0 111.906 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.76 -51.49 72.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.033 0.933 . . . . 0.0 110.323 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.0 mm -62.92 -33.33 59.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.827 -175.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.5 m -57.04 -21.01 27.91 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 175.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -89.09 -14.09 37.1 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.631 0.65 . . . . 0.0 111.653 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -71.0 134.12 85.68 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -66.05 139.46 56.15 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.563 2.175 . . . . 0.0 109.571 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.32 -32.48 7.1 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-O 118.652 -1.082 . . . . 0.0 112.165 -176.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.5 t -66.17 136.37 26.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 CA-C-N 118.464 1.132 . . . . 0.0 110.198 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -116.67 -96.42 0.47 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.487 1.115 . . . . 0.0 108.606 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.5 p -90.09 147.98 23.3 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.475 0.71 . . . . 0.0 109.889 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 tt -150.41 131.98 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 123.841 0.856 . . . . 0.0 110.1 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.08 110.24 12.3 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.69 1.196 . . . . 0.0 108.494 177.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.7 t -106.06 144.4 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.364 1.066 . . . . 0.0 109.061 176.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.3 t -145.17 131.71 19.82 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.881 0.872 . . . . 0.0 110.609 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 tt -74.28 -45.86 44.96 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.737 1.215 . . . . 0.0 109.581 169.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.28 -46.95 66.1 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.298 1.039 . . . . 0.0 111.471 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -89.6 -10.79 44.67 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.42 0.688 . . . . 0.0 111.676 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.9 m 53.21 55.56 8.64 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 125.435 1.494 . . . . 0.0 110.554 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -156.48 169.3 24.95 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -175.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.41 111.43 0.99 Allowed Glycine 0 CA--C 1.524 0.623 0 C-N-CA 126.292 1.901 . . . . 0.0 108.369 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.5 m -99.08 98.54 9.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.7 t -109.98 127.88 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 124.392 1.077 . . . . 0.0 109.269 -170.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -98.27 129.79 44.98 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 169.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -150.06 163.61 37.7 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.76 0.824 . . . . 0.0 110.975 -169.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -95.35 115.01 65.08 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.396 1.078 . . . . 0.0 109.306 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -45.94 -37.17 16.77 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 124.993 3.795 . . . . 0.0 114.616 173.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.9 mt -63.76 -32.62 74.17 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.717 0.807 . . . . 0.0 112.004 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.8 -41.55 7.21 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.732 0.813 . . . . 0.0 111.281 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 t -142.69 170.47 15.65 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.381 0.672 . . . . 0.0 110.247 -178.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.4 p -138.43 160.95 61.62 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.397 1.079 . . . . 0.0 110.349 -174.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -50.64 -40.39 55.56 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.609 2.873 . . . . 0.0 112.211 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -61.12 -47.21 87.33 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.507 1.123 . . . . 0.0 110.418 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.6 m -60.94 -50.57 72.87 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.506 0.722 . . . . 0.0 110.678 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 50.9 mt -59.25 -50.95 72.05 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.382 1.073 . . . . 0.0 110.354 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -53.87 -49.49 68.4 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 124.115 0.966 . . . . 0.0 110.558 174.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.21 -46.44 62.86 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.518 1.056 . . . . 0.0 111.966 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.32 -51.46 69.87 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.239 0.616 . . . . 0.0 111.228 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.0 mm -66.44 -37.15 79.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 117.838 0.29 . . . . 0.0 111.657 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -60.37 -43.84 96.17 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.277 0.631 . . . . 0.0 109.951 175.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -62.72 -42.73 99.8 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.881 0.872 . . . . 0.0 111.363 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.1 mtp -56.95 -44.65 82.77 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.776 0.43 . . . . 0.0 110.577 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.9 63.1 0.18 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 123.597 0.617 . . . . 0.0 111.947 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -140.41 158.26 44.28 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.047 0.939 . . . . 0.0 108.817 171.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -78.74 87.22 4.64 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.25 116.6 31.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.917 1.287 . . . . 0.0 109.183 -176.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.9 p -138.82 133.22 31.77 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.645 1.178 . . . . 0.0 109.365 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.1 mt -69.09 145.81 53.11 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.934 0.494 . . . . 0.0 111.299 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 67.9 p -73.3 -50.34 22.66 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 169.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 C--O 1.251 1.159 0 C-N-CA 125.688 1.595 . . . . 0.0 111.041 175.946 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 75.1 mt . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 120.374 0.131 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 76.1 p -99.34 156.42 17.01 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.609 1.164 . . . . 0.0 109.158 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -133.52 159.54 40.13 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 124.676 1.19 . . . . 0.0 109.999 -173.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -113.93 145.54 41.35 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.447 1.099 . . . . 0.0 108.818 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.4 t -139.32 155.35 47.76 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.014 0.926 . . . . 0.0 109.489 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.5 t -120.24 131.37 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.1 mt -128.56 120.24 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -74.79 134.35 41.8 Favored 'General case' 0 C--N 1.337 0.052 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.8 mt -125.65 110.84 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -175.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -99.45 152.87 19.5 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.4 2.14 60.43 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.053 -0.86 . . . . 0.0 112.66 -176.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.3 mtm -79.33 103.3 9.17 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 118.66 1.23 . . . . 0.0 107.94 175.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.4 t -84.47 -29.74 25.81 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.302 0.641 . . . . 0.0 111.803 -173.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.2 p -159.17 179.01 9.4 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.389 0.54 . . . . 0.0 110.589 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -59.33 -26.18 64.8 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.09 1.356 . . . . 0.0 113.25 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.8 m -56.06 -40.84 74.15 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.486 0.585 . . . . 0.0 111.169 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.2 m -63.06 -51.85 65.06 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 122.899 0.48 . . . . 0.0 109.777 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.1 t -50.34 -54.89 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.182 0.993 . . . . 0.0 110.232 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -57.45 -53.9 52.93 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.733 1.213 . . . . 0.0 111.215 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.0 p -60.47 -51.27 70.16 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.123 0.569 . . . . 0.0 111.429 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.9 mt -56.08 -55.09 20.23 Favored 'Isoleucine or valine' 0 C--N 1.339 0.152 0 C-N-CA 123.502 0.721 . . . . 0.0 109.63 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -52.95 -53.13 54.18 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.506 0.722 . . . . 0.0 110.64 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.07 -55.55 30.04 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.184 0.897 . . . . 0.0 112.349 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.43 -53.22 51.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 123.958 0.903 . . . . 0.0 111.057 -175.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.7 mm -63.45 -31.4 52.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.026 0.53 . . . . 0.0 111.269 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.0 t -54.51 -26.09 29.55 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -89.38 -5.25 57.61 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.418 0.687 . . . . 0.0 112.284 -175.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -71.83 144.36 88.03 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 118.76 0.709 . . . . 0.0 109.537 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -64.31 128.07 20.62 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.977 2.452 . . . . 0.0 110.202 -175.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.6 -33.33 6.64 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 118.652 -1.082 . . . . 0.0 112.243 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.15 139.38 20.53 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 CA-C-N 118.192 0.996 . . . . 0.0 110.081 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -119.37 -98.7 0.45 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.666 1.186 . . . . 0.0 108.256 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.8 p -85.15 147.41 26.63 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.2 tt -150.26 134.58 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.753 0.821 . . . . 0.0 109.162 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 89.2 mmt-85 -132.52 109.24 9.64 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.081 1.352 . . . . 0.0 108.373 -177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.0 t -103.68 147.1 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.788 1.235 . . . . 0.0 108.703 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.4 t -140.64 127.85 20.99 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.068 0.947 . . . . 0.0 110.588 -174.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.1 tp -69.34 -49.49 55.16 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.576 1.15 . . . . 0.0 109.437 171.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.4 -46.25 69.64 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.752 1.221 . . . . 0.0 111.687 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -89.46 -11.63 42.46 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.3 0.64 . . . . 0.0 111.582 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.6 m 53.46 54.24 10.39 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 125.367 1.467 . . . . 0.0 110.791 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.4 p30 -158.86 173.1 17.05 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.032 0.533 . . . . 0.0 111.626 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.6 119.3 2.04 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 126.101 1.81 . . . . 0.0 109.333 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.9 m -99.59 117.78 34.71 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 t -122.43 128.7 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 124.278 1.031 . . . . 0.0 109.725 -170.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -95.43 127.14 41.22 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 169.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -150.2 164.68 35.06 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.981 0.512 . . . . 0.0 112.175 -169.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -98.81 115.17 65.9 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.545 1.138 . . . . 0.0 110.136 172.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -44.98 -42.84 15.73 Favored 'Trans proline' 0 C--N 1.348 0.526 1 C-N-CA 125.556 4.171 . . . . 0.0 115.634 176.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.2 mt -68.31 -28.01 66.79 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.627 0.371 . . . . 0.0 111.941 -174.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.2 mt -99.68 -31.21 11.68 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.064 0.946 . . . . 0.0 111.726 -175.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.8 t -153.35 163.86 39.17 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.551 0.614 . . . . 0.0 109.956 176.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.4 p -131.22 163.31 50.25 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 124.834 1.254 . . . . 0.0 109.915 -177.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.88 -40.13 67.1 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.292 2.661 . . . . 0.0 112.419 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -66.76 -40.32 88.2 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.719 0.807 . . . . 0.0 111.601 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.4 m -62.36 -48.1 81.28 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.628 0.371 . . . . 0.0 110.047 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.5 mt -61.27 -47.72 84.71 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.104 0.961 . . . . 0.0 110.596 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -51.6 -50.99 59.12 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.416 1.086 . . . . 0.0 110.087 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.93 -46.34 84.22 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.24 0.924 . . . . 0.0 112.112 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.21 -50.6 71.12 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.45 0.7 . . . . 0.0 111.184 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.4 mt -58.6 -47.39 88.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.387 0.675 . . . . 0.0 109.691 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -55.25 -48.92 73.28 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.747 0.819 . . . . 0.0 110.42 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.5 -38.38 77.55 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.925 1.29 . . . . 0.0 112.472 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -56.03 -37.45 69.24 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 118.428 0.558 . . . . 0.0 111.127 175.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.18 56.09 0.07 OUTLIER Glycine 0 C--N 1.34 0.776 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 171.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -140.39 173.75 11.19 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.949 0.9 . . . . 0.0 110.037 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -108.51 88.27 2.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.43 138.54 36.37 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.99 0.916 . . . . 0.0 110.374 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.0 t -149.48 148.11 29.02 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.287 1.035 . . . . 0.0 109.18 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.8 mt -65.39 152.25 44.34 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.693 0.397 . . . . 0.0 111.181 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.4 t -139.15 38.43 2.11 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.11 1.364 . . . . 0.0 108.577 172.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.9 t70 . . . . . 0 C--O 1.251 1.155 0 C-N-CA 125.4 1.48 . . . . 0.0 107.941 -171.276 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 120.335 0.112 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.7 p -140.21 128.08 21.98 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.126 0.97 . . . . 0.0 109.226 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -145.18 171.69 14.18 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.073 1.349 . . . . 0.0 109.449 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -136.39 143.3 43.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.829 1.252 . . . . 0.0 108.825 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 t -135.52 153.57 51.68 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.898 1.279 . . . . 0.0 109.012 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.3 t -120.83 135.87 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 171.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.4 mt -130.53 124.87 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -175.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -67.14 131.56 46.05 Favored 'General case' 0 C--N 1.338 0.09 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.3 mt -129.59 98.74 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -99.23 150.83 21.68 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.81 4.42 56.88 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.234 0.921 . . . . 0.0 112.343 -173.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 57.6 mtm -79.02 108.41 12.48 Favored 'General case' 0 C--N 1.343 0.318 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.3 m -84.36 -38.58 20.15 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.542 1.137 . . . . 0.0 110.401 -171.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.7 p -156.91 -178.66 7.53 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.805 0.336 . . . . 0.0 110.502 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -55.39 -30.99 61.45 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.667 1.587 . . . . 0.0 113.416 -178.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 m -54.02 -42.59 69.28 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.409 0.684 . . . . 0.0 111.335 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.0 m -62.65 -53.26 57.19 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 122.912 0.485 . . . . 0.0 109.861 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.0 t -49.91 -54.41 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.462 1.105 . . . . 0.0 110.516 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -60.98 -50.88 71.58 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.409 1.084 . . . . 0.0 111.447 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.9 p -61.4 -51.77 67.38 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.81 0.444 . . . . 0.0 111.291 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.8 mt -52.61 -57.7 3.81 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 C-N-CA 124.052 0.941 . . . . 0.0 109.358 177.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -54.7 -45.47 73.98 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.094 0.557 . . . . 0.0 111.166 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.3 -53.96 34.83 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.337 0.97 . . . . 0.0 112.023 177.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.5 t -65.9 -54.5 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 117.552 0.676 . . . . 0.0 110.725 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.8 -40.65 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 123.545 0.738 . . . . 0.0 111.221 -175.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.2 p -56.6 -26.73 56.4 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -89.17 -6.05 57.25 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.747 0.819 . . . . 0.0 111.938 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -73.3 125.57 90.72 Favored Pre-proline 0 CA--C 1.535 0.384 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.89 124.84 10.53 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.781 2.987 . . . . 0.0 112.35 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.12 -37.83 3.35 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-O 119.033 -0.871 . . . . 0.0 112.056 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.3 t -67.86 127.42 29.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-N 117.873 0.836 . . . . 0.0 110.077 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -98.02 -102.41 0.2 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.744 1.218 . . . . 0.0 108.003 176.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 95.7 p -89.97 155.85 18.83 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.538 0.608 . . . . 0.0 110.247 176.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.9 tt -150.55 144.5 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.103 0.961 . . . . 0.0 109.822 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -140.21 108.81 5.9 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.51 1.124 . . . . 0.0 108.84 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.7 t -98.36 141.77 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.668 1.187 . . . . 0.0 108.534 174.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.6 t -135.4 125.78 26.61 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 123.776 0.83 . . . . 0.0 110.888 -173.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -64.85 -55.64 18.26 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.647 1.179 . . . . 0.0 108.804 171.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.68 -47.5 58.77 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 125.2 1.4 . . . . 0.0 112.275 -176.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -89.35 -9.35 50.74 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.069 0.548 . . . . 0.0 111.698 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.6 m 52.3 54.99 9.8 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 125.315 1.446 . . . . 0.0 110.864 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -158.7 173.79 16.03 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.31 0.644 . . . . 0.0 111.095 -174.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.92 119.35 2.02 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 125.708 1.623 . . . . 0.0 109.308 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.2 m -99.44 116.09 30.78 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 t -127.51 122.52 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 124.072 0.949 . . . . 0.0 109.672 -169.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -90.05 134.3 34.33 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -150.09 168.09 24.92 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.86 0.464 . . . . 0.0 112.235 -171.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -103.41 111.82 65.32 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.179 1.392 . . . . 0.0 109.155 171.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -42.66 -38.22 6.23 Favored 'Trans proline' 0 C--N 1.348 0.51 1 C-N-CA 125.402 4.068 . . . . 0.0 115.282 172.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.79 -35.95 82.28 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.142 0.577 . . . . 0.0 111.794 -177.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.6 mt -102.26 -29.95 11.38 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.036 0.934 . . . . 0.0 112.36 -171.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 t -150.65 173.06 14.58 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.387 0.675 . . . . 0.0 109.915 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.7 p -141.4 162.63 46.3 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 124.516 1.126 . . . . 0.0 109.919 -177.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -52.62 -41.03 71.33 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.253 2.635 . . . . 0.0 112.1 174.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -64.62 -41.92 95.85 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.074 0.95 . . . . 0.0 111.423 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.5 m -63.05 -48.42 78.78 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.964 0.505 . . . . 0.0 110.381 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 54.6 mt -61.1 -48.89 79.6 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.091 0.956 . . . . 0.0 110.319 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.6 ttp85 -52.2 -48.48 65.05 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 124.139 0.976 . . . . 0.0 110.148 172.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.98 -46.73 76.26 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.661 1.125 . . . . 0.0 112.244 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.29 -49.84 75.99 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 117.491 0.646 . . . . 0.0 110.967 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.0 mt -61.2 -42.55 93.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.266 0.626 . . . . 0.0 109.972 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -60.83 -44.79 96.48 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.497 1.119 . . . . 0.0 110.583 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -59.03 -39.0 80.61 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.297 1.039 . . . . 0.0 111.349 177.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.3 mtp -67.33 -7.44 24.63 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 175.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.47 57.18 1.29 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 123.893 0.758 . . . . 0.0 111.483 170.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -140.33 156.35 46.47 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.139 0.976 . . . . 0.0 109.59 174.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -81.27 87.54 6.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 176.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.43 122.47 42.59 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.435 1.094 . . . . 0.0 109.747 -174.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.2 m -144.49 136.53 26.13 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.545 1.138 . . . . 0.0 108.588 -177.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.6 mt -63.67 136.7 57.69 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.857 0.463 . . . . 0.0 111.497 -176.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.1 m -89.51 -52.65 4.91 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 169.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 C--O 1.25 1.129 0 C-N-CA 125.333 1.453 . . . . 0.0 109.008 -179.695 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 46.1 tp . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 81.9 p -136.66 123.22 20.94 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.432 1.093 . . . . 0.0 109.458 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -143.98 169.69 17.35 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.988 0.915 . . . . 0.0 109.411 170.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -140.05 139.98 36.06 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.648 1.179 . . . . 0.0 108.192 173.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 t -137.33 141.44 41.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.035 0.934 . . . . 0.0 109.908 -177.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.5 t -99.72 133.39 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 171.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.3 mt -129.05 118.99 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -73.01 132.47 43.44 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.0 mt -120.55 111.49 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 125.266 1.426 . . . . 0.0 107.679 -175.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -100.74 149.37 23.88 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.487 1.115 . . . . 0.0 109.425 174.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.78 15.11 37.94 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.911 1.243 . . . . 0.0 112.455 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 93.1 mtp -79.69 109.07 13.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.5 m -84.34 -47.11 11.06 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.015 0.926 . . . . 0.0 111.065 -169.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -154.92 177.33 11.42 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.804 0.841 . . . . 0.0 108.821 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -61.2 -21.27 63.67 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -174.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.3 m -55.06 -36.8 65.97 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.361 0.528 . . . . 0.0 111.189 173.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.1 m -64.62 -44.23 91.2 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 122.897 0.479 . . . . 0.0 110.578 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.7 t -54.26 -52.88 34.19 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 123.345 0.658 . . . . 0.0 109.326 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -57.77 -50.19 74.08 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.921 0.888 . . . . 0.0 111.186 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -59.82 -59.32 5.62 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.515 0.726 . . . . 0.0 110.959 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 73.7 mt -52.94 -52.59 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.385 1.074 . . . . 0.0 109.561 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -61.72 -54.76 38.13 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.723 0.409 . . . . 0.0 110.746 -175.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.46 -39.11 95.86 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.731 1.158 . . . . 0.0 113.278 -176.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.8 t -73.7 -57.28 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 117.724 0.762 . . . . 0.0 109.937 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.6 mt -67.9 -28.96 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 118.971 -0.537 . . . . 0.0 111.813 -170.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.2 p -53.45 -28.89 32.74 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.897 0.771 . . . . 0.0 112.726 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -88.98 -17.09 30.15 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.857 0.863 . . . . 0.0 111.614 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -71.41 141.9 86.12 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 118.666 0.666 . . . . 0.0 109.709 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -63.99 140.37 72.22 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.323 2.682 . . . . 0.0 111.165 -170.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.43 -32.93 6.22 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 118.744 -1.031 . . . . 0.0 112.149 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.02 141.73 15.76 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 118.356 1.078 . . . . 0.0 110.125 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -118.39 -109.44 0.36 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.155 1.382 . . . . 0.0 107.526 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.7 p -90.1 94.33 9.74 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.329 1.052 . . . . 0.0 109.067 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.5 tt -89.92 133.94 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 123.932 0.893 . . . . 0.0 109.32 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -129.85 97.17 4.42 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.863 1.265 . . . . 0.0 108.444 -172.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.6 t -95.6 147.76 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.921 0.889 . . . . 0.0 109.927 -176.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.4 t -148.71 127.01 12.18 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.851 0.86 . . . . 0.0 110.198 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.8 tt -73.9 -42.77 60.18 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.011 0.924 . . . . 0.0 109.584 170.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.12 -47.11 72.21 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.543 1.137 . . . . 0.0 111.574 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -89.36 -5.44 57.47 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.362 0.665 . . . . 0.0 111.42 176.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.1 m 53.75 53.55 11.22 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 126.054 1.741 . . . . 0.0 111.165 175.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -161.22 172.08 17.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.284 0.564 . . . . 0.0 112.34 -172.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.71 117.05 2.39 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.1 m -99.37 94.38 6.41 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 t -100.03 120.06 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 124.456 1.103 . . . . 0.0 109.58 -169.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -89.52 132.86 34.85 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 169.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -150.81 171.79 16.64 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -169.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -106.87 111.72 63.65 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 125.548 1.539 . . . . 0.0 108.826 171.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -44.06 -38.02 10.11 Favored 'Trans proline' 0 C--N 1.346 0.422 1 C-N-CA 125.397 4.065 . . . . 0.0 114.893 172.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.2 mt -65.12 -33.69 76.62 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.481 0.712 . . . . 0.0 111.696 -177.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.0 mt -101.07 -33.4 10.16 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.266 1.026 . . . . 0.0 112.048 -172.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -148.95 169.97 19.38 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.526 0.73 . . . . 0.0 109.931 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.9 p -141.3 161.85 50.69 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.533 1.133 . . . . 0.0 109.745 -176.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.79 -42.86 42.79 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.484 2.789 . . . . 0.0 112.835 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -65.51 -39.87 92.35 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.541 0.736 . . . . 0.0 111.793 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.0 m -63.06 -45.26 93.02 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.637 0.375 . . . . 0.0 110.103 176.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.1 mt -65.43 -43.5 90.27 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.268 1.027 . . . . 0.0 110.833 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -53.85 -49.41 68.5 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.865 0.866 . . . . 0.0 109.449 170.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.92 -44.54 71.8 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.7 1.143 . . . . 0.0 112.388 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.29 94.65 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.727 0.811 . . . . 0.0 111.153 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.0 mt -63.7 -43.05 97.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 123.001 0.521 . . . . 0.0 110.226 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -62.57 -38.8 91.53 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.541 0.736 . . . . 0.0 111.349 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -60.94 -43.09 99.18 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.536 0.735 . . . . 0.0 110.616 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.4 mtp -62.36 -47.25 85.01 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 119.392 -0.337 . . . . 0.0 110.556 173.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.05 61.02 0.12 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 123.71 0.671 . . . . 0.0 112.077 170.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -140.33 150.69 44.29 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.58 0.752 . . . . 0.0 109.371 171.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -79.7 93.2 5.5 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.39 133.68 43.36 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.939 0.896 . . . . 0.0 110.39 -174.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.8 p -139.04 132.61 30.43 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.95 1.3 . . . . 0.0 108.825 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.8 mt -62.52 131.31 48.68 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.268 0.627 . . . . 0.0 110.751 -177.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.4 m -93.73 -44.88 7.94 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 169.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 117.238 -1.363 . . . . 0.0 108.804 171.77 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 83.5 mt . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 111.186 0.069 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 51.2 p -140.05 153.92 46.92 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.359 1.064 . . . . 0.0 109.751 177.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -142.36 166.27 25.15 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.821 1.648 . . . . 0.0 108.901 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -120.72 143.91 48.51 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.005 1.322 . . . . 0.0 108.486 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 t -142.27 139.66 31.98 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 123.534 0.734 . . . . 0.0 109.892 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.5 t -99.81 118.37 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.4 mm -102.22 130.64 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 174.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -71.58 125.56 27.4 Favored 'General case' 0 N--CA 1.458 -0.065 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 169.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.4 mt -127.58 88.95 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -99.88 159.14 15.3 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.097 0.559 . . . . 0.0 109.755 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.64 21.22 56.71 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 119.285 -0.731 . . . . 0.0 112.759 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 70.1 mtm -79.71 128.55 33.55 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.1 p -84.45 -42.43 15.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.497 0.719 . . . . 0.0 110.983 -174.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.6 p -159.58 179.95 8.44 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.822 0.344 . . . . 0.0 110.73 -174.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -54.09 -31.03 50.69 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.662 1.585 . . . . 0.0 113.57 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m -54.59 -39.02 67.41 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.411 0.684 . . . . 0.0 111.372 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.8 m -63.99 -49.2 73.39 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 122.82 0.448 . . . . 0.0 110.198 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.1 t -52.35 -51.82 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.248 1.019 . . . . 0.0 109.646 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -58.43 -48.26 81.28 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.32 1.448 . . . . 0.0 111.789 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.0 m -60.9 -50.78 72.01 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.944 0.497 . . . . 0.0 110.829 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.5 mt -60.39 -55.44 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 123.619 0.768 . . . . 0.0 110.017 -176.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -57.36 -45.33 84.51 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.493 0.588 . . . . 0.0 110.853 -176.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.44 -61.64 7.25 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 123.79 0.71 . . . . 0.0 111.464 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.81 -56.38 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.067 0.947 . . . . 0.0 110.994 -175.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.0 mm -63.08 -33.73 62.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 118.764 -0.636 . . . . 0.0 111.835 -171.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.4 t -51.07 -35.2 33.6 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -89.38 -5.57 57.34 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.903 -0.57 . . . . 0.0 112.453 -175.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -68.22 147.95 98.28 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 119.417 1.008 . . . . 0.0 110.105 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -45.77 132.15 13.46 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 124.08 3.186 . . . . 0.0 112.738 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.82 -39.33 3.09 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 118.943 -0.921 . . . . 0.0 112.986 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.4 t -67.32 143.22 15.67 Favored 'Isoleucine or valine' 0 C--N 1.341 0.205 0 CA-C-N 118.089 0.944 . . . . 0.0 110.278 -177.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -117.63 -95.33 0.48 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.6 p -90.66 157.5 17.43 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.837 0.855 . . . . 0.0 110.078 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.5 tt -150.7 145.06 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 124.488 1.115 . . . . 0.0 108.601 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -131.98 107.83 8.94 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.128 0.971 . . . . 0.0 109.121 176.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.9 t -97.27 149.56 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.977 1.311 . . . . 0.0 109.047 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.3 t -145.14 123.02 11.96 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.266 0.627 . . . . 0.0 110.173 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.8 tp -67.04 -47.0 72.71 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.745 1.218 . . . . 0.0 109.931 172.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.93 -43.28 66.15 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.677 1.191 . . . . 0.0 111.7 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -89.2 -21.02 23.48 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.375 0.67 . . . . 0.0 111.147 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.9 m 57.48 57.29 4.45 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 125.267 1.427 . . . . 0.0 109.784 -174.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.6 p30 -152.81 171.63 17.96 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.47 0.708 . . . . 0.0 111.578 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -137.26 114.68 1.14 Allowed Glycine 0 C--N 1.337 0.615 0 C-N-CA 126.041 1.781 . . . . 0.0 108.894 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.3 m -99.11 99.9 10.97 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.0 t -103.26 133.17 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 124.817 1.247 . . . . 0.0 109.58 -170.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -103.21 125.17 49.76 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 172.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -150.17 171.02 17.57 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -168.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -101.25 113.22 65.83 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.353 1.461 . . . . 0.0 109.479 172.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -44.18 -40.2 12.34 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 125.17 3.914 . . . . 0.0 114.794 173.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.0 mt -63.19 -34.81 78.45 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.606 0.763 . . . . 0.0 111.703 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.8 mt -99.98 -29.26 12.65 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.107 0.963 . . . . 0.0 112.197 -172.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.7 t -153.07 160.25 42.92 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.645 0.657 . . . . 0.0 110.11 177.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.3 p -125.98 161.88 48.88 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 125.179 1.392 . . . . 0.0 109.658 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.99 -36.12 43.3 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.41 2.74 . . . . 0.0 112.924 172.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -67.94 -44.0 77.83 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.608 1.163 . . . . 0.0 110.717 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.2 m -62.78 -45.71 91.39 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.959 0.504 . . . . 0.0 110.296 176.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.9 mt -61.85 -48.84 78.74 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.699 0.8 . . . . 0.0 110.534 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.2 ttp85 -49.99 -47.45 52.87 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.267 1.027 . . . . 0.0 110.14 171.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.84 -51.09 41.29 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.41 1.005 . . . . 0.0 111.826 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.36 -43.76 96.22 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.769 0.785 . . . . 0.0 111.948 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.8 mm -60.9 -44.12 97.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 118.345 0.521 . . . . 0.0 110.507 176.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -58.98 -43.74 91.47 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.173 0.589 . . . . 0.0 110.17 175.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -60.66 -41.47 95.09 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.98 0.912 . . . . 0.0 111.213 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.4 mtp -61.92 -43.86 97.97 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.238 0.472 . . . . 0.0 110.592 173.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.06 60.7 0.2 Allowed Glycine 0 C--N 1.34 0.805 0 C-N-CA 123.786 0.707 . . . . 0.0 111.887 169.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -140.37 159.36 42.36 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.975 0.91 . . . . 0.0 109.313 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -73.46 98.25 2.72 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.87 127.95 46.0 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.049 1.339 . . . . 0.0 110.021 -173.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.1 m -150.11 152.79 35.3 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.472 1.109 . . . . 0.0 108.521 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -75.27 124.37 26.96 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 t -91.29 -59.91 2.03 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 171.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.6 t70 . . . . . 0 C--O 1.249 1.051 0 C-N-CA 125.373 1.469 . . . . 0.0 107.819 178.592 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 120.328 0.109 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.4 p -140.39 133.08 28.88 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.273 1.029 . . . . 0.0 109.64 176.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -145.2 165.75 27.43 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.31 1.444 . . . . 0.0 109.065 173.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -129.26 151.01 50.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.813 1.245 . . . . 0.0 109.025 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.5 t -149.62 153.74 37.54 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 123.784 0.834 . . . . 0.0 109.91 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.57 125.43 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 173.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.3 mt -121.36 121.62 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -67.63 131.12 45.0 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 173.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.1 mt -124.39 108.77 21.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.112 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -99.83 150.5 22.29 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.58 13.17 55.99 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.378 0.989 . . . . 0.0 113.06 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 71.5 mtm -79.58 117.17 20.27 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.711 1.255 . . . . 0.0 108.26 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.4 m -84.15 -43.01 15.41 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.093 0.957 . . . . 0.0 110.387 -172.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.9 p -157.38 -178.94 7.72 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.605 0.362 . . . . 0.0 110.419 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -57.6 -25.92 60.76 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.293 1.437 . . . . 0.0 113.425 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.8 t -57.28 -44.42 83.99 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.229 0.611 . . . . 0.0 110.638 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.0 m -61.27 -51.06 70.51 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.817 0.447 . . . . 0.0 109.916 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.4 t -50.45 -53.05 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.328 1.051 . . . . 0.0 110.229 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -57.02 -51.75 68.02 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.55 1.14 . . . . 0.0 111.15 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.4 m -58.91 -54.37 47.87 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.566 0.746 . . . . 0.0 111.392 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.2 mt -54.08 -56.2 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.46 1.104 . . . . 0.0 109.438 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -55.09 -53.41 56.27 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.14 0.976 . . . . 0.0 110.924 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.47 -53.82 42.01 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.463 1.03 . . . . 0.0 112.296 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.6 t -59.48 -53.42 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.449 0.7 . . . . 0.0 110.392 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.0 mt -63.62 -39.94 87.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.108 0.563 . . . . 0.0 111.237 -174.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.2 t -49.92 -34.68 21.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.99 0.916 . . . . 0.0 112.355 176.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -89.05 -9.8 49.88 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.699 0.8 . . . . 0.0 112.427 -172.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -72.56 137.62 80.59 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 119.341 0.973 . . . . 0.0 109.91 177.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.39 136.03 20.0 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.718 2.945 . . . . 0.0 112.259 172.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.69 -43.31 1.83 Allowed Glycine 0 CA--C 1.523 0.541 0 CA-C-O 119.221 -0.766 . . . . 0.0 111.823 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.6 t -69.78 133.72 31.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 CA-C-N 117.76 0.78 . . . . 0.0 109.513 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -107.25 -98.1 0.36 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.9 p -90.15 149.04 22.62 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.546 0.738 . . . . 0.0 109.917 176.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.6 tt -150.53 143.17 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.239 1.016 . . . . 0.0 109.574 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -138.59 118.76 13.52 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.836 1.254 . . . . 0.0 108.342 175.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.19 147.02 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.889 1.275 . . . . 0.0 108.225 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.1 t -139.67 127.5 22.01 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 123.828 0.851 . . . . 0.0 110.749 -174.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp -68.17 -50.5 54.04 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.649 1.179 . . . . 0.0 109.47 171.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.56 -46.29 70.19 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.825 1.25 . . . . 0.0 111.73 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -89.36 -10.55 46.24 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.261 0.624 . . . . 0.0 111.586 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.7 m 53.11 55.18 9.23 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.368 1.467 . . . . 0.0 110.846 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -158.88 171.43 20.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.953 0.501 . . . . 0.0 111.698 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.31 116.06 1.86 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 126.376 1.941 . . . . 0.0 109.162 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.8 m -99.33 112.17 24.4 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.0 t -120.0 136.26 57.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.429 1.092 . . . . 0.0 109.819 -170.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -109.64 128.29 55.13 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 169.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -150.3 173.37 14.05 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -168.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -105.4 112.67 64.82 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.442 1.497 . . . . 0.0 109.483 174.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -41.64 -39.71 4.94 Favored 'Trans proline' 0 C--N 1.348 0.52 1 C-N-CA 125.585 4.19 . . . . 0.0 115.272 171.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.6 -33.12 74.35 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.292 0.637 . . . . 0.0 112.017 -177.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.2 mt -106.39 -31.52 8.54 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.297 1.039 . . . . 0.0 112.293 -171.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 t -150.26 175.43 11.8 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.392 0.677 . . . . 0.0 109.961 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.4 p -149.07 164.62 20.38 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.2 1.0 . . . . 0.0 110.328 -174.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.32 -39.45 86.99 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.449 2.766 . . . . 0.0 112.096 174.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.51 -39.03 81.39 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.634 0.774 . . . . 0.0 111.447 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.6 m -62.93 -46.74 86.35 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 45.8 mt -59.87 -50.46 73.68 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.085 0.954 . . . . 0.0 110.609 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -51.53 -48.4 63.01 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.679 1.191 . . . . 0.0 110.46 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.71 -45.32 93.51 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.452 1.025 . . . . 0.0 112.219 177.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.85 -46.48 87.69 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.493 0.717 . . . . 0.0 110.991 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.1 mt -60.02 -44.07 93.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 123.528 0.731 . . . . 0.0 109.97 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -60.99 -42.49 98.51 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.638 0.775 . . . . 0.0 111.075 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -61.7 -43.43 98.87 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.663 0.785 . . . . 0.0 111.119 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.8 mtp -59.64 -45.17 92.79 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.746 0.419 . . . . 0.0 110.442 175.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.83 53.38 0.1 Allowed Glycine 0 C--N 1.341 0.817 0 C-N-CA 123.509 0.576 . . . . 0.0 112.477 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -140.46 133.01 28.67 Favored 'General case' 0 C--N 1.338 0.104 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 172.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -73.01 104.56 4.15 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -103.5 139.85 38.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.157 1.383 . . . . 0.0 110.59 -172.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.8 p -142.3 145.28 33.82 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.525 1.13 . . . . 0.0 108.793 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 52.6 mt -71.93 127.35 32.29 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.826 0.45 . . . . 0.0 110.189 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.82 -51.99 7.15 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 171.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.0 t70 . . . . . 0 C--O 1.249 1.071 0 C-N-CA 125.499 1.52 . . . . 0.0 108.09 179.822 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 47.1 tp . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 110.622 -0.14 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.1 p -140.03 142.7 36.21 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.282 1.033 . . . . 0.0 110.112 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -140.27 164.03 31.17 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.663 1.585 . . . . 0.0 108.265 170.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -127.27 150.0 49.76 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.471 1.108 . . . . 0.0 109.278 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -144.72 150.25 36.96 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.029 0.932 . . . . 0.0 109.706 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.0 t -112.5 127.18 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 171.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.0 mt -121.73 121.55 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -80.0 130.75 35.51 Favored 'General case' 0 N--CA 1.458 -0.061 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.8 mt -127.76 96.96 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -172.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -99.67 153.77 18.82 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.17 6.78 53.31 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.505 1.05 . . . . 0.0 112.345 -172.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 63.4 mtm -79.34 120.78 24.27 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.642 1.221 . . . . 0.0 108.474 175.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.5 p -84.4 -40.14 18.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.088 0.955 . . . . 0.0 110.989 -173.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.9 p -159.07 179.78 8.74 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.779 0.431 . . . . 0.0 110.327 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -59.22 -25.99 64.47 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.816 1.247 . . . . 0.0 113.279 -176.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.9 m -53.4 -41.28 65.81 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.488 0.586 . . . . 0.0 111.207 174.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.2 m -63.49 -48.35 77.99 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 123.384 0.674 . . . . 0.0 110.374 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.9 t -54.09 -52.17 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.348 1.059 . . . . 0.0 109.858 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -64.45 -46.38 83.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.904 0.881 . . . . 0.0 111.475 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.2 p -61.51 -47.41 85.73 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.085 0.402 . . . . 0.0 110.601 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.6 mt -56.24 -54.81 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 123.39 0.676 . . . . 0.0 109.613 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -49.95 -57.97 6.42 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.965 0.906 . . . . 0.0 110.204 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.55 -53.26 44.88 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.255 0.931 . . . . 0.0 112.583 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.83 -50.38 75.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.314 0.646 . . . . 0.0 111.116 -174.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.65 -32.65 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.091 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.1 m -55.2 -20.08 9.66 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -89.12 -10.83 45.8 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.866 0.757 . . . . 0.0 112.212 -176.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -73.19 127.21 89.57 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -47.45 128.9 15.67 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.854 3.036 . . . . 0.0 112.569 176.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.24 -33.18 6.74 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-O 118.592 -1.115 . . . . 0.0 112.655 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.6 t -65.27 136.91 25.93 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 CA-C-N 118.208 1.004 . . . . 0.0 110.623 -176.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -119.22 -103.06 0.41 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.34 1.456 . . . . 0.0 108.163 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 82.7 p -80.74 151.96 28.59 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.255 0.479 . . . . 0.0 110.133 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -150.25 138.88 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.248 1.019 . . . . 0.0 108.961 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -138.93 101.22 4.24 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.454 1.501 . . . . 0.0 107.712 -172.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 t -110.5 144.93 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.521 1.128 . . . . 0.0 108.865 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -146.51 130.93 17.64 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.312 0.645 . . . . 0.0 111.127 -175.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.8 tp -70.49 -48.82 53.87 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.882 1.273 . . . . 0.0 109.454 171.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.24 -46.26 69.07 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.759 1.224 . . . . 0.0 111.667 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -89.37 -10.15 47.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.194 0.597 . . . . 0.0 111.493 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.5 m 52.67 58.86 4.93 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.377 1.471 . . . . 0.0 110.488 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -158.42 169.19 25.01 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.203 0.525 . . . . 0.0 111.856 -174.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.82 113.58 1.05 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 126.652 2.073 . . . . 0.0 108.102 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.9 m -99.68 130.83 45.93 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 174.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.7 t -135.02 135.22 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 123.353 0.661 . . . . 0.0 109.766 -171.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -101.11 131.08 47.21 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 169.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -150.49 162.35 40.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.987 0.515 . . . . 0.0 111.99 -170.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -91.59 116.1 65.8 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 124.691 1.196 . . . . 0.0 109.49 170.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -48.59 -36.51 32.14 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 124.575 3.517 . . . . 0.0 114.231 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.4 mt -64.59 -28.95 69.98 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.602 0.761 . . . . 0.0 111.988 -176.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.7 mt -109.8 -28.63 8.7 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.047 0.939 . . . . 0.0 112.401 -172.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 t -152.43 178.63 9.34 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.792 0.724 . . . . 0.0 109.991 176.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.5 p -150.34 163.95 22.34 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.64 1.176 . . . . 0.0 109.756 -174.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.89 -38.49 85.95 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.257 2.638 . . . . 0.0 112.324 174.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -66.07 -45.34 81.66 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.26 1.024 . . . . 0.0 110.357 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 m -61.86 -47.26 85.81 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.185 0.594 . . . . 0.0 110.449 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.5 mt -60.16 -50.16 74.78 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.902 0.881 . . . . 0.0 110.382 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 57.5 ttp85 -52.04 -45.32 64.62 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.872 0.869 . . . . 0.0 110.342 172.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.73 -45.28 69.43 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.517 1.056 . . . . 0.0 112.163 175.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.85 -47.97 82.64 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.759 0.779 . . . . 0.0 111.265 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.1 mm -59.63 -45.53 94.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 122.668 0.387 . . . . 0.0 110.484 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -60.0 -41.81 92.93 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.251 1.02 . . . . 0.0 110.559 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.59 -44.49 96.19 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.952 0.901 . . . . 0.0 111.078 176.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.8 mtp -58.81 -41.55 87.04 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.737 0.415 . . . . 0.0 110.735 175.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.31 61.36 0.25 Allowed Glycine 0 C--N 1.34 0.76 0 C-N-CA 123.829 0.728 . . . . 0.0 112.107 169.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -140.45 155.02 46.84 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 123.955 0.902 . . . . 0.0 109.007 170.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -78.72 94.95 5.18 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.82 126.5 45.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.014 1.326 . . . . 0.0 109.897 -176.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.2 p -136.49 131.7 34.32 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.519 1.128 . . . . 0.0 109.162 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.5 mt -62.75 124.22 20.45 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.327 0.651 . . . . 0.0 109.591 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.6 t -97.39 -52.69 3.71 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.975 0.91 . . . . 0.0 109.605 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 117.069 -1.443 . . . . 0.0 108.847 -177.893 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.3 tt . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 46.4 p -139.73 161.21 38.09 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.52 1.128 . . . . 0.0 110.074 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -142.08 167.07 22.99 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.604 1.562 . . . . 0.0 108.695 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -129.12 153.8 47.32 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.573 1.149 . . . . 0.0 109.568 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -148.08 144.48 27.89 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.86 0.864 . . . . 0.0 110.073 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.7 t -106.9 107.46 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.7 mt -99.75 116.06 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -76.59 120.77 22.25 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 175.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -114.29 110.77 33.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -174.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -99.58 147.46 25.33 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.062 0.945 . . . . 0.0 108.639 173.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.44 4.98 52.59 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.328 0.966 . . . . 0.0 112.874 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 66.6 mtm -79.46 110.92 15.21 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.72 1.26 . . . . 0.0 107.982 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.8 p -84.4 -39.37 19.1 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.8 0.84 . . . . 0.0 110.965 -173.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.6 p -156.43 -179.47 8.2 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.715 0.293 . . . . 0.0 110.643 -175.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -55.16 -32.59 62.25 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.193 1.397 . . . . 0.0 112.981 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m -52.96 -39.85 63.26 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.416 0.687 . . . . 0.0 111.615 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.7 m -66.8 -48.05 70.16 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 122.858 0.463 . . . . 0.0 110.354 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.7 t -52.77 -55.08 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.046 0.938 . . . . 0.0 109.731 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -54.81 -52.95 61.06 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.141 1.376 . . . . 0.0 110.674 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.8 t -56.53 -55.87 28.44 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.697 0.799 . . . . 0.0 111.132 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.8 mt -57.21 -54.56 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.707 0.803 . . . . 0.0 109.641 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -55.02 -52.4 63.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.029 0.532 . . . . 0.0 110.666 -177.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.13 -51.11 60.34 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.681 1.134 . . . . 0.0 112.414 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.7 t -67.7 -57.24 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 117.801 0.801 . . . . 0.0 110.848 -176.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.4 mm -60.3 -34.54 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.561 0.744 . . . . 0.0 111.538 -173.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.9 p -54.13 -27.86 36.12 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -89.15 -20.04 24.74 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.29 0.636 . . . . 0.0 111.798 -175.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.59 141.72 93.31 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 118.509 0.595 . . . . 0.0 109.906 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -62.13 136.64 61.67 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.485 2.79 . . . . 0.0 111.304 -169.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.95 -40.39 2.45 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-O 118.996 -0.891 . . . . 0.0 111.583 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.2 131.52 33.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-N 118.103 0.952 . . . . 0.0 110.166 -176.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -101.2 -101.5 0.26 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.733 1.213 . . . . 0.0 107.732 173.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.5 p -87.92 151.48 22.79 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.77 0.828 . . . . 0.0 109.908 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.9 tt -150.18 137.92 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 123.907 0.883 . . . . 0.0 109.365 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -130.59 112.84 13.53 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.835 1.254 . . . . 0.0 108.479 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.9 t -101.4 147.92 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.379 1.072 . . . . 0.0 108.496 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.8 t -147.02 127.0 13.61 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.644 0.778 . . . . 0.0 110.463 -175.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.9 tp -70.32 -46.01 65.06 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.801 1.241 . . . . 0.0 109.937 172.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.64 -43.47 65.46 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.655 1.182 . . . . 0.0 111.498 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -89.26 -19.95 24.72 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.579 0.752 . . . . 0.0 111.099 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.5 m 57.43 53.82 7.15 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.478 1.511 . . . . 0.0 110.06 -175.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.9 p30 -153.85 172.93 16.59 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.976 0.511 . . . . 0.0 111.918 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.89 113.89 1.19 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 127.128 2.299 . . . . 0.0 107.96 176.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.0 m -98.96 104.34 16.38 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 t -111.47 133.48 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 124.517 1.127 . . . . 0.0 109.849 -169.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -103.58 133.39 48.68 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 169.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -150.45 170.51 18.91 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -171.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -103.19 112.89 66.04 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 125.586 1.554 . . . . 0.0 109.242 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -43.22 -38.98 8.29 Favored 'Trans proline' 0 C--N 1.348 0.531 1 C-N-CA 125.535 4.157 . . . . 0.0 114.987 173.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.41 -34.72 77.31 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.365 0.666 . . . . 0.0 111.811 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.6 mt -101.88 -32.14 10.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.248 1.019 . . . . 0.0 112.177 -172.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.5 t -152.04 175.83 12.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.185 0.594 . . . . 0.0 110.109 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.6 p -150.13 165.28 17.86 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 124.598 1.159 . . . . 0.0 109.635 -175.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -51.06 -46.18 32.42 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.606 2.871 . . . . 0.0 113.075 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -68.58 -34.67 76.2 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.186 0.594 . . . . 0.0 111.865 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.4 m -65.8 -45.45 82.33 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.126 0.421 . . . . 0.0 109.988 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.7 mt -64.45 -44.58 90.67 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.194 0.998 . . . . 0.0 110.692 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.6 ttp180 -53.78 -50.64 65.63 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.64 0.776 . . . . 0.0 109.18 171.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.74 -44.46 60.57 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.02 1.295 . . . . 0.0 112.565 176.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.09 -44.05 96.79 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.816 0.846 . . . . 0.0 111.09 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.6 mt -65.94 -39.76 85.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.21 0.604 . . . . 0.0 110.388 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -62.63 -38.88 91.98 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.506 0.722 . . . . 0.0 110.928 174.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -62.41 -41.36 98.63 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.321 0.648 . . . . 0.0 110.831 176.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.8 mtp -60.52 -48.39 81.96 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.028 0.376 . . . . 0.0 110.241 172.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.58 60.6 0.1 Allowed Glycine 0 C--N 1.341 0.811 0 C-N-CA 123.706 0.669 . . . . 0.0 111.956 170.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -140.35 149.97 43.38 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.624 0.77 . . . . 0.0 109.756 173.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -80.28 87.13 5.59 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.928 0.891 . . . . 0.0 108.691 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.57 140.8 33.23 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.006 0.923 . . . . 0.0 111.007 -175.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.0 t -150.31 160.15 43.93 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.698 1.199 . . . . 0.0 109.146 174.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -82.69 162.19 21.89 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.15 0.58 . . . . 0.0 110.205 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 71.1 m -79.28 69.03 5.42 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.391 0.676 . . . . 0.0 109.58 172.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 117.142 -1.409 . . . . 0.0 108.709 179.965 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 75.3 mt . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 120.41 0.148 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.5 p -99.53 166.57 11.09 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.788 1.235 . . . . 0.0 110.19 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -134.22 162.81 31.13 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.14 1.376 . . . . 0.0 109.262 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -125.41 145.53 50.01 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.971 1.308 . . . . 0.0 108.695 176.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.7 t -142.8 145.51 33.3 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.824 0.85 . . . . 0.0 109.625 176.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.5 t -106.51 130.88 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 172.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.4 mt -125.62 125.19 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -69.91 129.38 39.36 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.1 mt -121.63 103.82 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -100.01 150.8 22.07 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.077 0.951 . . . . 0.0 109.407 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.74 26.2 23.13 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.674 1.131 . . . . 0.0 112.099 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 93.4 mtp -85.59 111.55 20.15 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.6 p -84.5 -44.84 13.23 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.492 0.717 . . . . 0.0 111.469 -170.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.9 p -159.05 -179.97 8.51 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.415 0.686 . . . . 0.0 109.721 -175.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -56.22 -29.32 60.83 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.819 1.247 . . . . 0.0 113.204 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.5 m -52.19 -41.18 62.45 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.154 0.582 . . . . 0.0 111.428 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.5 m -64.84 -46.53 81.51 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 122.692 0.397 . . . . 0.0 110.503 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.8 t -53.06 -55.15 13.56 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 C-N-CA 123.489 0.716 . . . . 0.0 109.342 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -56.71 -52.11 66.21 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.563 1.145 . . . . 0.0 111.224 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.9 m -58.99 -56.61 20.01 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.68 0.792 . . . . 0.0 111.222 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.4 mt -56.08 -51.96 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 123.651 0.78 . . . . 0.0 109.401 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -56.51 -53.52 56.52 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.856 0.462 . . . . 0.0 110.68 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.8 -54.55 36.6 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.687 0.66 . . . . 0.0 112.372 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.3 t -62.81 -55.35 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.794 0.838 . . . . 0.0 111.043 -174.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.0 mm -62.33 -37.11 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 118.778 -0.63 . . . . 0.0 110.932 -175.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.8 t -51.86 -35.11 43.67 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 118.798 0.726 . . . . 0.0 112.358 175.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -89.0 -12.18 42.14 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.778 0.831 . . . . 0.0 111.988 -173.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -70.4 143.62 90.77 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 119.016 0.825 . . . . 0.0 109.631 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -62.26 137.76 67.74 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.343 2.695 . . . . 0.0 111.021 -171.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.43 -41.02 2.38 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-O 119.059 -0.856 . . . . 0.0 111.311 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.2 t -70.88 141.39 16.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.199 0 CA-C-N 118.106 0.953 . . . . 0.0 109.442 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -112.91 -94.28 0.46 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.5 p -90.82 155.61 18.64 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.713 0.805 . . . . 0.0 109.787 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.4 tt -150.85 137.17 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.058 0.943 . . . . 0.0 108.47 174.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -117.95 99.46 6.92 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.68 1.592 . . . . 0.0 108.565 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.2 t -94.3 144.9 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.791 0.836 . . . . 0.0 109.601 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.5 t -147.37 122.48 10.15 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.785 0.834 . . . . 0.0 110.14 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.9 tt -70.15 -43.75 70.23 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.187 0.995 . . . . 0.0 109.564 170.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.5 -45.83 69.81 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.216 1.006 . . . . 0.0 111.566 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -89.68 -5.57 56.94 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.48 0.712 . . . . 0.0 111.778 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.0 m 51.8 53.82 11.98 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.679 1.591 . . . . 0.0 111.212 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -159.5 173.42 16.2 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -174.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.65 118.77 1.93 Allowed Glycine 0 C--N 1.339 0.72 0 C-N-CA 126.208 1.861 . . . . 0.0 109.001 174.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.8 m -99.68 97.9 8.8 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.2 t -100.63 132.2 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.698 1.199 . . . . 0.0 110.198 -169.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -105.31 126.56 52.24 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 172.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -150.15 169.17 21.93 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -169.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -102.91 115.77 63.63 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.309 1.443 . . . . 0.0 109.709 175.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -45.17 -41.03 16.58 Favored 'Trans proline' 0 C--N 1.348 0.523 1 C-N-CA 125.806 4.338 . . . . 0.0 115.635 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.1 mt -67.12 -29.69 69.49 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.922 0.489 . . . . 0.0 111.781 -174.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.52 -35.3 9.92 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.872 0.869 . . . . 0.0 110.989 -175.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.4 t -150.79 170.98 17.95 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.538 0.608 . . . . 0.0 110.576 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.5 p -150.03 161.86 29.76 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.995 1.318 . . . . 0.0 109.507 -172.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -50.12 -48.46 19.7 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.684 2.923 . . . . 0.0 113.434 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -58.81 -40.18 83.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.724 0.81 . . . . 0.0 112.044 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 m -66.35 -45.26 80.78 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.247 0.619 . . . . 0.0 109.862 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.4 mt -64.3 -43.32 95.09 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.178 0.991 . . . . 0.0 110.944 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.0 ttp85 -56.3 -48.09 77.37 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.85 0.86 . . . . 0.0 109.573 172.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.11 -41.08 92.45 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.28 0.943 . . . . 0.0 112.571 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.34 -47.41 76.58 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.67 0.788 . . . . 0.0 111.036 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.0 mt -62.83 -41.39 92.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.242 0.617 . . . . 0.0 109.7 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -58.75 -43.58 90.33 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.359 0.664 . . . . 0.0 110.803 175.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.7 -39.5 88.75 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.735 0.814 . . . . 0.0 111.429 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.2 mtp -59.25 -44.8 92.38 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 118.234 0.47 . . . . 0.0 110.593 173.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.93 61.5 0.1 Allowed Glycine 0 C--N 1.341 0.84 0 C-N-CA 123.533 0.587 . . . . 0.0 111.88 169.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -140.5 156.64 46.27 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.98 0.912 . . . . 0.0 109.544 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -79.5 90.46 5.09 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 174.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.47 125.52 45.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.69 1.196 . . . . 0.0 109.774 -174.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.4 p -145.62 135.18 23.25 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.314 1.046 . . . . 0.0 108.949 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.3 141.12 56.6 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.682 0.793 . . . . 0.0 111.866 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.0 m -84.24 -41.91 16.44 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 169.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 . . . . . 0 C--O 1.251 1.132 0 CA-C-O 117.062 -1.447 . . . . 0.0 110.135 177.067 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.4 p -128.99 141.76 51.15 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.655 1.182 . . . . 0.0 109.48 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -135.68 170.41 16.01 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.861 1.665 . . . . 0.0 108.122 172.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -140.13 123.93 17.38 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 t -113.06 134.83 54.35 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.838 1.255 . . . . 0.0 109.22 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.3 t -99.55 125.27 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 169.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.5 mt -120.96 119.73 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -73.92 125.59 28.56 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.8 mt -118.22 107.43 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 125.053 1.341 . . . . 0.0 107.388 -176.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -99.79 135.5 41.12 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.58 0.9 20.07 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.854 1.216 . . . . 0.0 112.791 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.8 mtm -78.6 100.09 6.82 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.4 m -84.33 -36.09 22.8 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.974 1.31 . . . . 0.0 111.235 -169.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.1 p -153.45 179.57 8.66 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.026 0.376 . . . . 0.0 110.285 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -56.29 -30.13 62.08 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.178 1.391 . . . . 0.0 112.931 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 m -55.46 -43.91 75.9 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.434 0.694 . . . . 0.0 111.243 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.1 m -61.76 -53.13 60.16 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.5 t -49.91 -56.22 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.502 1.121 . . . . 0.0 110.146 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -63.34 -46.86 84.65 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.944 0.898 . . . . 0.0 111.586 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.6 p -60.99 -49.97 75.3 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.629 0.372 . . . . 0.0 110.994 -177.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.7 mt -55.88 -55.24 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -52.24 -54.35 32.22 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.792 0.837 . . . . 0.0 111.117 -176.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.14 -52.18 53.65 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 124.117 0.865 . . . . 0.0 112.458 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.2 t -64.03 -49.28 82.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 117.456 0.628 . . . . 0.0 111.044 -174.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.6 mm -64.65 -33.81 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.229 0.612 . . . . 0.0 111.217 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.1 t -53.71 -24.75 15.66 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 177.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -88.53 -8.33 54.99 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.424 0.69 . . . . 0.0 112.121 -172.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -74.06 128.18 86.83 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -46.81 133.84 17.51 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.703 2.935 . . . . 0.0 112.232 175.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.99 -42.11 1.97 Allowed Glycine 0 C--N 1.337 0.593 0 CA-C-O 119.037 -0.868 . . . . 0.0 111.47 -177.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.2 t -67.3 130.47 32.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 CA-C-N 117.846 0.823 . . . . 0.0 109.612 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -105.44 -94.48 0.35 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.4 p -90.05 154.96 19.41 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.482 0.713 . . . . 0.0 109.466 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.6 tt -150.25 135.42 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 37.7 mtt85 -131.56 93.9 3.43 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.66 1.184 . . . . 0.0 108.229 -169.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.2 t -95.29 141.91 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 123.648 0.779 . . . . 0.0 109.21 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.2 t -144.96 125.73 14.28 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.012 0.925 . . . . 0.0 110.283 -175.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 tt -71.43 -44.04 65.6 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.731 1.212 . . . . 0.0 110.039 172.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.05 -43.02 63.59 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.321 1.048 . . . . 0.0 111.449 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -89.4 -20.81 23.5 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.626 0.77 . . . . 0.0 111.141 177.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.7 m 57.76 54.68 6.03 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.646 1.578 . . . . 0.0 109.956 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.9 p30 -154.64 171.27 19.77 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.031 0.533 . . . . 0.0 112.104 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.92 114.34 1.56 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 126.506 2.003 . . . . 0.0 108.15 174.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.9 m -99.42 95.92 7.35 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.9 t -100.73 122.08 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 125.088 1.355 . . . . 0.0 109.12 -171.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -89.83 128.2 36.12 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -150.22 165.28 33.41 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -169.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -101.24 113.7 65.8 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.654 1.182 . . . . 0.0 108.885 171.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -45.57 -38.98 17.14 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.972 3.781 . . . . 0.0 114.884 174.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.0 mt -63.91 -28.9 70.15 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.736 0.814 . . . . 0.0 112.017 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.58 -41.81 7.18 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.08 0.952 . . . . 0.0 110.719 -175.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.8 t -143.83 156.97 44.66 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 123.64 0.776 . . . . 0.0 109.92 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.6 p -117.64 162.67 27.63 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 124.815 1.246 . . . . 0.0 109.9 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.07 -41.77 55.7 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.257 2.638 . . . . 0.0 112.385 171.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -63.36 -41.41 98.84 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.921 0.888 . . . . 0.0 111.872 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.9 m -59.67 -49.18 78.75 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.207 0.458 . . . . 0.0 110.026 176.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.4 mt -62.67 -45.71 91.56 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.021 0.929 . . . . 0.0 110.744 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 65.5 ttp85 -55.05 -50.51 68.91 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.032 0.933 . . . . 0.0 109.886 174.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.8 -42.65 86.19 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.633 1.111 . . . . 0.0 112.253 177.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.28 -39.25 94.05 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 117.446 0.623 . . . . 0.0 111.273 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.3 mt -69.72 -36.66 71.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.969 -0.457 . . . . 0.0 110.583 177.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -59.82 -41.09 90.53 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.83 -0.544 . . . . 0.0 110.273 171.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -63.2 -41.88 99.24 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.121 0.569 . . . . 0.0 111.246 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.7 mmm -57.72 -40.69 80.18 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.12 0.418 . . . . 0.0 110.663 172.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.86 55.77 0.31 Allowed Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.144 0.878 . . . . 0.0 111.622 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -140.44 151.04 44.57 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.752 0.821 . . . . 0.0 109.605 175.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -77.15 94.2 4.04 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.74 134.17 43.03 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.073 1.349 . . . . 0.0 109.639 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.2 t -146.31 140.49 26.49 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.842 0.857 . . . . 0.0 109.498 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.7 mt -69.75 134.68 48.88 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.048 0.539 . . . . 0.0 110.651 -175.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.0 m -92.05 -41.27 10.61 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 169.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.187 -1.387 . . . . 0.0 109.307 172.802 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.6 tt . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.4 p -139.5 154.97 47.81 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.424 1.09 . . . . 0.0 110.161 -178.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -138.44 164.08 30.28 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.747 1.619 . . . . 0.0 108.686 176.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -121.53 144.61 48.62 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.542 1.137 . . . . 0.0 108.986 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.3 t -139.3 143.05 37.71 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.059 0.944 . . . . 0.0 109.445 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.4 t -107.71 116.61 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 172.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.0 mm -99.77 124.14 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 174.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -82.1 111.76 18.53 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 174.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 57.2 mt -107.52 106.09 20.01 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 C-N-CA 124.531 1.132 . . . . 0.0 108.334 -173.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -99.75 128.46 45.84 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.52 -4.66 7.62 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.397 0.999 . . . . 0.0 112.917 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 62.9 mtm -78.56 105.86 10.12 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.9 m -84.45 -34.97 23.33 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.335 1.054 . . . . 0.0 109.99 -173.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 p -158.55 167.63 29.09 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.283 0.633 . . . . 0.0 109.98 -175.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -60.13 -20.97 60.9 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.014 1.325 . . . . 0.0 113.791 -170.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.9 p -52.71 -43.0 65.34 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.715 0.689 . . . . 0.0 110.65 171.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 76.7 m -66.74 -48.22 69.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.528 0.731 . . . . 0.0 110.5 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.7 t -50.79 -53.25 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 123.986 0.915 . . . . 0.0 110.353 176.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -58.24 -50.01 75.07 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.731 1.212 . . . . 0.0 111.107 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.2 m -59.5 -54.54 45.35 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.213 0.605 . . . . 0.0 111.206 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.4 mt -54.53 -54.89 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 124.717 1.207 . . . . 0.0 109.742 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -56.34 -53.11 61.21 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.567 0.747 . . . . 0.0 110.713 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.2 -51.61 45.72 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.525 1.06 . . . . 0.0 112.128 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.0 -54.3 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.349 0.659 . . . . 0.0 110.415 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.41 -36.65 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.002 0.521 . . . . 0.0 111.58 -174.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.9 m -52.27 -30.75 29.33 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.501 0.721 . . . . 0.0 112.767 176.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -89.22 -9.95 48.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.583 0.753 . . . . 0.0 112.242 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -74.66 140.09 74.7 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 118.901 0.773 . . . . 0.0 109.874 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -64.83 137.93 55.74 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.992 2.462 . . . . 0.0 110.131 -175.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.7 -37.39 3.61 Favored Glycine 0 CA--C 1.525 0.656 0 CA-C-O 118.898 -0.946 . . . . 0.0 111.748 -176.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.6 t -67.6 141.16 18.12 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 CA-C-N 117.98 0.89 . . . . 0.0 110.418 -175.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -120.73 -102.85 0.41 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.632 1.173 . . . . 0.0 108.501 176.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.7 p -84.55 147.19 27.15 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.553 0.615 . . . . 0.0 109.807 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -150.22 139.95 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 123.642 0.777 . . . . 0.0 110.055 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.24 101.86 4.99 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.946 1.298 . . . . 0.0 108.498 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -97.54 139.0 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 174.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.2 t -135.23 129.05 33.07 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.176 0.99 . . . . 0.0 110.662 -173.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.1 tp -66.73 -52.97 38.31 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.36 1.064 . . . . 0.0 109.145 170.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.8 -49.03 66.45 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 125.041 1.336 . . . . 0.0 111.908 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -89.3 -6.28 56.87 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.012 0.525 . . . . 0.0 111.861 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.8 m 51.27 53.71 12.43 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.257 1.423 . . . . 0.0 111.229 176.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -156.98 172.17 19.16 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.811 0.444 . . . . 0.0 111.725 -174.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.97 112.38 1.01 Allowed Glycine 0 C--N 1.338 0.667 0 C-N-CA 126.215 1.864 . . . . 0.0 108.982 177.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.9 m -99.04 103.81 15.78 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 t -115.02 127.6 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 124.579 1.151 . . . . 0.0 109.831 -169.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -96.17 132.79 41.22 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 168.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -150.11 166.74 28.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.491 0.716 . . . . 0.0 110.887 -170.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -99.81 113.66 65.22 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.395 1.078 . . . . 0.0 109.062 172.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -43.02 -37.85 6.67 Favored 'Trans proline' 0 C--N 1.349 0.58 1 C-N-CA 125.377 4.051 . . . . 0.0 115.137 172.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.8 mt -63.89 -32.3 73.77 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.449 0.699 . . . . 0.0 111.997 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.72 -43.31 6.5 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.935 0.894 . . . . 0.0 111.076 -174.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.8 t -142.86 176.75 8.83 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.423 0.689 . . . . 0.0 110.315 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.0 p -150.26 162.0 29.06 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 124.271 1.028 . . . . 0.0 110.288 -172.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -53.25 -43.57 56.2 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.645 2.896 . . . . 0.0 112.899 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.17 -34.66 78.58 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.635 0.774 . . . . 0.0 112.183 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.5 m -71.51 -47.08 57.63 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.177 0.591 . . . . 0.0 109.816 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 59.8 mt -59.56 -47.72 84.45 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.903 0.881 . . . . 0.0 110.123 177.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 62.7 ttp85 -53.97 -50.04 67.42 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.31 1.044 . . . . 0.0 110.06 172.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.34 -44.84 65.83 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.641 1.115 . . . . 0.0 112.461 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.16 -42.47 98.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.479 0.639 . . . . 0.0 111.106 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.0 mt -66.5 -41.8 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 122.934 0.493 . . . . 0.0 110.526 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -59.49 -41.88 90.84 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.55 0.74 . . . . 0.0 110.563 174.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.22 -44.85 95.65 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.378 0.671 . . . . 0.0 111.098 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.0 mtm -60.87 -36.18 78.54 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.701 0.401 . . . . 0.0 111.215 174.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.68 59.12 0.31 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 123.803 0.716 . . . . 0.0 112.225 169.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -140.3 146.79 38.99 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.923 0.889 . . . . 0.0 108.638 172.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -76.01 90.99 3.04 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.59 132.68 44.77 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.278 1.031 . . . . 0.0 109.886 -177.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.1 m -140.32 152.76 46.09 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.077 1.351 . . . . 0.0 107.646 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.415 HD22 ' H ' ' A' ' 70' ' ' LEU . 2.2 mm? -68.35 145.7 53.93 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.9 p -59.1 -45.3 91.21 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.572 0.349 . . . . 0.0 110.334 169.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 116.933 -1.508 . . . . 0.0 109.2 176.188 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 50.1 tp . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 110.571 -0.159 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.1 p -124.3 103.23 8.1 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.915 1.286 . . . . 0.0 109.914 -172.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -117.32 164.49 14.75 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.376 1.071 . . . . 0.0 108.789 170.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -133.02 146.83 52.1 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.141 0.977 . . . . 0.0 109.717 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.1 t -138.85 142.3 38.62 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.28 1.032 . . . . 0.0 109.518 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.5 t -112.75 102.35 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 175.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.7 mt -99.99 112.98 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -66.05 123.69 20.55 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.1 mt -111.31 125.89 68.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -131.79 151.18 51.85 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.396 0.679 . . . . 0.0 109.861 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.47 36.23 6.62 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.803 1.192 . . . . 0.0 112.095 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -88.67 144.6 26.18 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 117.68 0.74 . . . . 0.0 109.015 174.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.0 p -84.69 -43.73 14.07 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.393 0.677 . . . . 0.0 109.807 177.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.7 p -163.69 -175.51 4.17 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.702 0.801 . . . . 0.0 109.956 -175.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -61.17 -27.64 68.55 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.121 1.369 . . . . 0.0 113.863 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.9 p -59.16 -33.53 71.03 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.638 0.654 . . . . 0.0 111.455 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 80.3 m -60.8 -56.07 25.57 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.154 0.582 . . . . 0.0 109.572 175.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.2 t -53.53 -47.19 60.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.788 1.235 . . . . 0.0 111.08 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -56.47 -52.91 62.94 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.83 0.852 . . . . 0.0 110.679 176.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.5 t -59.15 -51.17 71.18 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.881 0.872 . . . . 0.0 111.259 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.4 mt -52.65 -53.19 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.775 1.23 . . . . 0.0 109.551 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -54.74 -53.16 58.7 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.507 0.723 . . . . 0.0 110.698 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.14 -51.72 48.51 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.389 0.995 . . . . 0.0 112.266 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.0 t -58.94 -52.38 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.728 0.811 . . . . 0.0 110.436 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.24 -37.79 79.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 119.018 -0.515 . . . . 0.0 111.516 -176.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.6 m -52.21 -29.65 23.64 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 177.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -89.22 -8.34 53.73 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.482 0.713 . . . . 0.0 112.416 -175.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -73.84 138.28 76.61 Favored Pre-proline 0 CA--C 1.535 0.365 0 CA-C-N 119.082 0.855 . . . . 0.0 110.254 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -66.47 131.34 26.02 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.858 2.372 . . . . 0.0 109.394 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.24 -39.29 2.96 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-O 118.915 -0.936 . . . . 0.0 111.444 -175.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.6 t -66.43 135.63 28.14 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 117.955 0.878 . . . . 0.0 109.8 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -111.47 -99.62 0.41 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.024 1.329 . . . . 0.0 107.886 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.3 p -90.43 154.66 19.49 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.768 0.827 . . . . 0.0 109.628 172.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 tt -150.6 146.13 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 123.474 0.71 . . . . 0.0 110.447 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -140.1 107.91 5.67 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.837 1.255 . . . . 0.0 107.711 169.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.0 t -98.42 130.65 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 170.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.9 t -124.7 130.83 53.17 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.426 1.09 . . . . 0.0 110.169 -173.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.8 tp -72.56 -48.49 39.67 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.25 1.02 . . . . 0.0 108.936 172.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.85 -47.36 74.28 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.94 1.296 . . . . 0.0 111.626 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -89.3 -7.55 55.15 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.982 0.513 . . . . 0.0 111.525 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.6 m 53.45 54.01 10.76 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 125.234 1.413 . . . . 0.0 111.153 175.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -159.29 169.91 23.02 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.919 -175.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.35 107.2 1.0 Allowed Glycine 0 C--N 1.337 0.596 0 C-N-CA 126.613 2.054 . . . . 0.0 108.614 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.0 m -98.6 96.17 7.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.4 t -109.31 127.49 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 124.587 1.155 . . . . 0.0 108.924 -172.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -97.91 130.7 44.78 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 169.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -150.21 170.7 18.34 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.268 0.627 . . . . 0.0 112.171 -169.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -106.07 114.6 62.36 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.033 1.333 . . . . 0.0 109.477 173.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -44.3 -36.26 9.07 Favored 'Trans proline' 0 C--N 1.348 0.527 1 C-N-CA 125.528 4.152 . . . . 0.0 115.486 174.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.02 -32.36 74.05 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.259 0.624 . . . . 0.0 111.99 -176.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.3 mt -108.17 -29.62 8.83 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.005 0.922 . . . . 0.0 112.371 -171.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.5 t -148.11 175.25 11.18 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.719 0.69 . . . . 0.0 109.615 173.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.8 p -146.94 163.39 28.92 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 123.65 0.78 . . . . 0.0 110.33 -175.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -52.08 -41.99 61.54 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.475 2.783 . . . . 0.0 112.012 173.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -67.82 -39.62 83.89 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.724 0.81 . . . . 0.0 111.474 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.8 m -61.65 -50.36 72.82 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.83 0.452 . . . . 0.0 109.998 176.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 50.8 mt -60.2 -48.13 83.02 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.271 1.029 . . . . 0.0 110.63 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -54.09 -51.2 64.9 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.62 1.168 . . . . 0.0 110.279 175.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.52 -44.73 85.66 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.482 1.039 . . . . 0.0 111.803 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.3 -46.86 86.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.27 0.628 . . . . 0.0 111.354 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -61.34 -39.6 83.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 123.069 0.548 . . . . 0.0 110.093 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.73 -40.68 95.74 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.98 0.512 . . . . 0.0 110.901 177.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -64.01 -43.17 96.44 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.053 0.941 . . . . 0.0 110.982 176.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 79.5 mmm -56.09 -41.39 75.1 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.546 0.738 . . . . 0.0 110.2 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.15 53.5 0.23 Allowed Glycine 0 C--N 1.341 0.859 0 C-N-CA 123.994 0.806 . . . . 0.0 112.02 169.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -140.45 145.61 37.19 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.634 0.774 . . . . 0.0 109.347 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -68.76 100.84 1.22 Allowed 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.39 120.63 40.83 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.194 1.398 . . . . 0.0 109.938 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.2 p -142.32 137.23 30.42 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.653 0.781 . . . . 0.0 109.915 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.5 mt -73.82 137.97 44.16 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.213 0.605 . . . . 0.0 110.988 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.5 m -77.61 -43.73 30.61 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 168.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 C--O 1.251 1.173 0 C-N-CA 125.765 1.626 . . . . 0.0 110.315 -179.219 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_